data_4a4e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4a4e _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.4 m95 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -128.51 154.76 45.79 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.19 127.07 24.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.84 8.99 47.19 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.527 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.5 148.86 22.8 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -91.52 151.26 20.83 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -158.16 -169.58 2.84 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 121.479 0.657 . . . . 0.0 110.005 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.5 m -127.07 144.07 51.12 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 173.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.18 160.12 39.36 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.0 mm -93.82 109.59 22.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -68.62 123.71 21.62 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.9 m -63.19 -20.03 65.04 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.86 -39.48 19.84 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.517 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -108.03 -15.42 14.52 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.642 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.33 1.35 69.57 Favored Glycine 0 C--N 1.313 -0.717 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 77.4 m -90.55 164.19 14.32 Favored 'General case' 0 N--CA 1.405 -2.685 0 C-N-CA 124.303 1.041 . . . . 0.0 112.327 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -89.5 129.26 40.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.349 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -137.56 152.58 73.16 Favored Pre-proline 0 C--N 1.286 -2.187 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.795 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.97 133.33 23.11 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.624 2.216 . . . . 0.0 111.555 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.75 153.81 41.35 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.27 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 m -118.23 135.88 53.99 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.3 mt -68.82 120.49 16.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 120.958 0.409 . . . . 0.0 110.587 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.71 -38.44 9.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.968 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -159.3 152.21 21.94 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.4 mt -128.87 136.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 122.65 0.38 . . . . 0.0 110.343 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -109.27 99.52 8.78 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -71.27 -18.54 62.42 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.078 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -73.46 -40.58 64.05 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.21 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -90.83 -7.3 52.68 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 61.86 32.8 17.92 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.79 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.5 p -122.74 164.05 19.03 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.168 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.669 ' SG ' HD12 ' A' ' 141' ' ' LEU . 16.8 p -148.44 155.86 41.75 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.75 0.31 . . . . 0.0 110.396 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.77 130.19 46.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 31.6 m -123.3 147.24 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 75.2 t -104.7 122.55 57.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.17 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -70.27 114.97 8.93 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.64 0.588 . . . . 0.0 110.192 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 45.7 m -67.76 131.83 46.3 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.069 -176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.1 -15.37 63.04 Favored Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.852 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -116.75 -47.88 2.69 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.732 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.34 14.38 38.7 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.938 -1.125 . . . . 0.0 114.086 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -94.63 162.63 13.71 Favored 'General case' 0 CA--C 1.479 -1.776 0 C-N-CA 119.606 -0.838 . . . . 0.0 108.986 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.2 ppt_? -133.78 136.38 44.5 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -141.98 151.76 42.81 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.62 -174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.76 120.52 40.5 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -125.75 163.49 22.74 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.254 -174.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -85.88 143.31 28.3 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.8 mt -58.57 -39.79 81.28 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.623 0.577 . . . . 0.0 110.683 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.6 t -80.91 -5.52 57.52 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.426 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -106.96 -8.53 16.58 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.514 0.673 . . . . 0.0 109.706 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.669 HD12 ' SG ' ' A' ' 123' ' ' CYS . 67.1 mt -66.59 162.61 20.57 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.856 176.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 41.3 mt -128.49 159.94 33.88 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 30.3 m . . . . . 0 C--N 1.296 -1.731 0 O-C-N 123.658 0.599 . . . . 0.0 111.595 -175.905 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.421 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 86.8 m95 . . . . . 0 N--CA 1.438 -1.055 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 8.9 ptpp? -128.95 153.45 47.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.16 127.43 24.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.75 8.71 56.95 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.761 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 2.5 t0 -99.96 146.8 26.28 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -83.67 154.95 23.4 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 121.294 0.569 . . . . 0.0 111.418 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -160.0 -174.47 4.58 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.4 m -125.03 140.97 52.43 Favored 'General case' 0 C--N 1.258 -3.386 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 174.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.76 159.97 38.99 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.152 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.98 111.58 25.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -68.76 121.96 17.59 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.6 m -63.49 -19.74 65.01 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 123.952 0.782 . . . . 0.0 112.821 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -84.57 -42.13 15.76 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.174 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -106.74 -15.47 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.674 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.14 -5.24 77.6 Favored Glycine 0 N--CA 1.462 0.431 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.425 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 68.0 m -90.65 166.99 12.86 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 123.75 0.82 . . . . 0.0 113.176 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.3 mt -86.88 133.2 30.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.984 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -140.67 152.46 66.07 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.477 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.24 127.8 14.71 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.237 1.958 . . . . 0.0 110.965 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.01 150.36 39.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 120.904 0.383 . . . . 0.0 110.192 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 m -114.99 135.84 53.79 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 53.0 mt -68.32 118.93 13.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.891 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.68 -36.69 12.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.911 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m -159.19 150.04 19.8 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.0 mt -126.94 132.78 69.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 122.971 0.508 . . . . 0.0 110.514 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -108.94 110.38 21.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -75.37 -21.34 58.4 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.992 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -73.51 -36.57 65.77 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.241 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -94.97 -8.86 35.73 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.359 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 57.63 35.65 25.9 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.924 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.1 p -121.93 163.01 20.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.905 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.588 ' SG ' HD12 ' A' ' 141' ' ' LEU . 11.2 p -148.34 153.45 38.64 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 120.816 0.341 . . . . 0.0 110.282 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.6 t -96.34 132.44 40.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.9 m -123.49 147.13 27.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.0 t -106.3 120.94 58.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -70.58 115.74 10.09 Favored 'General case' 0 C--O 1.259 1.577 0 CA-C-O 121.386 0.612 . . . . 0.0 109.978 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.0 m -69.04 129.58 40.31 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.313 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.81 -17.48 58.57 Favored Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.026 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.93 -52.72 2.73 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.207 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.11 22.17 8.96 Favored Glycine 0 N--CA 1.435 -1.383 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.734 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -105.62 161.91 13.97 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.7 ppt_? -135.08 136.08 41.74 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -143.18 151.32 40.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -101.96 119.74 39.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.634 0.73 . . . . 0.0 109.27 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -126.24 163.5 23.06 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.042 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -85.36 143.93 28.34 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 60.5 mt -59.06 -37.01 76.04 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.794 0.807 . . . . 0.0 109.495 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.3 m -73.75 -19.76 60.69 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.117 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -102.57 -8.93 20.59 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.29 0.567 . . . . 0.0 110.332 -173.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.588 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.4 mt -63.45 160.72 15.71 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.939 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.9 mt -125.3 159.93 30.51 Favored 'General case' 0 C--N 1.254 -3.586 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.2 m . . . . . 0 C--N 1.29 -1.997 0 O-C-N 123.577 0.548 . . . . 0.0 110.264 -178.575 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 79.8 m95 . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -129.76 157.73 41.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.23 128.71 25.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.508 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.56 -1.77 36.76 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.204 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB2' HD13 ' A' ' 113' ' ' ILE . 24.6 m-20 -96.79 135.32 38.9 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 122.68 -0.306 . . . . 0.0 111.08 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 14.6 mtmt -77.47 147.76 35.73 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-O 121.335 0.588 . . . . 0.0 110.901 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.9 p -154.53 -166.5 2.35 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 114.579 -1.192 . . . . 0.0 107.96 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 73.2 m -129.03 141.37 51.26 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.61 160.36 38.73 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.2 mm -93.92 112.58 27.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -68.33 120.72 14.91 Favored 'General case' 0 CA--C 1.473 -1.981 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.434 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 72.6 m -61.65 -20.46 63.44 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.947 0.779 . . . . 0.0 112.631 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -84.73 -39.8 18.06 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.565 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -109.02 -15.95 14.24 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.042 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.13 -3.95 78.45 Favored Glycine 0 N--CA 1.464 0.524 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.328 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 70.7 m -90.62 168.15 12.01 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.8 mt -90.31 133.64 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.666 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -142.36 152.01 59.54 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.43 135.19 26.06 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.505 2.137 . . . . 0.0 111.381 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.95 150.69 34.51 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.941 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 20.7 m -111.27 135.83 51.25 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 44.5 mt -67.94 117.12 9.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 123.34 0.4 . . . . 0.0 110.49 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.08 -38.6 11.53 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.205 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 p -159.19 146.87 17.49 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 62.5 mt -124.36 135.32 64.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -109.35 106.23 15.95 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -75.73 -13.72 60.31 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -73.26 -41.88 63.14 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -96.39 -7.52 34.84 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.702 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 57.36 33.67 23.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.336 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 79.8 p -118.38 161.98 19.06 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.065 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 141' ' ' LEU . 15.1 p -147.81 152.91 38.48 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.359 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 88.7 t -95.82 131.66 42.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.1 m -123.21 146.92 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 77.7 t -106.26 120.01 56.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -66.41 111.99 3.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.782 0.676 . . . . 0.0 110.386 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.4 m -65.62 129.95 41.56 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.727 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.32 -21.22 41.68 Favored Glycine 0 N--CA 1.425 -2.087 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.786 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -106.95 -50.46 3.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.101 -177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.72 3.56 37.02 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.149 -1.024 . . . . 0.0 114.223 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 95.1 m-20 -87.73 163.16 16.65 Favored 'General case' 0 CA--C 1.479 -1.772 0 CA-C-N 117.804 0.802 . . . . 0.0 109.916 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.8 ppt_? -134.25 136.53 43.67 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.079 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.434 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 8.8 tt0 -144.92 151.24 38.36 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.971 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 39.9 tt0 -102.7 124.7 48.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -127.57 163.92 23.12 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -175.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -87.37 142.88 27.55 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.22 -39.76 76.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.431 0.634 . . . . 0.0 110.561 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 m -79.63 -4.63 52.51 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.883 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -108.96 -7.75 15.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.52 0.676 . . . . 0.0 109.306 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.543 HD12 ' SG ' ' A' ' 123' ' ' CYS . 67.7 mt -69.58 163.83 24.63 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.652 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 21.1 mt -130.65 162.85 28.48 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.31 -1.137 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.136 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.41 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 77.7 m95 . . . . . 0 CA--C 1.502 -0.887 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -130.92 154.96 47.56 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.17 127.43 22.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-O 121.032 0.444 . . . . 0.0 110.754 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.1 5.77 46.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.505 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -103.75 149.08 25.33 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 120.705 0.288 . . . . 0.0 110.23 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -88.5 150.91 22.86 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.808 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -155.82 -168.02 2.66 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.953 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.9 m -129.35 144.95 51.44 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.39 160.22 39.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.902 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.2 mm -93.89 110.04 22.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.73 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -66.31 121.79 16.05 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 t -61.18 -22.35 64.65 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 123.885 0.74 . . . . 0.0 110.589 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -80.58 -42.19 22.71 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.719 -173.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -106.37 -14.9 14.96 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.274 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.69 0.53 68.54 Favored Glycine 0 N--CA 1.462 0.429 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.97 164.15 14.09 Favored 'General case' 0 N--CA 1.403 -2.788 0 C-N-CA 124.852 1.261 . . . . 0.0 112.325 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.3 mt -88.02 133.51 30.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.61 0.764 . . . . 0.0 110.144 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -144.07 152.48 54.86 Favored Pre-proline 0 C--N 1.304 -1.397 0 C-N-CA 123.158 0.583 . . . . 0.0 109.868 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.07 133.68 23.68 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.695 2.263 . . . . 0.0 111.873 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.71 153.36 40.9 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.967 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.2 m -117.55 135.79 53.71 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 48.5 mt -66.25 118.1 8.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 123.104 0.562 . . . . 0.0 111.322 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.21 -38.43 10.57 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.97 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 m -158.26 151.85 23.45 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.5 mt -127.26 134.18 66.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -108.59 102.88 11.91 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -71.06 -18.45 62.56 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.27 -174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -72.82 -39.9 66.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -93.8 -7.51 43.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 61.81 27.49 16.79 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.793 0.837 . . . . 0.0 110.062 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.8 p -119.64 165.7 14.13 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.342 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' A' ' 141' ' ' LEU . 12.0 p -148.08 152.49 37.45 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.9 t -96.73 131.19 44.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.1 m -123.57 147.11 28.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 133' ' ' ARG . 55.3 t -106.75 122.89 61.31 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -70.95 114.49 9.06 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.545 0.688 . . . . 0.0 110.13 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.5 m -63.96 129.47 40.19 Favored 'General case' 0 N--CA 1.407 -2.607 0 CA-C-N 113.712 -1.586 . . . . 0.0 111.287 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.83 -13.97 57.64 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.316 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -109.66 -44.79 3.78 Favored 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 122.547 -0.384 . . . . 0.0 110.231 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.18 10.07 56.37 Favored Glycine 0 N--CA 1.436 -1.357 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.923 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -91.94 163.86 13.86 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 117.586 0.693 . . . . 0.0 109.487 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -135.27 139.11 44.15 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -145.82 151.21 37.56 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -101.39 121.85 42.67 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -128.65 163.21 25.56 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.957 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 19.9 m-80 -86.17 144.56 27.42 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.1 mt -57.93 -40.94 81.68 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.848 0.717 . . . . 0.0 110.652 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 m -81.38 -7.23 59.54 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.302 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 19.2 t70 -101.98 -5.03 25.13 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.558 HD12 ' SG ' ' A' ' 123' ' ' CYS . 68.8 mt -69.62 171.63 8.67 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.276 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 27.2 mt -138.34 162.89 33.22 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.0 m . . . . . 0 C--N 1.308 -1.237 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.519 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.9 m95 . . . . . 0 N--CA 1.435 -1.205 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -116.79 152.15 35.0 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.646 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.17 128.54 26.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.94 23.29 25.72 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.657 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -115.74 149.72 38.02 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -84.23 148.78 26.53 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 123.026 0.53 . . . . 0.0 110.102 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 p -157.92 -167.89 2.36 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.7 m -131.18 142.08 50.15 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.47 160.16 38.25 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.907 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.0 mm -95.07 108.18 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -67.88 123.78 21.53 Favored 'General case' 0 CA--C 1.469 -2.147 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.289 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -62.04 -22.09 65.45 Favored 'General case' 0 C--N 1.282 -2.326 0 O-C-N 123.95 0.781 . . . . 0.0 112.674 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -83.58 -36.91 23.58 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -108.46 -16.46 14.22 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.155 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.2 0.45 70.96 Favored Glycine 0 C--N 1.304 -1.236 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.707 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 99.4 m -90.84 167.38 12.5 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 124.491 1.117 . . . . 0.0 111.887 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.39 133.1 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.48 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.3 m-85 -139.48 152.05 68.07 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.088 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.62 133.32 23.74 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.313 2.009 . . . . 0.0 111.189 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.02 156.64 44.05 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.818 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.0 m -119.99 135.52 54.89 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mt -70.31 123.88 25.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 122.747 0.419 . . . . 0.0 110.679 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.95 -36.07 10.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.164 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 64.1 m -161.38 149.97 15.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.41 129.73 73.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -105.67 101.85 11.34 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -73.16 -12.67 60.97 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.234 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.56 -40.68 63.75 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.255 0.55 . . . . 0.0 109.605 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -99.32 -7.02 26.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.1 30.27 17.78 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.868 0.867 . . . . 0.0 110.306 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 52.7 p -119.99 165.53 14.56 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.245 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 141' ' ' LEU . 15.6 p -148.09 152.74 37.87 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.1 t -96.15 131.01 44.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.6 m -122.98 146.83 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.5 t -105.78 120.39 56.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.91 114.7 7.45 Favored 'General case' 0 C--O 1.257 1.462 0 O-C-N 123.923 0.764 . . . . 0.0 110.107 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 87.8 m -67.52 128.98 38.47 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.655 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.23 -22.82 30.27 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.696 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -100.82 -52.37 3.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 122.324 -0.515 . . . . 0.0 109.877 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.39 11.25 29.68 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.85 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -93.87 162.54 13.87 Favored 'General case' 0 CA--C 1.466 -2.265 0 C-N-CA 119.434 -0.907 . . . . 0.0 109.739 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.3 ppt_? -133.54 136.25 44.87 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -142.08 150.93 41.85 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -102.55 116.45 32.63 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.759 0.79 . . . . 0.0 109.271 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -121.03 163.78 17.78 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.617 -173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -85.88 139.87 30.88 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.0 mt -55.22 -40.82 71.29 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.375 0.67 . . . . 0.0 111.354 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.2 t -80.67 -6.2 58.05 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.797 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -104.76 -7.86 19.2 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.743 0.782 . . . . 0.0 109.052 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.591 HD12 ' SG ' ' A' ' 123' ' ' CYS . 66.1 mt -67.16 163.98 19.07 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.638 176.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 26.8 mt -132.39 163.66 28.21 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 p . . . . . 0 C--N 1.31 -1.113 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.379 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 75.0 m95 . . . . . 0 N--CA 1.431 -1.384 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.61 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 8.4 ptpp? -126.0 153.78 43.87 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.51 129.14 26.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.96 3.07 42.44 Favored Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.063 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.61 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 12.1 m-20 -98.01 136.32 38.44 Favored 'General case' 0 CA--C 1.486 -1.518 0 O-C-N 122.602 -0.352 . . . . 0.0 110.488 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.9 mtmt -81.19 143.7 32.15 Favored 'General case' 0 N--CA 1.401 -2.905 0 CA-C-O 121.291 0.567 . . . . 0.0 109.63 171.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.31 -167.51 2.73 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.9 m -128.6 145.11 51.23 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.33 160.26 39.58 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.682 0.614 . . . . 0.0 109.817 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mm -93.29 109.62 22.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.491 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -68.1 125.68 27.11 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.835 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.8 m -64.5 -20.82 66.44 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -83.95 -41.16 17.63 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -105.33 -15.96 14.89 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.392 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.25 0.86 79.1 Favored Glycine 0 C--N 1.311 -0.839 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.014 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 74.9 m -90.27 168.85 11.6 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 124.117 0.967 . . . . 0.0 111.75 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.1 mt -89.07 135.41 25.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.451 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.1 m-85 -142.99 152.12 57.76 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.46 136.13 27.94 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.663 2.242 . . . . 0.0 111.413 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.96 154.17 39.01 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.0 m -114.68 135.49 54.1 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 96' ' ' ASP . 49.7 mt -67.39 115.51 5.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 122.949 0.499 . . . . 0.0 110.705 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.44 -35.41 13.0 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.193 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -157.96 148.38 20.56 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.5 mt -123.25 133.01 70.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -108.31 97.56 7.23 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -71.74 -14.73 62.09 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.977 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -73.24 -41.34 63.83 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.018 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -94.89 -6.88 41.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.216 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 62.56 29.52 17.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.4 1.08 . . . . 0.0 110.096 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 46.7 p -117.94 166.75 12.14 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.618 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.603 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.6 p -148.45 152.12 36.38 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.0 t -95.86 131.09 43.53 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.6 m -122.71 146.73 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.4 t -105.28 119.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -68.14 111.1 4.3 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-O 121.574 0.702 . . . . 0.0 110.858 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 96.2 m -70.58 129.79 40.12 Favored 'General case' 0 N--CA 1.397 -3.101 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.576 -175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.11 -13.81 63.04 Favored Glycine 0 N--CA 1.418 -2.502 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.296 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.7 -54.01 2.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.95 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 107.27 17.42 11.51 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.957 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -101.64 168.61 9.36 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.269 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.1 ppt_? -137.73 140.11 40.52 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -146.14 151.59 37.91 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 123.696 0.798 . . . . 0.0 109.43 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -101.67 123.35 45.52 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.497 0.665 . . . . 0.0 109.507 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -129.31 163.39 25.8 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.022 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 22.6 m-80 -85.8 146.03 26.95 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.22 -35.15 74.79 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.751 0.786 . . . . 0.0 109.587 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.3 p -74.52 -17.87 60.69 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.667 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -105.47 -4.81 20.9 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.715 0.769 . . . . 0.0 110.471 -173.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.603 HD12 ' SG ' ' A' ' 123' ' ' CYS . 52.9 mt -68.11 160.73 28.38 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.886 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.6 mt -132.14 164.47 26.23 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 C--N 1.304 -1.377 0 C-N-CA 122.93 0.492 . . . . 0.0 110.151 178.164 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 78.8 m95 . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -130.07 152.72 49.22 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.52 131.46 29.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 123.481 0.488 . . . . 0.0 110.102 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.23 4.6 50.34 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.25 145.03 30.81 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -80.69 154.36 27.36 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-O 121.574 0.702 . . . . 0.0 111.138 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.3 p -159.67 -171.56 3.33 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.7 m -129.13 143.72 50.96 Favored 'General case' 0 C--N 1.261 -3.245 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.45 158.66 43.81 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.104 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -93.14 110.86 23.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.519 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.424 ' CD2' ' HB2' ' A' ' 104' ' ' GLU . 6.2 t90 -68.63 125.42 26.47 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.453 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 68.5 m -60.9 -22.96 64.84 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.027 0.829 . . . . 0.0 112.829 -177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.424 ' HB2' ' CD2' ' A' ' 102' ' ' TRP . 4.9 mm-40 -83.62 -42.0 17.2 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.739 -174.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -105.91 -16.23 14.7 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.058 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.67 1.02 75.98 Favored Glycine 0 C--N 1.312 -0.762 0 N-CA-C 111.419 -0.673 . . . . 0.0 111.419 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 78.7 m -89.92 165.86 13.84 Favored 'General case' 0 N--CA 1.414 -2.262 0 C-N-CA 124.028 0.931 . . . . 0.0 111.693 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -90.28 129.24 41.46 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.819 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 95.7 m-85 -134.63 152.22 77.31 Favored Pre-proline 0 C--N 1.285 -2.232 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.865 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.13 130.23 17.35 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.277 1.985 . . . . 0.0 110.837 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.12 150.73 39.86 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.942 0.401 . . . . 0.0 110.066 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.1 m -115.99 135.85 53.58 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 50.9 mt -64.7 123.79 18.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 123.602 0.564 . . . . 0.0 110.781 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.31 -38.2 8.16 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.147 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.1 p -159.43 148.58 18.2 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.7 mt -124.41 130.51 73.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.718 0.294 . . . . 0.0 110.526 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -109.37 103.36 12.27 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.03 -16.9 60.58 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.869 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -73.26 -39.08 65.71 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.061 0.457 . . . . 0.0 110.181 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -95.18 -7.63 38.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.606 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 62.56 26.81 15.91 Favored 'General case' 0 C--O 1.248 1.016 0 C-N-CA 124.8 1.24 . . . . 0.0 110.504 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 82.5 p -118.83 165.16 14.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.425 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.1 p -148.06 151.39 35.61 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.3 t -96.19 132.56 40.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 29.2 m -123.54 147.57 27.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 56.9 t -106.5 122.06 59.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.849 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -70.78 114.08 8.5 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 123.747 0.654 . . . . 0.0 110.71 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.7 m -65.54 130.33 42.93 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.908 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.16 -13.4 66.4 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.151 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.59 -48.93 2.67 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.901 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 101.28 7.11 50.1 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.426 -0.892 . . . . 0.0 114.193 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 89.2 m-20 -88.32 162.91 16.32 Favored 'General case' 0 CA--C 1.474 -1.946 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.214 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.6 ppt_? -132.38 136.45 46.82 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.453 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 11.0 tt0 -144.06 151.1 39.19 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.05 126.38 48.98 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -130.7 163.25 27.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -84.33 144.92 28.54 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.0 mt -57.48 -42.74 83.26 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.557 0.694 . . . . 0.0 110.612 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 p -78.36 -7.83 57.75 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.217 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -101.83 -13.76 17.56 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.58 HD12 ' SG ' ' A' ' 123' ' ' CYS . 65.4 mt -61.2 160.39 10.46 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.231 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 27.8 mt -126.41 162.44 25.56 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.298 -1.65 0 O-C-N 123.596 0.56 . . . . 0.0 109.93 -179.749 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.5 m95 . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -125.83 153.41 44.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.42 128.26 26.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.34 10.98 40.22 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.921 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.63 150.06 27.34 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -91.76 150.06 21.29 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 120.956 0.408 . . . . 0.0 109.957 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -155.95 -168.38 2.75 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.7 m -128.36 141.16 51.51 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.62 160.42 36.7 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.7 mm -97.04 109.49 23.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -65.7 121.75 15.71 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -60.95 -19.55 61.04 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 124.104 0.878 . . . . 0.0 112.647 -175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.88 -43.12 14.4 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.016 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.53 -15.9 14.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.233 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.7 0.09 79.04 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-O 121.564 0.536 . . . . 0.0 112.058 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.428 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 79.4 m -89.63 162.49 15.59 Favored 'General case' 0 N--CA 1.407 -2.621 0 C-N-CA 123.772 0.829 . . . . 0.0 111.768 -177.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.4 mt -88.04 130.67 37.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.617 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -136.43 152.21 74.47 Favored Pre-proline 0 C--N 1.289 -2.054 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.789 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.02 130.21 17.44 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.279 1.986 . . . . 0.0 110.827 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.66 147.42 31.98 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 120.974 0.416 . . . . 0.0 110.324 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.4 m -113.68 135.89 53.43 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.4 mt -68.26 119.99 14.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 122.734 0.414 . . . . 0.0 110.601 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.89 -30.97 12.44 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.737 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.2 p -161.23 154.76 21.79 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.5 mt -128.33 132.8 67.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.19 102.9 12.0 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -72.13 -16.69 62.0 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.447 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -73.48 -40.26 64.26 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.467 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -97.12 -6.93 33.83 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.8 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 63.13 30.87 16.04 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-O 122.027 0.917 . . . . 0.0 109.949 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.1 p -120.67 166.72 13.3 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.922 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.641 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.6 p -148.7 152.19 36.22 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 87.4 t -95.84 130.61 44.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 22.5 m -123.29 147.31 27.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.0 121.26 58.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -71.2 114.69 9.52 Favored 'General case' 0 C--O 1.257 1.478 0 CA-C-O 121.611 0.72 . . . . 0.0 110.312 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.7 m -66.23 130.63 43.87 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.736 -1.575 . . . . 0.0 110.877 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.86 -21.26 42.58 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.201 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -108.14 -52.68 2.73 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.893 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.88 20.37 10.75 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.796 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -101.37 161.23 13.78 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.55 173.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.3 ppt_? -132.21 135.94 46.66 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -145.18 149.88 35.75 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 37.8 tt0 -102.92 124.29 48.16 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -127.79 163.4 24.43 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.331 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -83.11 142.09 31.5 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.6 mt -55.6 -41.61 73.67 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.921 0.763 . . . . 0.0 111.443 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 m -76.4 -15.66 59.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.895 0.378 . . . . 0.0 111.312 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -95.63 -9.55 31.81 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.802 0.81 . . . . 0.0 109.428 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.641 HD12 ' SG ' ' A' ' 123' ' ' CYS . 62.3 mt -65.35 163.58 15.3 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.284 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.1 mt -131.15 162.41 29.97 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.3 p . . . . . 0 C--N 1.308 -1.225 0 O-C-N 123.281 0.363 . . . . 0.0 110.141 -178.404 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.0 m95 . . . . . 0 N--CA 1.443 -0.818 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -125.78 155.61 40.77 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.66 128.22 25.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.989 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.75 -1.61 48.74 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.966 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.2 146.13 24.22 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -86.59 149.86 24.63 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.092 0.473 . . . . 0.0 111.039 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.9 p -156.7 -168.03 2.56 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.635 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.5 m -129.7 149.21 51.55 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.21 160.38 39.59 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 123.574 0.546 . . . . 0.0 109.684 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -94.07 110.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -68.44 124.28 23.1 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.8 m -64.34 -18.03 64.25 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 123.93 0.769 . . . . 0.0 112.662 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.86 -41.79 17.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -104.96 -15.16 15.2 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.626 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.67 2.0 68.23 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 109' ' ' TYR . 98.7 m -90.71 165.03 13.91 Favored 'General case' 0 N--CA 1.406 -2.633 0 C-N-CA 124.494 1.117 . . . . 0.0 112.286 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 mt -90.83 131.33 38.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.556 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 107' ' ' CYS . 98.3 m-85 -141.41 152.31 63.46 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.74 134.98 31.67 Favored 'Trans proline' 0 C--O 1.24 0.624 0 C-N-CA 122.68 2.253 . . . . 0.0 112.143 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.23 157.24 43.53 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.945 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 m -121.46 135.46 55.04 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.3 mt -66.88 118.6 10.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 C-N-CA 123.5 0.72 . . . . 0.0 111.287 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.51 -38.04 11.09 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.627 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 p -157.92 152.21 24.54 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 64.6 mt -126.13 129.58 72.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -108.98 99.67 8.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.21 -20.72 65.74 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.171 -175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -40.3 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 110.461 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -90.51 -7.87 51.84 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.072 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 65.17 26.83 12.38 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.853 1.261 . . . . 0.0 108.994 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.7 p -120.66 169.35 10.46 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.461 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.675 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.7 p -148.6 151.32 34.83 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 123.034 0.533 . . . . 0.0 109.618 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.7 t -96.19 132.33 40.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.64 148.37 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.44 121.06 58.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -67.44 115.09 6.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.787 0.68 . . . . 0.0 110.371 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.5 m -67.56 129.84 41.17 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.85 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.23 -16.29 56.2 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.142 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -109.89 -43.51 3.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.156 0.503 . . . . 0.0 110.536 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.06 59.58 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.006 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -87.95 162.96 16.59 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.179 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -133.68 136.21 44.57 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -144.66 151.4 38.91 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 44.4 tt0 -102.23 122.19 43.7 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 121.539 0.685 . . . . 0.0 109.75 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -126.22 163.52 22.98 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.89 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -85.73 145.48 27.25 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.2 mt -58.81 -39.65 81.81 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.641 0.588 . . . . 0.0 111.225 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.3 p -81.05 -10.14 59.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.16 0.505 . . . . 0.0 111.598 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.96 -13.82 22.11 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.675 HD12 ' SG ' ' A' ' 123' ' ' CYS . 56.3 mt -63.99 160.25 18.26 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.549 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 24.0 mt -130.68 165.12 23.54 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 C--N 1.304 -1.397 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.318 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.4 m95 . . . . . 0 N--CA 1.437 -1.078 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -126.52 150.05 49.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.01 128.22 25.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.981 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.14 12.59 42.03 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.916 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.92 148.22 31.0 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -85.04 154.81 21.85 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.614 0.721 . . . . 0.0 111.649 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -161.25 -170.71 2.75 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.778 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.6 m -126.97 140.86 52.01 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.23 159.97 38.64 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.956 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.0 mm -93.1 113.62 28.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.229 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -69.17 119.77 13.97 Favored 'General case' 0 CA--C 1.467 -2.213 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.2 m -64.0 -17.68 63.55 Favored 'General case' 0 C--N 1.278 -2.503 0 O-C-N 123.983 0.802 . . . . 0.0 112.706 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.87 -42.61 16.19 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.274 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -105.71 -15.96 14.82 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.704 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.45 71.52 Favored Glycine 0 N--CA 1.461 0.326 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.132 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.5 m -90.75 166.5 13.09 Favored 'General case' 0 N--CA 1.406 -2.627 0 C-N-CA 124.052 0.941 . . . . 0.0 113.223 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.6 mt -89.39 134.51 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.61 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -141.46 152.26 63.16 Favored Pre-proline 0 C--N 1.304 -1.381 0 C-N-CA 123.032 0.533 . . . . 0.0 110.273 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 128.97 16.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.335 2.023 . . . . 0.0 111.023 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.1 150.34 37.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.12 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.5 m -113.87 136.25 53.09 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.22 121.06 15.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.231 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.18 -31.64 12.35 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.682 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.4 p -164.42 153.05 12.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -127.12 129.55 71.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.74 0.416 . . . . 0.0 110.309 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.83 99.41 8.76 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -67.99 -19.75 64.97 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -73.25 -39.89 65.08 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.285 0.565 . . . . 0.0 109.893 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -89.97 -8.65 51.2 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.573 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 61.34 25.32 15.3 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.072 0.949 . . . . 0.0 110.492 -173.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 73.9 p -117.63 162.28 18.28 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.452 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.576 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.6 p -145.12 150.69 37.23 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 84.3 t -95.68 131.95 41.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 29.1 m -123.12 147.83 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 75.9 t -105.22 122.05 58.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -69.63 114.89 8.27 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.403 0.62 . . . . 0.0 110.077 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.9 m -66.36 129.96 41.6 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.717 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.53 -16.58 55.96 Favored Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.835 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -109.4 -46.65 3.51 Favored 'General case' 0 N--CA 1.434 -1.242 0 O-C-N 122.196 -0.591 . . . . 0.0 111.017 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.58 11.83 49.72 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.914 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -94.0 160.91 14.51 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.105 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.6 ppt_? -133.44 135.29 44.48 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -147.44 151.86 37.13 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -173.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 36.7 tt0 -102.02 126.8 49.04 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-O 121.981 0.896 . . . . 0.0 110.874 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -124.03 164.06 20.15 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.442 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.8 m-80 -86.93 144.38 26.98 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.5 mt -56.4 -44.1 79.94 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.725 0.64 . . . . 0.0 110.94 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.1 m -77.09 -9.82 58.98 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.262 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.03 -9.5 20.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.235 0.541 . . . . 0.0 109.813 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.576 HD12 ' SG ' ' A' ' 123' ' ' CYS . 63.9 mt -64.1 159.07 21.16 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.254 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 40.2 mt -126.76 162.29 26.16 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--N 1.302 -1.47 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.573 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.3 m95 . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -122.15 152.71 39.64 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.16 128.39 26.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.156 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.65 9.76 48.98 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.906 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.22 148.01 25.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -86.53 153.52 21.77 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.343 0.592 . . . . 0.0 110.841 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.8 p -162.77 -168.6 1.83 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.73 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 67.6 m -129.08 141.27 51.26 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.08 159.79 39.06 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -93.82 110.48 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -67.65 120.67 14.42 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.403 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 67.5 m -61.13 -21.51 63.8 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 123.814 0.696 . . . . 0.0 112.757 -177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -83.95 -37.35 22.4 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.381 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -111.17 -15.68 13.61 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.064 -177.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.59 -5.74 72.64 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.111 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.5 m -90.39 166.47 13.26 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 124.122 0.969 . . . . 0.0 113.593 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.2 mt -87.94 133.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.817 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -142.88 152.66 59.5 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.9 131.57 21.31 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.393 2.062 . . . . 0.0 111.522 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.38 154.51 41.71 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.9 m -118.75 135.92 54.24 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.1 mt -69.23 118.03 12.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.052 0.541 . . . . 0.0 110.687 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.87 -35.15 13.51 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.218 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.0 m -160.28 153.7 22.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.7 mt -127.2 134.2 66.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 123.479 0.487 . . . . 0.0 109.952 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -109.37 103.81 12.8 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -73.16 -18.53 61.26 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 120.971 0.415 . . . . 0.0 111.599 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.21 -37.39 66.45 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.017 0.437 . . . . 0.0 110.612 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -96.8 -7.71 32.98 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.801 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 61.81 26.49 16.08 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.027 0.918 . . . . 0.0 110.404 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.0 p -118.36 161.83 19.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.358 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.548 ' SG ' HD12 ' A' ' 141' ' ' LEU . 10.9 p -147.78 152.14 37.2 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.4 t -96.24 131.84 42.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.3 147.25 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.57 122.17 60.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -69.75 113.8 7.34 Favored 'General case' 0 CA--C 1.491 -1.293 0 O-C-N 123.68 0.612 . . . . 0.0 110.279 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.3 m -65.09 129.12 38.55 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.706 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.88 -20.21 40.76 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.694 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -105.3 -43.53 4.97 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.163 0.506 . . . . 0.0 110.416 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.28 59.94 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.095 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -91.93 163.99 13.81 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -133.52 135.94 44.72 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.403 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 11.1 tt0 -143.4 150.39 39.02 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.37 120.9 41.28 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -126.63 163.74 22.8 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.115 -174.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 17.7 m-80 -85.6 142.96 28.73 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.01 -38.8 73.61 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.751 0.786 . . . . 0.0 110.272 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.5 p -78.88 -7.59 58.08 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.993 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 16.0 t70 -109.8 -4.66 15.91 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.801 0.81 . . . . 0.0 109.323 -175.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.548 HD12 ' SG ' ' A' ' 123' ' ' CYS . 65.8 mt -69.46 162.52 27.26 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.497 175.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 28.0 mt -130.66 162.33 29.64 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.304 -1.38 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.72 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 78.2 m95 . . . . . 0 CA--C 1.509 -0.602 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -130.92 155.45 46.75 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.303 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.62 127.05 23.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 O-C-N 123.561 0.538 . . . . 0.0 110.258 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.54 -0.82 32.5 Favored Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.339 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -100.51 148.03 25.24 Favored 'General case' 0 CA--C 1.479 -1.751 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.208 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -87.97 155.26 19.93 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.314 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.0 p -157.58 -169.54 2.91 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.5 m -127.41 140.48 52.14 Favored 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 174.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.69 160.11 38.53 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -94.19 110.61 23.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.864 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -67.19 120.22 13.39 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.442 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 71.2 m -63.05 -17.86 62.71 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 124.107 0.88 . . . . 0.0 112.672 -175.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.08 -40.73 17.95 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.149 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -110.27 -16.48 13.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.534 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.49 -4.64 83.75 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.318 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 66.0 m -90.61 165.39 13.76 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.6 mt -87.36 130.63 36.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.318 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -139.66 152.7 69.11 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.858 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.58 129.62 17.03 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.503 2.135 . . . . 0.0 111.575 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.87 39.77 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.081 -0.387 . . . . 0.0 110.122 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.3 m -116.7 136.04 53.29 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.33 121.71 15.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 123.11 0.564 . . . . 0.0 110.847 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.58 -35.28 9.19 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.675 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.1 p -157.83 152.26 24.77 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.2 mt -128.75 131.83 68.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -106.4 105.08 14.94 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -72.42 -20.15 61.47 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.83 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -74.87 -40.51 60.92 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.166 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -90.88 -7.97 50.72 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.684 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 60.3 29.17 18.79 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.357 1.063 . . . . 0.0 109.983 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.7 p -119.94 165.53 14.52 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.619 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.575 ' SG ' HD12 ' A' ' 141' ' ' LEU . 10.7 p -147.85 152.15 37.14 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.6 t -95.94 130.82 44.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.1 m -123.17 146.75 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.9 t -106.29 120.41 57.29 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -69.07 112.76 5.89 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.492 0.663 . . . . 0.0 109.887 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.7 m -67.93 129.65 40.56 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.805 -174.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.9 -17.41 58.12 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.559 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -108.97 -47.4 3.45 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.719 0.295 . . . . 0.0 111.345 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.63 40.59 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.479 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -98.5 161.58 13.6 Favored 'General case' 0 CA--C 1.48 -1.713 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.453 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -134.16 136.29 43.69 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.442 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 6.7 tt0 -142.93 151.35 40.86 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.673 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -101.73 121.39 41.97 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.831 0.824 . . . . 0.0 109.026 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -126.35 163.61 22.89 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.482 -1.236 . . . . 0.0 108.103 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -86.1 142.88 28.36 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.0 mt -56.16 -40.49 73.97 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.859 0.724 . . . . 0.0 110.586 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.6 t -80.44 -6.03 57.47 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.51 0.672 . . . . 0.0 110.345 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -106.28 -8.37 17.32 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 121.432 -0.793 . . . . 0.0 109.301 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.575 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.3 mt -66.8 159.18 28.62 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.111 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 33.9 mt -126.73 162.15 26.47 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.296 -1.744 0 O-C-N 123.464 0.478 . . . . 0.0 110.114 -179.319 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 75.9 m95 . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -119.62 153.38 35.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.83 128.29 25.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.641 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.68 7.08 54.09 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.256 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -96.67 150.02 21.15 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -93.21 141.38 28.49 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-O 120.895 0.378 . . . . 0.0 110.044 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.0 p -152.11 -163.35 1.71 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 73.7 m -132.2 150.01 52.25 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.0 160.36 40.09 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.6 mm -92.83 113.44 27.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -70.77 125.59 27.26 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.7 m -62.52 -20.88 65.07 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 123.388 0.675 . . . . 0.0 112.708 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.96 -42.1 16.62 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.199 -174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -108.32 -14.65 14.64 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.034 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.85 -2.43 74.36 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.436 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 96.4 m -90.03 166.79 13.24 Favored 'General case' 0 N--CA 1.414 -2.227 0 C-N-CA 124.268 1.027 . . . . 0.0 112.723 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.8 mt -87.96 132.63 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.8 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 97.4 m-85 -140.98 152.02 64.05 Favored Pre-proline 0 C--N 1.291 -1.942 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.838 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.51 129.84 18.59 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.616 2.211 . . . . 0.0 112.25 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.49 149.85 38.12 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 m -114.64 136.11 53.41 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.6 mt -69.01 119.81 15.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 O-C-N 123.476 0.485 . . . . 0.0 111.063 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.57 -37.1 11.01 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.883 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.3 p -159.65 153.24 22.64 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.25 132.37 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -108.19 106.05 16.05 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -74.3 -20.48 60.11 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.802 -174.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -73.75 -38.99 64.56 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.117 0.484 . . . . 0.0 110.125 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -95.0 -7.25 40.33 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.617 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 61.63 28.45 17.62 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 124.141 0.976 . . . . 0.0 110.017 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 60.1 p -118.56 168.99 10.17 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.033 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.641 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.4 p -149.0 150.86 33.54 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.1 t -95.89 131.21 43.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.58 147.42 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.993 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 68.9 t -107.46 123.14 62.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -69.96 111.94 6.02 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.432 0.634 . . . . 0.0 110.339 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.9 m -62.77 129.82 42.19 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.966 -175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.66 -20.47 38.4 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.688 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -107.73 -41.44 5.01 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.039 0.447 . . . . 0.0 110.842 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.04 8.78 58.79 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.454 -0.879 . . . . 0.0 114.177 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -91.83 162.48 14.42 Favored 'General case' 0 CA--C 1.482 -1.664 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.031 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -134.44 138.41 44.74 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -144.82 150.86 37.88 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -102.59 122.17 43.84 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -126.41 164.02 22.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.418 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 16.4 m-80 -88.47 143.45 26.97 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.2 mt -55.84 -40.26 72.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 123.79 0.681 . . . . 0.0 111.612 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.0 t -76.39 -16.56 59.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.168 0.509 . . . . 0.0 110.118 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 9.0 t70 -101.16 -0.77 35.45 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.663 0.744 . . . . 0.0 109.684 -172.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.641 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.1 mt -72.05 164.46 26.11 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.256 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.1 mt -132.73 164.18 27.35 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.306 -1.308 0 C-N-CA 122.891 0.476 . . . . 0.0 109.982 -179.523 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 76.4 m95 . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -124.0 153.71 40.9 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.64 127.85 24.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.047 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.21 12.58 45.13 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.972 -0.633 . . . . 0.0 111.774 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -100.33 145.33 28.28 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.78 140.8 29.45 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.4 -163.42 1.67 Allowed 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.015 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.8 m -131.45 147.42 52.55 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.02 160.33 39.63 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.936 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.8 mm -93.27 110.71 23.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -67.62 122.28 17.71 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.4 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 74.2 m -60.19 -25.39 65.54 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 123.957 0.786 . . . . 0.0 112.482 -177.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.32 -41.59 24.57 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.179 -172.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -108.0 -15.67 14.47 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.061 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.32 -4.07 78.78 Favored Glycine 0 N--CA 1.465 0.615 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.12 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.6 m -91.01 166.58 12.94 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.02 132.54 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.318 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -142.17 152.04 60.23 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.526 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -69.95 133.27 24.83 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.443 2.095 . . . . 0.0 111.607 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.64 146.91 29.51 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.825 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -112.77 135.77 53.14 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.2 mt -66.98 122.46 18.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 123.072 0.549 . . . . 0.0 110.595 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.79 -36.82 10.08 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.371 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.2 p -158.7 151.3 21.92 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 64.2 mt -125.37 132.27 71.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.425 ' OD1' ' HE3' ' A' ' 119' ' ' LYS . 9.6 t70 -108.48 104.1 13.37 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -72.78 -16.9 61.63 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HE3' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -73.51 -36.24 65.71 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.136 0.493 . . . . 0.0 110.12 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -98.48 -8.07 27.36 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.38 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 59.72 32.28 21.33 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.935 0.874 . . . . 0.0 109.938 -173.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.8 p -120.6 167.87 11.97 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.84 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.64 ' SG ' HD12 ' A' ' 141' ' ' LEU . 11.0 p -148.49 152.12 36.35 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.9 t -95.94 131.14 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.9 m -123.34 146.91 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' A' ' 133' ' ' ARG . 75.8 t -105.65 120.68 56.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.723 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -68.43 114.13 6.59 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.639 0.587 . . . . 0.0 110.273 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.3 m -66.56 129.4 39.73 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.913 -174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.09 -10.01 74.63 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.51 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -113.99 -51.25 2.79 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.977 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.11 6.18 45.77 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.93 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 96.2 m-20 -89.38 162.42 15.8 Favored 'General case' 0 CA--C 1.472 -2.057 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.248 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.1 ppt_? -135.6 136.05 40.74 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-O 121.27 0.557 . . . . 0.0 110.104 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.4 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 11.1 tt0 -141.9 150.98 42.22 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.314 -174.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -102.64 118.99 38.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.683 0.754 . . . . 0.0 109.406 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -124.21 163.31 21.85 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.443 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -83.86 145.25 28.74 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.6 mt -58.39 -38.74 77.94 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.784 0.678 . . . . 0.0 111.003 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.8 m -80.49 -10.99 59.73 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.32 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.17 -9.63 27.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.601 0.715 . . . . 0.0 109.193 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.64 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.4 mt -68.56 166.25 17.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.01 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 18.8 mt -136.35 163.82 29.56 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.7 m . . . . . 0 C--N 1.312 -1.031 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.81 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 86.1 m95 . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -128.95 157.57 41.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.735 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.65 128.04 26.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.9 6.79 56.92 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.925 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.29 144.27 28.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -85.84 152.82 22.7 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.537 0.684 . . . . 0.0 111.629 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.6 p -161.91 -170.95 2.7 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.919 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 74.7 m -127.41 144.42 51.06 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.09 160.05 40.1 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 mm -94.27 111.53 25.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -69.05 123.18 20.35 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.457 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 70.7 m -63.28 -18.84 64.01 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 123.969 0.793 . . . . 0.0 112.966 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -83.33 -41.55 18.1 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.346 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -106.37 -16.38 14.57 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.971 -1.092 . . . . 0.0 111.418 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.96 0.75 86.26 Favored Glycine 0 C--N 1.31 -0.874 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 71.0 m -90.89 164.59 13.98 Favored 'General case' 0 N--CA 1.421 -1.883 0 C-N-CA 124.885 1.274 . . . . 0.0 112.473 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 mt -88.89 132.12 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -139.46 152.5 69.12 Favored Pre-proline 0 C--N 1.284 -2.267 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.33 134.72 27.44 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.639 2.226 . . . . 0.0 111.18 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.41 153.59 40.64 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.208 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.0 m -119.65 135.39 54.83 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 57.0 mt -64.5 122.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 123.439 0.695 . . . . 0.0 110.652 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.71 -38.98 9.69 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.819 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.8 m -158.48 149.68 20.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 64.3 mt -123.56 132.43 71.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 122.971 0.508 . . . . 0.0 109.809 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.92 104.1 13.49 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -74.57 -14.66 60.82 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.954 0.407 . . . . 0.0 111.866 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -74.08 -40.93 62.42 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.238 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -96.84 -8.45 30.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.6 33.29 20.41 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.953 0.883 . . . . 0.0 110.026 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.1 p -120.72 165.33 15.25 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.983 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.614 ' SG ' HD12 ' A' ' 141' ' ' LEU . 12.5 p -148.15 152.5 37.4 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 95.3 t -95.78 131.38 42.7 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 27.8 m -123.63 147.3 28.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.7 t -105.23 122.81 58.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -69.42 114.22 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.479 0.656 . . . . 0.0 109.92 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.3 m -65.4 130.23 42.58 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.547 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.82 -24.86 15.6 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.792 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -99.39 -51.73 3.71 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 122.448 -0.442 . . . . 0.0 111.027 -176.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.36 19.78 17.47 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.437 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -103.51 162.03 13.38 Favored 'General case' 0 CA--C 1.479 -1.77 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.363 173.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.4 ppt_? -133.42 140.23 47.2 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.457 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 9.4 tt0 -147.75 150.84 35.02 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.504 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 34.8 tt0 -103.18 122.54 44.93 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.534 0.683 . . . . 0.0 109.669 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -125.41 162.91 23.77 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' ' 140' ' ' ASP . 19.2 m-80 -83.38 144.02 29.92 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.1 mt -58.2 -41.68 84.52 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.672 0.608 . . . . 0.0 110.515 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.8 m -80.08 -5.67 56.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.459 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.48 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 27.3 t70 -110.61 -2.18 16.5 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.56 0.695 . . . . 0.0 109.281 -176.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.614 HD12 ' SG ' ' A' ' 123' ' ' CYS . 60.0 mt -68.6 163.92 22.58 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.686 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 35.3 mt -125.44 157.79 36.02 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 C--N 1.291 -1.948 0 O-C-N 123.479 0.487 . . . . 0.0 110.275 -176.876 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.7 m95 . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -126.51 155.44 42.34 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.26 132.61 30.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.97 18.19 44.6 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.215 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -113.2 149.82 33.17 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -86.01 149.58 25.07 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 123.647 0.779 . . . . 0.0 110.624 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -159.47 -168.72 2.38 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 68.7 m -130.38 145.3 51.78 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.99 160.3 40.11 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.635 0.255 . . . . 0.0 110.796 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.38 112.28 25.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.81 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.414 ' CD2' ' HB2' ' A' ' 104' ' ' GLU . 5.2 t90 -70.49 124.44 24.21 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 m -62.69 -23.45 67.14 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.53 0.681 . . . . 0.0 112.559 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.414 ' HB2' ' CD2' ' A' ' 102' ' ' TRP . 5.0 mm-40 -81.23 -39.79 24.82 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.263 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -108.8 -15.8 14.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.923 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.89 -1.47 83.98 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 75.1 m -90.29 164.93 14.18 Favored 'General case' 0 N--CA 1.419 -2.0 0 C-N-CA 124.592 1.157 . . . . 0.0 112.928 -176.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.8 mt -87.75 132.92 31.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.259 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -142.23 152.52 61.31 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.158 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 139.35 39.66 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 122.861 2.374 . . . . 0.0 111.868 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.9 157.49 43.23 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.463 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 m -119.55 135.56 54.73 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.9 mt -70.41 118.74 15.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 122.812 0.445 . . . . 0.0 110.538 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.38 -29.85 14.79 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.963 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.9 p -161.79 153.37 18.77 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.4 mt -126.94 133.98 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.485 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 11.1 t70 -108.41 100.98 10.2 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 174.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -72.01 -16.34 62.06 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -73.57 -40.4 63.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.283 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 37.9 mmt-85 -93.76 -7.8 42.51 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 60.85 30.28 19.55 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.343 1.057 . . . . 0.0 109.685 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -119.07 165.93 13.53 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.606 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.3 p -148.12 150.69 34.31 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.6 t -95.98 130.49 44.59 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.9 m -123.06 147.0 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' A' ' 133' ' ' ARG . 62.2 t -104.85 120.1 54.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.083 178.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -66.93 115.13 6.34 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.352 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.1 m -72.6 129.3 37.95 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.454 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.48 -14.81 63.79 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -118.09 -44.61 2.69 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 122.456 -0.438 . . . . 0.0 110.96 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.26 8.23 56.61 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.987 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.55 163.03 14.74 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 117.777 0.788 . . . . 0.0 109.289 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.7 ppt_? -133.02 139.0 47.0 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -147.68 151.7 36.57 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.494 0.718 . . . . 0.0 109.075 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -101.89 126.65 48.83 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.587 0.708 . . . . 0.0 109.835 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -129.27 163.38 25.79 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.131 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -85.84 144.06 27.92 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.5 mt -57.94 -40.12 79.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 123.736 0.648 . . . . 0.0 110.905 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.8 m -80.75 -5.21 56.81 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.266 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -106.99 -14.27 14.99 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.606 HD12 ' SG ' ' A' ' 123' ' ' CYS . 53.3 mt -60.69 154.62 21.04 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-O 121.548 0.69 . . . . 0.0 110.527 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 36.7 mt -120.0 156.65 30.47 Favored 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.022 -176.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.28 -2.444 0 O-C-N 123.843 0.714 . . . . 0.0 109.289 -179.563 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.1 m95 . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -126.78 155.03 43.46 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.14 128.33 23.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 120.968 0.413 . . . . 0.0 109.946 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.64 5.32 54.05 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.917 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.41 140.78 29.19 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -89.28 144.14 26.31 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.22 -164.61 2.0 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 68.6 m -129.19 141.11 51.25 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.68 160.26 38.08 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.172 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.71 111.07 24.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.307 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -66.25 119.11 10.94 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.7 m -63.53 -17.35 62.69 Favored 'General case' 0 C--N 1.274 -2.678 0 C-N-CA 123.928 0.891 . . . . 0.0 113.099 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -83.14 -37.39 23.8 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 114.557 -1.202 . . . . 0.0 111.629 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -116.36 -15.55 10.95 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.245 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.28 -6.14 77.46 Favored Glycine 0 C--N 1.316 -0.538 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.059 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 78.0 m -90.38 164.98 14.11 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.5 mt -86.56 133.44 29.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.931 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -141.8 152.16 61.76 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.07 130.79 19.57 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.37 2.047 . . . . 0.0 111.667 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.59 151.41 39.0 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.199 -0.313 . . . . 0.0 110.537 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.6 m -116.87 135.76 53.48 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.163 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 52.2 mt -65.68 117.82 7.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 123.288 0.635 . . . . 0.0 110.913 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.99 -37.0 11.89 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.853 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -160.27 149.56 17.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.2 133.89 67.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.43 102.49 11.37 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -70.95 -20.88 62.41 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.136 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -73.79 -38.01 64.76 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.044 0.45 . . . . 0.0 110.977 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -92.1 -7.65 47.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.195 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 60.49 30.81 20.06 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 124.149 0.906 . . . . 0.0 110.102 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 52.1 p -121.75 166.79 13.78 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.231 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.64 ' SG ' HD12 ' A' ' 141' ' ' LEU . 10.7 p -148.51 152.13 36.34 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 92.5 t -95.57 131.37 42.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.14 147.19 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 67.1 t -106.93 121.57 59.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.54 112.94 5.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.568 0.699 . . . . 0.0 110.354 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.9 m -66.5 130.07 41.98 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.972 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.73 -5.5 83.53 Favored Glycine 0 N--CA 1.432 -1.627 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.201 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -117.28 -50.73 2.55 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.817 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.45 34.04 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 119.857 -1.163 . . . . 0.0 114.059 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -97.09 162.71 13.25 Favored 'General case' 0 CA--C 1.482 -1.661 0 C-N-CA 119.344 -0.943 . . . . 0.0 109.553 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -134.04 139.45 46.02 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.201 0.524 . . . . 0.0 109.866 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -147.13 150.44 34.98 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.378 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 41.4 tt0 -103.02 120.87 41.43 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -126.3 163.73 22.58 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.219 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 18.1 m-80 -85.06 142.79 29.31 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.5 mt -59.32 -36.49 75.76 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.877 0.846 . . . . 0.0 109.919 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.6 p -79.62 -10.3 59.77 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.665 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.07 -4.54 15.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.511 0.672 . . . . 0.0 109.763 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.64 HD12 ' SG ' ' A' ' 123' ' ' CYS . 71.2 mt -67.23 162.71 22.01 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.716 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.5 mt -128.94 159.86 34.51 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.438 -177.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.298 -1.673 0 O-C-N 123.495 0.497 . . . . 0.0 109.961 -179.013 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 78.5 m95 . . . . . 0 CA--C 1.505 -0.765 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -130.95 155.9 46.01 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.57 128.28 25.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.78 7.62 52.97 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.755 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.41 147.34 25.35 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -91.54 150.94 20.97 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.2 p -155.63 -168.04 2.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 67.0 m -129.6 145.21 51.51 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.44 159.95 40.22 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 123.215 0.322 . . . . 0.0 110.281 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.9 mm -92.27 112.61 26.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.342 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -69.48 118.21 12.07 Favored 'General case' 0 CA--C 1.471 -2.077 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.2 m -58.88 -23.1 60.54 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 122.068 0.937 . . . . 0.0 112.194 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.06 -39.74 23.03 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.987 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -108.77 -16.54 14.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.704 0.764 . . . . 0.0 109.855 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.84 -6.53 69.87 Favored Glycine 0 C--O 1.225 -0.448 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.997 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 65.3 m -90.96 167.53 12.34 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.0 mt -88.0 132.13 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.506 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -140.1 152.47 67.47 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.209 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.09 130.4 18.86 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.416 2.077 . . . . 0.0 111.24 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.16 149.62 35.3 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.963 0.411 . . . . 0.0 110.312 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.6 m -117.54 136.17 53.44 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 56.7 mt -65.74 121.76 15.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 O-C-N 123.548 0.53 . . . . 0.0 111.156 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.14 -34.59 9.98 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.919 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.8 p -161.12 150.89 17.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.7 mt -127.43 133.37 68.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 117.931 0.332 . . . . 0.0 110.111 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -108.82 103.68 12.79 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.65 -14.32 61.56 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.271 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -73.68 -41.3 62.85 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.877 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -98.22 -6.12 31.89 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.401 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 63.64 29.33 15.1 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.828 0.851 . . . . 0.0 109.308 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 47.1 p -117.29 165.41 13.49 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.916 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.618 ' SG ' HD12 ' A' ' 141' ' ' LEU . 11.6 p -148.55 152.39 36.74 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 120.676 0.274 . . . . 0.0 110.272 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.3 t -96.25 130.63 44.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.72 147.25 28.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 53.5 t -106.07 123.54 60.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.139 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -72.05 113.77 9.44 Favored 'General case' 0 C--O 1.257 1.5 0 CA-C-O 121.479 0.656 . . . . 0.0 110.475 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.5 m -69.2 130.21 42.01 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.742 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.76 -10.17 72.67 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.838 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -118.54 -53.05 2.34 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.719 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.21 17.43 15.87 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.728 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -99.71 165.61 11.51 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -132.99 142.46 48.85 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -145.51 151.28 37.92 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.98 121.65 42.57 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.424 0.631 . . . . 0.0 109.52 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -125.33 163.41 22.61 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 15.7 m-80 -85.62 143.48 28.41 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.1 mt -58.49 -38.3 77.35 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.682 0.754 . . . . 0.0 110.607 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.4 p -80.42 -8.67 59.62 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.992 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 12.6 t70 -105.33 -8.15 18.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.618 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.0 mt -65.86 157.8 29.56 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.625 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.3 mt -124.76 161.32 26.68 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -176.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.294 -1.846 0 O-C-N 123.542 0.526 . . . . 0.0 110.278 -178.547 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.402 ' CD1' HD13 ' A' ' 141' ' ' LEU . 83.1 m95 . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 110.694 -0.113 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -125.24 151.61 45.69 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.23 128.41 26.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.86 10.83 54.79 Favored Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.372 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -103.85 153.22 21.0 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -86.43 147.87 25.81 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 123.677 0.791 . . . . 0.0 110.51 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -156.64 -168.85 2.81 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 69.2 m -130.64 141.74 50.43 Favored 'General case' 0 C--N 1.264 -3.123 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.71 160.15 38.41 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 123.313 0.383 . . . . 0.0 110.651 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.4 mm -94.55 109.93 22.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.087 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -66.21 121.28 14.86 Favored 'General case' 0 CA--C 1.473 -1.996 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.9 m -61.33 -19.7 62.11 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 124.067 0.947 . . . . 0.0 112.341 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -84.36 -42.35 15.82 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.35 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -104.57 -16.09 15.13 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.648 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.25 -1.27 65.3 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 71.1 m -90.37 162.56 15.07 Favored 'General case' 0 N--CA 1.408 -2.569 0 C-N-CA 124.323 1.049 . . . . 0.0 112.177 -175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.4 mt -86.6 133.77 29.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.099 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -140.31 152.26 66.42 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 131.5 19.49 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.425 2.083 . . . . 0.0 111.228 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.62 154.57 42.96 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.437 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.0 m -119.33 135.95 54.48 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.7 mt -68.77 124.12 23.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 122.922 0.489 . . . . 0.0 111.346 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.51 -32.32 11.88 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.876 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.4 p -163.89 152.84 13.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.93 132.18 70.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 122.818 0.447 . . . . 0.0 109.826 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.408 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 10.1 t70 -109.4 102.54 11.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 173.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.51 -21.82 63.64 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.635 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -73.57 -36.25 65.55 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.603 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.408 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 35.2 mmt180 -93.35 -8.52 41.71 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 61.08 28.51 18.23 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.196 0.998 . . . . 0.0 110.186 -173.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.6 p -119.95 166.18 13.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.127 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.631 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.4 p -148.45 150.73 33.98 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.3 t -96.1 132.5 40.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 27.7 m -124.03 147.55 28.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.4 t -104.99 121.46 56.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.071 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -69.89 116.63 10.5 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-O 121.548 0.69 . . . . 0.0 110.84 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.2 m -66.2 129.86 41.24 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.176 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.78 -16.82 59.95 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.047 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -115.15 -51.81 2.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.432 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.26 17.06 28.12 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.644 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 90.6 m-20 -93.48 162.48 13.95 Favored 'General case' 0 CA--C 1.472 -2.053 0 C-N-CA 119.499 -0.88 . . . . 0.0 108.642 174.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.7 ppt_? -131.72 135.46 46.86 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -142.61 151.11 41.15 Favored 'General case' 0 N--CA 1.409 -2.486 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.323 -173.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -101.77 122.0 43.13 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.798 0.809 . . . . 0.0 109.904 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -126.82 163.54 23.36 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.434 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.449 ' HB2' ' CB ' ' A' ' 140' ' ' ASP . 17.9 m-80 -88.59 143.45 26.94 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 61.8 mt -57.07 -40.69 77.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.204 0.602 . . . . 0.0 111.253 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.6 t -80.87 -8.53 59.74 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.317 0.58 . . . . 0.0 110.736 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.449 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 21.4 t70 -102.16 -10.71 19.39 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.631 HD12 ' SG ' ' A' ' 123' ' ' CYS . 60.8 mt -66.59 157.81 31.43 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.23 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 28.5 mt -125.27 161.58 26.63 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -176.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--N 1.297 -1.704 0 O-C-N 123.282 0.364 . . . . 0.0 110.557 -178.909 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 84.8 m95 . . . . . 0 C--O 1.244 0.805 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -131.47 156.11 46.22 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.39 131.94 29.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.13 3.68 54.24 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.574 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.411 ' HB2' HD13 ' A' ' 113' ' ' ILE . 62.5 m-20 -99.56 139.48 35.16 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -83.66 145.51 28.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.8 p -153.45 -161.97 1.37 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.6 m -135.78 146.59 47.76 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.0 161.12 38.13 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.571 -176.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.8 mm -92.77 112.43 26.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -69.02 124.29 23.34 Favored 'General case' 0 CA--C 1.474 -1.964 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.415 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 66.1 m -59.52 -25.36 64.43 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.977 0.798 . . . . 0.0 112.366 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -81.53 -41.84 21.07 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.485 -0.78 . . . . 0.0 113.102 -174.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -105.82 -15.87 14.82 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.578 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.74 -0.74 76.18 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.94 164.62 14.49 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 124.013 0.925 . . . . 0.0 112.263 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 mt -88.39 131.2 36.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.248 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -140.08 152.39 67.34 Favored Pre-proline 0 C--N 1.291 -1.97 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.467 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.73 137.14 26.78 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.227 1.951 . . . . 0.0 111.399 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.96 148.66 29.35 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.893 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.3 m -112.42 136.05 52.38 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.411 HD13 ' HB2' ' A' ' 96' ' ' ASP . 57.5 mt -66.39 118.64 9.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 C-N-CA 123.202 0.601 . . . . 0.0 110.945 -178.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.29 -41.92 8.79 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.934 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.0 m -157.58 149.71 22.44 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -123.48 132.26 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 123.314 0.384 . . . . 0.0 110.213 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.12 108.73 19.51 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -75.56 -17.42 60.06 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.166 -173.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -73.31 -41.73 63.19 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -94.21 -8.03 40.45 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.004 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 60.86 31.52 20.03 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.288 1.035 . . . . 0.0 110.035 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 49.3 p -119.38 167.38 11.97 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.729 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.615 ' SG ' HD12 ' A' ' 141' ' ' LEU . 11.7 p -148.33 151.83 36.04 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.637 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.0 t -96.07 132.59 39.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.87 148.41 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 68.0 t -106.24 120.56 57.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.475 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.47 116.03 8.56 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.675 0.61 . . . . 0.0 110.713 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.5 m -71.54 129.57 39.09 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.883 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.21 -14.9 64.4 Favored Glycine 0 N--CA 1.429 -1.793 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.908 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -117.71 -44.47 2.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 120.971 0.415 . . . . 0.0 110.718 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.8 10.8 52.04 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.011 -1.09 . . . . 0.0 114.437 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -91.29 162.58 14.56 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-N 117.93 0.865 . . . . 0.0 109.267 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -132.07 137.75 47.89 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.415 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 6.0 tt0 -145.7 151.83 38.64 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -101.72 124.73 47.86 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -176.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -129.16 163.77 24.81 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.629 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -87.58 144.04 26.89 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 62.9 mt -58.77 -39.33 80.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.676 0.75 . . . . 0.0 110.273 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.7 p -73.8 -17.12 61.12 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.481 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -101.89 -7.8 22.15 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -173.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.615 HD12 ' SG ' ' A' ' 123' ' ' CYS . 62.4 mt -66.9 157.48 33.07 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.095 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.9 mt -126.25 160.81 29.28 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.293 -1.886 0 O-C-N 123.571 0.545 . . . . 0.0 110.4 -179.021 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 CA--C 1.514 -0.428 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.0 m -104.85 92.22 4.16 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.87 -38.2 85.87 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.67 -29.62 67.11 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.0 m -110.23 21.55 16.59 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.367 0.603 . . . . 0.0 110.359 -176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 mt -82.35 16.47 2.04 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -175.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -121.75 -16.25 7.72 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.642 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -116.62 130.13 56.56 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.073 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -139.05 163.91 31.17 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -128.51 154.76 45.79 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.19 127.07 24.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.84 8.99 47.19 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.527 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.5 148.86 22.8 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -91.52 151.26 20.83 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -158.16 -169.58 2.84 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 121.479 0.657 . . . . 0.0 110.005 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.5 m -127.07 144.07 51.12 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 173.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.18 160.12 39.36 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.0 mm -93.82 109.59 22.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -68.62 123.71 21.62 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.9 m -63.19 -20.03 65.04 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.86 -39.48 19.84 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.517 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -108.03 -15.42 14.52 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.642 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.33 1.35 69.57 Favored Glycine 0 C--N 1.313 -0.717 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 77.4 m -90.55 164.19 14.32 Favored 'General case' 0 N--CA 1.405 -2.685 0 C-N-CA 124.303 1.041 . . . . 0.0 112.327 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -89.5 129.26 40.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.349 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -137.56 152.58 73.16 Favored Pre-proline 0 C--N 1.286 -2.187 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.795 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.97 133.33 23.11 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.624 2.216 . . . . 0.0 111.555 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.75 153.81 41.35 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.27 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 m -118.23 135.88 53.99 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.3 mt -68.82 120.49 16.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 120.958 0.409 . . . . 0.0 110.587 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.71 -38.44 9.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.968 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -159.3 152.21 21.94 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.4 mt -128.87 136.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 122.65 0.38 . . . . 0.0 110.343 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -109.27 99.52 8.78 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -71.27 -18.54 62.42 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.078 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -73.46 -40.58 64.05 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.21 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -90.83 -7.3 52.68 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 61.86 32.8 17.92 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.79 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.5 p -122.74 164.05 19.03 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.168 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.669 ' SG ' HD12 ' A' ' 141' ' ' LEU . 16.8 p -148.44 155.86 41.75 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.75 0.31 . . . . 0.0 110.396 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.77 130.19 46.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 31.6 m -123.3 147.24 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 75.2 t -104.7 122.55 57.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.17 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -70.27 114.97 8.93 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.64 0.588 . . . . 0.0 110.192 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 45.7 m -67.76 131.83 46.3 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.069 -176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.1 -15.37 63.04 Favored Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.852 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -116.75 -47.88 2.69 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.732 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.34 14.38 38.7 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.938 -1.125 . . . . 0.0 114.086 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -94.63 162.63 13.71 Favored 'General case' 0 CA--C 1.479 -1.776 0 C-N-CA 119.606 -0.838 . . . . 0.0 108.986 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.2 ppt_? -133.78 136.38 44.5 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -141.98 151.76 42.81 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.62 -174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.76 120.52 40.5 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -125.75 163.49 22.74 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.254 -174.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -85.88 143.31 28.3 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.8 mt -58.57 -39.79 81.28 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.623 0.577 . . . . 0.0 110.683 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.6 t -80.91 -5.52 57.52 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.426 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -106.96 -8.53 16.58 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.514 0.673 . . . . 0.0 109.706 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.669 HD12 ' SG ' ' A' ' 123' ' ' CYS . 67.1 mt -66.59 162.61 20.57 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.856 176.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 41.3 mt -128.49 159.94 33.88 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 30.3 m -67.43 144.4 97.88 Favored Pre-proline 0 C--N 1.296 -1.731 0 O-C-N 123.658 0.599 . . . . 0.0 111.595 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.67 150.41 82.36 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 123.053 2.502 . . . . 0.0 112.27 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.4 mt -85.37 140.8 15.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 39.5 t -135.08 6.49 3.36 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.093 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.424 -1.77 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.818 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.502 -0.882 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.6 m -97.59 120.51 38.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 74.6 -35.92 0.31 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.825 1.65 . . . . 0.0 114.034 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.56 109.91 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.813 0.845 . . . . 0.0 112.374 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -91.94 0.66 57.47 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.19 0.995 . . . . 0.0 110.117 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 89' ' ' LEU . 5.1 tt -84.39 6.26 23.93 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 123.012 1.387 . . . . 0.0 108.364 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -99.32 -5.46 29.65 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.92 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -129.47 108.94 10.65 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.918 0.866 . . . . 0.0 111.102 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.421 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 86.8 m95 -119.73 164.48 15.88 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.054 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 8.9 ptpp? -128.95 153.45 47.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.16 127.43 24.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.75 8.71 56.95 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.761 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 2.5 t0 -99.96 146.8 26.28 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -83.67 154.95 23.4 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 121.294 0.569 . . . . 0.0 111.418 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -160.0 -174.47 4.58 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.4 m -125.03 140.97 52.43 Favored 'General case' 0 C--N 1.258 -3.386 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 174.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.76 159.97 38.99 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.152 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.98 111.58 25.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -68.76 121.96 17.59 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.6 m -63.49 -19.74 65.01 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 123.952 0.782 . . . . 0.0 112.821 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -84.57 -42.13 15.76 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.174 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -106.74 -15.47 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.674 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.14 -5.24 77.6 Favored Glycine 0 N--CA 1.462 0.431 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.425 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 68.0 m -90.65 166.99 12.86 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 123.75 0.82 . . . . 0.0 113.176 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.3 mt -86.88 133.2 30.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.984 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -140.67 152.46 66.07 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.477 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.24 127.8 14.71 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.237 1.958 . . . . 0.0 110.965 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.01 150.36 39.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 120.904 0.383 . . . . 0.0 110.192 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 m -114.99 135.84 53.79 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 53.0 mt -68.32 118.93 13.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.891 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.68 -36.69 12.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.911 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m -159.19 150.04 19.8 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.0 mt -126.94 132.78 69.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 122.971 0.508 . . . . 0.0 110.514 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -108.94 110.38 21.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -75.37 -21.34 58.4 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.992 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -73.51 -36.57 65.77 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.241 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -94.97 -8.86 35.73 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.359 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 57.63 35.65 25.9 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.924 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.1 p -121.93 163.01 20.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.905 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.588 ' SG ' HD12 ' A' ' 141' ' ' LEU . 11.2 p -148.34 153.45 38.64 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 120.816 0.341 . . . . 0.0 110.282 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.6 t -96.34 132.44 40.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.9 m -123.49 147.13 27.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.0 t -106.3 120.94 58.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -70.58 115.74 10.09 Favored 'General case' 0 C--O 1.259 1.577 0 CA-C-O 121.386 0.612 . . . . 0.0 109.978 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.0 m -69.04 129.58 40.31 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.313 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.81 -17.48 58.57 Favored Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.026 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.93 -52.72 2.73 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.207 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.11 22.17 8.96 Favored Glycine 0 N--CA 1.435 -1.383 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.734 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -105.62 161.91 13.97 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.7 ppt_? -135.08 136.08 41.74 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -143.18 151.32 40.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -101.96 119.74 39.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.634 0.73 . . . . 0.0 109.27 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -126.24 163.5 23.06 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.042 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -85.36 143.93 28.34 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 60.5 mt -59.06 -37.01 76.04 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.794 0.807 . . . . 0.0 109.495 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.3 m -73.75 -19.76 60.69 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.117 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -102.57 -8.93 20.59 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.29 0.567 . . . . 0.0 110.332 -173.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.588 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.4 mt -63.45 160.72 15.71 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.939 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.9 mt -125.3 159.93 30.51 Favored 'General case' 0 C--N 1.254 -3.586 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.2 m -67.36 135.63 93.3 Favored Pre-proline 0 C--N 1.29 -1.997 0 O-C-N 123.577 0.548 . . . . 0.0 110.264 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.58 150.88 79.41 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 123.172 2.581 . . . . 0.0 113.372 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.6 mt -81.25 172.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 18.8 p -73.33 17.01 0.15 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 124.16 0.984 . . . . 0.0 113.297 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 . . . . . 0 N--CA 1.427 -1.589 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -177.323 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 43.8 t30 . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 p -88.3 -13.34 41.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.353 0.597 . . . . 0.0 112.396 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -169.44 103.08 0.35 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.07 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 76.6 109.92 0.07 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.211 -1.813 . . . . 0.0 111.029 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -108.64 13.75 24.96 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.567 0.699 . . . . 0.0 112.334 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.583 HD21 ' O ' ' A' ' 89' ' ' LEU . 5.8 tt -94.81 2.36 55.47 Favored 'General case' 0 C--O 1.202 -1.41 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -92.24 -3.62 55.23 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.801 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -135.26 136.31 41.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.153 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 79.8 m95 -141.93 165.08 28.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -175.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -129.76 157.73 41.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.23 128.71 25.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.508 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.56 -1.77 36.76 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.204 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB2' HD13 ' A' ' 113' ' ' ILE . 24.6 m-20 -96.79 135.32 38.9 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 122.68 -0.306 . . . . 0.0 111.08 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 14.6 mtmt -77.47 147.76 35.73 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-O 121.335 0.588 . . . . 0.0 110.901 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.9 p -154.53 -166.5 2.35 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 114.579 -1.192 . . . . 0.0 107.96 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 73.2 m -129.03 141.37 51.26 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.61 160.36 38.73 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.2 mm -93.92 112.58 27.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -68.33 120.72 14.91 Favored 'General case' 0 CA--C 1.473 -1.981 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.434 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 72.6 m -61.65 -20.46 63.44 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.947 0.779 . . . . 0.0 112.631 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -84.73 -39.8 18.06 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.565 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -109.02 -15.95 14.24 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.042 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.13 -3.95 78.45 Favored Glycine 0 N--CA 1.464 0.524 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.328 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 70.7 m -90.62 168.15 12.01 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.8 mt -90.31 133.64 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.666 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -142.36 152.01 59.54 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.43 135.19 26.06 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.505 2.137 . . . . 0.0 111.381 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.95 150.69 34.51 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.941 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 20.7 m -111.27 135.83 51.25 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 44.5 mt -67.94 117.12 9.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 123.34 0.4 . . . . 0.0 110.49 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.08 -38.6 11.53 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.205 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 p -159.19 146.87 17.49 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 62.5 mt -124.36 135.32 64.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -109.35 106.23 15.95 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -75.73 -13.72 60.31 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -73.26 -41.88 63.14 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -96.39 -7.52 34.84 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.702 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 57.36 33.67 23.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.336 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 79.8 p -118.38 161.98 19.06 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.065 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 141' ' ' LEU . 15.1 p -147.81 152.91 38.48 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.359 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 88.7 t -95.82 131.66 42.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.1 m -123.21 146.92 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 77.7 t -106.26 120.01 56.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -66.41 111.99 3.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.782 0.676 . . . . 0.0 110.386 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.4 m -65.62 129.95 41.56 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.727 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.32 -21.22 41.68 Favored Glycine 0 N--CA 1.425 -2.087 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.786 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -106.95 -50.46 3.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.101 -177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.72 3.56 37.02 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.149 -1.024 . . . . 0.0 114.223 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 95.1 m-20 -87.73 163.16 16.65 Favored 'General case' 0 CA--C 1.479 -1.772 0 CA-C-N 117.804 0.802 . . . . 0.0 109.916 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.8 ppt_? -134.25 136.53 43.67 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.079 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.434 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 8.8 tt0 -144.92 151.24 38.36 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.971 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 39.9 tt0 -102.7 124.7 48.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -127.57 163.92 23.12 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -175.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -87.37 142.88 27.55 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.22 -39.76 76.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.431 0.634 . . . . 0.0 110.561 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 m -79.63 -4.63 52.51 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.883 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -108.96 -7.75 15.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.52 0.676 . . . . 0.0 109.306 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.543 HD12 ' SG ' ' A' ' 123' ' ' CYS . 67.7 mt -69.58 163.83 24.63 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.652 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 21.1 mt -130.65 162.85 28.48 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.0 m -71.5 141.46 85.44 Favored Pre-proline 0 C--N 1.31 -1.137 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -60.66 142.65 98.4 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.339 2.026 . . . . 0.0 112.557 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.1 mt -84.67 144.33 9.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.714 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 46.4 t -137.73 96.12 3.17 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--N 1.287 -2.131 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.488 179.758 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.5 t -122.79 24.19 9.17 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.787 0.803 . . . . 0.0 110.188 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.48 -19.53 6.9 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.96 14.56 31.6 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.3 m 63.05 26.45 15.44 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.336 1.065 . . . . 0.0 109.954 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.627 HD21 ' O ' ' A' ' 89' ' ' LEU . 6.5 tt -84.89 0.81 49.8 Favored 'General case' 0 C--O 1.207 -1.147 0 C-N-CA 125.448 1.499 . . . . 0.0 110.498 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -99.46 6.67 45.89 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.37 -0.831 . . . . 0.0 110.365 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -140.75 127.53 20.42 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.397 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.41 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 77.7 m95 -138.18 164.72 28.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -130.92 154.96 47.56 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.17 127.43 22.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-O 121.032 0.444 . . . . 0.0 110.754 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.1 5.77 46.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.505 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -103.75 149.08 25.33 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 120.705 0.288 . . . . 0.0 110.23 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -88.5 150.91 22.86 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.808 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -155.82 -168.02 2.66 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.953 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.495 ' OG ' HG13 ' A' ' 145' ' ' ILE . 72.9 m -129.35 144.95 51.44 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.39 160.22 39.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.902 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.2 mm -93.89 110.04 22.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.73 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -66.31 121.79 16.05 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 t -61.18 -22.35 64.65 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 123.885 0.74 . . . . 0.0 110.589 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -80.58 -42.19 22.71 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.719 -173.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -106.37 -14.9 14.96 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.274 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.69 0.53 68.54 Favored Glycine 0 N--CA 1.462 0.429 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.97 164.15 14.09 Favored 'General case' 0 N--CA 1.403 -2.788 0 C-N-CA 124.852 1.261 . . . . 0.0 112.325 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.3 mt -88.02 133.51 30.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.61 0.764 . . . . 0.0 110.144 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -144.07 152.48 54.86 Favored Pre-proline 0 C--N 1.304 -1.397 0 C-N-CA 123.158 0.583 . . . . 0.0 109.868 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.07 133.68 23.68 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.695 2.263 . . . . 0.0 111.873 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.71 153.36 40.9 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.967 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.2 m -117.55 135.79 53.71 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 48.5 mt -66.25 118.1 8.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 123.104 0.562 . . . . 0.0 111.322 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.21 -38.43 10.57 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.97 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 m -158.26 151.85 23.45 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.5 mt -127.26 134.18 66.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -108.59 102.88 11.91 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -71.06 -18.45 62.56 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.27 -174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -72.82 -39.9 66.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -93.8 -7.51 43.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 61.81 27.49 16.79 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.793 0.837 . . . . 0.0 110.062 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.8 p -119.64 165.7 14.13 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.342 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' A' ' 141' ' ' LEU . 12.0 p -148.08 152.49 37.45 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.9 t -96.73 131.19 44.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.1 m -123.57 147.11 28.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 133' ' ' ARG . 55.3 t -106.75 122.89 61.31 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -70.95 114.49 9.06 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.545 0.688 . . . . 0.0 110.13 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.5 m -63.96 129.47 40.19 Favored 'General case' 0 N--CA 1.407 -2.607 0 CA-C-N 113.712 -1.586 . . . . 0.0 111.287 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.83 -13.97 57.64 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.316 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -109.66 -44.79 3.78 Favored 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 122.547 -0.384 . . . . 0.0 110.231 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.18 10.07 56.37 Favored Glycine 0 N--CA 1.436 -1.357 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.923 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -91.94 163.86 13.86 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 117.586 0.693 . . . . 0.0 109.487 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -135.27 139.11 44.15 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -145.82 151.21 37.56 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -101.39 121.85 42.67 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -128.65 163.21 25.56 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.957 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 19.9 m-80 -86.17 144.56 27.42 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.1 mt -57.93 -40.94 81.68 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.848 0.717 . . . . 0.0 110.652 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 m -81.38 -7.23 59.54 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.302 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 19.2 t70 -101.98 -5.03 25.13 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.558 HD12 ' SG ' ' A' ' 123' ' ' CYS . 68.8 mt -69.62 171.63 8.67 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.276 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 27.2 mt -138.34 162.89 33.22 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.0 m -67.62 137.75 93.24 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.53 142.33 94.6 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.042 2.495 . . . . 0.0 115.327 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.495 HG13 ' OG ' ' A' ' 99' ' ' SER . 39.8 mt -92.17 159.0 2.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 114.3 -1.318 . . . . 0.0 107.831 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.449 ' N ' HG21 ' A' ' 145' ' ' ILE . 52.4 t 73.44 11.89 4.79 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.801 1.64 . . . . 0.0 109.779 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 . . . . . 0 C--N 1.301 -1.533 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.622 177.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 45.2 m -139.09 98.58 3.55 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.723 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.09 -9.39 17.84 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.91 157.35 37.63 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.487 -0.778 . . . . 0.0 108.933 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -94.22 23.92 4.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.85 0.833 . . . . 0.0 109.407 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.83 33.65 3.51 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.466 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.509 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 47.5 mt-30 -113.66 -48.47 2.93 Favored 'General case' 0 C--O 1.209 -1.027 0 C-N-CA 120.451 -0.499 . . . . 0.0 112.24 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -100.66 136.1 41.06 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.746 0.784 . . . . 0.0 112.692 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -135.0 164.72 26.98 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.732 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -116.79 152.15 35.0 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.646 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.17 128.54 26.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.94 23.29 25.72 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.657 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -115.74 149.72 38.02 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -84.23 148.78 26.53 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 123.026 0.53 . . . . 0.0 110.102 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 p -157.92 -167.89 2.36 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.501 ' OG ' HG13 ' A' ' 145' ' ' ILE . 66.7 m -131.18 142.08 50.15 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.47 160.16 38.25 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.907 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.0 mm -95.07 108.18 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -67.88 123.78 21.53 Favored 'General case' 0 CA--C 1.469 -2.147 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.289 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -62.04 -22.09 65.45 Favored 'General case' 0 C--N 1.282 -2.326 0 O-C-N 123.95 0.781 . . . . 0.0 112.674 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -83.58 -36.91 23.58 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -108.46 -16.46 14.22 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.155 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.2 0.45 70.96 Favored Glycine 0 C--N 1.304 -1.236 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.707 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 99.4 m -90.84 167.38 12.5 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 124.491 1.117 . . . . 0.0 111.887 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.39 133.1 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.48 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.3 m-85 -139.48 152.05 68.07 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.088 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.62 133.32 23.74 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.313 2.009 . . . . 0.0 111.189 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.02 156.64 44.05 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.818 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.0 m -119.99 135.52 54.89 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mt -70.31 123.88 25.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 122.747 0.419 . . . . 0.0 110.679 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.95 -36.07 10.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.164 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 64.1 m -161.38 149.97 15.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.41 129.73 73.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -105.67 101.85 11.34 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -73.16 -12.67 60.97 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.234 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.56 -40.68 63.75 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.255 0.55 . . . . 0.0 109.605 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -99.32 -7.02 26.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.1 30.27 17.78 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.868 0.867 . . . . 0.0 110.306 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 52.7 p -119.99 165.53 14.56 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.245 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.591 ' SG ' HD12 ' A' ' 141' ' ' LEU . 15.6 p -148.09 152.74 37.87 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.1 t -96.15 131.01 44.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.6 m -122.98 146.83 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.5 t -105.78 120.39 56.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.91 114.7 7.45 Favored 'General case' 0 C--O 1.257 1.462 0 O-C-N 123.923 0.764 . . . . 0.0 110.107 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 87.8 m -67.52 128.98 38.47 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.655 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.23 -22.82 30.27 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.696 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -100.82 -52.37 3.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 122.324 -0.515 . . . . 0.0 109.877 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.39 11.25 29.68 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.85 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -93.87 162.54 13.87 Favored 'General case' 0 CA--C 1.466 -2.265 0 C-N-CA 119.434 -0.907 . . . . 0.0 109.739 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.3 ppt_? -133.54 136.25 44.87 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -142.08 150.93 41.85 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -102.55 116.45 32.63 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.759 0.79 . . . . 0.0 109.271 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -121.03 163.78 17.78 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.617 -173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -85.88 139.87 30.88 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 90' ' ' GLN . 71.0 mt -55.22 -40.82 71.29 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.375 0.67 . . . . 0.0 111.354 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.2 t -80.67 -6.2 58.05 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.797 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -104.76 -7.86 19.2 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.743 0.782 . . . . 0.0 109.052 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.591 HD12 ' SG ' ' A' ' 123' ' ' CYS . 66.1 mt -67.16 163.98 19.07 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.638 176.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 26.8 mt -132.39 163.66 28.21 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 p -67.94 140.55 93.83 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.37 142.78 98.94 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 123.215 2.61 . . . . 0.0 115.006 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.501 HG13 ' OG ' ' A' ' 99' ' ' SER . 39.4 mt -91.6 138.11 20.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 173.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 34.9 t -136.5 22.89 3.17 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-O 121.746 0.784 . . . . 0.0 108.964 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 C--N 1.3 -1.576 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.086 -177.506 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.6 t30 . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 m -89.39 87.52 7.13 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.55 -12.15 21.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.235 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.91 161.18 40.62 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 m -84.06 84.4 7.61 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.14 -0.16 14.76 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.259 1.028 . . . . 0.0 109.554 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -108.65 -22.11 12.4 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.012 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -141.85 134.7 28.71 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -129.09 165.46 21.18 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.61 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 8.4 ptpp? -126.0 153.78 43.87 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.51 129.14 26.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.96 3.07 42.44 Favored Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.063 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.61 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 12.1 m-20 -98.01 136.32 38.44 Favored 'General case' 0 CA--C 1.486 -1.518 0 O-C-N 122.602 -0.352 . . . . 0.0 110.488 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.9 mtmt -81.19 143.7 32.15 Favored 'General case' 0 N--CA 1.401 -2.905 0 CA-C-O 121.291 0.567 . . . . 0.0 109.63 171.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.31 -167.51 2.73 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.9 m -128.6 145.11 51.23 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.33 160.26 39.58 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.682 0.614 . . . . 0.0 109.817 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mm -93.29 109.62 22.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.491 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -68.1 125.68 27.11 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.835 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.8 m -64.5 -20.82 66.44 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -83.95 -41.16 17.63 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -105.33 -15.96 14.89 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.392 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.25 0.86 79.1 Favored Glycine 0 C--N 1.311 -0.839 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.014 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 74.9 m -90.27 168.85 11.6 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 124.117 0.967 . . . . 0.0 111.75 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.1 mt -89.07 135.41 25.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.451 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.1 m-85 -142.99 152.12 57.76 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.46 136.13 27.94 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.663 2.242 . . . . 0.0 111.413 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.96 154.17 39.01 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.0 m -114.68 135.49 54.1 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 96' ' ' ASP . 49.7 mt -67.39 115.51 5.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 122.949 0.499 . . . . 0.0 110.705 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.44 -35.41 13.0 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.193 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -157.96 148.38 20.56 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.5 mt -123.25 133.01 70.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -108.31 97.56 7.23 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -71.74 -14.73 62.09 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.977 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -73.24 -41.34 63.83 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.018 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -94.89 -6.88 41.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.216 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 62.56 29.52 17.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.4 1.08 . . . . 0.0 110.096 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 46.7 p -117.94 166.75 12.14 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.618 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.603 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.6 p -148.45 152.12 36.38 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.0 t -95.86 131.09 43.53 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.6 m -122.71 146.73 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 72.4 t -105.28 119.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -68.14 111.1 4.3 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-O 121.574 0.702 . . . . 0.0 110.858 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 96.2 m -70.58 129.79 40.12 Favored 'General case' 0 N--CA 1.397 -3.101 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.576 -175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.11 -13.81 63.04 Favored Glycine 0 N--CA 1.418 -2.502 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.296 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.7 -54.01 2.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.95 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 107.27 17.42 11.51 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.957 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -101.64 168.61 9.36 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.269 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.1 ppt_? -137.73 140.11 40.52 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -146.14 151.59 37.91 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 123.696 0.798 . . . . 0.0 109.43 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -101.67 123.35 45.52 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.497 0.665 . . . . 0.0 109.507 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -129.31 163.39 25.8 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.022 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 22.6 m-80 -85.8 146.03 26.95 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.22 -35.15 74.79 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.751 0.786 . . . . 0.0 109.587 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.3 p -74.52 -17.87 60.69 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.667 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -105.47 -4.81 20.9 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.715 0.769 . . . . 0.0 110.471 -173.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.603 HD12 ' SG ' ' A' ' 123' ' ' CYS . 52.9 mt -68.11 160.73 28.38 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.886 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.6 mt -132.14 164.47 26.23 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 39.9 m -67.4 137.61 93.73 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 122.93 0.492 . . . . 0.0 110.151 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.92 147.25 84.7 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.29 2.66 . . . . 0.0 115.118 -171.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.7 mt -100.29 142.02 16.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 38.9 t -136.35 115.01 11.98 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 C--N 1.29 -1.995 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.906 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.1 t -77.18 149.54 35.56 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-O 121.252 0.548 . . . . 0.0 110.768 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.78 49.33 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.99 92.1 8.85 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 121.975 0.893 . . . . 0.0 109.36 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 m -104.38 31.38 4.68 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.94 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.502 HD21 ' O ' ' A' ' 89' ' ' LEU . 4.1 tt -88.78 1.84 54.54 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 123.355 1.55 . . . . 0.0 107.477 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.91 3.07 33.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.619 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -128.9 119.05 23.71 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.137 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 78.8 m95 -135.92 164.66 27.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -130.07 152.72 49.22 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.52 131.46 29.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 123.481 0.488 . . . . 0.0 110.102 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.23 4.6 50.34 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.25 145.03 30.81 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -80.69 154.36 27.36 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-O 121.574 0.702 . . . . 0.0 111.138 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.3 p -159.67 -171.56 3.33 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.439 ' OG ' HG13 ' A' ' 145' ' ' ILE . 75.7 m -129.13 143.72 50.96 Favored 'General case' 0 C--N 1.261 -3.245 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.45 158.66 43.81 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.104 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -93.14 110.86 23.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.519 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.424 ' CD2' ' HB2' ' A' ' 104' ' ' GLU . 6.2 t90 -68.63 125.42 26.47 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.453 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 68.5 m -60.9 -22.96 64.84 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.027 0.829 . . . . 0.0 112.829 -177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.424 ' HB2' ' CD2' ' A' ' 102' ' ' TRP . 4.9 mm-40 -83.62 -42.0 17.2 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.739 -174.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -105.91 -16.23 14.7 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.058 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.67 1.02 75.98 Favored Glycine 0 C--N 1.312 -0.762 0 N-CA-C 111.419 -0.673 . . . . 0.0 111.419 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 78.7 m -89.92 165.86 13.84 Favored 'General case' 0 N--CA 1.414 -2.262 0 C-N-CA 124.028 0.931 . . . . 0.0 111.693 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -90.28 129.24 41.46 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.819 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 95.7 m-85 -134.63 152.22 77.31 Favored Pre-proline 0 C--N 1.285 -2.232 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.865 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.13 130.23 17.35 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.277 1.985 . . . . 0.0 110.837 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.12 150.73 39.86 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.942 0.401 . . . . 0.0 110.066 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.1 m -115.99 135.85 53.58 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 50.9 mt -64.7 123.79 18.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 123.602 0.564 . . . . 0.0 110.781 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.31 -38.2 8.16 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.147 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.1 p -159.43 148.58 18.2 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.7 mt -124.41 130.51 73.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.718 0.294 . . . . 0.0 110.526 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -109.37 103.36 12.27 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.03 -16.9 60.58 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.869 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -73.26 -39.08 65.71 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.061 0.457 . . . . 0.0 110.181 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -95.18 -7.63 38.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.606 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 62.56 26.81 15.91 Favored 'General case' 0 C--O 1.248 1.016 0 C-N-CA 124.8 1.24 . . . . 0.0 110.504 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 82.5 p -118.83 165.16 14.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.425 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.58 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.1 p -148.06 151.39 35.61 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.3 t -96.19 132.56 40.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 29.2 m -123.54 147.57 27.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 56.9 t -106.5 122.06 59.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.849 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -70.78 114.08 8.5 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 123.747 0.654 . . . . 0.0 110.71 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.7 m -65.54 130.33 42.93 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.908 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.16 -13.4 66.4 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.151 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.59 -48.93 2.67 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.901 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 101.28 7.11 50.1 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.426 -0.892 . . . . 0.0 114.193 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 89.2 m-20 -88.32 162.91 16.32 Favored 'General case' 0 CA--C 1.474 -1.946 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.214 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.6 ppt_? -132.38 136.45 46.82 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.453 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 11.0 tt0 -144.06 151.1 39.19 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.05 126.38 48.98 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -130.7 163.25 27.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -84.33 144.92 28.54 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.0 mt -57.48 -42.74 83.26 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.557 0.694 . . . . 0.0 110.612 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 p -78.36 -7.83 57.75 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.217 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -101.83 -13.76 17.56 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.58 HD12 ' SG ' ' A' ' 123' ' ' CYS . 65.4 mt -61.2 160.39 10.46 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.231 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 27.8 mt -126.41 162.44 25.56 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.1 m -67.36 137.05 93.59 Favored Pre-proline 0 C--N 1.298 -1.65 0 O-C-N 123.596 0.56 . . . . 0.0 109.93 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -59.65 147.24 92.79 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.364 2.709 . . . . 0.0 114.818 -172.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.439 HG13 ' OG ' ' A' ' 99' ' ' SER . 35.3 mt -93.73 141.06 15.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 174.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.38 43.7 0.83 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 124.886 1.274 . . . . 0.0 110.624 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.426 -1.628 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.284 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 CA--C 1.503 -0.855 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.8 m -72.98 122.23 21.37 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.42 -18.72 65.53 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.578 0.351 . . . . 0.0 111.134 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 68.94 96.22 0.06 Allowed 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 125.228 1.411 . . . . 0.0 113.28 172.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.3 m -113.11 86.43 2.38 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.515 HD21 ' O ' ' A' ' 89' ' ' LEU . 2.6 tt -109.34 -2.79 17.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.484 1.135 . . . . 0.0 110.07 -175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -118.92 0.55 11.37 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.206 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -130.05 109.56 10.94 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -126.71 164.35 21.49 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -125.83 153.41 44.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.42 128.26 26.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.34 10.98 40.22 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.921 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.63 150.06 27.34 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -91.76 150.06 21.29 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 120.956 0.408 . . . . 0.0 109.957 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -155.95 -168.38 2.75 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.494 ' OG ' HG13 ' A' ' 145' ' ' ILE . 66.7 m -128.36 141.16 51.51 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.62 160.42 36.7 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.7 mm -97.04 109.49 23.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -65.7 121.75 15.71 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -60.95 -19.55 61.04 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 124.104 0.878 . . . . 0.0 112.647 -175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.88 -43.12 14.4 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.016 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.53 -15.9 14.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.233 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.7 0.09 79.04 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-O 121.564 0.536 . . . . 0.0 112.058 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.428 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 79.4 m -89.63 162.49 15.59 Favored 'General case' 0 N--CA 1.407 -2.621 0 C-N-CA 123.772 0.829 . . . . 0.0 111.768 -177.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.4 mt -88.04 130.67 37.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.617 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -136.43 152.21 74.47 Favored Pre-proline 0 C--N 1.289 -2.054 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.789 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.02 130.21 17.44 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.279 1.986 . . . . 0.0 110.827 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.66 147.42 31.98 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 120.974 0.416 . . . . 0.0 110.324 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.4 m -113.68 135.89 53.43 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.4 mt -68.26 119.99 14.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 122.734 0.414 . . . . 0.0 110.601 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.89 -30.97 12.44 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.737 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.2 p -161.23 154.76 21.79 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.5 mt -128.33 132.8 67.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.19 102.9 12.0 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -72.13 -16.69 62.0 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.447 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -73.48 -40.26 64.26 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.467 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -97.12 -6.93 33.83 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.8 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 63.13 30.87 16.04 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-O 122.027 0.917 . . . . 0.0 109.949 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.1 p -120.67 166.72 13.3 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.922 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.641 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.6 p -148.7 152.19 36.22 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 87.4 t -95.84 130.61 44.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 22.5 m -123.29 147.31 27.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.0 121.26 58.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -71.2 114.69 9.52 Favored 'General case' 0 C--O 1.257 1.478 0 CA-C-O 121.611 0.72 . . . . 0.0 110.312 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.7 m -66.23 130.63 43.87 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.736 -1.575 . . . . 0.0 110.877 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.86 -21.26 42.58 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.201 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -108.14 -52.68 2.73 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.893 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.88 20.37 10.75 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.796 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -101.37 161.23 13.78 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.55 173.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.3 ppt_? -132.21 135.94 46.66 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -145.18 149.88 35.75 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 37.8 tt0 -102.92 124.29 48.16 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -127.79 163.4 24.43 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.331 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -83.11 142.09 31.5 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.6 mt -55.6 -41.61 73.67 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.921 0.763 . . . . 0.0 111.443 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 m -76.4 -15.66 59.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.895 0.378 . . . . 0.0 111.312 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -95.63 -9.55 31.81 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.802 0.81 . . . . 0.0 109.428 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.641 HD12 ' SG ' ' A' ' 123' ' ' CYS . 62.3 mt -65.35 163.58 15.3 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.284 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.1 mt -131.15 162.41 29.97 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.3 p -69.17 138.46 89.62 Favored Pre-proline 0 C--N 1.308 -1.225 0 O-C-N 123.281 0.363 . . . . 0.0 110.141 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.84 142.42 96.28 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.688 2.259 . . . . 0.0 114.468 -173.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.494 HG13 ' OG ' ' A' ' 99' ' ' SER . 58.1 mt -80.91 152.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 114.249 -1.341 . . . . 0.0 107.888 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 47.0 t -124.1 106.57 10.45 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--N 1.298 -1.663 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.071 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 119.591 -0.242 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.6 p 56.01 -167.52 0.1 Allowed 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.508 1.123 . . . . 0.0 110.553 -173.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.44 -8.79 46.81 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.486 0.66 . . . . 0.0 109.637 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.77 80.48 8.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.976 0.893 . . . . 0.0 111.253 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -164.11 19.5 0.06 Allowed 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 126.26 1.824 . . . . 0.0 106.737 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.37 63.32 4.86 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 122.701 1.239 . . . . 0.0 108.955 -168.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -141.88 -0.43 1.33 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.167 -1.833 . . . . 0.0 110.564 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -126.82 113.63 16.86 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.405 0.622 . . . . 0.0 111.138 -174.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -130.57 163.98 25.9 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -125.78 155.61 40.77 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.66 128.22 25.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.989 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.75 -1.61 48.74 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.966 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.2 146.13 24.22 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -86.59 149.86 24.63 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.092 0.473 . . . . 0.0 111.039 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.9 p -156.7 -168.03 2.56 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.635 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.491 ' OG ' HG13 ' A' ' 145' ' ' ILE . 75.5 m -129.7 149.21 51.55 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.21 160.38 39.59 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 123.574 0.546 . . . . 0.0 109.684 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -94.07 110.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -68.44 124.28 23.1 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.8 m -64.34 -18.03 64.25 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 123.93 0.769 . . . . 0.0 112.662 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.86 -41.79 17.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -104.96 -15.16 15.2 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.626 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.67 2.0 68.23 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 109' ' ' TYR . 98.7 m -90.71 165.03 13.91 Favored 'General case' 0 N--CA 1.406 -2.633 0 C-N-CA 124.494 1.117 . . . . 0.0 112.286 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 mt -90.83 131.33 38.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.556 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 107' ' ' CYS . 98.3 m-85 -141.41 152.31 63.46 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.74 134.98 31.67 Favored 'Trans proline' 0 C--O 1.24 0.624 0 C-N-CA 122.68 2.253 . . . . 0.0 112.143 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.23 157.24 43.53 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.945 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 m -121.46 135.46 55.04 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.3 mt -66.88 118.6 10.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 C-N-CA 123.5 0.72 . . . . 0.0 111.287 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.51 -38.04 11.09 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.627 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 p -157.92 152.21 24.54 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 64.6 mt -126.13 129.58 72.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -108.98 99.67 8.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.21 -20.72 65.74 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.171 -175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -40.3 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 110.461 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -90.51 -7.87 51.84 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.072 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 65.17 26.83 12.38 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.853 1.261 . . . . 0.0 108.994 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.7 p -120.66 169.35 10.46 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.461 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.675 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.7 p -148.6 151.32 34.83 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 123.034 0.533 . . . . 0.0 109.618 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.7 t -96.19 132.33 40.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.64 148.37 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.44 121.06 58.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -67.44 115.09 6.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.787 0.68 . . . . 0.0 110.371 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.5 m -67.56 129.84 41.17 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.85 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.23 -16.29 56.2 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.142 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -109.89 -43.51 3.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.156 0.503 . . . . 0.0 110.536 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.06 59.58 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.006 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -87.95 162.96 16.59 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.179 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -133.68 136.21 44.57 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -144.66 151.4 38.91 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 44.4 tt0 -102.23 122.19 43.7 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 121.539 0.685 . . . . 0.0 109.75 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -126.22 163.52 22.98 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.89 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -85.73 145.48 27.25 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.2 mt -58.81 -39.65 81.81 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.641 0.588 . . . . 0.0 111.225 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.3 p -81.05 -10.14 59.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.16 0.505 . . . . 0.0 111.598 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.96 -13.82 22.11 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.675 HD12 ' SG ' ' A' ' 123' ' ' CYS . 56.3 mt -63.99 160.25 18.26 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.549 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 24.0 mt -130.68 165.12 23.54 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.0 m -66.84 136.82 94.6 Favored Pre-proline 0 C--N 1.304 -1.397 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.89 145.21 97.1 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.409 2.74 . . . . 0.0 115.556 -172.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.491 HG13 ' OG ' ' A' ' 99' ' ' SER . 28.9 mt -103.2 140.16 22.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.592 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 43.2 t -162.85 98.68 0.97 Allowed 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 C--N 1.284 -2.26 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.799 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.5 m -75.39 112.76 12.03 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.49 -7.37 53.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.858 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 67.74 81.67 0.19 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 125.443 1.497 . . . . 0.0 111.146 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.3 m -109.32 15.94 22.74 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.629 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.433 HD21 ' O ' ' A' ' 89' ' ' LEU . 1.8 tt -99.42 -1.02 39.69 Favored 'General case' 0 C--O 1.209 -1.074 0 CA-C-O 123.132 1.444 . . . . 0.0 107.67 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -110.4 -2.32 16.68 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.685 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -115.33 109.45 17.94 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -129.33 164.41 23.63 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -126.52 150.05 49.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.01 128.22 25.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.981 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.14 12.59 42.03 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.916 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.92 148.22 31.0 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -85.04 154.81 21.85 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.614 0.721 . . . . 0.0 111.649 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -161.25 -170.71 2.75 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.778 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.6 m -126.97 140.86 52.01 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.23 159.97 38.64 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.956 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.0 mm -93.1 113.62 28.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.229 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -69.17 119.77 13.97 Favored 'General case' 0 CA--C 1.467 -2.213 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.2 m -64.0 -17.68 63.55 Favored 'General case' 0 C--N 1.278 -2.503 0 O-C-N 123.983 0.802 . . . . 0.0 112.706 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.87 -42.61 16.19 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.274 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -105.71 -15.96 14.82 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.704 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.45 71.52 Favored Glycine 0 N--CA 1.461 0.326 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.132 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.5 m -90.75 166.5 13.09 Favored 'General case' 0 N--CA 1.406 -2.627 0 C-N-CA 124.052 0.941 . . . . 0.0 113.223 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.6 mt -89.39 134.51 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.61 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -141.46 152.26 63.16 Favored Pre-proline 0 C--N 1.304 -1.381 0 C-N-CA 123.032 0.533 . . . . 0.0 110.273 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 128.97 16.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.335 2.023 . . . . 0.0 111.023 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.1 150.34 37.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.12 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.5 m -113.87 136.25 53.09 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.22 121.06 15.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.231 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.18 -31.64 12.35 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.682 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.4 p -164.42 153.05 12.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.3 mt -127.12 129.55 71.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.74 0.416 . . . . 0.0 110.309 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.83 99.41 8.76 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -67.99 -19.75 64.97 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -73.25 -39.89 65.08 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.285 0.565 . . . . 0.0 109.893 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -89.97 -8.65 51.2 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.573 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 61.34 25.32 15.3 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.072 0.949 . . . . 0.0 110.492 -173.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 73.9 p -117.63 162.28 18.28 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.452 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.576 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.6 p -145.12 150.69 37.23 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 84.3 t -95.68 131.95 41.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 29.1 m -123.12 147.83 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 75.9 t -105.22 122.05 58.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -69.63 114.89 8.27 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.403 0.62 . . . . 0.0 110.077 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.9 m -66.36 129.96 41.6 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.717 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.53 -16.58 55.96 Favored Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.835 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -109.4 -46.65 3.51 Favored 'General case' 0 N--CA 1.434 -1.242 0 O-C-N 122.196 -0.591 . . . . 0.0 111.017 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.58 11.83 49.72 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.914 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -94.0 160.91 14.51 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.105 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.6 ppt_? -133.44 135.29 44.48 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -147.44 151.86 37.13 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -173.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 36.7 tt0 -102.02 126.8 49.04 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-O 121.981 0.896 . . . . 0.0 110.874 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -124.03 164.06 20.15 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.442 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.8 m-80 -86.93 144.38 26.98 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.5 mt -56.4 -44.1 79.94 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.725 0.64 . . . . 0.0 110.94 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.1 m -77.09 -9.82 58.98 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.262 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.03 -9.5 20.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.235 0.541 . . . . 0.0 109.813 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.576 HD12 ' SG ' ' A' ' 123' ' ' CYS . 63.9 mt -64.1 159.07 21.16 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.254 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 40.2 mt -126.76 162.29 26.16 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.5 m -71.75 137.5 82.83 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.14 139.69 88.63 Favored 'Trans proline' 0 CA--C 1.502 -1.093 0 C-N-CA 122.542 2.161 . . . . 0.0 113.424 -172.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.427 HG21 ' H ' ' A' ' 147' ' ' GLU . 19.5 mt -77.48 142.98 13.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 45.2 t -119.78 16.59 12.7 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 122.052 0.929 . . . . 0.0 109.098 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.427 ' H ' HG21 ' A' ' 145' ' ' ILE . 5.9 mm-40 . . . . . 0 C--N 1.292 -1.91 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.839 -175.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -167.42 149.72 5.92 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.5 -15.08 38.61 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.03 107.95 8.07 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.783 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.8 m -82.38 9.8 8.35 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.347 0.594 . . . . 0.0 111.369 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.608 HD21 ' O ' ' A' ' 89' ' ' LEU . 4.8 tt -79.03 10.17 3.7 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 123.093 1.425 . . . . 0.0 109.529 -178.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -107.05 1.25 24.16 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.352 -0.842 . . . . 0.0 109.46 174.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -121.56 122.14 39.02 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -136.44 163.93 29.34 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -122.15 152.71 39.64 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.16 128.39 26.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.156 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.65 9.76 48.98 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.906 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.22 148.01 25.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -86.53 153.52 21.77 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.343 0.592 . . . . 0.0 110.841 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.8 p -162.77 -168.6 1.83 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.73 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 67.6 m -129.08 141.27 51.26 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.08 159.79 39.06 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -93.82 110.48 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -67.65 120.67 14.42 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.403 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 67.5 m -61.13 -21.51 63.8 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 123.814 0.696 . . . . 0.0 112.757 -177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -83.95 -37.35 22.4 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.381 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -111.17 -15.68 13.61 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.064 -177.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.59 -5.74 72.64 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.111 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.5 m -90.39 166.47 13.26 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 124.122 0.969 . . . . 0.0 113.593 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.2 mt -87.94 133.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.817 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -142.88 152.66 59.5 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.9 131.57 21.31 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.393 2.062 . . . . 0.0 111.522 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.38 154.51 41.71 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.9 m -118.75 135.92 54.24 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.1 mt -69.23 118.03 12.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.052 0.541 . . . . 0.0 110.687 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.87 -35.15 13.51 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.218 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.0 m -160.28 153.7 22.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.7 mt -127.2 134.2 66.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 123.479 0.487 . . . . 0.0 109.952 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -109.37 103.81 12.8 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -73.16 -18.53 61.26 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 120.971 0.415 . . . . 0.0 111.599 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.21 -37.39 66.45 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.017 0.437 . . . . 0.0 110.612 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -96.8 -7.71 32.98 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.801 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 61.81 26.49 16.08 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.027 0.918 . . . . 0.0 110.404 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.0 p -118.36 161.83 19.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.358 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.548 ' SG ' HD12 ' A' ' 141' ' ' LEU . 10.9 p -147.78 152.14 37.2 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.4 t -96.24 131.84 42.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.3 147.25 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.57 122.17 60.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -69.75 113.8 7.34 Favored 'General case' 0 CA--C 1.491 -1.293 0 O-C-N 123.68 0.612 . . . . 0.0 110.279 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.3 m -65.09 129.12 38.55 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.706 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.88 -20.21 40.76 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.694 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -105.3 -43.53 4.97 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.163 0.506 . . . . 0.0 110.416 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.28 59.94 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.095 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -91.93 163.99 13.81 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -133.52 135.94 44.72 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.403 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 11.1 tt0 -143.4 150.39 39.02 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.37 120.9 41.28 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -126.63 163.74 22.8 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.115 -174.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 17.7 m-80 -85.6 142.96 28.73 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.01 -38.8 73.61 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.751 0.786 . . . . 0.0 110.272 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.5 p -78.88 -7.59 58.08 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.993 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 16.0 t70 -109.8 -4.66 15.91 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.801 0.81 . . . . 0.0 109.323 -175.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.548 HD12 ' SG ' ' A' ' 123' ' ' CYS . 65.8 mt -69.46 162.52 27.26 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.497 175.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 28.0 mt -130.66 162.33 29.64 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m -70.99 141.41 86.7 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.3 140.01 92.74 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 121.968 1.779 . . . . 0.0 112.629 -176.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.1 mt -69.2 150.82 10.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.134 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 71.2 m -75.81 78.53 2.74 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-O 121.582 0.706 . . . . 0.0 109.845 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 . . . . . 0 N--CA 1.429 -1.489 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.909 178.803 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 . . . . . 0 CA--C 1.507 -0.689 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -128.69 -3.45 5.32 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.481 0.658 . . . . 0.0 111.464 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.17 -27.38 12.93 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.262 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 90' ' ' GLN . . . -132.11 19.24 4.5 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.828 0.823 . . . . 0.0 111.179 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.9 p -90.89 12.61 18.95 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.01 -1.09 35.2 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.104 0.954 . . . . 0.0 110.214 -178.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 30.1 pt20 -106.42 3.4 27.29 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.56 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -132.54 120.57 22.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.26 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -139.03 164.29 30.15 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -130.92 155.45 46.75 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.303 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.62 127.05 23.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 O-C-N 123.561 0.538 . . . . 0.0 110.258 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.54 -0.82 32.5 Favored Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.339 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -100.51 148.03 25.24 Favored 'General case' 0 CA--C 1.479 -1.751 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.208 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -87.97 155.26 19.93 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.314 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.0 p -157.58 -169.54 2.91 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.5 m -127.41 140.48 52.14 Favored 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 174.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.69 160.11 38.53 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -94.19 110.61 23.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.864 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -67.19 120.22 13.39 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.442 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 71.2 m -63.05 -17.86 62.71 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 124.107 0.88 . . . . 0.0 112.672 -175.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.08 -40.73 17.95 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.149 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -110.27 -16.48 13.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.534 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.49 -4.64 83.75 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.318 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 66.0 m -90.61 165.39 13.76 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.6 mt -87.36 130.63 36.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.318 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -139.66 152.7 69.11 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.858 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.58 129.62 17.03 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.503 2.135 . . . . 0.0 111.575 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.87 39.77 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.081 -0.387 . . . . 0.0 110.122 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.3 m -116.7 136.04 53.29 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.33 121.71 15.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 123.11 0.564 . . . . 0.0 110.847 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.58 -35.28 9.19 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.675 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.1 p -157.83 152.26 24.77 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.2 mt -128.75 131.83 68.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -106.4 105.08 14.94 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -72.42 -20.15 61.47 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.83 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -74.87 -40.51 60.92 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.166 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -90.88 -7.97 50.72 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.684 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 60.3 29.17 18.79 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.357 1.063 . . . . 0.0 109.983 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.7 p -119.94 165.53 14.52 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.619 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.575 ' SG ' HD12 ' A' ' 141' ' ' LEU . 10.7 p -147.85 152.15 37.14 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.6 t -95.94 130.82 44.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.1 m -123.17 146.75 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.9 t -106.29 120.41 57.29 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -69.07 112.76 5.89 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.492 0.663 . . . . 0.0 109.887 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.7 m -67.93 129.65 40.56 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.805 -174.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.9 -17.41 58.12 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.559 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -108.97 -47.4 3.45 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.719 0.295 . . . . 0.0 111.345 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.63 40.59 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.479 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -98.5 161.58 13.6 Favored 'General case' 0 CA--C 1.48 -1.713 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.453 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -134.16 136.29 43.69 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.442 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 6.7 tt0 -142.93 151.35 40.86 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.673 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -101.73 121.39 41.97 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.831 0.824 . . . . 0.0 109.026 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -126.35 163.61 22.89 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.482 -1.236 . . . . 0.0 108.103 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -86.1 142.88 28.36 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 54.0 mt -56.16 -40.49 73.97 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.859 0.724 . . . . 0.0 110.586 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.6 t -80.44 -6.03 57.47 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.51 0.672 . . . . 0.0 110.345 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -106.28 -8.37 17.32 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 121.432 -0.793 . . . . 0.0 109.301 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.575 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.3 mt -66.8 159.18 28.62 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.111 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 33.9 mt -126.73 162.15 26.47 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.4 m -68.37 135.3 90.99 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 123.464 0.478 . . . . 0.0 110.114 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.92 147.12 95.84 Favored 'Trans proline' 0 CA--C 1.505 -0.927 0 C-N-CA 123.236 2.624 . . . . 0.0 113.78 -172.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.3 mt -87.04 136.18 23.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.1 t -95.92 91.55 6.07 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-O 121.401 0.619 . . . . 0.0 109.654 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 C--N 1.294 -1.828 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.284 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 . . . . . 0 CA--C 1.508 -0.655 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.8 m -95.37 134.08 38.57 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.78 81.86 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.278 0.561 . . . . 0.0 111.265 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.92 106.0 14.98 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.637 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.6 p -80.4 2.72 23.84 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.835 0.826 . . . . 0.0 111.566 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.567 HD21 ' O ' ' A' ' 89' ' ' LEU . 5.1 tt -95.66 6.15 49.65 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.935 1.35 . . . . 0.0 107.589 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -102.02 -0.28 33.9 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.187 176.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -129.3 126.58 39.32 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.129 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -137.36 164.82 27.68 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -119.62 153.38 35.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.83 128.29 25.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.641 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.68 7.08 54.09 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.256 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -96.67 150.02 21.15 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -93.21 141.38 28.49 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-O 120.895 0.378 . . . . 0.0 110.044 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.0 p -152.11 -163.35 1.71 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.532 ' OG ' HG13 ' A' ' 145' ' ' ILE . 73.7 m -132.2 150.01 52.25 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.0 160.36 40.09 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.6 mm -92.83 113.44 27.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -70.77 125.59 27.26 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.7 m -62.52 -20.88 65.07 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 123.388 0.675 . . . . 0.0 112.708 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.96 -42.1 16.62 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.199 -174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -108.32 -14.65 14.64 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.034 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.85 -2.43 74.36 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.436 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 96.4 m -90.03 166.79 13.24 Favored 'General case' 0 N--CA 1.414 -2.227 0 C-N-CA 124.268 1.027 . . . . 0.0 112.723 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.8 mt -87.96 132.63 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.8 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 97.4 m-85 -140.98 152.02 64.05 Favored Pre-proline 0 C--N 1.291 -1.942 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.838 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.51 129.84 18.59 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.616 2.211 . . . . 0.0 112.25 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.49 149.85 38.12 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 m -114.64 136.11 53.41 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.6 mt -69.01 119.81 15.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 O-C-N 123.476 0.485 . . . . 0.0 111.063 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.57 -37.1 11.01 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.883 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.3 p -159.65 153.24 22.64 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.25 132.37 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -108.19 106.05 16.05 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -74.3 -20.48 60.11 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.802 -174.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -73.75 -38.99 64.56 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.117 0.484 . . . . 0.0 110.125 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -95.0 -7.25 40.33 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.617 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 61.63 28.45 17.62 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 124.141 0.976 . . . . 0.0 110.017 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 60.1 p -118.56 168.99 10.17 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.033 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.641 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.4 p -149.0 150.86 33.54 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.1 t -95.89 131.21 43.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.58 147.42 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.993 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 68.9 t -107.46 123.14 62.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -69.96 111.94 6.02 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.432 0.634 . . . . 0.0 110.339 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.9 m -62.77 129.82 42.19 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.966 -175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.66 -20.47 38.4 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.688 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -107.73 -41.44 5.01 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.039 0.447 . . . . 0.0 110.842 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.04 8.78 58.79 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.454 -0.879 . . . . 0.0 114.177 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -91.83 162.48 14.42 Favored 'General case' 0 CA--C 1.482 -1.664 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.031 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -134.44 138.41 44.74 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -144.82 150.86 37.88 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -102.59 122.17 43.84 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -126.41 164.02 22.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.418 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 16.4 m-80 -88.47 143.45 26.97 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.2 mt -55.84 -40.26 72.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 123.79 0.681 . . . . 0.0 111.612 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.0 t -76.39 -16.56 59.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.168 0.509 . . . . 0.0 110.118 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 9.0 t70 -101.16 -0.77 35.45 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.663 0.744 . . . . 0.0 109.684 -172.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.641 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.1 mt -72.05 164.46 26.11 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.256 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.1 mt -132.73 164.18 27.35 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.1 m -70.05 138.81 87.47 Favored Pre-proline 0 C--N 1.306 -1.308 0 C-N-CA 122.891 0.476 . . . . 0.0 109.982 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.91 141.15 88.67 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 123.339 2.693 . . . . 0.0 116.09 -170.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.532 HG13 ' OG ' ' A' ' 99' ' ' SER . 35.7 mt -100.28 144.18 12.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 174.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 44.8 t -119.39 104.64 10.53 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.146 0.498 . . . . 0.0 109.672 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 N--CA 1.413 -2.32 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 176.16 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 CA--C 1.505 -0.786 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.4 m -72.38 124.03 24.29 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.51 -33.02 74.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.132 0.492 . . . . 0.0 110.444 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.47 87.69 6.64 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.461 0.648 . . . . 0.0 109.824 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.2 m -104.98 3.82 31.07 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.985 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 89' ' ' LEU . 4.8 tt -97.68 -0.01 46.3 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.323 1.535 . . . . 0.0 106.863 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -108.61 4.56 24.11 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.442 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -131.71 117.82 19.15 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -132.57 164.94 25.53 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.649 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -124.0 153.71 40.9 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.64 127.85 24.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.047 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.21 12.58 45.13 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.972 -0.633 . . . . 0.0 111.774 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -100.33 145.33 28.28 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.78 140.8 29.45 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.4 -163.42 1.67 Allowed 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.015 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.508 ' OG ' HG13 ' A' ' 145' ' ' ILE . 72.8 m -131.45 147.42 52.55 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.02 160.33 39.63 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.936 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.8 mm -93.27 110.71 23.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -67.62 122.28 17.71 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.4 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 74.2 m -60.19 -25.39 65.54 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 123.957 0.786 . . . . 0.0 112.482 -177.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.32 -41.59 24.57 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.179 -172.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -108.0 -15.67 14.47 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.061 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.32 -4.07 78.78 Favored Glycine 0 N--CA 1.465 0.615 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.12 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.6 m -91.01 166.58 12.94 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.02 132.54 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.318 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -142.17 152.04 60.23 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.526 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -69.95 133.27 24.83 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.443 2.095 . . . . 0.0 111.607 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.64 146.91 29.51 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.825 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -112.77 135.77 53.14 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.2 mt -66.98 122.46 18.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 123.072 0.549 . . . . 0.0 110.595 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.79 -36.82 10.08 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.371 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.2 p -158.7 151.3 21.92 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 64.2 mt -125.37 132.27 71.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.425 ' OD1' ' HE3' ' A' ' 119' ' ' LYS . 9.6 t70 -108.48 104.1 13.37 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -72.78 -16.9 61.63 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HE3' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -73.51 -36.24 65.71 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.136 0.493 . . . . 0.0 110.12 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -98.48 -8.07 27.36 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.38 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 59.72 32.28 21.33 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.935 0.874 . . . . 0.0 109.938 -173.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.8 p -120.6 167.87 11.97 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.84 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.64 ' SG ' HD12 ' A' ' 141' ' ' LEU . 11.0 p -148.49 152.12 36.35 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.9 t -95.94 131.14 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.9 m -123.34 146.91 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' A' ' 133' ' ' ARG . 75.8 t -105.65 120.68 56.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.723 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -68.43 114.13 6.59 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.639 0.587 . . . . 0.0 110.273 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.3 m -66.56 129.4 39.73 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.913 -174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.09 -10.01 74.63 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.51 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -113.99 -51.25 2.79 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.977 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.11 6.18 45.77 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.93 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 96.2 m-20 -89.38 162.42 15.8 Favored 'General case' 0 CA--C 1.472 -2.057 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.248 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.1 ppt_? -135.6 136.05 40.74 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-O 121.27 0.557 . . . . 0.0 110.104 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.4 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 11.1 tt0 -141.9 150.98 42.22 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.314 -174.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -102.64 118.99 38.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.683 0.754 . . . . 0.0 109.406 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -124.21 163.31 21.85 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.443 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -83.86 145.25 28.74 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.6 mt -58.39 -38.74 77.94 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.784 0.678 . . . . 0.0 111.003 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.8 m -80.49 -10.99 59.73 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.32 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.17 -9.63 27.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.601 0.715 . . . . 0.0 109.193 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.64 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.4 mt -68.56 166.25 17.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.01 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 18.8 mt -136.35 163.82 29.56 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.7 m -67.76 141.5 94.97 Favored Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.15 142.43 98.28 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 123.247 2.631 . . . . 0.0 114.59 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.508 HG13 ' OG ' ' A' ' 99' ' ' SER . 37.5 mt -93.01 136.66 24.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 36.6 t -158.52 98.49 1.54 Allowed 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 . . . . . 0 C--N 1.292 -1.933 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.289 -175.919 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 120.45 0.167 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 p -130.66 157.84 41.67 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 122.008 -0.432 . . . . 0.0 109.946 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.13 -28.02 16.57 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.439 0.638 . . . . 0.0 109.788 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.7 22.13 2.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.132 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 p -108.84 30.79 6.19 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.876 0.846 . . . . 0.0 109.113 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.17 1.6 12.94 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.799 -1.091 . . . . 0.0 113.764 -172.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -110.39 -1.33 17.18 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.748 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -120.2 115.11 22.98 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.981 0.896 . . . . 0.0 110.608 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 86.1 m95 -132.65 163.97 27.75 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.975 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -128.95 157.57 41.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.735 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.65 128.04 26.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.9 6.79 56.92 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.925 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.29 144.27 28.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -85.84 152.82 22.7 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.537 0.684 . . . . 0.0 111.629 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.6 p -161.91 -170.95 2.7 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.919 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 74.7 m -127.41 144.42 51.06 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.09 160.05 40.1 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 mm -94.27 111.53 25.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -69.05 123.18 20.35 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.457 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 70.7 m -63.28 -18.84 64.01 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 123.969 0.793 . . . . 0.0 112.966 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -83.33 -41.55 18.1 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.346 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -106.37 -16.38 14.57 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.971 -1.092 . . . . 0.0 111.418 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.96 0.75 86.26 Favored Glycine 0 C--N 1.31 -0.874 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 71.0 m -90.89 164.59 13.98 Favored 'General case' 0 N--CA 1.421 -1.883 0 C-N-CA 124.885 1.274 . . . . 0.0 112.473 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 mt -88.89 132.12 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -139.46 152.5 69.12 Favored Pre-proline 0 C--N 1.284 -2.267 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.33 134.72 27.44 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.639 2.226 . . . . 0.0 111.18 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.41 153.59 40.64 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.208 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.0 m -119.65 135.39 54.83 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 57.0 mt -64.5 122.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 123.439 0.695 . . . . 0.0 110.652 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.71 -38.98 9.69 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.819 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.8 m -158.48 149.68 20.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 64.3 mt -123.56 132.43 71.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 122.971 0.508 . . . . 0.0 109.809 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.92 104.1 13.49 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -74.57 -14.66 60.82 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.954 0.407 . . . . 0.0 111.866 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -74.08 -40.93 62.42 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.238 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -96.84 -8.45 30.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.6 33.29 20.41 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.953 0.883 . . . . 0.0 110.026 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.1 p -120.72 165.33 15.25 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.983 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.614 ' SG ' HD12 ' A' ' 141' ' ' LEU . 12.5 p -148.15 152.5 37.4 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 95.3 t -95.78 131.38 42.7 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 27.8 m -123.63 147.3 28.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.7 t -105.23 122.81 58.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -69.42 114.22 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.479 0.656 . . . . 0.0 109.92 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.3 m -65.4 130.23 42.58 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.547 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.82 -24.86 15.6 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.792 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -99.39 -51.73 3.71 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 122.448 -0.442 . . . . 0.0 111.027 -176.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.36 19.78 17.47 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.437 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -103.51 162.03 13.38 Favored 'General case' 0 CA--C 1.479 -1.77 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.363 173.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.4 ppt_? -133.42 140.23 47.2 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.457 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 9.4 tt0 -147.75 150.84 35.02 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.504 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 34.8 tt0 -103.18 122.54 44.93 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.534 0.683 . . . . 0.0 109.669 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -125.41 162.91 23.77 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' ' 140' ' ' ASP . 19.2 m-80 -83.38 144.02 29.92 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.1 mt -58.2 -41.68 84.52 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.672 0.608 . . . . 0.0 110.515 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.8 m -80.08 -5.67 56.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.459 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.48 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 27.3 t70 -110.61 -2.18 16.5 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.56 0.695 . . . . 0.0 109.281 -176.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.614 HD12 ' SG ' ' A' ' 123' ' ' CYS . 60.0 mt -68.6 163.92 22.58 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.686 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 35.3 mt -125.44 157.79 36.02 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.4 m -70.75 140.63 86.7 Favored Pre-proline 0 C--N 1.291 -1.948 0 O-C-N 123.479 0.487 . . . . 0.0 110.275 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.29 149.52 80.37 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.193 2.596 . . . . 0.0 113.126 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.6 mt -90.15 139.28 17.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 32.9 t -140.8 24.95 2.18 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.897 0.856 . . . . 0.0 109.384 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.261 1.673 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.812 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.505 -0.765 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.8 t -113.05 -17.29 12.46 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.185 0.517 . . . . 0.0 111.822 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.19 -43.01 15.36 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.76 126.67 33.15 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 170.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -69.57 90.47 0.56 Allowed 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 122.09 0.948 . . . . 0.0 111.019 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tt -132.37 16.56 4.48 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.727 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -103.8 -8.58 19.68 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.302 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -104.34 109.2 20.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.003 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -128.41 163.6 24.51 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.981 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -126.51 155.44 42.34 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.26 132.61 30.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.97 18.19 44.6 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.215 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -113.2 149.82 33.17 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -86.01 149.58 25.07 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 123.647 0.779 . . . . 0.0 110.624 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -159.47 -168.72 2.38 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 68.7 m -130.38 145.3 51.78 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.99 160.3 40.11 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.635 0.255 . . . . 0.0 110.796 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.38 112.28 25.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.81 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.414 ' CD2' ' HB2' ' A' ' 104' ' ' GLU . 5.2 t90 -70.49 124.44 24.21 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 m -62.69 -23.45 67.14 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.53 0.681 . . . . 0.0 112.559 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.414 ' HB2' ' CD2' ' A' ' 102' ' ' TRP . 5.0 mm-40 -81.23 -39.79 24.82 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.263 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -108.8 -15.8 14.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.923 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.89 -1.47 83.98 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 75.1 m -90.29 164.93 14.18 Favored 'General case' 0 N--CA 1.419 -2.0 0 C-N-CA 124.592 1.157 . . . . 0.0 112.928 -176.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.8 mt -87.75 132.92 31.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.259 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -142.23 152.52 61.31 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.158 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 139.35 39.66 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 122.861 2.374 . . . . 0.0 111.868 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.9 157.49 43.23 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.463 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 m -119.55 135.56 54.73 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.9 mt -70.41 118.74 15.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 122.812 0.445 . . . . 0.0 110.538 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.38 -29.85 14.79 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.963 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.9 p -161.79 153.37 18.77 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.4 mt -126.94 133.98 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.485 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 11.1 t70 -108.41 100.98 10.2 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 174.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -72.01 -16.34 62.06 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -73.57 -40.4 63.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.283 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 37.9 mmt-85 -93.76 -7.8 42.51 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 60.85 30.28 19.55 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.343 1.057 . . . . 0.0 109.685 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -119.07 165.93 13.53 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.606 ' SG ' HD12 ' A' ' 141' ' ' LEU . 9.3 p -148.12 150.69 34.31 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.6 t -95.98 130.49 44.59 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.9 m -123.06 147.0 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' A' ' 133' ' ' ARG . 62.2 t -104.85 120.1 54.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.083 178.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -66.93 115.13 6.34 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.352 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.1 m -72.6 129.3 37.95 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.454 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.48 -14.81 63.79 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -118.09 -44.61 2.69 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 122.456 -0.438 . . . . 0.0 110.96 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.26 8.23 56.61 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.987 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.55 163.03 14.74 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 117.777 0.788 . . . . 0.0 109.289 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.7 ppt_? -133.02 139.0 47.0 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -147.68 151.7 36.57 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.494 0.718 . . . . 0.0 109.075 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -101.89 126.65 48.83 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.587 0.708 . . . . 0.0 109.835 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -129.27 163.38 25.79 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.131 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -85.84 144.06 27.92 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.5 mt -57.94 -40.12 79.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 123.736 0.648 . . . . 0.0 110.905 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.8 m -80.75 -5.21 56.81 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.266 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -106.99 -14.27 14.99 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.606 HD12 ' SG ' ' A' ' 123' ' ' CYS . 53.3 mt -60.69 154.62 21.04 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-O 121.548 0.69 . . . . 0.0 110.527 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 36.7 mt -120.0 156.65 30.47 Favored 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.022 -176.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.2 m -68.8 140.65 91.8 Favored Pre-proline 0 C--N 1.28 -2.444 0 O-C-N 123.843 0.714 . . . . 0.0 109.289 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.74 145.91 98.16 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.361 2.041 . . . . 0.0 112.804 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.4 mt -98.99 148.99 5.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.3 m -85.01 20.51 1.85 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.02 0.928 . . . . 0.0 112.796 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 . . . . . 0 C--N 1.309 -1.172 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.855 -178.062 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 4.1 m-20 . . . . . 0 CA--C 1.505 -0.77 0 CA-C-O 120.62 0.248 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 m -105.67 87.35 2.58 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-O 121.401 0.62 . . . . 0.0 110.497 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.47 -55.75 0.05 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.726 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.37 166.78 22.66 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.9 t -107.22 29.79 6.8 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 89' ' ' LEU . 4.4 tt -79.95 -0.36 34.8 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-O 122.642 1.211 . . . . 0.0 109.553 -175.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 84' ' ' ASN . 19.9 pt20 -105.19 3.33 30.04 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.815 176.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -113.15 112.02 23.09 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.346 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -131.68 164.99 24.72 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.246 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -126.78 155.03 43.46 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.14 128.33 23.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 120.968 0.413 . . . . 0.0 109.946 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.64 5.32 54.05 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.917 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.41 140.78 29.19 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -89.28 144.14 26.31 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.22 -164.61 2.0 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 68.6 m -129.19 141.11 51.25 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.68 160.26 38.08 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.172 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.71 111.07 24.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.307 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -66.25 119.11 10.94 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.7 m -63.53 -17.35 62.69 Favored 'General case' 0 C--N 1.274 -2.678 0 C-N-CA 123.928 0.891 . . . . 0.0 113.099 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -83.14 -37.39 23.8 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 114.557 -1.202 . . . . 0.0 111.629 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -116.36 -15.55 10.95 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.245 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.28 -6.14 77.46 Favored Glycine 0 C--N 1.316 -0.538 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.059 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 78.0 m -90.38 164.98 14.11 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.5 mt -86.56 133.44 29.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.931 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -141.8 152.16 61.76 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.07 130.79 19.57 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.37 2.047 . . . . 0.0 111.667 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.59 151.41 39.0 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.199 -0.313 . . . . 0.0 110.537 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.6 m -116.87 135.76 53.48 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.163 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 52.2 mt -65.68 117.82 7.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 123.288 0.635 . . . . 0.0 110.913 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.99 -37.0 11.89 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.853 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -160.27 149.56 17.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.2 133.89 67.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.43 102.49 11.37 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -70.95 -20.88 62.41 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.136 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -73.79 -38.01 64.76 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.044 0.45 . . . . 0.0 110.977 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -92.1 -7.65 47.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.195 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 60.49 30.81 20.06 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 124.149 0.906 . . . . 0.0 110.102 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 52.1 p -121.75 166.79 13.78 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.231 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.64 ' SG ' HD12 ' A' ' 141' ' ' LEU . 10.7 p -148.51 152.13 36.34 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 92.5 t -95.57 131.37 42.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.14 147.19 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 67.1 t -106.93 121.57 59.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.54 112.94 5.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.568 0.699 . . . . 0.0 110.354 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.9 m -66.5 130.07 41.98 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.972 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.73 -5.5 83.53 Favored Glycine 0 N--CA 1.432 -1.627 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.201 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -117.28 -50.73 2.55 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.817 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.45 34.04 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 119.857 -1.163 . . . . 0.0 114.059 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -97.09 162.71 13.25 Favored 'General case' 0 CA--C 1.482 -1.661 0 C-N-CA 119.344 -0.943 . . . . 0.0 109.553 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -134.04 139.45 46.02 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.201 0.524 . . . . 0.0 109.866 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -147.13 150.44 34.98 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.378 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 41.4 tt0 -103.02 120.87 41.43 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -126.3 163.73 22.58 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.219 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 18.1 m-80 -85.06 142.79 29.31 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.5 mt -59.32 -36.49 75.76 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.877 0.846 . . . . 0.0 109.919 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.6 p -79.62 -10.3 59.77 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.665 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.07 -4.54 15.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.511 0.672 . . . . 0.0 109.763 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.64 HD12 ' SG ' ' A' ' 123' ' ' CYS . 71.2 mt -67.23 162.71 22.01 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.716 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.5 mt -128.94 159.86 34.51 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.438 -177.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.4 m -69.43 140.43 90.03 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 123.495 0.497 . . . . 0.0 109.961 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.42 145.65 92.61 Favored 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 122.943 2.429 . . . . 0.0 114.599 -173.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 68.1 mt -86.5 157.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 113.523 -1.671 . . . . 0.0 106.505 174.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 28.5 t -76.72 85.39 3.35 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 122.112 0.958 . . . . 0.0 109.446 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 N--CA 1.409 -2.494 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 175.621 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . 0.547 ' HE ' ' HA ' ' A' 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.6 t30 . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 49.5 m -136.24 83.31 2.0 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -177.99 -83.11 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.711 1.204 . . . . 0.0 107.92 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 90' ' ' GLN . . . 47.64 -82.39 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.365 1.866 . . . . 0.0 114.582 175.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 p -82.23 -12.95 57.77 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.59 0.71 . . . . 0.0 111.769 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.452 HD21 ' O ' ' A' ' 89' ' ' LEU . 1.7 tt -97.98 -1.08 43.53 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 122.433 1.111 . . . . 0.0 109.577 -178.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 20.9 pt20 -105.57 -3.53 22.24 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.755 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -125.41 119.83 29.36 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.904 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -132.12 164.37 26.44 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -130.95 155.9 46.01 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.57 128.28 25.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.78 7.62 52.97 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.755 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.41 147.34 25.35 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -91.54 150.94 20.97 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.2 p -155.63 -168.04 2.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 67.0 m -129.6 145.21 51.51 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.44 159.95 40.22 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 123.215 0.322 . . . . 0.0 110.281 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.9 mm -92.27 112.61 26.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.342 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -69.48 118.21 12.07 Favored 'General case' 0 CA--C 1.471 -2.077 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.2 m -58.88 -23.1 60.54 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 122.068 0.937 . . . . 0.0 112.194 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.06 -39.74 23.03 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.987 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -108.77 -16.54 14.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.704 0.764 . . . . 0.0 109.855 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.84 -6.53 69.87 Favored Glycine 0 C--O 1.225 -0.448 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.997 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 65.3 m -90.96 167.53 12.34 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.0 mt -88.0 132.13 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.506 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -140.1 152.47 67.47 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.209 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.09 130.4 18.86 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.416 2.077 . . . . 0.0 111.24 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.16 149.62 35.3 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.963 0.411 . . . . 0.0 110.312 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.6 m -117.54 136.17 53.44 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 56.7 mt -65.74 121.76 15.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 O-C-N 123.548 0.53 . . . . 0.0 111.156 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.14 -34.59 9.98 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.919 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.8 p -161.12 150.89 17.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 67.7 mt -127.43 133.37 68.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 117.931 0.332 . . . . 0.0 110.111 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -108.82 103.68 12.79 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.65 -14.32 61.56 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.271 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -73.68 -41.3 62.85 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.877 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -98.22 -6.12 31.89 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.401 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 63.64 29.33 15.1 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.828 0.851 . . . . 0.0 109.308 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 47.1 p -117.29 165.41 13.49 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.916 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.618 ' SG ' HD12 ' A' ' 141' ' ' LEU . 11.6 p -148.55 152.39 36.74 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 120.676 0.274 . . . . 0.0 110.272 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.3 t -96.25 130.63 44.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.72 147.25 28.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 53.5 t -106.07 123.54 60.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.139 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -72.05 113.77 9.44 Favored 'General case' 0 C--O 1.257 1.5 0 CA-C-O 121.479 0.656 . . . . 0.0 110.475 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.5 m -69.2 130.21 42.01 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.742 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.76 -10.17 72.67 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.838 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -118.54 -53.05 2.34 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.719 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.21 17.43 15.87 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.728 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -99.71 165.61 11.51 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -132.99 142.46 48.85 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -145.51 151.28 37.92 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.98 121.65 42.57 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.424 0.631 . . . . 0.0 109.52 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -125.33 163.41 22.61 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 15.7 m-80 -85.62 143.48 28.41 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.1 mt -58.49 -38.3 77.35 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.682 0.754 . . . . 0.0 110.607 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.4 p -80.42 -8.67 59.62 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.992 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 12.6 t70 -105.33 -8.15 18.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.618 HD12 ' SG ' ' A' ' 123' ' ' CYS . 61.0 mt -65.86 157.8 29.56 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.625 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.3 mt -124.76 161.32 26.68 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -176.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.8 m -68.16 135.2 91.45 Favored Pre-proline 0 C--N 1.294 -1.846 0 O-C-N 123.542 0.526 . . . . 0.0 110.278 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -62.73 146.15 95.1 Favored 'Trans proline' 0 CA--C 1.508 -0.786 0 C-N-CA 123.729 2.953 . . . . 0.0 115.094 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.47 HG21 ' N ' ' A' ' 146' ' ' CYS . 45.7 mt -90.6 153.92 3.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.47 ' N ' HG21 ' A' ' 145' ' ' ILE . 42.0 t 74.81 -1.77 3.0 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 125.198 1.399 . . . . 0.0 110.848 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 . . . . . 0 C--N 1.289 -2.057 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.495 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.403 0.144 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.3 m -76.39 106.39 7.99 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 73.81 -49.61 0.68 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.008 2.123 . . . . 0.0 113.342 173.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.41 101.97 2.06 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.057 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.0 m -152.44 19.33 0.64 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.5 tt -91.18 58.01 3.58 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -154.39 11.91 0.4 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.778 -1.556 . . . . 0.0 111.207 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -109.94 108.14 18.3 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.402 ' CD1' HD13 ' A' ' 141' ' ' LEU . 83.1 m95 -133.64 163.75 28.73 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.694 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -125.24 151.61 45.69 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.23 128.41 26.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.86 10.83 54.79 Favored Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.372 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -103.85 153.22 21.0 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -86.43 147.87 25.81 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 123.677 0.791 . . . . 0.0 110.51 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -156.64 -168.85 2.81 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 69.2 m -130.64 141.74 50.43 Favored 'General case' 0 C--N 1.264 -3.123 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.71 160.15 38.41 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 123.313 0.383 . . . . 0.0 110.651 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.4 mm -94.55 109.93 22.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.087 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -66.21 121.28 14.86 Favored 'General case' 0 CA--C 1.473 -1.996 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.9 m -61.33 -19.7 62.11 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 124.067 0.947 . . . . 0.0 112.341 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -84.36 -42.35 15.82 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.35 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -104.57 -16.09 15.13 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.648 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.25 -1.27 65.3 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 71.1 m -90.37 162.56 15.07 Favored 'General case' 0 N--CA 1.408 -2.569 0 C-N-CA 124.323 1.049 . . . . 0.0 112.177 -175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.4 mt -86.6 133.77 29.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.099 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -140.31 152.26 66.42 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 131.5 19.49 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.425 2.083 . . . . 0.0 111.228 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.62 154.57 42.96 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.437 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.0 m -119.33 135.95 54.48 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.7 mt -68.77 124.12 23.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 122.922 0.489 . . . . 0.0 111.346 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.51 -32.32 11.88 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.876 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.4 p -163.89 152.84 13.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.93 132.18 70.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 122.818 0.447 . . . . 0.0 109.826 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.408 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 10.1 t70 -109.4 102.54 11.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 173.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.51 -21.82 63.64 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.635 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -73.57 -36.25 65.55 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.603 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.408 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 35.2 mmt180 -93.35 -8.52 41.71 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 61.08 28.51 18.23 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.196 0.998 . . . . 0.0 110.186 -173.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.6 p -119.95 166.18 13.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.127 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.631 ' SG ' HD12 ' A' ' 141' ' ' LEU . 8.4 p -148.45 150.73 33.98 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.3 t -96.1 132.5 40.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 27.7 m -124.03 147.55 28.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.4 t -104.99 121.46 56.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.071 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -69.89 116.63 10.5 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-O 121.548 0.69 . . . . 0.0 110.84 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.2 m -66.2 129.86 41.24 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.176 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.78 -16.82 59.95 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.047 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -115.15 -51.81 2.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.432 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.26 17.06 28.12 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.644 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 90.6 m-20 -93.48 162.48 13.95 Favored 'General case' 0 CA--C 1.472 -2.053 0 C-N-CA 119.499 -0.88 . . . . 0.0 108.642 174.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.7 ppt_? -131.72 135.46 46.86 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -142.61 151.11 41.15 Favored 'General case' 0 N--CA 1.409 -2.486 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.323 -173.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -101.77 122.0 43.13 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.798 0.809 . . . . 0.0 109.904 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -126.82 163.54 23.36 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.434 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.449 ' HB2' ' CB ' ' A' ' 140' ' ' ASP . 17.9 m-80 -88.59 143.45 26.94 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 61.8 mt -57.07 -40.69 77.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.204 0.602 . . . . 0.0 111.253 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.6 t -80.87 -8.53 59.74 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.317 0.58 . . . . 0.0 110.736 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.449 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 21.4 t70 -102.16 -10.71 19.39 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.631 HD12 ' SG ' ' A' ' 123' ' ' CYS . 60.8 mt -66.59 157.81 31.43 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.23 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 28.5 mt -125.27 161.58 26.63 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -176.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.6 m -68.8 138.69 90.6 Favored Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 123.282 0.364 . . . . 0.0 110.557 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.84 147.07 95.09 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 123.543 2.829 . . . . 0.0 113.779 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.3 mt -94.54 145.9 7.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 40.9 t -147.98 98.7 2.98 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 . . . . . 0 C--N 1.295 -1.774 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.208 -178.683 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 p30 . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 87' ' ' ALA . 19.2 m -66.7 123.32 19.78 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 72.72 -8.2 1.29 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.895 1.278 . . . . 0.0 111.539 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 85' ' ' THR . . . -104.99 7.34 34.05 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.607 0.718 . . . . 0.0 110.023 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -105.96 19.5 20.43 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 89' ' ' LEU . 4.4 tt -92.07 25.41 2.87 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 79.5 mt-30 -102.43 -19.02 15.1 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.7 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -88.18 110.14 20.46 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.954 0.883 . . . . 0.0 111.711 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -132.33 164.05 27.32 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.399 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -131.47 156.11 46.22 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.39 131.94 29.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.13 3.68 54.24 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.574 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.411 ' HB2' HD13 ' A' ' 113' ' ' ILE . 62.5 m-20 -99.56 139.48 35.16 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -83.66 145.51 28.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.8 p -153.45 -161.97 1.37 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.41 ' OG ' HG13 ' A' ' 145' ' ' ILE . 70.6 m -135.78 146.59 47.76 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.0 161.12 38.13 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.571 -176.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.8 mm -92.77 112.43 26.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -69.02 124.29 23.34 Favored 'General case' 0 CA--C 1.474 -1.964 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.415 ' HG ' ' CD ' ' A' ' 134' ' ' GLU . 66.1 m -59.52 -25.36 64.43 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.977 0.798 . . . . 0.0 112.366 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -81.53 -41.84 21.07 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.485 -0.78 . . . . 0.0 113.102 -174.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -105.82 -15.87 14.82 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.578 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.74 -0.74 76.18 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.94 164.62 14.49 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 124.013 0.925 . . . . 0.0 112.263 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 mt -88.39 131.2 36.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.248 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -140.08 152.39 67.34 Favored Pre-proline 0 C--N 1.291 -1.97 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.467 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.73 137.14 26.78 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.227 1.951 . . . . 0.0 111.399 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.96 148.66 29.35 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.893 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.3 m -112.42 136.05 52.38 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.411 HD13 ' HB2' ' A' ' 96' ' ' ASP . 57.5 mt -66.39 118.64 9.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 C-N-CA 123.202 0.601 . . . . 0.0 110.945 -178.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.29 -41.92 8.79 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.934 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.0 m -157.58 149.71 22.44 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -123.48 132.26 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 123.314 0.384 . . . . 0.0 110.213 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.12 108.73 19.51 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -75.56 -17.42 60.06 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.166 -173.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -73.31 -41.73 63.19 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -94.21 -8.03 40.45 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.004 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 60.86 31.52 20.03 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.288 1.035 . . . . 0.0 110.035 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 49.3 p -119.38 167.38 11.97 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.729 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.615 ' SG ' HD12 ' A' ' 141' ' ' LEU . 11.7 p -148.33 151.83 36.04 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.637 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.0 t -96.07 132.59 39.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.87 148.41 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 68.0 t -106.24 120.56 57.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.475 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.47 116.03 8.56 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.675 0.61 . . . . 0.0 110.713 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.5 m -71.54 129.57 39.09 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.883 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.21 -14.9 64.4 Favored Glycine 0 N--CA 1.429 -1.793 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.908 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -117.71 -44.47 2.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 120.971 0.415 . . . . 0.0 110.718 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.8 10.8 52.04 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.011 -1.09 . . . . 0.0 114.437 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -91.29 162.58 14.56 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-N 117.93 0.865 . . . . 0.0 109.267 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -132.07 137.75 47.89 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.415 ' CD ' ' HG ' ' A' ' 103' ' ' SER . 6.0 tt0 -145.7 151.83 38.64 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -101.72 124.73 47.86 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -176.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -129.16 163.77 24.81 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.629 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -87.58 144.04 26.89 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' A' ' 90' ' ' GLN . 62.9 mt -58.77 -39.33 80.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.676 0.75 . . . . 0.0 110.273 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.7 p -73.8 -17.12 61.12 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.481 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -101.89 -7.8 22.15 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -173.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.615 HD12 ' SG ' ' A' ' 123' ' ' CYS . 62.4 mt -66.9 157.48 33.07 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.095 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.9 mt -126.25 160.81 29.28 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.4 m -69.83 139.39 88.32 Favored Pre-proline 0 C--N 1.293 -1.886 0 O-C-N 123.571 0.545 . . . . 0.0 110.4 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.62 153.17 63.57 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.921 3.081 . . . . 0.0 115.287 -172.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.41 HG13 ' OG ' ' A' ' 99' ' ' SER . 22.0 mt -100.3 153.93 4.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 43.4 t -117.26 82.45 1.82 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.48 0.657 . . . . 0.0 109.294 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 . . . . . 0 C--N 1.297 -1.689 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.411 -177.659 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.4 m95 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -128.51 154.76 45.79 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.19 127.07 24.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.84 8.99 47.19 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.527 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.406 ' HB3' HD12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -97.5 148.86 22.8 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -91.52 151.26 20.83 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -158.16 -169.58 2.84 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 121.479 0.657 . . . . 0.0 110.005 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.5 m -127.07 144.07 51.12 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 173.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.18 160.12 39.36 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.0 mm -93.82 109.59 22.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -68.62 123.71 21.62 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.9 m -63.19 -20.03 65.04 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.86 -39.48 19.84 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.517 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -108.03 -15.42 14.52 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.642 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.33 1.35 69.57 Favored Glycine 0 C--N 1.313 -0.717 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 77.4 m -90.55 164.19 14.32 Favored 'General case' 0 N--CA 1.405 -2.685 0 C-N-CA 124.303 1.041 . . . . 0.0 112.327 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -89.5 129.26 40.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.349 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -137.56 152.58 73.16 Favored Pre-proline 0 C--N 1.286 -2.187 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.795 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.97 133.33 23.11 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.624 2.216 . . . . 0.0 111.555 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.75 153.81 41.35 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.27 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 m -118.23 135.88 53.99 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 96' ' ' ASP . 51.3 mt -68.82 120.49 16.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 120.958 0.409 . . . . 0.0 110.587 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.71 -38.44 9.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.968 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -159.3 152.21 21.94 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 123' ' ' CYS . 63.4 mt -128.87 136.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 122.65 0.38 . . . . 0.0 110.343 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -109.27 99.52 8.78 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -71.27 -18.54 62.42 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.078 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -73.46 -40.58 64.05 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.21 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -90.83 -7.3 52.68 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 61.86 32.8 17.92 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.79 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.5 p -122.74 164.05 19.03 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.168 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.669 ' SG ' HD11 ' A' ' 141' ' ' LEU . 16.8 p -148.44 155.86 41.75 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.75 0.31 . . . . 0.0 110.396 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.77 130.19 46.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 31.6 m -123.3 147.24 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 133' ' ' ARG . 75.2 t -104.7 122.55 57.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.17 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -70.27 114.97 8.93 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.64 0.588 . . . . 0.0 110.192 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 45.7 m -67.76 131.83 46.3 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.069 -176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.1 -15.37 63.04 Favored Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.852 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -116.75 -47.88 2.69 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.732 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.34 14.38 38.7 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.938 -1.125 . . . . 0.0 114.086 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -94.63 162.63 13.71 Favored 'General case' 0 CA--C 1.479 -1.776 0 C-N-CA 119.606 -0.838 . . . . 0.0 108.986 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.2 ppt_? -133.78 136.38 44.5 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -141.98 151.76 42.81 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.62 -174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.76 120.52 40.5 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -125.75 163.49 22.74 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.254 -174.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -85.88 143.31 28.3 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.411 HD21 HG23 ' A' ' 116' ' ' ILE . 66.8 mt -58.57 -39.79 81.28 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.623 0.577 . . . . 0.0 110.683 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.6 t -80.91 -5.52 57.52 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.426 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -106.96 -8.53 16.58 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.514 0.673 . . . . 0.0 109.706 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.669 HD11 ' SG ' ' A' ' 123' ' ' CYS . 67.1 mt -66.59 162.61 20.57 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.856 176.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 41.3 mt -128.49 159.94 33.88 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 30.3 m . . . . . 0 C--N 1.296 -1.731 0 O-C-N 123.658 0.599 . . . . 0.0 111.595 -175.905 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.444 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 86.8 m95 . . . . . 0 N--CA 1.438 -1.055 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 8.9 ptpp? -128.95 153.45 47.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.16 127.43 24.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.75 8.71 56.95 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.761 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 2.5 t0 -99.96 146.8 26.28 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -83.67 154.95 23.4 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 121.294 0.569 . . . . 0.0 111.418 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -160.0 -174.47 4.58 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.4 m -125.03 140.97 52.43 Favored 'General case' 0 C--N 1.258 -3.386 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 174.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.76 159.97 38.99 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.152 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.98 111.58 25.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -68.76 121.96 17.59 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.6 m -63.49 -19.74 65.01 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 123.952 0.782 . . . . 0.0 112.821 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -84.57 -42.13 15.76 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.174 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -106.74 -15.47 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.674 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.14 -5.24 77.6 Favored Glycine 0 N--CA 1.462 0.431 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.425 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 68.0 m -90.65 166.99 12.86 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 123.75 0.82 . . . . 0.0 113.176 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.3 mt -86.88 133.2 30.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.984 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -140.67 152.46 66.07 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.477 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.24 127.8 14.71 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.237 1.958 . . . . 0.0 110.965 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.01 150.36 39.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 120.904 0.383 . . . . 0.0 110.192 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 m -114.99 135.84 53.79 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 53.0 mt -68.32 118.93 13.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.891 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.68 -36.69 12.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.911 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m -159.19 150.04 19.8 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.4 HG23 HD21 ' A' ' 138' ' ' LEU . 69.0 mt -126.94 132.78 69.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 122.971 0.508 . . . . 0.0 110.514 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -108.94 110.38 21.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -75.37 -21.34 58.4 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.992 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -73.51 -36.57 65.77 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.241 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -94.97 -8.86 35.73 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.359 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 57.63 35.65 25.9 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.924 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 47.1 p -121.93 163.01 20.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.905 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.599 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.2 p -148.34 153.45 38.64 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 120.816 0.341 . . . . 0.0 110.282 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.6 t -96.34 132.44 40.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.9 m -123.49 147.13 27.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.0 t -106.3 120.94 58.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -70.58 115.74 10.09 Favored 'General case' 0 C--O 1.259 1.577 0 CA-C-O 121.386 0.612 . . . . 0.0 109.978 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.0 m -69.04 129.58 40.31 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.313 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.81 -17.48 58.57 Favored Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.026 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.93 -52.72 2.73 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.207 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.11 22.17 8.96 Favored Glycine 0 N--CA 1.435 -1.383 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.734 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -105.62 161.91 13.97 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.7 ppt_? -135.08 136.08 41.74 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -143.18 151.32 40.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -101.96 119.74 39.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.634 0.73 . . . . 0.0 109.27 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -126.24 163.5 23.06 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.042 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.3 m-80 -85.36 143.93 28.34 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.4 HD21 HG23 ' A' ' 116' ' ' ILE . 60.5 mt -59.06 -37.01 76.04 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.794 0.807 . . . . 0.0 109.495 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.3 m -73.75 -19.76 60.69 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.117 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -102.57 -8.93 20.59 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.29 0.567 . . . . 0.0 110.332 -173.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.599 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.4 mt -63.45 160.72 15.71 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.939 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.9 mt -125.3 159.93 30.51 Favored 'General case' 0 C--N 1.254 -3.586 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.2 m . . . . . 0 C--N 1.29 -1.997 0 O-C-N 123.577 0.548 . . . . 0.0 110.264 -178.575 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.479 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 79.8 m95 . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -129.76 157.73 41.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.23 128.71 25.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.508 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.56 -1.77 36.76 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.204 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.481 ' HB2' HD12 ' A' ' 113' ' ' ILE . 24.6 m-20 -96.79 135.32 38.9 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 122.68 -0.306 . . . . 0.0 111.08 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 14.6 mtmt -77.47 147.76 35.73 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-O 121.335 0.588 . . . . 0.0 110.901 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.9 p -154.53 -166.5 2.35 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 114.579 -1.192 . . . . 0.0 107.96 -177.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 73.2 m -129.03 141.37 51.26 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.61 160.36 38.73 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.2 mm -93.92 112.58 27.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -68.33 120.72 14.91 Favored 'General case' 0 CA--C 1.473 -1.981 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.6 m -61.65 -20.46 63.44 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.947 0.779 . . . . 0.0 112.631 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -84.73 -39.8 18.06 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.565 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -109.02 -15.95 14.24 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.042 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.13 -3.95 78.45 Favored Glycine 0 N--CA 1.464 0.524 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.328 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 70.7 m -90.62 168.15 12.01 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.8 mt -90.31 133.64 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.666 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -142.36 152.01 59.54 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.43 135.19 26.06 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.505 2.137 . . . . 0.0 111.381 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.95 150.69 34.51 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.941 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 20.7 m -111.27 135.83 51.25 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 96' ' ' ASP . 44.5 mt -67.94 117.12 9.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 123.34 0.4 . . . . 0.0 110.49 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.08 -38.6 11.53 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.205 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 p -159.19 146.87 17.49 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.41 HG23 HD21 ' A' ' 138' ' ' LEU . 62.5 mt -124.36 135.32 64.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -109.35 106.23 15.95 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -75.73 -13.72 60.31 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -73.26 -41.88 63.14 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -96.39 -7.52 34.84 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.702 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 57.36 33.67 23.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.336 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 79.8 p -118.38 161.98 19.06 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.065 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.55 ' SG ' HD11 ' A' ' 141' ' ' LEU . 15.1 p -147.81 152.91 38.48 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.359 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 88.7 t -95.82 131.66 42.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.1 m -123.21 146.92 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 77.7 t -106.26 120.01 56.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -66.41 111.99 3.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.782 0.676 . . . . 0.0 110.386 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.4 m -65.62 129.95 41.56 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.727 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.32 -21.22 41.68 Favored Glycine 0 N--CA 1.425 -2.087 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.786 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -106.95 -50.46 3.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.101 -177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.72 3.56 37.02 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.149 -1.024 . . . . 0.0 114.223 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 95.1 m-20 -87.73 163.16 16.65 Favored 'General case' 0 CA--C 1.479 -1.772 0 CA-C-N 117.804 0.802 . . . . 0.0 109.916 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.8 ppt_? -134.25 136.53 43.67 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.079 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -144.92 151.24 38.36 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.971 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 39.9 tt0 -102.7 124.7 48.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -127.57 163.92 23.12 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -175.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 16.6 m-80 -87.37 142.88 27.55 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.41 HD21 HG23 ' A' ' 116' ' ' ILE . 51.0 mt -57.22 -39.76 76.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.431 0.634 . . . . 0.0 110.561 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 m -79.63 -4.63 52.51 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.883 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -108.96 -7.75 15.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.52 0.676 . . . . 0.0 109.306 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.55 HD11 ' SG ' ' A' ' 123' ' ' CYS . 67.7 mt -69.58 163.83 24.63 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.652 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 21.1 mt -130.65 162.85 28.48 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.31 -1.137 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.136 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 77.7 m95 . . . . . 0 CA--C 1.502 -0.887 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -130.92 154.96 47.56 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.17 127.43 22.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-O 121.032 0.444 . . . . 0.0 110.754 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.1 5.77 46.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.505 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -103.75 149.08 25.33 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 120.705 0.288 . . . . 0.0 110.23 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -88.5 150.91 22.86 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.808 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.41 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.4 p -155.82 -168.02 2.66 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.953 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.553 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.9 m -129.35 144.95 51.44 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.39 160.22 39.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.902 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.2 mm -93.89 110.04 22.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.73 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -66.31 121.79 16.05 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 t -61.18 -22.35 64.65 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 123.885 0.74 . . . . 0.0 110.589 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -80.58 -42.19 22.71 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.719 -173.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -106.37 -14.9 14.96 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.274 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.69 0.53 68.54 Favored Glycine 0 N--CA 1.462 0.429 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.97 164.15 14.09 Favored 'General case' 0 N--CA 1.403 -2.788 0 C-N-CA 124.852 1.261 . . . . 0.0 112.325 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.3 mt -88.02 133.51 30.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.61 0.764 . . . . 0.0 110.144 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -144.07 152.48 54.86 Favored Pre-proline 0 C--N 1.304 -1.397 0 C-N-CA 123.158 0.583 . . . . 0.0 109.868 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.07 133.68 23.68 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.695 2.263 . . . . 0.0 111.873 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.71 153.36 40.9 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.967 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.2 m -117.55 135.79 53.71 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 48.5 mt -66.25 118.1 8.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 123.104 0.562 . . . . 0.0 111.322 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.21 -38.43 10.57 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.97 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 m -158.26 151.85 23.45 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.414 HG23 HD21 ' A' ' 138' ' ' LEU . 63.5 mt -127.26 134.18 66.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -108.59 102.88 11.91 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -71.06 -18.45 62.56 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.27 -174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -72.82 -39.9 66.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -93.8 -7.51 43.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 61.81 27.49 16.79 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.793 0.837 . . . . 0.0 110.062 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.8 p -119.64 165.7 14.13 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.342 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.573 ' SG ' HD11 ' A' ' 141' ' ' LEU . 12.0 p -148.08 152.49 37.45 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.9 t -96.73 131.19 44.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.1 m -123.57 147.11 28.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 133' ' ' ARG . 55.3 t -106.75 122.89 61.31 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -70.95 114.49 9.06 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.545 0.688 . . . . 0.0 110.13 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.5 m -63.96 129.47 40.19 Favored 'General case' 0 N--CA 1.407 -2.607 0 CA-C-N 113.712 -1.586 . . . . 0.0 111.287 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.83 -13.97 57.64 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.316 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -109.66 -44.79 3.78 Favored 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 122.547 -0.384 . . . . 0.0 110.231 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.18 10.07 56.37 Favored Glycine 0 N--CA 1.436 -1.357 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.923 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -91.94 163.86 13.86 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 117.586 0.693 . . . . 0.0 109.487 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -135.27 139.11 44.15 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -145.82 151.21 37.56 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -101.39 121.85 42.67 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -128.65 163.21 25.56 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.957 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 19.9 m-80 -86.17 144.56 27.42 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.414 HD21 HG23 ' A' ' 116' ' ' ILE . 47.1 mt -57.93 -40.94 81.68 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.848 0.717 . . . . 0.0 110.652 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 m -81.38 -7.23 59.54 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.302 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 19.2 t70 -101.98 -5.03 25.13 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.573 HD11 ' SG ' ' A' ' 123' ' ' CYS . 68.8 mt -69.62 171.63 8.67 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.276 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 27.2 mt -138.34 162.89 33.22 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.0 m . . . . . 0 C--N 1.308 -1.237 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.519 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.9 m95 . . . . . 0 N--CA 1.435 -1.205 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -116.79 152.15 35.0 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.646 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.17 128.54 26.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.94 23.29 25.72 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.657 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -115.74 149.72 38.02 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 3.1 mtmt -84.23 148.78 26.53 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 123.026 0.53 . . . . 0.0 110.102 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 p -157.92 -167.89 2.36 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.7 m -131.18 142.08 50.15 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.47 160.16 38.25 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.907 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.0 mm -95.07 108.18 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -67.88 123.78 21.53 Favored 'General case' 0 CA--C 1.469 -2.147 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.289 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -62.04 -22.09 65.45 Favored 'General case' 0 C--N 1.282 -2.326 0 O-C-N 123.95 0.781 . . . . 0.0 112.674 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -83.58 -36.91 23.58 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -108.46 -16.46 14.22 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.155 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.2 0.45 70.96 Favored Glycine 0 C--N 1.304 -1.236 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.707 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 99.4 m -90.84 167.38 12.5 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 124.491 1.117 . . . . 0.0 111.887 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.39 133.1 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.48 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.47 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.3 m-85 -139.48 152.05 68.07 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.088 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.62 133.32 23.74 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.313 2.009 . . . . 0.0 111.189 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.02 156.64 44.05 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.818 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 23.0 m -119.99 135.52 54.89 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mt -70.31 123.88 25.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 122.747 0.419 . . . . 0.0 110.679 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.95 -36.07 10.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.164 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 64.1 m -161.38 149.97 15.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.43 HG23 HD21 ' A' ' 138' ' ' LEU . 71.1 mt -124.41 129.73 73.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -105.67 101.85 11.34 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -73.16 -12.67 60.97 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.234 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.56 -40.68 63.75 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.255 0.55 . . . . 0.0 109.605 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -99.32 -7.02 26.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.1 30.27 17.78 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.868 0.867 . . . . 0.0 110.306 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 52.7 p -119.99 165.53 14.56 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.245 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.597 ' SG ' HD11 ' A' ' 141' ' ' LEU . 15.6 p -148.09 152.74 37.87 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.1 t -96.15 131.01 44.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.6 m -122.98 146.83 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 133' ' ' ARG . 65.5 t -105.78 120.39 56.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.91 114.7 7.45 Favored 'General case' 0 C--O 1.257 1.462 0 O-C-N 123.923 0.764 . . . . 0.0 110.107 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 87.8 m -67.52 128.98 38.47 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.655 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.23 -22.82 30.27 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.696 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -100.82 -52.37 3.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 122.324 -0.515 . . . . 0.0 109.877 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.39 11.25 29.68 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.85 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -93.87 162.54 13.87 Favored 'General case' 0 CA--C 1.466 -2.265 0 C-N-CA 119.434 -0.907 . . . . 0.0 109.739 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.3 ppt_? -133.54 136.25 44.87 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -142.08 150.93 41.85 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -102.55 116.45 32.63 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.759 0.79 . . . . 0.0 109.271 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -121.03 163.78 17.78 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.617 -173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -85.88 139.87 30.88 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.43 HD21 HG23 ' A' ' 116' ' ' ILE . 71.0 mt -55.22 -40.82 71.29 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.375 0.67 . . . . 0.0 111.354 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.2 t -80.67 -6.2 58.05 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.797 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -104.76 -7.86 19.2 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.743 0.782 . . . . 0.0 109.052 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.597 HD11 ' SG ' ' A' ' 123' ' ' CYS . 66.1 mt -67.16 163.98 19.07 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.638 176.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 26.8 mt -132.39 163.66 28.21 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 p . . . . . 0 C--N 1.31 -1.113 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.379 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 75.0 m95 . . . . . 0 N--CA 1.431 -1.384 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.627 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 8.4 ptpp? -126.0 153.78 43.87 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.51 129.14 26.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.96 3.07 42.44 Favored Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.063 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.627 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 12.1 m-20 -98.01 136.32 38.44 Favored 'General case' 0 CA--C 1.486 -1.518 0 O-C-N 122.602 -0.352 . . . . 0.0 110.488 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 13.9 mtmt -81.19 143.7 32.15 Favored 'General case' 0 N--CA 1.401 -2.905 0 CA-C-O 121.291 0.567 . . . . 0.0 109.63 171.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.31 -167.51 2.73 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.9 m -128.6 145.11 51.23 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.33 160.26 39.58 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.682 0.614 . . . . 0.0 109.817 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mm -93.29 109.62 22.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.491 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -68.1 125.68 27.11 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.835 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.8 m -64.5 -20.82 66.44 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -83.95 -41.16 17.63 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -105.33 -15.96 14.89 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.392 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.25 0.86 79.1 Favored Glycine 0 C--N 1.311 -0.839 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.014 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.499 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 74.9 m -90.27 168.85 11.6 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 124.117 0.967 . . . . 0.0 111.75 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.1 mt -89.07 135.41 25.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.1 m-85 -142.99 152.12 57.76 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.46 136.13 27.94 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.663 2.242 . . . . 0.0 111.413 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.96 154.17 39.01 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 31.0 m -114.68 135.49 54.1 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.529 HD12 ' HB2' ' A' ' 96' ' ' ASP . 49.7 mt -67.39 115.51 5.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 122.949 0.499 . . . . 0.0 110.705 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.44 -35.41 13.0 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.193 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -157.96 148.38 20.56 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.425 HG23 HD21 ' A' ' 138' ' ' LEU . 65.5 mt -123.25 133.01 70.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -108.31 97.56 7.23 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -71.74 -14.73 62.09 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.977 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -73.24 -41.34 63.83 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.018 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -94.89 -6.88 41.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.216 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 62.56 29.52 17.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.4 1.08 . . . . 0.0 110.096 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 46.7 p -117.94 166.75 12.14 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.618 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.6 p -148.45 152.12 36.38 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.0 t -95.86 131.09 43.53 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.6 m -122.71 146.73 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 133' ' ' ARG . 72.4 t -105.28 119.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -68.14 111.1 4.3 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-O 121.574 0.702 . . . . 0.0 110.858 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 96.2 m -70.58 129.79 40.12 Favored 'General case' 0 N--CA 1.397 -3.101 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.576 -175.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.11 -13.81 63.04 Favored Glycine 0 N--CA 1.418 -2.502 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.296 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.7 -54.01 2.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.95 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 107.27 17.42 11.51 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.957 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -101.64 168.61 9.36 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.269 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.472 ' HB3' HG22 ' A' ' 126' ' ' VAL . 7.1 ppt_? -137.73 140.11 40.52 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -146.14 151.59 37.91 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 123.696 0.798 . . . . 0.0 109.43 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -101.67 123.35 45.52 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.497 0.665 . . . . 0.0 109.507 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -129.31 163.39 25.8 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.022 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 22.6 m-80 -85.8 146.03 26.95 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.425 HD21 HG23 ' A' ' 116' ' ' ILE . 52.5 mt -60.22 -35.15 74.79 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.751 0.786 . . . . 0.0 109.587 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.3 p -74.52 -17.87 60.69 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.667 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -105.47 -4.81 20.9 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.715 0.769 . . . . 0.0 110.471 -173.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.608 HD11 ' SG ' ' A' ' 123' ' ' CYS . 52.9 mt -68.11 160.73 28.38 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.886 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.6 mt -132.14 164.47 26.23 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 C--N 1.304 -1.377 0 C-N-CA 122.93 0.492 . . . . 0.0 110.151 178.164 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.444 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 78.8 m95 . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -130.07 152.72 49.22 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.52 131.46 29.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 123.481 0.488 . . . . 0.0 110.102 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.23 4.6 50.34 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.25 145.03 30.81 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -80.69 154.36 27.36 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-O 121.574 0.702 . . . . 0.0 111.138 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.3 p -159.67 -171.56 3.33 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.7 m -129.13 143.72 50.96 Favored 'General case' 0 C--N 1.261 -3.245 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.45 158.66 43.81 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.104 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -93.14 110.86 23.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.519 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.413 ' CD2' ' HB2' ' A' ' 104' ' ' GLU . 6.2 t90 -68.63 125.42 26.47 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m -60.9 -22.96 64.84 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.027 0.829 . . . . 0.0 112.829 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 102' ' ' TRP . 4.9 mm-40 -83.62 -42.0 17.2 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.739 -174.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -105.91 -16.23 14.7 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.058 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.67 1.02 75.98 Favored Glycine 0 C--N 1.312 -0.762 0 N-CA-C 111.419 -0.673 . . . . 0.0 111.419 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 78.7 m -89.92 165.86 13.84 Favored 'General case' 0 N--CA 1.414 -2.262 0 C-N-CA 124.028 0.931 . . . . 0.0 111.693 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -90.28 129.24 41.46 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.819 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 95.7 m-85 -134.63 152.22 77.31 Favored Pre-proline 0 C--N 1.285 -2.232 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.865 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.13 130.23 17.35 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.277 1.985 . . . . 0.0 110.837 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.12 150.73 39.86 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.942 0.401 . . . . 0.0 110.066 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.1 m -115.99 135.85 53.58 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 50.9 mt -64.7 123.79 18.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 123.602 0.564 . . . . 0.0 110.781 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.31 -38.2 8.16 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.147 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.1 p -159.43 148.58 18.2 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.458 HG23 HD21 ' A' ' 138' ' ' LEU . 69.7 mt -124.41 130.51 73.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.718 0.294 . . . . 0.0 110.526 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -109.37 103.36 12.27 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.03 -16.9 60.58 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.869 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -73.26 -39.08 65.71 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.061 0.457 . . . . 0.0 110.181 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -95.18 -7.63 38.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.606 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 62.56 26.81 15.91 Favored 'General case' 0 C--O 1.248 1.016 0 C-N-CA 124.8 1.24 . . . . 0.0 110.504 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 82.5 p -118.83 165.16 14.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.425 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.1 p -148.06 151.39 35.61 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 89.3 t -96.19 132.56 40.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 29.2 m -123.54 147.57 27.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 56.9 t -106.5 122.06 59.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.849 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -70.78 114.08 8.5 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 123.747 0.654 . . . . 0.0 110.71 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.7 m -65.54 130.33 42.93 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.908 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.16 -13.4 66.4 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.151 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.59 -48.93 2.67 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.901 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 101.28 7.11 50.1 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.426 -0.892 . . . . 0.0 114.193 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 89.2 m-20 -88.32 162.91 16.32 Favored 'General case' 0 CA--C 1.474 -1.946 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.214 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.6 ppt_? -132.38 136.45 46.82 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -144.06 151.1 39.19 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 40.6 tt0 -102.05 126.38 48.98 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -130.7 163.25 27.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.9 m-80 -84.33 144.92 28.54 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.458 HD21 HG23 ' A' ' 116' ' ' ILE . 55.0 mt -57.48 -42.74 83.26 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.557 0.694 . . . . 0.0 110.612 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 p -78.36 -7.83 57.75 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.217 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -101.83 -13.76 17.56 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.588 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.4 mt -61.2 160.39 10.46 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.231 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 27.8 mt -126.41 162.44 25.56 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.298 -1.65 0 O-C-N 123.596 0.56 . . . . 0.0 109.93 -179.749 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.5 m95 . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -125.83 153.41 44.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.42 128.26 26.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.34 10.98 40.22 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.921 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.63 150.06 27.34 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -91.76 150.06 21.29 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 120.956 0.408 . . . . 0.0 109.957 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -155.95 -168.38 2.75 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.603 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.7 m -128.36 141.16 51.51 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.62 160.42 36.7 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.7 mm -97.04 109.49 23.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -65.7 121.75 15.71 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -60.95 -19.55 61.04 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 124.104 0.878 . . . . 0.0 112.647 -175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.88 -43.12 14.4 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.016 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.53 -15.9 14.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.233 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.7 0.09 79.04 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-O 121.564 0.536 . . . . 0.0 112.058 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.491 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 79.4 m -89.63 162.49 15.59 Favored 'General case' 0 N--CA 1.407 -2.621 0 C-N-CA 123.772 0.829 . . . . 0.0 111.768 -177.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.4 mt -88.04 130.67 37.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.617 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -136.43 152.21 74.47 Favored Pre-proline 0 C--N 1.289 -2.054 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.789 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.02 130.21 17.44 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.279 1.986 . . . . 0.0 110.827 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.66 147.42 31.98 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 120.974 0.416 . . . . 0.0 110.324 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.4 m -113.68 135.89 53.43 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.4 mt -68.26 119.99 14.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 122.734 0.414 . . . . 0.0 110.601 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.89 -30.97 12.44 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.737 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.2 p -161.23 154.76 21.79 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.437 HG23 HD21 ' A' ' 138' ' ' LEU . 69.5 mt -128.33 132.8 67.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.19 102.9 12.0 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -72.13 -16.69 62.0 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.447 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -73.48 -40.26 64.26 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.467 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -97.12 -6.93 33.83 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.8 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 63.13 30.87 16.04 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-O 122.027 0.917 . . . . 0.0 109.949 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.1 p -120.67 166.72 13.3 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.922 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.648 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.6 p -148.7 152.19 36.22 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 87.4 t -95.84 130.61 44.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 22.5 m -123.29 147.31 27.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' A' ' 133' ' ' ARG . 66.9 t -106.0 121.26 58.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -71.2 114.69 9.52 Favored 'General case' 0 C--O 1.257 1.478 0 CA-C-O 121.611 0.72 . . . . 0.0 110.312 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.7 m -66.23 130.63 43.87 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.736 -1.575 . . . . 0.0 110.877 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.86 -21.26 42.58 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.201 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -108.14 -52.68 2.73 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.893 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.88 20.37 10.75 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.796 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -101.37 161.23 13.78 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.55 173.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.3 ppt_? -132.21 135.94 46.66 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -145.18 149.88 35.75 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 37.8 tt0 -102.92 124.29 48.16 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -127.79 163.4 24.43 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.331 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -83.11 142.09 31.5 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.437 HD21 HG23 ' A' ' 116' ' ' ILE . 44.6 mt -55.6 -41.61 73.67 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.921 0.763 . . . . 0.0 111.443 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 m -76.4 -15.66 59.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.895 0.378 . . . . 0.0 111.312 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -95.63 -9.55 31.81 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.802 0.81 . . . . 0.0 109.428 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.648 HD11 ' SG ' ' A' ' 123' ' ' CYS . 62.3 mt -65.35 163.58 15.3 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.284 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.1 mt -131.15 162.41 29.97 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.3 p . . . . . 0 C--N 1.308 -1.225 0 O-C-N 123.281 0.363 . . . . 0.0 110.141 -178.404 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 82.0 m95 . . . . . 0 N--CA 1.443 -0.818 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -125.78 155.61 40.77 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.66 128.22 25.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.989 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.75 -1.61 48.74 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.966 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.2 146.13 24.22 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -86.59 149.86 24.63 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.092 0.473 . . . . 0.0 111.039 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.9 p -156.7 -168.03 2.56 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.635 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.537 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.5 m -129.7 149.21 51.55 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.21 160.38 39.59 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 123.574 0.546 . . . . 0.0 109.684 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -94.07 110.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -68.44 124.28 23.1 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.8 m -64.34 -18.03 64.25 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 123.93 0.769 . . . . 0.0 112.662 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.86 -41.79 17.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -104.96 -15.16 15.2 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.626 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.67 2.0 68.23 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.555 ' HB2' ' CE2' ' A' ' 109' ' ' TYR . 98.7 m -90.71 165.03 13.91 Favored 'General case' 0 N--CA 1.406 -2.633 0 C-N-CA 124.494 1.117 . . . . 0.0 112.286 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 mt -90.83 131.33 38.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.556 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 107' ' ' CYS . 98.3 m-85 -141.41 152.31 63.46 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.74 134.98 31.67 Favored 'Trans proline' 0 C--O 1.24 0.624 0 C-N-CA 122.68 2.253 . . . . 0.0 112.143 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.23 157.24 43.53 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.945 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 m -121.46 135.46 55.04 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 49.3 mt -66.88 118.6 10.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 C-N-CA 123.5 0.72 . . . . 0.0 111.287 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.51 -38.04 11.09 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.627 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 p -157.92 152.21 24.54 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.522 HG23 HD21 ' A' ' 138' ' ' LEU . 64.6 mt -126.13 129.58 72.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -108.98 99.67 8.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.21 -20.72 65.74 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.171 -175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.447 ' H ' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -72.04 -40.3 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 110.461 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -90.51 -7.87 51.84 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.072 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 65.17 26.83 12.38 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.853 1.261 . . . . 0.0 108.994 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 64.7 p -120.66 169.35 10.46 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.461 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.7 p -148.6 151.32 34.83 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 123.034 0.533 . . . . 0.0 109.618 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.7 t -96.19 132.33 40.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.9 m -123.64 148.37 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.44 121.06 58.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -67.44 115.09 6.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.787 0.68 . . . . 0.0 110.371 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.5 m -67.56 129.84 41.17 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.85 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.23 -16.29 56.2 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.142 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -109.89 -43.51 3.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.156 0.503 . . . . 0.0 110.536 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.06 59.58 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.006 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -87.95 162.96 16.59 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.179 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.6 ppt_? -133.68 136.21 44.57 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -144.66 151.4 38.91 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 44.4 tt0 -102.23 122.19 43.7 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 121.539 0.685 . . . . 0.0 109.75 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -126.22 163.52 22.98 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.89 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 20.3 m-80 -85.73 145.48 27.25 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 116' ' ' ILE . 39.2 mt -58.81 -39.65 81.81 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.641 0.588 . . . . 0.0 111.225 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.3 p -81.05 -10.14 59.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.16 0.505 . . . . 0.0 111.598 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 38.1 t70 -96.96 -13.82 22.11 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 123' ' ' CYS . 56.3 mt -63.99 160.25 18.26 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.549 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 24.0 mt -130.68 165.12 23.54 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 C--N 1.304 -1.397 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.318 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.4 m95 . . . . . 0 N--CA 1.437 -1.078 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -126.52 150.05 49.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.01 128.22 25.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.981 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.14 12.59 42.03 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.916 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.92 148.22 31.0 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -85.04 154.81 21.85 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.614 0.721 . . . . 0.0 111.649 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -161.25 -170.71 2.75 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.778 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.6 m -126.97 140.86 52.01 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.23 159.97 38.64 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.956 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.0 mm -93.1 113.62 28.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.229 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -69.17 119.77 13.97 Favored 'General case' 0 CA--C 1.467 -2.213 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.2 m -64.0 -17.68 63.55 Favored 'General case' 0 C--N 1.278 -2.503 0 O-C-N 123.983 0.802 . . . . 0.0 112.706 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.87 -42.61 16.19 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.274 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -105.71 -15.96 14.82 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.704 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.45 71.52 Favored Glycine 0 N--CA 1.461 0.326 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.132 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.5 m -90.75 166.5 13.09 Favored 'General case' 0 N--CA 1.406 -2.627 0 C-N-CA 124.052 0.941 . . . . 0.0 113.223 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.6 mt -89.39 134.51 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.61 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -141.46 152.26 63.16 Favored Pre-proline 0 C--N 1.304 -1.381 0 C-N-CA 123.032 0.533 . . . . 0.0 110.273 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 128.97 16.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.335 2.023 . . . . 0.0 111.023 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.1 150.34 37.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.12 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.5 m -113.87 136.25 53.09 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.22 121.06 15.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.231 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.18 -31.64 12.35 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.682 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.4 p -164.42 153.05 12.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.451 HG23 HD21 ' A' ' 138' ' ' LEU . 77.3 mt -127.12 129.55 71.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.74 0.416 . . . . 0.0 110.309 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.83 99.41 8.76 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -67.99 -19.75 64.97 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -73.25 -39.89 65.08 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.285 0.565 . . . . 0.0 109.893 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -89.97 -8.65 51.2 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.573 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 61.34 25.32 15.3 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.072 0.949 . . . . 0.0 110.492 -173.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 73.9 p -117.63 162.28 18.28 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.452 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.6 p -145.12 150.69 37.23 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 84.3 t -95.68 131.95 41.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 29.1 m -123.12 147.83 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 75.9 t -105.22 122.05 58.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -69.63 114.89 8.27 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.403 0.62 . . . . 0.0 110.077 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.9 m -66.36 129.96 41.6 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.717 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.53 -16.58 55.96 Favored Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.835 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -109.4 -46.65 3.51 Favored 'General case' 0 N--CA 1.434 -1.242 0 O-C-N 122.196 -0.591 . . . . 0.0 111.017 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.58 11.83 49.72 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.914 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -94.0 160.91 14.51 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.105 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.6 ppt_? -133.44 135.29 44.48 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -147.44 151.86 37.13 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -173.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 36.7 tt0 -102.02 126.8 49.04 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-O 121.981 0.896 . . . . 0.0 110.874 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -124.03 164.06 20.15 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.442 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.8 m-80 -86.93 144.38 26.98 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.451 HD21 HG23 ' A' ' 116' ' ' ILE . 44.5 mt -56.4 -44.1 79.94 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.725 0.64 . . . . 0.0 110.94 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.1 m -77.09 -9.82 58.98 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.262 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.03 -9.5 20.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.235 0.541 . . . . 0.0 109.813 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.585 HD11 ' SG ' ' A' ' 123' ' ' CYS . 63.9 mt -64.1 159.07 21.16 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.254 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 40.2 mt -126.76 162.29 26.16 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--N 1.302 -1.47 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.573 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.3 m95 . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -122.15 152.71 39.64 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.16 128.39 26.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.156 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.65 9.76 48.98 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.906 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.22 148.01 25.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -86.53 153.52 21.77 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.343 0.592 . . . . 0.0 110.841 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.8 p -162.77 -168.6 1.83 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.73 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 67.6 m -129.08 141.27 51.26 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.08 159.79 39.06 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -93.82 110.48 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -67.65 120.67 14.42 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.5 m -61.13 -21.51 63.8 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 123.814 0.696 . . . . 0.0 112.757 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -83.95 -37.35 22.4 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.381 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -111.17 -15.68 13.61 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.064 -177.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.59 -5.74 72.64 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.111 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.5 m -90.39 166.47 13.26 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 124.122 0.969 . . . . 0.0 113.593 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.2 mt -87.94 133.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.817 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -142.88 152.66 59.5 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.9 131.57 21.31 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.393 2.062 . . . . 0.0 111.522 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.38 154.51 41.71 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.9 m -118.75 135.92 54.24 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.1 mt -69.23 118.03 12.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.052 0.541 . . . . 0.0 110.687 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.87 -35.15 13.51 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.218 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.0 m -160.28 153.7 22.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.7 mt -127.2 134.2 66.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 123.479 0.487 . . . . 0.0 109.952 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -109.37 103.81 12.8 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -73.16 -18.53 61.26 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 120.971 0.415 . . . . 0.0 111.599 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.21 -37.39 66.45 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.017 0.437 . . . . 0.0 110.612 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -96.8 -7.71 32.98 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.801 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 61.81 26.49 16.08 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.027 0.918 . . . . 0.0 110.404 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.0 p -118.36 161.83 19.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.358 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' A' ' 141' ' ' LEU . 10.9 p -147.78 152.14 37.2 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.4 t -96.24 131.84 42.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.7 m -123.3 147.25 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.57 122.17 60.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -69.75 113.8 7.34 Favored 'General case' 0 CA--C 1.491 -1.293 0 O-C-N 123.68 0.612 . . . . 0.0 110.279 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.3 m -65.09 129.12 38.55 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.706 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.88 -20.21 40.76 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.694 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -105.3 -43.53 4.97 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.163 0.506 . . . . 0.0 110.416 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.28 59.94 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.095 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -91.93 163.99 13.81 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.4 ppt_? -133.52 135.94 44.72 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -143.4 150.39 39.02 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.37 120.9 41.28 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -126.63 163.74 22.8 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.115 -174.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 17.7 m-80 -85.6 142.96 28.73 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.01 -38.8 73.61 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.751 0.786 . . . . 0.0 110.272 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.5 p -78.88 -7.59 58.08 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.993 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 16.0 t70 -109.8 -4.66 15.91 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.801 0.81 . . . . 0.0 109.323 -175.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.553 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.8 mt -69.46 162.52 27.26 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.497 175.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 28.0 mt -130.66 162.33 29.64 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.304 -1.38 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.72 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 78.2 m95 . . . . . 0 CA--C 1.509 -0.602 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -130.92 155.45 46.75 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.303 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.62 127.05 23.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 O-C-N 123.561 0.538 . . . . 0.0 110.258 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.54 -0.82 32.5 Favored Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.339 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -100.51 148.03 25.24 Favored 'General case' 0 CA--C 1.479 -1.751 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.208 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 53.3 mtpt -87.97 155.26 19.93 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.314 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.0 p -157.58 -169.54 2.91 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.5 m -127.41 140.48 52.14 Favored 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 174.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.69 160.11 38.53 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -94.19 110.61 23.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.864 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -67.19 120.22 13.39 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 71.2 m -63.05 -17.86 62.71 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 124.107 0.88 . . . . 0.0 112.672 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.08 -40.73 17.95 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.149 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -110.27 -16.48 13.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.534 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.49 -4.64 83.75 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.318 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 66.0 m -90.61 165.39 13.76 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.6 mt -87.36 130.63 36.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.318 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -139.66 152.7 69.11 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.858 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.58 129.62 17.03 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.503 2.135 . . . . 0.0 111.575 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.87 39.77 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.081 -0.387 . . . . 0.0 110.122 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 22.3 m -116.7 136.04 53.29 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.33 121.71 15.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 123.11 0.564 . . . . 0.0 110.847 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.58 -35.28 9.19 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.675 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.1 p -157.83 152.26 24.77 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.403 HG23 HD21 ' A' ' 138' ' ' LEU . 66.2 mt -128.75 131.83 68.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -106.4 105.08 14.94 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -72.42 -20.15 61.47 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.83 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -74.87 -40.51 60.92 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.166 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -90.88 -7.97 50.72 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.684 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 60.3 29.17 18.79 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.357 1.063 . . . . 0.0 109.983 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.7 p -119.94 165.53 14.52 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.619 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 141' ' ' LEU . 10.7 p -147.85 152.15 37.14 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.6 t -95.94 130.82 44.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.1 m -123.17 146.75 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.9 t -106.29 120.41 57.29 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -69.07 112.76 5.89 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.492 0.663 . . . . 0.0 109.887 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.7 m -67.93 129.65 40.56 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.805 -174.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.9 -17.41 58.12 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.559 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -108.97 -47.4 3.45 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.719 0.295 . . . . 0.0 111.345 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.63 40.59 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.479 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -98.5 161.58 13.6 Favored 'General case' 0 CA--C 1.48 -1.713 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.453 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.5 ppt_? -134.16 136.29 43.69 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -142.93 151.35 40.86 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.673 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -101.73 121.39 41.97 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.831 0.824 . . . . 0.0 109.026 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -126.35 163.61 22.89 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.482 -1.236 . . . . 0.0 108.103 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -86.1 142.88 28.36 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.403 HD21 HG23 ' A' ' 116' ' ' ILE . 54.0 mt -56.16 -40.49 73.97 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.859 0.724 . . . . 0.0 110.586 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.6 t -80.44 -6.03 57.47 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.51 0.672 . . . . 0.0 110.345 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -106.28 -8.37 17.32 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 121.432 -0.793 . . . . 0.0 109.301 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.585 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.3 mt -66.8 159.18 28.62 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.111 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 33.9 mt -126.73 162.15 26.47 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.296 -1.744 0 O-C-N 123.464 0.478 . . . . 0.0 110.114 -179.319 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 75.9 m95 . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -119.62 153.38 35.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.83 128.29 25.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.641 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.68 7.08 54.09 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.256 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HB3' HD12 ' A' ' 113' ' ' ILE . 2.0 t0 -96.67 150.02 21.15 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -93.21 141.38 28.49 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-O 120.895 0.378 . . . . 0.0 110.044 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.0 p -152.11 -163.35 1.71 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 73.7 m -132.2 150.01 52.25 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.0 160.36 40.09 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.6 mm -92.83 113.44 27.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -70.77 125.59 27.26 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.7 m -62.52 -20.88 65.07 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 123.388 0.675 . . . . 0.0 112.708 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.96 -42.1 16.62 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.199 -174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -108.32 -14.65 14.64 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.034 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.85 -2.43 74.36 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 96.4 m -90.03 166.79 13.24 Favored 'General case' 0 N--CA 1.414 -2.227 0 C-N-CA 124.268 1.027 . . . . 0.0 112.723 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.8 mt -87.96 132.63 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.8 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 97.4 m-85 -140.98 152.02 64.05 Favored Pre-proline 0 C--N 1.291 -1.942 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.838 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.51 129.84 18.59 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.616 2.211 . . . . 0.0 112.25 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.49 149.85 38.12 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 m -114.64 136.11 53.41 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 96' ' ' ASP . 46.6 mt -69.01 119.81 15.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 O-C-N 123.476 0.485 . . . . 0.0 111.063 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.57 -37.1 11.01 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.883 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.3 p -159.65 153.24 22.64 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.452 HG23 HD21 ' A' ' 138' ' ' LEU . 72.4 mt -125.25 132.37 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -108.19 106.05 16.05 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -74.3 -20.48 60.11 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.802 -174.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -73.75 -38.99 64.56 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.117 0.484 . . . . 0.0 110.125 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -95.0 -7.25 40.33 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.617 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 61.63 28.45 17.62 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 124.141 0.976 . . . . 0.0 110.017 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 60.1 p -118.56 168.99 10.17 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.033 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.649 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.4 p -149.0 150.86 33.54 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.1 t -95.89 131.21 43.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.58 147.42 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.993 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 68.9 t -107.46 123.14 62.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -69.96 111.94 6.02 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.432 0.634 . . . . 0.0 110.339 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.9 m -62.77 129.82 42.19 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.966 -175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.66 -20.47 38.4 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.688 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -107.73 -41.44 5.01 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.039 0.447 . . . . 0.0 110.842 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.04 8.78 58.79 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.454 -0.879 . . . . 0.0 114.177 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -91.83 162.48 14.42 Favored 'General case' 0 CA--C 1.482 -1.664 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.031 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -134.44 138.41 44.74 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -144.82 150.86 37.88 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -102.59 122.17 43.84 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -126.41 164.02 22.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.418 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 16.4 m-80 -88.47 143.45 26.97 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.452 HD21 HG23 ' A' ' 116' ' ' ILE . 47.2 mt -55.84 -40.26 72.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 123.79 0.681 . . . . 0.0 111.612 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.0 t -76.39 -16.56 59.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.168 0.509 . . . . 0.0 110.118 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 9.0 t70 -101.16 -0.77 35.45 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.663 0.744 . . . . 0.0 109.684 -172.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.649 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.1 mt -72.05 164.46 26.11 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.256 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.1 mt -132.73 164.18 27.35 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.306 -1.308 0 C-N-CA 122.891 0.476 . . . . 0.0 109.982 -179.523 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 76.4 m95 . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -124.0 153.71 40.9 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.64 127.85 24.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.047 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.21 12.58 45.13 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.972 -0.633 . . . . 0.0 111.774 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -100.33 145.33 28.28 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.78 140.8 29.45 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.4 -163.42 1.67 Allowed 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.015 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.8 m -131.45 147.42 52.55 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.02 160.33 39.63 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.936 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.8 mm -93.27 110.71 23.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -67.62 122.28 17.71 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.2 m -60.19 -25.39 65.54 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 123.957 0.786 . . . . 0.0 112.482 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.32 -41.59 24.57 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.179 -172.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -108.0 -15.67 14.47 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.061 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.32 -4.07 78.78 Favored Glycine 0 N--CA 1.465 0.615 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.12 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.6 m -91.01 166.58 12.94 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.02 132.54 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.318 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -142.17 152.04 60.23 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.526 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -69.95 133.27 24.83 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.443 2.095 . . . . 0.0 111.607 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.64 146.91 29.51 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.825 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -112.77 135.77 53.14 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.2 mt -66.98 122.46 18.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 123.072 0.549 . . . . 0.0 110.595 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.79 -36.82 10.08 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.371 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.2 p -158.7 151.3 21.92 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.462 HG23 HD21 ' A' ' 138' ' ' LEU . 64.2 mt -125.37 132.27 71.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.436 ' OD1' ' HE3' ' A' ' 119' ' ' LYS . 9.6 t70 -108.48 104.1 13.37 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -72.78 -16.9 61.63 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HE3' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -73.51 -36.24 65.71 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.136 0.493 . . . . 0.0 110.12 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -98.48 -8.07 27.36 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.38 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 59.72 32.28 21.33 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.935 0.874 . . . . 0.0 109.938 -173.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.8 p -120.6 167.87 11.97 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.84 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.641 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.0 p -148.49 152.12 36.35 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.9 t -95.94 131.14 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.9 m -123.34 146.91 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 133' ' ' ARG . 75.8 t -105.65 120.68 56.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.723 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -68.43 114.13 6.59 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.639 0.587 . . . . 0.0 110.273 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.3 m -66.56 129.4 39.73 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.913 -174.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.09 -10.01 74.63 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.51 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -113.99 -51.25 2.79 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.977 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.11 6.18 45.77 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.93 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 96.2 m-20 -89.38 162.42 15.8 Favored 'General case' 0 CA--C 1.472 -2.057 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.248 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.1 ppt_? -135.6 136.05 40.74 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-O 121.27 0.557 . . . . 0.0 110.104 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -141.9 150.98 42.22 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.314 -174.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -102.64 118.99 38.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.683 0.754 . . . . 0.0 109.406 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -124.21 163.31 21.85 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.443 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -83.86 145.25 28.74 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.462 HD21 HG23 ' A' ' 116' ' ' ILE . 52.6 mt -58.39 -38.74 77.94 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.784 0.678 . . . . 0.0 111.003 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.8 m -80.49 -10.99 59.73 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.32 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.17 -9.63 27.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.601 0.715 . . . . 0.0 109.193 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.641 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.4 mt -68.56 166.25 17.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.01 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 18.8 mt -136.35 163.82 29.56 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.7 m . . . . . 0 C--N 1.312 -1.031 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.81 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.449 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 86.1 m95 . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -128.95 157.57 41.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.735 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.65 128.04 26.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.9 6.79 56.92 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.925 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.29 144.27 28.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -85.84 152.82 22.7 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.537 0.684 . . . . 0.0 111.629 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.6 p -161.91 -170.95 2.7 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.919 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 74.7 m -127.41 144.42 51.06 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.09 160.05 40.1 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 mm -94.27 111.53 25.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -69.05 123.18 20.35 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.7 m -63.28 -18.84 64.01 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 123.969 0.793 . . . . 0.0 112.966 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -83.33 -41.55 18.1 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.346 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -106.37 -16.38 14.57 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.971 -1.092 . . . . 0.0 111.418 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.96 0.75 86.26 Favored Glycine 0 C--N 1.31 -0.874 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 71.0 m -90.89 164.59 13.98 Favored 'General case' 0 N--CA 1.421 -1.883 0 C-N-CA 124.885 1.274 . . . . 0.0 112.473 -176.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 mt -88.89 132.12 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.451 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.1 m-85 -139.46 152.5 69.12 Favored Pre-proline 0 C--N 1.284 -2.267 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.33 134.72 27.44 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.639 2.226 . . . . 0.0 111.18 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.41 153.59 40.64 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.208 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.0 m -119.65 135.39 54.83 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 57.0 mt -64.5 122.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 123.439 0.695 . . . . 0.0 110.652 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.71 -38.98 9.69 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.819 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.8 m -158.48 149.68 20.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.435 HG23 HD21 ' A' ' 138' ' ' LEU . 64.3 mt -123.56 132.43 71.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 122.971 0.508 . . . . 0.0 109.809 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.92 104.1 13.49 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -74.57 -14.66 60.82 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.954 0.407 . . . . 0.0 111.866 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -74.08 -40.93 62.42 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.238 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -96.84 -8.45 30.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.6 33.29 20.41 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.953 0.883 . . . . 0.0 110.026 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 61.1 p -120.72 165.33 15.25 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.983 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 141' ' ' LEU . 12.5 p -148.15 152.5 37.4 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 95.3 t -95.78 131.38 42.7 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 27.8 m -123.63 147.3 28.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 133' ' ' ARG . 62.7 t -105.23 122.81 58.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -69.42 114.22 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.479 0.656 . . . . 0.0 109.92 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.3 m -65.4 130.23 42.58 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.547 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.82 -24.86 15.6 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.792 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -99.39 -51.73 3.71 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 122.448 -0.442 . . . . 0.0 111.027 -176.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.36 19.78 17.47 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.437 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -103.51 162.03 13.38 Favored 'General case' 0 CA--C 1.479 -1.77 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.363 173.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.4 ppt_? -133.42 140.23 47.2 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.75 150.84 35.02 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.504 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 34.8 tt0 -103.18 122.54 44.93 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.534 0.683 . . . . 0.0 109.669 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -125.41 162.91 23.77 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 140' ' ' ASP . 19.2 m-80 -83.38 144.02 29.92 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.435 HD21 HG23 ' A' ' 116' ' ' ILE . 59.1 mt -58.2 -41.68 84.52 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.672 0.608 . . . . 0.0 110.515 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.8 m -80.08 -5.67 56.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.459 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.492 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 27.3 t70 -110.61 -2.18 16.5 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.56 0.695 . . . . 0.0 109.281 -176.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 123' ' ' CYS . 60.0 mt -68.6 163.92 22.58 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.686 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 35.3 mt -125.44 157.79 36.02 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 C--N 1.291 -1.948 0 O-C-N 123.479 0.487 . . . . 0.0 110.275 -176.876 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.7 m95 . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -126.51 155.44 42.34 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.26 132.61 30.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.97 18.19 44.6 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.215 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -113.2 149.82 33.17 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -86.01 149.58 25.07 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 123.647 0.779 . . . . 0.0 110.624 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -159.47 -168.72 2.38 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 68.7 m -130.38 145.3 51.78 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.99 160.3 40.11 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.635 0.255 . . . . 0.0 110.796 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.38 112.28 25.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.81 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.4 ' CD2' ' HB2' ' A' ' 104' ' ' GLU . 5.2 t90 -70.49 124.44 24.21 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 m -62.69 -23.45 67.14 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.53 0.681 . . . . 0.0 112.559 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 102' ' ' TRP . 5.0 mm-40 -81.23 -39.79 24.82 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.263 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -108.8 -15.8 14.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.923 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.89 -1.47 83.98 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 75.1 m -90.29 164.93 14.18 Favored 'General case' 0 N--CA 1.419 -2.0 0 C-N-CA 124.592 1.157 . . . . 0.0 112.928 -176.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.8 mt -87.75 132.92 31.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.259 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.7 m-85 -142.23 152.52 61.31 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.158 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 139.35 39.66 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 122.861 2.374 . . . . 0.0 111.868 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.9 157.49 43.23 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.463 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 m -119.55 135.56 54.73 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.9 mt -70.41 118.74 15.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 122.812 0.445 . . . . 0.0 110.538 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.38 -29.85 14.79 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.963 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.9 p -161.79 153.37 18.77 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.4 mt -126.94 133.98 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.485 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 11.1 t70 -108.41 100.98 10.2 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 174.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -72.01 -16.34 62.06 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -73.57 -40.4 63.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.283 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 37.9 mmt-85 -93.76 -7.8 42.51 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 60.85 30.28 19.55 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.343 1.057 . . . . 0.0 109.685 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -119.07 165.93 13.53 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.3 p -148.12 150.69 34.31 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 90.6 t -95.98 130.49 44.59 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.9 m -123.06 147.0 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 133' ' ' ARG . 62.2 t -104.85 120.1 54.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.083 178.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -66.93 115.13 6.34 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.352 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.1 m -72.6 129.3 37.95 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.454 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.48 -14.81 63.79 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -118.09 -44.61 2.69 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 122.456 -0.438 . . . . 0.0 110.96 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.26 8.23 56.61 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.987 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.55 163.03 14.74 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 117.777 0.788 . . . . 0.0 109.289 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.7 ppt_? -133.02 139.0 47.0 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -147.68 151.7 36.57 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.494 0.718 . . . . 0.0 109.075 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 38.8 tt0 -101.89 126.65 48.83 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.587 0.708 . . . . 0.0 109.835 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -129.27 163.38 25.79 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.131 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -85.84 144.06 27.92 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.5 mt -57.94 -40.12 79.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 123.736 0.648 . . . . 0.0 110.905 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.8 m -80.75 -5.21 56.81 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.266 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -106.99 -14.27 14.99 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 123' ' ' CYS . 53.3 mt -60.69 154.62 21.04 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-O 121.548 0.69 . . . . 0.0 110.527 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 36.7 mt -120.0 156.65 30.47 Favored 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.022 -176.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.28 -2.444 0 O-C-N 123.843 0.714 . . . . 0.0 109.289 -179.563 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.1 m95 . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -126.78 155.03 43.46 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.14 128.33 23.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 120.968 0.413 . . . . 0.0 109.946 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.64 5.32 54.05 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.917 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.41 140.78 29.19 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -89.28 144.14 26.31 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.22 -164.61 2.0 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 68.6 m -129.19 141.11 51.25 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.68 160.26 38.08 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.172 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.71 111.07 24.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.307 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -66.25 119.11 10.94 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.7 m -63.53 -17.35 62.69 Favored 'General case' 0 C--N 1.274 -2.678 0 C-N-CA 123.928 0.891 . . . . 0.0 113.099 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -83.14 -37.39 23.8 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 114.557 -1.202 . . . . 0.0 111.629 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -116.36 -15.55 10.95 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.245 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.28 -6.14 77.46 Favored Glycine 0 C--N 1.316 -0.538 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.059 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 78.0 m -90.38 164.98 14.11 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.5 mt -86.56 133.44 29.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.931 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -141.8 152.16 61.76 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.07 130.79 19.57 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.37 2.047 . . . . 0.0 111.667 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.59 151.41 39.0 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.199 -0.313 . . . . 0.0 110.537 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.6 m -116.87 135.76 53.48 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.163 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 52.2 mt -65.68 117.82 7.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 123.288 0.635 . . . . 0.0 110.913 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.99 -37.0 11.89 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.853 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -160.27 149.56 17.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.414 HG23 HD21 ' A' ' 138' ' ' LEU . 69.1 mt -122.2 133.89 67.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.43 102.49 11.37 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -70.95 -20.88 62.41 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.136 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -38.01 64.76 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.044 0.45 . . . . 0.0 110.977 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -92.1 -7.65 47.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.195 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 60.49 30.81 20.06 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 124.149 0.906 . . . . 0.0 110.102 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 52.1 p -121.75 166.79 13.78 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.231 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.645 ' SG ' HD11 ' A' ' 141' ' ' LEU . 10.7 p -148.51 152.13 36.34 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 92.5 t -95.57 131.37 42.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.7 m -123.14 147.19 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' A' ' 133' ' ' ARG . 67.1 t -106.93 121.57 59.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.54 112.94 5.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.568 0.699 . . . . 0.0 110.354 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.9 m -66.5 130.07 41.98 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.972 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.73 -5.5 83.53 Favored Glycine 0 N--CA 1.432 -1.627 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.201 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -117.28 -50.73 2.55 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.817 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.45 34.04 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 119.857 -1.163 . . . . 0.0 114.059 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -97.09 162.71 13.25 Favored 'General case' 0 CA--C 1.482 -1.661 0 C-N-CA 119.344 -0.943 . . . . 0.0 109.553 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.401 ' HB3' HG22 ' A' ' 126' ' ' VAL . 6.3 ppt_? -134.04 139.45 46.02 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.201 0.524 . . . . 0.0 109.866 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -147.13 150.44 34.98 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.378 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 41.4 tt0 -103.02 120.87 41.43 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -126.3 163.73 22.58 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.219 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 18.1 m-80 -85.06 142.79 29.31 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.414 HD21 HG23 ' A' ' 116' ' ' ILE . 51.5 mt -59.32 -36.49 75.76 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.877 0.846 . . . . 0.0 109.919 177.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.6 p -79.62 -10.3 59.77 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.665 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.405 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 32.2 t70 -110.07 -4.54 15.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.511 0.672 . . . . 0.0 109.763 -176.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.645 HD11 ' SG ' ' A' ' 123' ' ' CYS . 71.2 mt -67.23 162.71 22.01 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.716 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.5 mt -128.94 159.86 34.51 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.438 -177.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.298 -1.673 0 O-C-N 123.495 0.497 . . . . 0.0 109.961 -179.013 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 78.5 m95 . . . . . 0 CA--C 1.505 -0.765 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -130.95 155.9 46.01 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.57 128.28 25.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.78 7.62 52.97 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.755 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.41 147.34 25.35 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -91.54 150.94 20.97 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.2 p -155.63 -168.04 2.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 67.0 m -129.6 145.21 51.51 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.44 159.95 40.22 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 123.215 0.322 . . . . 0.0 110.281 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.9 mm -92.27 112.61 26.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.342 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -69.48 118.21 12.07 Favored 'General case' 0 CA--C 1.471 -2.077 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.2 m -58.88 -23.1 60.54 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 122.068 0.937 . . . . 0.0 112.194 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.06 -39.74 23.03 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.987 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -108.77 -16.54 14.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.704 0.764 . . . . 0.0 109.855 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.84 -6.53 69.87 Favored Glycine 0 C--O 1.225 -0.448 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.997 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 65.3 m -90.96 167.53 12.34 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.0 mt -88.0 132.13 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.506 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -140.1 152.47 67.47 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.209 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.09 130.4 18.86 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.416 2.077 . . . . 0.0 111.24 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.16 149.62 35.3 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.963 0.411 . . . . 0.0 110.312 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.6 m -117.54 136.17 53.44 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 56.7 mt -65.74 121.76 15.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 O-C-N 123.548 0.53 . . . . 0.0 111.156 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.14 -34.59 9.98 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.919 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.8 p -161.12 150.89 17.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 123' ' ' CYS . 67.7 mt -127.43 133.37 68.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 117.931 0.332 . . . . 0.0 110.111 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -108.82 103.68 12.79 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.65 -14.32 61.56 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.271 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -73.68 -41.3 62.85 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.877 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -98.22 -6.12 31.89 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.401 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 63.64 29.33 15.1 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.828 0.851 . . . . 0.0 109.308 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 47.1 p -117.29 165.41 13.49 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.916 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.625 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.6 p -148.55 152.39 36.74 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 120.676 0.274 . . . . 0.0 110.272 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.3 t -96.25 130.63 44.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.72 147.25 28.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 53.5 t -106.07 123.54 60.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.139 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -72.05 113.77 9.44 Favored 'General case' 0 C--O 1.257 1.5 0 CA-C-O 121.479 0.656 . . . . 0.0 110.475 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.5 m -69.2 130.21 42.01 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.742 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.76 -10.17 72.67 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.838 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -118.54 -53.05 2.34 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.719 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.21 17.43 15.87 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.728 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -99.71 165.61 11.51 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -132.99 142.46 48.85 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -145.51 151.28 37.92 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.98 121.65 42.57 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.424 0.631 . . . . 0.0 109.52 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -125.33 163.41 22.61 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 15.7 m-80 -85.62 143.48 28.41 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.1 mt -58.49 -38.3 77.35 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.682 0.754 . . . . 0.0 110.607 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.4 p -80.42 -8.67 59.62 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.992 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.542 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 12.6 t70 -105.33 -8.15 18.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.625 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.0 mt -65.86 157.8 29.56 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.625 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.3 mt -124.76 161.32 26.68 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -176.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.294 -1.846 0 O-C-N 123.542 0.526 . . . . 0.0 110.278 -178.547 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.414 ' CD1' HD12 ' A' ' 141' ' ' LEU . 83.1 m95 . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 110.694 -0.113 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -125.24 151.61 45.69 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.23 128.41 26.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.86 10.83 54.79 Favored Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.372 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -103.85 153.22 21.0 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -86.43 147.87 25.81 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 123.677 0.791 . . . . 0.0 110.51 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -156.64 -168.85 2.81 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 69.2 m -130.64 141.74 50.43 Favored 'General case' 0 C--N 1.264 -3.123 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.71 160.15 38.41 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 123.313 0.383 . . . . 0.0 110.651 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.4 mm -94.55 109.93 22.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.087 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -66.21 121.28 14.86 Favored 'General case' 0 CA--C 1.473 -1.996 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.9 m -61.33 -19.7 62.11 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 124.067 0.947 . . . . 0.0 112.341 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -84.36 -42.35 15.82 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.35 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -104.57 -16.09 15.13 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.648 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.25 -1.27 65.3 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 71.1 m -90.37 162.56 15.07 Favored 'General case' 0 N--CA 1.408 -2.569 0 C-N-CA 124.323 1.049 . . . . 0.0 112.177 -175.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.4 mt -86.6 133.77 29.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.099 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -140.31 152.26 66.42 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 131.5 19.49 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.425 2.083 . . . . 0.0 111.228 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.62 154.57 42.96 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.437 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.0 m -119.33 135.95 54.48 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.7 mt -68.77 124.12 23.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 122.922 0.489 . . . . 0.0 111.346 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.51 -32.32 11.88 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.876 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.4 p -163.89 152.84 13.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.429 HG23 HD21 ' A' ' 138' ' ' LEU . 68.7 mt -126.93 132.18 70.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 122.818 0.447 . . . . 0.0 109.826 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.418 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 10.1 t70 -109.4 102.54 11.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 173.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.51 -21.82 63.64 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.635 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -73.57 -36.25 65.55 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.603 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 35.2 mmt180 -93.35 -8.52 41.71 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 61.08 28.51 18.23 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.196 0.998 . . . . 0.0 110.186 -173.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 66.6 p -119.95 166.18 13.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.127 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.648 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.4 p -148.45 150.73 33.98 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.41 HG11 ' HD3' ' A' ' 133' ' ' ARG . 92.3 t -96.1 132.5 40.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 27.7 m -124.03 147.55 28.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.4 t -104.99 121.46 56.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.071 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -69.89 116.63 10.5 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-O 121.548 0.69 . . . . 0.0 110.84 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.2 m -66.2 129.86 41.24 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.176 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.78 -16.82 59.95 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.047 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -115.15 -51.81 2.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.432 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.26 17.06 28.12 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.644 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 90.6 m-20 -93.48 162.48 13.95 Favored 'General case' 0 CA--C 1.472 -2.053 0 C-N-CA 119.499 -0.88 . . . . 0.0 108.642 174.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.7 ppt_? -131.72 135.46 46.86 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -142.61 151.11 41.15 Favored 'General case' 0 N--CA 1.409 -2.486 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.323 -173.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -101.77 122.0 43.13 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.798 0.809 . . . . 0.0 109.904 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -126.82 163.54 23.36 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.434 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.463 ' HB2' ' CB ' ' A' ' 140' ' ' ASP . 17.9 m-80 -88.59 143.45 26.94 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.429 HD21 HG23 ' A' ' 116' ' ' ILE . 61.8 mt -57.07 -40.69 77.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.204 0.602 . . . . 0.0 111.253 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.6 t -80.87 -8.53 59.74 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.317 0.58 . . . . 0.0 110.736 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.463 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 21.4 t70 -102.16 -10.71 19.39 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.648 HD11 ' SG ' ' A' ' 123' ' ' CYS . 60.8 mt -66.59 157.81 31.43 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.23 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 28.5 mt -125.27 161.58 26.63 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -176.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--N 1.297 -1.704 0 O-C-N 123.282 0.364 . . . . 0.0 110.557 -178.909 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 84.8 m95 . . . . . 0 C--O 1.244 0.805 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -131.47 156.11 46.22 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.39 131.94 29.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.13 3.68 54.24 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.574 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.485 ' HB2' HD12 ' A' ' 113' ' ' ILE . 62.5 m-20 -99.56 139.48 35.16 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -83.66 145.51 28.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.8 p -153.45 -161.97 1.37 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 70.6 m -135.78 146.59 47.76 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.0 161.12 38.13 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.571 -176.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.8 mm -92.77 112.43 26.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -69.02 124.29 23.34 Favored 'General case' 0 CA--C 1.474 -1.964 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.1 m -59.52 -25.36 64.43 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.977 0.798 . . . . 0.0 112.366 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -81.53 -41.84 21.07 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.485 -0.78 . . . . 0.0 113.102 -174.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -105.82 -15.87 14.82 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.578 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.74 -0.74 76.18 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 78.3 m -89.94 164.62 14.49 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 124.013 0.925 . . . . 0.0 112.263 -176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.413 HG23 HD12 ' A' ' 142' ' ' LEU . 29.8 mt -88.39 131.2 36.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -140.08 152.39 67.34 Favored Pre-proline 0 C--N 1.291 -1.97 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.467 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.73 137.14 26.78 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.227 1.951 . . . . 0.0 111.399 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.96 148.66 29.35 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.893 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.3 m -112.42 136.05 52.38 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 96' ' ' ASP . 57.5 mt -66.39 118.64 9.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 C-N-CA 123.202 0.601 . . . . 0.0 110.945 -178.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.29 -41.92 8.79 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.934 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.0 m -157.58 149.71 22.44 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -123.48 132.26 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 123.314 0.384 . . . . 0.0 110.213 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.12 108.73 19.51 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -75.56 -17.42 60.06 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.166 -173.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -73.31 -41.73 63.19 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -94.21 -8.03 40.45 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.004 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 60.86 31.52 20.03 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.288 1.035 . . . . 0.0 110.035 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 49.3 p -119.38 167.38 11.97 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.729 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.7 p -148.33 151.83 36.04 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.637 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 98.0 t -96.07 132.59 39.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.8 m -123.87 148.41 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 68.0 t -106.24 120.56 57.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.475 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.47 116.03 8.56 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.675 0.61 . . . . 0.0 110.713 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.5 m -71.54 129.57 39.09 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.883 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.21 -14.9 64.4 Favored Glycine 0 N--CA 1.429 -1.793 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.908 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -117.71 -44.47 2.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 120.971 0.415 . . . . 0.0 110.718 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.8 10.8 52.04 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.011 -1.09 . . . . 0.0 114.437 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -91.29 162.58 14.56 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-N 117.93 0.865 . . . . 0.0 109.267 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 ppt_? -132.07 137.75 47.89 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -145.7 151.83 38.64 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 43.9 tt0 -101.72 124.73 47.86 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -176.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -129.16 163.77 24.81 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.629 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 17.8 m-80 -87.58 144.04 26.89 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 62.9 mt -58.77 -39.33 80.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.676 0.75 . . . . 0.0 110.273 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.7 p -73.8 -17.12 61.12 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.481 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 16.0 t70 -101.89 -7.8 22.15 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -173.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 123' ' ' CYS . 62.4 mt -66.9 157.48 33.07 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.095 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 32.9 mt -126.25 160.81 29.28 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.293 -1.886 0 O-C-N 123.571 0.545 . . . . 0.0 110.4 -179.021 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 CA--C 1.514 -0.428 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.0 m -104.85 92.22 4.16 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.87 -38.2 85.87 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.67 -29.62 67.11 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.0 m -110.23 21.55 16.59 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.367 0.603 . . . . 0.0 110.359 -176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 mt -82.35 16.47 2.04 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -175.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -121.75 -16.25 7.72 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.642 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -116.62 130.13 56.56 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.073 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -139.05 163.91 31.17 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -128.51 154.76 45.79 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.19 127.07 24.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.84 8.99 47.19 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.527 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.406 ' HB3' HD12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -97.5 148.86 22.8 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -91.52 151.26 20.83 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -158.16 -169.58 2.84 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 121.479 0.657 . . . . 0.0 110.005 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.5 m -127.07 144.07 51.12 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 173.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.18 160.12 39.36 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.0 mm -93.82 109.59 22.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -68.62 123.71 21.62 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.9 m -63.19 -20.03 65.04 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.86 -39.48 19.84 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.517 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -108.03 -15.42 14.52 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.642 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.33 1.35 69.57 Favored Glycine 0 C--N 1.313 -0.717 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 77.4 m -90.55 164.19 14.32 Favored 'General case' 0 N--CA 1.405 -2.685 0 C-N-CA 124.303 1.041 . . . . 0.0 112.327 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -89.5 129.26 40.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.349 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -137.56 152.58 73.16 Favored Pre-proline 0 C--N 1.286 -2.187 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.795 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.97 133.33 23.11 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.624 2.216 . . . . 0.0 111.555 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.75 153.81 41.35 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.27 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 m -118.23 135.88 53.99 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 96' ' ' ASP . 51.3 mt -68.82 120.49 16.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 120.958 0.409 . . . . 0.0 110.587 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.71 -38.44 9.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.968 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -159.3 152.21 21.94 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 123' ' ' CYS . 63.4 mt -128.87 136.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 122.65 0.38 . . . . 0.0 110.343 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -109.27 99.52 8.78 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -71.27 -18.54 62.42 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.078 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -73.46 -40.58 64.05 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.21 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -90.83 -7.3 52.68 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 61.86 32.8 17.92 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.79 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.5 p -122.74 164.05 19.03 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.168 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.669 ' SG ' HD11 ' A' ' 141' ' ' LEU . 16.8 p -148.44 155.86 41.75 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.75 0.31 . . . . 0.0 110.396 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.77 130.19 46.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 31.6 m -123.3 147.24 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 133' ' ' ARG . 75.2 t -104.7 122.55 57.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.17 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -70.27 114.97 8.93 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.64 0.588 . . . . 0.0 110.192 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 45.7 m -67.76 131.83 46.3 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.069 -176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.1 -15.37 63.04 Favored Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.852 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -116.75 -47.88 2.69 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.732 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.34 14.38 38.7 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.938 -1.125 . . . . 0.0 114.086 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -94.63 162.63 13.71 Favored 'General case' 0 CA--C 1.479 -1.776 0 C-N-CA 119.606 -0.838 . . . . 0.0 108.986 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.2 ppt_? -133.78 136.38 44.5 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -141.98 151.76 42.81 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.62 -174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.76 120.52 40.5 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -125.75 163.49 22.74 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.254 -174.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -85.88 143.31 28.3 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.411 HD21 HG23 ' A' ' 116' ' ' ILE . 66.8 mt -58.57 -39.79 81.28 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.623 0.577 . . . . 0.0 110.683 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.6 t -80.91 -5.52 57.52 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.426 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -106.96 -8.53 16.58 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.514 0.673 . . . . 0.0 109.706 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.669 HD11 ' SG ' ' A' ' 123' ' ' CYS . 67.1 mt -66.59 162.61 20.57 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.856 176.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 41.3 mt -128.49 159.94 33.88 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 30.3 m -67.43 144.4 97.88 Favored Pre-proline 0 C--N 1.296 -1.731 0 O-C-N 123.658 0.599 . . . . 0.0 111.595 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.67 150.41 82.36 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 123.053 2.502 . . . . 0.0 112.27 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.4 mt -85.37 140.8 15.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 39.5 t -135.08 6.49 3.36 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.093 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.424 -1.77 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.818 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.502 -0.882 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.6 m -97.59 120.51 38.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 74.6 -35.92 0.31 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.825 1.65 . . . . 0.0 114.034 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.56 109.91 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.813 0.845 . . . . 0.0 112.374 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -91.94 0.66 57.47 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.19 0.995 . . . . 0.0 110.117 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 89' ' ' LEU . 5.1 tt -84.39 6.26 23.93 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 123.012 1.387 . . . . 0.0 108.364 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -99.32 -5.46 29.65 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.92 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -129.47 108.94 10.65 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.918 0.866 . . . . 0.0 111.102 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.444 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 86.8 m95 -119.73 164.48 15.88 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.054 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 8.9 ptpp? -128.95 153.45 47.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.16 127.43 24.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.75 8.71 56.95 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.761 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 2.5 t0 -99.96 146.8 26.28 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -83.67 154.95 23.4 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 121.294 0.569 . . . . 0.0 111.418 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -160.0 -174.47 4.58 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.4 m -125.03 140.97 52.43 Favored 'General case' 0 C--N 1.258 -3.386 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 174.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.76 159.97 38.99 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.152 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.98 111.58 25.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -68.76 121.96 17.59 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.6 m -63.49 -19.74 65.01 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 123.952 0.782 . . . . 0.0 112.821 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -84.57 -42.13 15.76 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.174 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -106.74 -15.47 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.674 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.14 -5.24 77.6 Favored Glycine 0 N--CA 1.462 0.431 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.425 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 68.0 m -90.65 166.99 12.86 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 123.75 0.82 . . . . 0.0 113.176 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.3 mt -86.88 133.2 30.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.984 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -140.67 152.46 66.07 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.477 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.24 127.8 14.71 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.237 1.958 . . . . 0.0 110.965 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.01 150.36 39.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 120.904 0.383 . . . . 0.0 110.192 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 m -114.99 135.84 53.79 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 53.0 mt -68.32 118.93 13.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.891 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.68 -36.69 12.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.911 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m -159.19 150.04 19.8 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.4 HG23 HD21 ' A' ' 138' ' ' LEU . 69.0 mt -126.94 132.78 69.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 122.971 0.508 . . . . 0.0 110.514 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -108.94 110.38 21.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -75.37 -21.34 58.4 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.992 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -73.51 -36.57 65.77 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.241 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -94.97 -8.86 35.73 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.359 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 57.63 35.65 25.9 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.924 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 47.1 p -121.93 163.01 20.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.905 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.599 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.2 p -148.34 153.45 38.64 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 120.816 0.341 . . . . 0.0 110.282 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.6 t -96.34 132.44 40.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.9 m -123.49 147.13 27.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.0 t -106.3 120.94 58.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -70.58 115.74 10.09 Favored 'General case' 0 C--O 1.259 1.577 0 CA-C-O 121.386 0.612 . . . . 0.0 109.978 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.0 m -69.04 129.58 40.31 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.313 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.81 -17.48 58.57 Favored Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.026 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.93 -52.72 2.73 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.207 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.11 22.17 8.96 Favored Glycine 0 N--CA 1.435 -1.383 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.734 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -105.62 161.91 13.97 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.7 ppt_? -135.08 136.08 41.74 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -143.18 151.32 40.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -101.96 119.74 39.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.634 0.73 . . . . 0.0 109.27 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -126.24 163.5 23.06 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.042 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.3 m-80 -85.36 143.93 28.34 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.4 HD21 HG23 ' A' ' 116' ' ' ILE . 60.5 mt -59.06 -37.01 76.04 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.794 0.807 . . . . 0.0 109.495 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.3 m -73.75 -19.76 60.69 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.117 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -102.57 -8.93 20.59 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.29 0.567 . . . . 0.0 110.332 -173.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.599 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.4 mt -63.45 160.72 15.71 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.939 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.9 mt -125.3 159.93 30.51 Favored 'General case' 0 C--N 1.254 -3.586 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.2 m -67.36 135.63 93.3 Favored Pre-proline 0 C--N 1.29 -1.997 0 O-C-N 123.577 0.548 . . . . 0.0 110.264 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.58 150.88 79.41 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 123.172 2.581 . . . . 0.0 113.372 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.6 mt -81.25 172.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 18.8 p -73.33 17.01 0.15 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 124.16 0.984 . . . . 0.0 113.297 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 . . . . . 0 N--CA 1.427 -1.589 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -177.323 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.666 ' N ' ' HG ' ' A' ' 88' ' ' SER . 43.8 t30 . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 p -88.3 -13.34 41.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.353 0.597 . . . . 0.0 112.396 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -169.44 103.08 0.35 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.07 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 76.6 109.92 0.07 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.211 -1.813 . . . . 0.0 111.029 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.666 ' HG ' ' N ' ' A' ' 84' ' ' ASN . 50.5 m -108.64 13.75 24.96 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.567 0.699 . . . . 0.0 112.334 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 89' ' ' LEU . 5.8 tt -94.81 2.36 55.47 Favored 'General case' 0 C--O 1.202 -1.41 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -92.24 -3.62 55.23 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.801 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -135.26 136.31 41.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.153 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.479 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 79.8 m95 -141.93 165.08 28.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -175.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -129.76 157.73 41.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.23 128.71 25.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.508 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.56 -1.77 36.76 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.204 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.481 ' HB2' HD12 ' A' ' 113' ' ' ILE . 24.6 m-20 -96.79 135.32 38.9 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 122.68 -0.306 . . . . 0.0 111.08 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 14.6 mtmt -77.47 147.76 35.73 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-O 121.335 0.588 . . . . 0.0 110.901 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.9 p -154.53 -166.5 2.35 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 114.579 -1.192 . . . . 0.0 107.96 -177.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 73.2 m -129.03 141.37 51.26 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.61 160.36 38.73 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.2 mm -93.92 112.58 27.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -68.33 120.72 14.91 Favored 'General case' 0 CA--C 1.473 -1.981 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.6 m -61.65 -20.46 63.44 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.947 0.779 . . . . 0.0 112.631 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -84.73 -39.8 18.06 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.565 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -109.02 -15.95 14.24 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.042 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.13 -3.95 78.45 Favored Glycine 0 N--CA 1.464 0.524 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.328 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 70.7 m -90.62 168.15 12.01 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.8 mt -90.31 133.64 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.666 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -142.36 152.01 59.54 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.43 135.19 26.06 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.505 2.137 . . . . 0.0 111.381 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.95 150.69 34.51 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.941 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 20.7 m -111.27 135.83 51.25 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 96' ' ' ASP . 44.5 mt -67.94 117.12 9.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 123.34 0.4 . . . . 0.0 110.49 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.08 -38.6 11.53 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.205 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 p -159.19 146.87 17.49 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.41 HG23 HD21 ' A' ' 138' ' ' LEU . 62.5 mt -124.36 135.32 64.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -109.35 106.23 15.95 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -75.73 -13.72 60.31 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -73.26 -41.88 63.14 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -96.39 -7.52 34.84 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.702 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 57.36 33.67 23.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.336 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 79.8 p -118.38 161.98 19.06 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.065 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.55 ' SG ' HD11 ' A' ' 141' ' ' LEU . 15.1 p -147.81 152.91 38.48 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.359 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 88.7 t -95.82 131.66 42.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.1 m -123.21 146.92 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 77.7 t -106.26 120.01 56.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -66.41 111.99 3.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.782 0.676 . . . . 0.0 110.386 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.4 m -65.62 129.95 41.56 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.727 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.32 -21.22 41.68 Favored Glycine 0 N--CA 1.425 -2.087 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.786 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -106.95 -50.46 3.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.101 -177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.72 3.56 37.02 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.149 -1.024 . . . . 0.0 114.223 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 95.1 m-20 -87.73 163.16 16.65 Favored 'General case' 0 CA--C 1.479 -1.772 0 CA-C-N 117.804 0.802 . . . . 0.0 109.916 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.8 ppt_? -134.25 136.53 43.67 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.079 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -144.92 151.24 38.36 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.971 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 39.9 tt0 -102.7 124.7 48.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -127.57 163.92 23.12 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -175.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 16.6 m-80 -87.37 142.88 27.55 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.41 HD21 HG23 ' A' ' 116' ' ' ILE . 51.0 mt -57.22 -39.76 76.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.431 0.634 . . . . 0.0 110.561 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 m -79.63 -4.63 52.51 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.883 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -108.96 -7.75 15.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.52 0.676 . . . . 0.0 109.306 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.55 HD11 ' SG ' ' A' ' 123' ' ' CYS . 67.7 mt -69.58 163.83 24.63 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.652 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 21.1 mt -130.65 162.85 28.48 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.0 m -71.5 141.46 85.44 Favored Pre-proline 0 C--N 1.31 -1.137 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -60.66 142.65 98.4 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.339 2.026 . . . . 0.0 112.557 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.433 HG22 ' HG3' ' A' ' 147' ' ' GLU . 36.1 mt -84.67 144.33 9.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.714 -176.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 46.4 t -137.73 96.12 3.17 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.433 ' HG3' HG22 ' A' ' 145' ' ' ILE . 44.0 mt-10 . . . . . 0 C--N 1.287 -2.131 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.488 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.5 t -122.79 24.19 9.17 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.787 0.803 . . . . 0.0 110.188 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.48 -19.53 6.9 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.96 14.56 31.6 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.3 m 63.05 26.45 15.44 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.336 1.065 . . . . 0.0 109.954 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 89' ' ' LEU . 6.5 tt -84.89 0.81 49.8 Favored 'General case' 0 C--O 1.207 -1.147 0 C-N-CA 125.448 1.499 . . . . 0.0 110.498 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -99.46 6.67 45.89 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.37 -0.831 . . . . 0.0 110.365 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -140.75 127.53 20.42 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.397 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 77.7 m95 -138.18 164.72 28.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -130.92 154.96 47.56 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.17 127.43 22.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-O 121.032 0.444 . . . . 0.0 110.754 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.1 5.77 46.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.505 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -103.75 149.08 25.33 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 120.705 0.288 . . . . 0.0 110.23 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -88.5 150.91 22.86 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.808 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.41 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.4 p -155.82 -168.02 2.66 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.953 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.553 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.9 m -129.35 144.95 51.44 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.39 160.22 39.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.902 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.2 mm -93.89 110.04 22.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.73 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -66.31 121.79 16.05 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 t -61.18 -22.35 64.65 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 123.885 0.74 . . . . 0.0 110.589 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -80.58 -42.19 22.71 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.719 -173.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -106.37 -14.9 14.96 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.274 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.69 0.53 68.54 Favored Glycine 0 N--CA 1.462 0.429 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.97 164.15 14.09 Favored 'General case' 0 N--CA 1.403 -2.788 0 C-N-CA 124.852 1.261 . . . . 0.0 112.325 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.3 mt -88.02 133.51 30.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.61 0.764 . . . . 0.0 110.144 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -144.07 152.48 54.86 Favored Pre-proline 0 C--N 1.304 -1.397 0 C-N-CA 123.158 0.583 . . . . 0.0 109.868 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.07 133.68 23.68 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.695 2.263 . . . . 0.0 111.873 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.71 153.36 40.9 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.967 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.2 m -117.55 135.79 53.71 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 48.5 mt -66.25 118.1 8.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 123.104 0.562 . . . . 0.0 111.322 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.21 -38.43 10.57 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.97 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 m -158.26 151.85 23.45 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.414 HG23 HD21 ' A' ' 138' ' ' LEU . 63.5 mt -127.26 134.18 66.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -108.59 102.88 11.91 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -71.06 -18.45 62.56 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.27 -174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -72.82 -39.9 66.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -93.8 -7.51 43.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 61.81 27.49 16.79 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.793 0.837 . . . . 0.0 110.062 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.8 p -119.64 165.7 14.13 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.342 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.573 ' SG ' HD11 ' A' ' 141' ' ' LEU . 12.0 p -148.08 152.49 37.45 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.9 t -96.73 131.19 44.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.1 m -123.57 147.11 28.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 133' ' ' ARG . 55.3 t -106.75 122.89 61.31 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -70.95 114.49 9.06 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.545 0.688 . . . . 0.0 110.13 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.5 m -63.96 129.47 40.19 Favored 'General case' 0 N--CA 1.407 -2.607 0 CA-C-N 113.712 -1.586 . . . . 0.0 111.287 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.83 -13.97 57.64 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.316 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -109.66 -44.79 3.78 Favored 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 122.547 -0.384 . . . . 0.0 110.231 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.18 10.07 56.37 Favored Glycine 0 N--CA 1.436 -1.357 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.923 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -91.94 163.86 13.86 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 117.586 0.693 . . . . 0.0 109.487 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -135.27 139.11 44.15 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -145.82 151.21 37.56 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -101.39 121.85 42.67 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -128.65 163.21 25.56 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.957 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 19.9 m-80 -86.17 144.56 27.42 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.414 HD21 HG23 ' A' ' 116' ' ' ILE . 47.1 mt -57.93 -40.94 81.68 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.848 0.717 . . . . 0.0 110.652 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 m -81.38 -7.23 59.54 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.302 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 19.2 t70 -101.98 -5.03 25.13 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.573 HD11 ' SG ' ' A' ' 123' ' ' CYS . 68.8 mt -69.62 171.63 8.67 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.276 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 27.2 mt -138.34 162.89 33.22 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.0 m -67.62 137.75 93.24 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.53 142.33 94.6 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.042 2.495 . . . . 0.0 115.327 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.505 HG13 ' OG ' ' A' ' 99' ' ' SER . 39.8 mt -92.17 159.0 2.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 114.3 -1.318 . . . . 0.0 107.831 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.4 t 73.44 11.89 4.79 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.801 1.64 . . . . 0.0 109.779 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 . . . . . 0 C--N 1.301 -1.533 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.622 177.994 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.534 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.6 OUTLIER . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.425 ' HA ' HE22 ' A' ' 90' ' ' GLN . 45.2 m -139.09 98.58 3.55 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.723 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.09 -9.39 17.84 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.91 157.35 37.63 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.487 -0.778 . . . . 0.0 108.933 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -94.22 23.92 4.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.85 0.833 . . . . 0.0 109.407 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.83 33.65 3.51 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.466 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 47.5 mt-30 -113.66 -48.47 2.93 Favored 'General case' 0 C--O 1.209 -1.027 0 C-N-CA 120.451 -0.499 . . . . 0.0 112.24 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -100.66 136.1 41.06 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.746 0.784 . . . . 0.0 112.692 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -135.0 164.72 26.98 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.732 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -116.79 152.15 35.0 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.646 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.17 128.54 26.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.94 23.29 25.72 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.657 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -115.74 149.72 38.02 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 3.1 mtmt -84.23 148.78 26.53 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 123.026 0.53 . . . . 0.0 110.102 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 p -157.92 -167.89 2.36 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.7 m -131.18 142.08 50.15 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.47 160.16 38.25 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.907 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.0 mm -95.07 108.18 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -67.88 123.78 21.53 Favored 'General case' 0 CA--C 1.469 -2.147 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.289 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -62.04 -22.09 65.45 Favored 'General case' 0 C--N 1.282 -2.326 0 O-C-N 123.95 0.781 . . . . 0.0 112.674 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -83.58 -36.91 23.58 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -108.46 -16.46 14.22 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.155 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.2 0.45 70.96 Favored Glycine 0 C--N 1.304 -1.236 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.707 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 99.4 m -90.84 167.38 12.5 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 124.491 1.117 . . . . 0.0 111.887 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.39 133.1 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.48 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.47 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.3 m-85 -139.48 152.05 68.07 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.088 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.62 133.32 23.74 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.313 2.009 . . . . 0.0 111.189 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.02 156.64 44.05 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.818 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 23.0 m -119.99 135.52 54.89 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mt -70.31 123.88 25.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 122.747 0.419 . . . . 0.0 110.679 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.95 -36.07 10.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.164 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 64.1 m -161.38 149.97 15.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.43 HG23 HD21 ' A' ' 138' ' ' LEU . 71.1 mt -124.41 129.73 73.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -105.67 101.85 11.34 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -73.16 -12.67 60.97 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.234 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.56 -40.68 63.75 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.255 0.55 . . . . 0.0 109.605 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -99.32 -7.02 26.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.1 30.27 17.78 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.868 0.867 . . . . 0.0 110.306 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 52.7 p -119.99 165.53 14.56 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.245 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.597 ' SG ' HD11 ' A' ' 141' ' ' LEU . 15.6 p -148.09 152.74 37.87 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.1 t -96.15 131.01 44.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.6 m -122.98 146.83 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 133' ' ' ARG . 65.5 t -105.78 120.39 56.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.91 114.7 7.45 Favored 'General case' 0 C--O 1.257 1.462 0 O-C-N 123.923 0.764 . . . . 0.0 110.107 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 87.8 m -67.52 128.98 38.47 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.655 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.23 -22.82 30.27 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.696 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -100.82 -52.37 3.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 122.324 -0.515 . . . . 0.0 109.877 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.39 11.25 29.68 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.85 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -93.87 162.54 13.87 Favored 'General case' 0 CA--C 1.466 -2.265 0 C-N-CA 119.434 -0.907 . . . . 0.0 109.739 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.3 ppt_? -133.54 136.25 44.87 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -142.08 150.93 41.85 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -102.55 116.45 32.63 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.759 0.79 . . . . 0.0 109.271 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -121.03 163.78 17.78 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.617 -173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -85.88 139.87 30.88 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.527 ' HB3' ' O ' ' A' ' 90' ' ' GLN . 71.0 mt -55.22 -40.82 71.29 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.375 0.67 . . . . 0.0 111.354 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.2 t -80.67 -6.2 58.05 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.797 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -104.76 -7.86 19.2 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.743 0.782 . . . . 0.0 109.052 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.597 HD11 ' SG ' ' A' ' 123' ' ' CYS . 66.1 mt -67.16 163.98 19.07 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.638 176.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 26.8 mt -132.39 163.66 28.21 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 p -67.94 140.55 93.83 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.37 142.78 98.94 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 123.215 2.61 . . . . 0.0 115.006 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.519 HG13 ' OG ' ' A' ' 99' ' ' SER . 39.4 mt -91.6 138.11 20.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 173.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 34.9 t -136.5 22.89 3.17 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-O 121.746 0.784 . . . . 0.0 108.964 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 C--N 1.3 -1.576 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.086 -177.506 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.6 t30 . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 m -89.39 87.52 7.13 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.55 -12.15 21.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.235 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.91 161.18 40.62 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 m -84.06 84.4 7.61 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.14 -0.16 14.76 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.259 1.028 . . . . 0.0 109.554 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -108.65 -22.11 12.4 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.012 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -141.85 134.7 28.71 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 75.0 m95 -129.09 165.46 21.18 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -175.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.627 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 8.4 ptpp? -126.0 153.78 43.87 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.51 129.14 26.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.96 3.07 42.44 Favored Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.063 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.627 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 12.1 m-20 -98.01 136.32 38.44 Favored 'General case' 0 CA--C 1.486 -1.518 0 O-C-N 122.602 -0.352 . . . . 0.0 110.488 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 13.9 mtmt -81.19 143.7 32.15 Favored 'General case' 0 N--CA 1.401 -2.905 0 CA-C-O 121.291 0.567 . . . . 0.0 109.63 171.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.31 -167.51 2.73 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.9 m -128.6 145.11 51.23 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.33 160.26 39.58 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.682 0.614 . . . . 0.0 109.817 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mm -93.29 109.62 22.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.491 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -68.1 125.68 27.11 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.835 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.8 m -64.5 -20.82 66.44 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -83.95 -41.16 17.63 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -105.33 -15.96 14.89 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.392 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.25 0.86 79.1 Favored Glycine 0 C--N 1.311 -0.839 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.014 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.499 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 74.9 m -90.27 168.85 11.6 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 124.117 0.967 . . . . 0.0 111.75 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.1 mt -89.07 135.41 25.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.1 m-85 -142.99 152.12 57.76 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.46 136.13 27.94 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.663 2.242 . . . . 0.0 111.413 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.96 154.17 39.01 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 31.0 m -114.68 135.49 54.1 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.529 HD12 ' HB2' ' A' ' 96' ' ' ASP . 49.7 mt -67.39 115.51 5.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 122.949 0.499 . . . . 0.0 110.705 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.44 -35.41 13.0 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.193 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -157.96 148.38 20.56 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.425 HG23 HD21 ' A' ' 138' ' ' LEU . 65.5 mt -123.25 133.01 70.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -108.31 97.56 7.23 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -71.74 -14.73 62.09 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.977 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -73.24 -41.34 63.83 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.018 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -94.89 -6.88 41.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.216 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 62.56 29.52 17.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.4 1.08 . . . . 0.0 110.096 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 46.7 p -117.94 166.75 12.14 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.618 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.6 p -148.45 152.12 36.38 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.0 t -95.86 131.09 43.53 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.6 m -122.71 146.73 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 133' ' ' ARG . 72.4 t -105.28 119.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -68.14 111.1 4.3 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-O 121.574 0.702 . . . . 0.0 110.858 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 96.2 m -70.58 129.79 40.12 Favored 'General case' 0 N--CA 1.397 -3.101 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.576 -175.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.11 -13.81 63.04 Favored Glycine 0 N--CA 1.418 -2.502 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.296 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.7 -54.01 2.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.95 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 107.27 17.42 11.51 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.957 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -101.64 168.61 9.36 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.269 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.472 ' HB3' HG22 ' A' ' 126' ' ' VAL . 7.1 ppt_? -137.73 140.11 40.52 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -146.14 151.59 37.91 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 123.696 0.798 . . . . 0.0 109.43 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -101.67 123.35 45.52 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.497 0.665 . . . . 0.0 109.507 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -129.31 163.39 25.8 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.022 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 22.6 m-80 -85.8 146.03 26.95 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.425 HD21 HG23 ' A' ' 116' ' ' ILE . 52.5 mt -60.22 -35.15 74.79 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.751 0.786 . . . . 0.0 109.587 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.3 p -74.52 -17.87 60.69 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.667 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -105.47 -4.81 20.9 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.715 0.769 . . . . 0.0 110.471 -173.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.608 HD11 ' SG ' ' A' ' 123' ' ' CYS . 52.9 mt -68.11 160.73 28.38 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.886 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.6 mt -132.14 164.47 26.23 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 39.9 m -67.4 137.61 93.73 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 122.93 0.492 . . . . 0.0 110.151 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.92 147.25 84.7 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.29 2.66 . . . . 0.0 115.118 -171.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.7 mt -100.29 142.02 16.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 38.9 t -136.35 115.01 11.98 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 C--N 1.29 -1.995 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.906 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.1 t -77.18 149.54 35.56 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-O 121.252 0.548 . . . . 0.0 110.768 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.78 49.33 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.99 92.1 8.85 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 121.975 0.893 . . . . 0.0 109.36 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 m -104.38 31.38 4.68 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.94 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 89' ' ' LEU . 4.1 tt -88.78 1.84 54.54 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 123.355 1.55 . . . . 0.0 107.477 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.91 3.07 33.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.619 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -128.9 119.05 23.71 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.137 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.444 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 78.8 m95 -135.92 164.66 27.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -130.07 152.72 49.22 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.52 131.46 29.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 123.481 0.488 . . . . 0.0 110.102 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.23 4.6 50.34 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.25 145.03 30.81 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -80.69 154.36 27.36 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-O 121.574 0.702 . . . . 0.0 111.138 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.3 p -159.67 -171.56 3.33 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.7 m -129.13 143.72 50.96 Favored 'General case' 0 C--N 1.261 -3.245 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.45 158.66 43.81 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.104 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -93.14 110.86 23.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.519 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.413 ' CD2' ' HB2' ' A' ' 104' ' ' GLU . 6.2 t90 -68.63 125.42 26.47 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m -60.9 -22.96 64.84 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.027 0.829 . . . . 0.0 112.829 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 102' ' ' TRP . 4.9 mm-40 -83.62 -42.0 17.2 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.739 -174.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -105.91 -16.23 14.7 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.058 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.67 1.02 75.98 Favored Glycine 0 C--N 1.312 -0.762 0 N-CA-C 111.419 -0.673 . . . . 0.0 111.419 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 78.7 m -89.92 165.86 13.84 Favored 'General case' 0 N--CA 1.414 -2.262 0 C-N-CA 124.028 0.931 . . . . 0.0 111.693 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -90.28 129.24 41.46 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.819 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 95.7 m-85 -134.63 152.22 77.31 Favored Pre-proline 0 C--N 1.285 -2.232 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.865 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.412 ' HG3' ' HB3' ' A' ' 147' ' ' GLU . 56.3 Cg_endo -71.13 130.23 17.35 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.277 1.985 . . . . 0.0 110.837 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.12 150.73 39.86 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.942 0.401 . . . . 0.0 110.066 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.1 m -115.99 135.85 53.58 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 50.9 mt -64.7 123.79 18.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 123.602 0.564 . . . . 0.0 110.781 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.31 -38.2 8.16 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.147 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.1 p -159.43 148.58 18.2 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.458 HG23 HD21 ' A' ' 138' ' ' LEU . 69.7 mt -124.41 130.51 73.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.718 0.294 . . . . 0.0 110.526 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -109.37 103.36 12.27 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.03 -16.9 60.58 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.869 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -73.26 -39.08 65.71 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.061 0.457 . . . . 0.0 110.181 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -95.18 -7.63 38.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.606 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 62.56 26.81 15.91 Favored 'General case' 0 C--O 1.248 1.016 0 C-N-CA 124.8 1.24 . . . . 0.0 110.504 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 82.5 p -118.83 165.16 14.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.425 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.1 p -148.06 151.39 35.61 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 89.3 t -96.19 132.56 40.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 29.2 m -123.54 147.57 27.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 56.9 t -106.5 122.06 59.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.849 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -70.78 114.08 8.5 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 123.747 0.654 . . . . 0.0 110.71 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.7 m -65.54 130.33 42.93 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.908 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.16 -13.4 66.4 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.151 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.59 -48.93 2.67 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.901 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 101.28 7.11 50.1 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.426 -0.892 . . . . 0.0 114.193 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 89.2 m-20 -88.32 162.91 16.32 Favored 'General case' 0 CA--C 1.474 -1.946 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.214 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.6 ppt_? -132.38 136.45 46.82 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -144.06 151.1 39.19 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 40.6 tt0 -102.05 126.38 48.98 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -130.7 163.25 27.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.9 m-80 -84.33 144.92 28.54 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.458 HD21 HG23 ' A' ' 116' ' ' ILE . 55.0 mt -57.48 -42.74 83.26 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.557 0.694 . . . . 0.0 110.612 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 p -78.36 -7.83 57.75 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.217 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -101.83 -13.76 17.56 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.588 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.4 mt -61.2 160.39 10.46 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.231 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 27.8 mt -126.41 162.44 25.56 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.1 m -67.36 137.05 93.59 Favored Pre-proline 0 C--N 1.298 -1.65 0 O-C-N 123.596 0.56 . . . . 0.0 109.93 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -59.65 147.24 92.79 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.364 2.709 . . . . 0.0 114.818 -172.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.457 HG13 ' OG ' ' A' ' 99' ' ' SER . 35.3 mt -93.73 141.06 15.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 174.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.38 43.7 0.83 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 124.886 1.274 . . . . 0.0 110.624 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.412 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 34.7 tt0 . . . . . 0 N--CA 1.426 -1.628 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.488 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.503 -0.855 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.8 m -72.98 122.23 21.37 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.42 -18.72 65.53 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.578 0.351 . . . . 0.0 111.134 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 68.94 96.22 0.06 Allowed 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 125.228 1.411 . . . . 0.0 113.28 172.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.3 m -113.11 86.43 2.38 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 89' ' ' LEU . 2.6 tt -109.34 -2.79 17.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.484 1.135 . . . . 0.0 110.07 -175.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -118.92 0.55 11.37 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.206 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -130.05 109.56 10.94 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -126.71 164.35 21.49 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -125.83 153.41 44.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.42 128.26 26.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.34 10.98 40.22 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.921 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.63 150.06 27.34 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -91.76 150.06 21.29 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 120.956 0.408 . . . . 0.0 109.957 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -155.95 -168.38 2.75 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.603 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.7 m -128.36 141.16 51.51 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.62 160.42 36.7 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.7 mm -97.04 109.49 23.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -65.7 121.75 15.71 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -60.95 -19.55 61.04 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 124.104 0.878 . . . . 0.0 112.647 -175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.88 -43.12 14.4 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.016 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.53 -15.9 14.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.233 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.7 0.09 79.04 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-O 121.564 0.536 . . . . 0.0 112.058 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.491 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 79.4 m -89.63 162.49 15.59 Favored 'General case' 0 N--CA 1.407 -2.621 0 C-N-CA 123.772 0.829 . . . . 0.0 111.768 -177.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.4 mt -88.04 130.67 37.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.617 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -136.43 152.21 74.47 Favored Pre-proline 0 C--N 1.289 -2.054 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.789 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.02 130.21 17.44 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.279 1.986 . . . . 0.0 110.827 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.66 147.42 31.98 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 120.974 0.416 . . . . 0.0 110.324 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.4 m -113.68 135.89 53.43 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.4 mt -68.26 119.99 14.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 122.734 0.414 . . . . 0.0 110.601 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.89 -30.97 12.44 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.737 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.2 p -161.23 154.76 21.79 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.437 HG23 HD21 ' A' ' 138' ' ' LEU . 69.5 mt -128.33 132.8 67.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.19 102.9 12.0 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -72.13 -16.69 62.0 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.447 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -73.48 -40.26 64.26 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.467 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -97.12 -6.93 33.83 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.8 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 63.13 30.87 16.04 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-O 122.027 0.917 . . . . 0.0 109.949 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.1 p -120.67 166.72 13.3 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.922 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.648 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.6 p -148.7 152.19 36.22 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 87.4 t -95.84 130.61 44.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 22.5 m -123.29 147.31 27.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' A' ' 133' ' ' ARG . 66.9 t -106.0 121.26 58.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -71.2 114.69 9.52 Favored 'General case' 0 C--O 1.257 1.478 0 CA-C-O 121.611 0.72 . . . . 0.0 110.312 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.7 m -66.23 130.63 43.87 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.736 -1.575 . . . . 0.0 110.877 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.86 -21.26 42.58 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.201 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -108.14 -52.68 2.73 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.893 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.88 20.37 10.75 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.796 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -101.37 161.23 13.78 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.55 173.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.3 ppt_? -132.21 135.94 46.66 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -145.18 149.88 35.75 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 37.8 tt0 -102.92 124.29 48.16 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -127.79 163.4 24.43 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.331 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -83.11 142.09 31.5 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.437 HD21 HG23 ' A' ' 116' ' ' ILE . 44.6 mt -55.6 -41.61 73.67 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.921 0.763 . . . . 0.0 111.443 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 m -76.4 -15.66 59.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.895 0.378 . . . . 0.0 111.312 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -95.63 -9.55 31.81 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.802 0.81 . . . . 0.0 109.428 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.648 HD11 ' SG ' ' A' ' 123' ' ' CYS . 62.3 mt -65.35 163.58 15.3 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.284 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.1 mt -131.15 162.41 29.97 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.3 p -69.17 138.46 89.62 Favored Pre-proline 0 C--N 1.308 -1.225 0 O-C-N 123.281 0.363 . . . . 0.0 110.141 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.84 142.42 96.28 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.688 2.259 . . . . 0.0 114.468 -173.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.509 HG13 ' OG ' ' A' ' 99' ' ' SER . 58.1 mt -80.91 152.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 114.249 -1.341 . . . . 0.0 107.888 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 47.0 t -124.1 106.57 10.45 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--N 1.298 -1.663 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.071 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 119.591 -0.242 . . . . 0.0 111.4 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.6 p 56.01 -167.52 0.1 Allowed 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.508 1.123 . . . . 0.0 110.553 -173.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.44 -8.79 46.81 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.486 0.66 . . . . 0.0 109.637 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.77 80.48 8.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.976 0.893 . . . . 0.0 111.253 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -164.11 19.5 0.06 Allowed 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 126.26 1.824 . . . . 0.0 106.737 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.37 63.32 4.86 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 122.701 1.239 . . . . 0.0 108.955 -168.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -141.88 -0.43 1.33 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.167 -1.833 . . . . 0.0 110.564 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -126.82 113.63 16.86 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.405 0.622 . . . . 0.0 111.138 -174.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 82.0 m95 -130.57 163.98 25.9 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -125.78 155.61 40.77 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.66 128.22 25.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.989 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.75 -1.61 48.74 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.966 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.2 146.13 24.22 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -86.59 149.86 24.63 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.092 0.473 . . . . 0.0 111.039 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.9 p -156.7 -168.03 2.56 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.635 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.537 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.5 m -129.7 149.21 51.55 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.21 160.38 39.59 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 123.574 0.546 . . . . 0.0 109.684 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -94.07 110.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -68.44 124.28 23.1 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.8 m -64.34 -18.03 64.25 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 123.93 0.769 . . . . 0.0 112.662 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.86 -41.79 17.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -104.96 -15.16 15.2 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.626 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.67 2.0 68.23 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.555 ' HB2' ' CE2' ' A' ' 109' ' ' TYR . 98.7 m -90.71 165.03 13.91 Favored 'General case' 0 N--CA 1.406 -2.633 0 C-N-CA 124.494 1.117 . . . . 0.0 112.286 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 mt -90.83 131.33 38.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.556 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 107' ' ' CYS . 98.3 m-85 -141.41 152.31 63.46 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.74 134.98 31.67 Favored 'Trans proline' 0 C--O 1.24 0.624 0 C-N-CA 122.68 2.253 . . . . 0.0 112.143 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.23 157.24 43.53 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.945 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 m -121.46 135.46 55.04 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 49.3 mt -66.88 118.6 10.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 C-N-CA 123.5 0.72 . . . . 0.0 111.287 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.51 -38.04 11.09 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.627 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 p -157.92 152.21 24.54 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.522 HG23 HD21 ' A' ' 138' ' ' LEU . 64.6 mt -126.13 129.58 72.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -108.98 99.67 8.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.21 -20.72 65.74 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.171 -175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.447 ' H ' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -72.04 -40.3 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 110.461 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -90.51 -7.87 51.84 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.072 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 65.17 26.83 12.38 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.853 1.261 . . . . 0.0 108.994 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 64.7 p -120.66 169.35 10.46 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.461 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.7 p -148.6 151.32 34.83 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 123.034 0.533 . . . . 0.0 109.618 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.7 t -96.19 132.33 40.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.9 m -123.64 148.37 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.44 121.06 58.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -67.44 115.09 6.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.787 0.68 . . . . 0.0 110.371 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.5 m -67.56 129.84 41.17 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.85 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.23 -16.29 56.2 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.142 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -109.89 -43.51 3.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.156 0.503 . . . . 0.0 110.536 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.06 59.58 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.006 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -87.95 162.96 16.59 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.179 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.6 ppt_? -133.68 136.21 44.57 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -144.66 151.4 38.91 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 44.4 tt0 -102.23 122.19 43.7 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 121.539 0.685 . . . . 0.0 109.75 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -126.22 163.52 22.98 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.89 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 20.3 m-80 -85.73 145.48 27.25 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 116' ' ' ILE . 39.2 mt -58.81 -39.65 81.81 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.641 0.588 . . . . 0.0 111.225 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.3 p -81.05 -10.14 59.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.16 0.505 . . . . 0.0 111.598 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 38.1 t70 -96.96 -13.82 22.11 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 123' ' ' CYS . 56.3 mt -63.99 160.25 18.26 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.549 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 24.0 mt -130.68 165.12 23.54 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.0 m -66.84 136.82 94.6 Favored Pre-proline 0 C--N 1.304 -1.397 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.89 145.21 97.1 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.409 2.74 . . . . 0.0 115.556 -172.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.503 HG13 ' OG ' ' A' ' 99' ' ' SER . 28.9 mt -103.2 140.16 22.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.592 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 43.2 t -162.85 98.68 0.97 Allowed 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 C--N 1.284 -2.26 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.799 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.565 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.5 m -75.39 112.76 12.03 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.49 -7.37 53.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.858 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 67.74 81.67 0.19 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 125.443 1.497 . . . . 0.0 111.146 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.3 m -109.32 15.94 22.74 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.629 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 89' ' ' LEU . 1.8 tt -99.42 -1.02 39.69 Favored 'General case' 0 C--O 1.209 -1.074 0 CA-C-O 123.132 1.444 . . . . 0.0 107.67 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -110.4 -2.32 16.68 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.685 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -115.33 109.45 17.94 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -129.33 164.41 23.63 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -126.52 150.05 49.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.01 128.22 25.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.981 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.14 12.59 42.03 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.916 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.92 148.22 31.0 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -85.04 154.81 21.85 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.614 0.721 . . . . 0.0 111.649 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -161.25 -170.71 2.75 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.778 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.6 m -126.97 140.86 52.01 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.23 159.97 38.64 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.956 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.0 mm -93.1 113.62 28.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.229 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -69.17 119.77 13.97 Favored 'General case' 0 CA--C 1.467 -2.213 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.2 m -64.0 -17.68 63.55 Favored 'General case' 0 C--N 1.278 -2.503 0 O-C-N 123.983 0.802 . . . . 0.0 112.706 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.87 -42.61 16.19 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.274 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -105.71 -15.96 14.82 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.704 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.45 71.52 Favored Glycine 0 N--CA 1.461 0.326 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.132 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.5 m -90.75 166.5 13.09 Favored 'General case' 0 N--CA 1.406 -2.627 0 C-N-CA 124.052 0.941 . . . . 0.0 113.223 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.6 mt -89.39 134.51 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.61 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -141.46 152.26 63.16 Favored Pre-proline 0 C--N 1.304 -1.381 0 C-N-CA 123.032 0.533 . . . . 0.0 110.273 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 128.97 16.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.335 2.023 . . . . 0.0 111.023 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.1 150.34 37.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.12 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.5 m -113.87 136.25 53.09 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.22 121.06 15.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.231 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.18 -31.64 12.35 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.682 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.4 p -164.42 153.05 12.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.451 HG23 HD21 ' A' ' 138' ' ' LEU . 77.3 mt -127.12 129.55 71.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.74 0.416 . . . . 0.0 110.309 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.83 99.41 8.76 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -67.99 -19.75 64.97 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -73.25 -39.89 65.08 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.285 0.565 . . . . 0.0 109.893 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -89.97 -8.65 51.2 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.573 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 61.34 25.32 15.3 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.072 0.949 . . . . 0.0 110.492 -173.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 73.9 p -117.63 162.28 18.28 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.452 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.6 p -145.12 150.69 37.23 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 84.3 t -95.68 131.95 41.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 29.1 m -123.12 147.83 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 75.9 t -105.22 122.05 58.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -69.63 114.89 8.27 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.403 0.62 . . . . 0.0 110.077 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.9 m -66.36 129.96 41.6 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.717 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.53 -16.58 55.96 Favored Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.835 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -109.4 -46.65 3.51 Favored 'General case' 0 N--CA 1.434 -1.242 0 O-C-N 122.196 -0.591 . . . . 0.0 111.017 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.58 11.83 49.72 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.914 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -94.0 160.91 14.51 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.105 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.6 ppt_? -133.44 135.29 44.48 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -147.44 151.86 37.13 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -173.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 36.7 tt0 -102.02 126.8 49.04 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-O 121.981 0.896 . . . . 0.0 110.874 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -124.03 164.06 20.15 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.442 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.8 m-80 -86.93 144.38 26.98 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.451 HD21 HG23 ' A' ' 116' ' ' ILE . 44.5 mt -56.4 -44.1 79.94 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.725 0.64 . . . . 0.0 110.94 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.1 m -77.09 -9.82 58.98 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.262 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.03 -9.5 20.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.235 0.541 . . . . 0.0 109.813 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.585 HD11 ' SG ' ' A' ' 123' ' ' CYS . 63.9 mt -64.1 159.07 21.16 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.254 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 40.2 mt -126.76 162.29 26.16 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.5 m -71.75 137.5 82.83 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.441 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 22.7 Cg_endo -60.14 139.69 88.63 Favored 'Trans proline' 0 CA--C 1.502 -1.093 0 C-N-CA 122.542 2.161 . . . . 0.0 113.424 -172.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 147' ' ' GLU . 19.5 mt -77.48 142.98 13.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 45.2 t -119.78 16.59 12.7 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 122.052 0.929 . . . . 0.0 109.098 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.536 ' H ' HG22 ' A' ' 145' ' ' ILE . 5.9 mm-40 . . . . . 0 C--N 1.292 -1.91 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.839 -175.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.545 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -167.42 149.72 5.92 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.5 -15.08 38.61 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.03 107.95 8.07 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.783 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.8 m -82.38 9.8 8.35 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.347 0.594 . . . . 0.0 111.369 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 89' ' ' LEU . 4.8 tt -79.03 10.17 3.7 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 123.093 1.425 . . . . 0.0 109.529 -178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -107.05 1.25 24.16 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.352 -0.842 . . . . 0.0 109.46 174.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -121.56 122.14 39.02 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -136.44 163.93 29.34 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -122.15 152.71 39.64 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.16 128.39 26.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.156 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.65 9.76 48.98 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.906 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.22 148.01 25.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -86.53 153.52 21.77 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.343 0.592 . . . . 0.0 110.841 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.8 p -162.77 -168.6 1.83 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.73 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 67.6 m -129.08 141.27 51.26 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.08 159.79 39.06 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -93.82 110.48 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -67.65 120.67 14.42 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.5 m -61.13 -21.51 63.8 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 123.814 0.696 . . . . 0.0 112.757 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -83.95 -37.35 22.4 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.381 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -111.17 -15.68 13.61 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.064 -177.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.59 -5.74 72.64 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.111 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.5 m -90.39 166.47 13.26 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 124.122 0.969 . . . . 0.0 113.593 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.2 mt -87.94 133.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.817 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -142.88 152.66 59.5 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.9 131.57 21.31 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.393 2.062 . . . . 0.0 111.522 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.38 154.51 41.71 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.9 m -118.75 135.92 54.24 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.1 mt -69.23 118.03 12.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.052 0.541 . . . . 0.0 110.687 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.87 -35.15 13.51 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.218 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.0 m -160.28 153.7 22.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.7 mt -127.2 134.2 66.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 123.479 0.487 . . . . 0.0 109.952 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -109.37 103.81 12.8 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -73.16 -18.53 61.26 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 120.971 0.415 . . . . 0.0 111.599 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.21 -37.39 66.45 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.017 0.437 . . . . 0.0 110.612 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -96.8 -7.71 32.98 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.801 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 61.81 26.49 16.08 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.027 0.918 . . . . 0.0 110.404 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.0 p -118.36 161.83 19.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.358 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' A' ' 141' ' ' LEU . 10.9 p -147.78 152.14 37.2 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.4 t -96.24 131.84 42.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.7 m -123.3 147.25 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.57 122.17 60.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -69.75 113.8 7.34 Favored 'General case' 0 CA--C 1.491 -1.293 0 O-C-N 123.68 0.612 . . . . 0.0 110.279 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.3 m -65.09 129.12 38.55 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.706 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.88 -20.21 40.76 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.694 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -105.3 -43.53 4.97 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.163 0.506 . . . . 0.0 110.416 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.28 59.94 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.095 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -91.93 163.99 13.81 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.4 ppt_? -133.52 135.94 44.72 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -143.4 150.39 39.02 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.37 120.9 41.28 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -126.63 163.74 22.8 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.115 -174.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 17.7 m-80 -85.6 142.96 28.73 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.01 -38.8 73.61 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.751 0.786 . . . . 0.0 110.272 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.5 p -78.88 -7.59 58.08 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.993 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 16.0 t70 -109.8 -4.66 15.91 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.801 0.81 . . . . 0.0 109.323 -175.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.553 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.8 mt -69.46 162.52 27.26 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.497 175.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 28.0 mt -130.66 162.33 29.64 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m -70.99 141.41 86.7 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.438 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 10.0 Cg_endo -58.3 140.01 92.74 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 121.968 1.779 . . . . 0.0 112.629 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.1 mt -69.2 150.82 10.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.134 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 71.2 m -75.81 78.53 2.74 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-O 121.582 0.706 . . . . 0.0 109.845 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 . . . . . 0 N--CA 1.429 -1.489 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.909 178.803 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 . . . . . 0 CA--C 1.507 -0.689 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -128.69 -3.45 5.32 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.481 0.658 . . . . 0.0 111.464 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.17 -27.38 12.93 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.262 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' GLN . . . -132.11 19.24 4.5 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.828 0.823 . . . . 0.0 111.179 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.9 p -90.89 12.61 18.95 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.01 -1.09 35.2 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.104 0.954 . . . . 0.0 110.214 -178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 30.1 pt20 -106.42 3.4 27.29 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.56 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -132.54 120.57 22.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.26 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -139.03 164.29 30.15 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -130.92 155.45 46.75 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.303 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.62 127.05 23.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 O-C-N 123.561 0.538 . . . . 0.0 110.258 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.54 -0.82 32.5 Favored Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.339 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -100.51 148.03 25.24 Favored 'General case' 0 CA--C 1.479 -1.751 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.208 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 53.3 mtpt -87.97 155.26 19.93 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.314 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.0 p -157.58 -169.54 2.91 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.5 m -127.41 140.48 52.14 Favored 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 174.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.69 160.11 38.53 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -94.19 110.61 23.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.864 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -67.19 120.22 13.39 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 71.2 m -63.05 -17.86 62.71 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 124.107 0.88 . . . . 0.0 112.672 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.08 -40.73 17.95 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.149 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -110.27 -16.48 13.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.534 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.49 -4.64 83.75 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.318 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 66.0 m -90.61 165.39 13.76 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.6 mt -87.36 130.63 36.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.318 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -139.66 152.7 69.11 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.858 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.58 129.62 17.03 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.503 2.135 . . . . 0.0 111.575 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.87 39.77 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.081 -0.387 . . . . 0.0 110.122 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 22.3 m -116.7 136.04 53.29 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.33 121.71 15.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 123.11 0.564 . . . . 0.0 110.847 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.58 -35.28 9.19 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.675 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.1 p -157.83 152.26 24.77 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.403 HG23 HD21 ' A' ' 138' ' ' LEU . 66.2 mt -128.75 131.83 68.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -106.4 105.08 14.94 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -72.42 -20.15 61.47 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.83 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -74.87 -40.51 60.92 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.166 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -90.88 -7.97 50.72 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.684 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 60.3 29.17 18.79 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.357 1.063 . . . . 0.0 109.983 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.7 p -119.94 165.53 14.52 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.619 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 141' ' ' LEU . 10.7 p -147.85 152.15 37.14 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.6 t -95.94 130.82 44.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.1 m -123.17 146.75 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.9 t -106.29 120.41 57.29 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -69.07 112.76 5.89 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.492 0.663 . . . . 0.0 109.887 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.7 m -67.93 129.65 40.56 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.805 -174.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.9 -17.41 58.12 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.559 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -108.97 -47.4 3.45 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.719 0.295 . . . . 0.0 111.345 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.63 40.59 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.479 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -98.5 161.58 13.6 Favored 'General case' 0 CA--C 1.48 -1.713 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.453 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.5 ppt_? -134.16 136.29 43.69 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -142.93 151.35 40.86 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.673 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -101.73 121.39 41.97 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.831 0.824 . . . . 0.0 109.026 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -126.35 163.61 22.89 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.482 -1.236 . . . . 0.0 108.103 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -86.1 142.88 28.36 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.403 HD21 HG23 ' A' ' 116' ' ' ILE . 54.0 mt -56.16 -40.49 73.97 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.859 0.724 . . . . 0.0 110.586 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.6 t -80.44 -6.03 57.47 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.51 0.672 . . . . 0.0 110.345 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -106.28 -8.37 17.32 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 121.432 -0.793 . . . . 0.0 109.301 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.585 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.3 mt -66.8 159.18 28.62 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.111 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 33.9 mt -126.73 162.15 26.47 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.4 m -68.37 135.3 90.99 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 123.464 0.478 . . . . 0.0 110.114 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.92 147.12 95.84 Favored 'Trans proline' 0 CA--C 1.505 -0.927 0 C-N-CA 123.236 2.624 . . . . 0.0 113.78 -172.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.3 mt -87.04 136.18 23.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.1 t -95.92 91.55 6.07 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-O 121.401 0.619 . . . . 0.0 109.654 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 C--N 1.294 -1.828 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.284 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.518 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.655 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.8 m -95.37 134.08 38.57 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.78 81.86 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.278 0.561 . . . . 0.0 111.265 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.92 106.0 14.98 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.637 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.6 p -80.4 2.72 23.84 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.835 0.826 . . . . 0.0 111.566 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 89' ' ' LEU . 5.1 tt -95.66 6.15 49.65 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.935 1.35 . . . . 0.0 107.589 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -102.02 -0.28 33.9 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.187 176.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -129.3 126.58 39.32 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.129 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -137.36 164.82 27.68 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -119.62 153.38 35.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.83 128.29 25.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.641 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.68 7.08 54.09 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.256 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HB3' HD12 ' A' ' 113' ' ' ILE . 2.0 t0 -96.67 150.02 21.15 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -93.21 141.38 28.49 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-O 120.895 0.378 . . . . 0.0 110.044 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.0 p -152.11 -163.35 1.71 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.542 ' OG ' HG13 ' A' ' 145' ' ' ILE . 73.7 m -132.2 150.01 52.25 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.0 160.36 40.09 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.6 mm -92.83 113.44 27.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -70.77 125.59 27.26 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.7 m -62.52 -20.88 65.07 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 123.388 0.675 . . . . 0.0 112.708 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.96 -42.1 16.62 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.199 -174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -108.32 -14.65 14.64 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.034 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.85 -2.43 74.36 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 96.4 m -90.03 166.79 13.24 Favored 'General case' 0 N--CA 1.414 -2.227 0 C-N-CA 124.268 1.027 . . . . 0.0 112.723 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.8 mt -87.96 132.63 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.8 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 97.4 m-85 -140.98 152.02 64.05 Favored Pre-proline 0 C--N 1.291 -1.942 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.838 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.51 129.84 18.59 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.616 2.211 . . . . 0.0 112.25 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.49 149.85 38.12 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 m -114.64 136.11 53.41 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 96' ' ' ASP . 46.6 mt -69.01 119.81 15.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 O-C-N 123.476 0.485 . . . . 0.0 111.063 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.57 -37.1 11.01 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.883 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.3 p -159.65 153.24 22.64 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.452 HG23 HD21 ' A' ' 138' ' ' LEU . 72.4 mt -125.25 132.37 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -108.19 106.05 16.05 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -74.3 -20.48 60.11 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.802 -174.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -73.75 -38.99 64.56 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.117 0.484 . . . . 0.0 110.125 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -95.0 -7.25 40.33 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.617 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 61.63 28.45 17.62 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 124.141 0.976 . . . . 0.0 110.017 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 60.1 p -118.56 168.99 10.17 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.033 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.649 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.4 p -149.0 150.86 33.54 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.1 t -95.89 131.21 43.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.58 147.42 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.993 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 68.9 t -107.46 123.14 62.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -69.96 111.94 6.02 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.432 0.634 . . . . 0.0 110.339 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.9 m -62.77 129.82 42.19 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.966 -175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.66 -20.47 38.4 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.688 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -107.73 -41.44 5.01 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.039 0.447 . . . . 0.0 110.842 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.04 8.78 58.79 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.454 -0.879 . . . . 0.0 114.177 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -91.83 162.48 14.42 Favored 'General case' 0 CA--C 1.482 -1.664 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.031 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -134.44 138.41 44.74 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -144.82 150.86 37.88 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -102.59 122.17 43.84 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -126.41 164.02 22.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.418 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 16.4 m-80 -88.47 143.45 26.97 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.452 HD21 HG23 ' A' ' 116' ' ' ILE . 47.2 mt -55.84 -40.26 72.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 123.79 0.681 . . . . 0.0 111.612 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.0 t -76.39 -16.56 59.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.168 0.509 . . . . 0.0 110.118 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 9.0 t70 -101.16 -0.77 35.45 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.663 0.744 . . . . 0.0 109.684 -172.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.649 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.1 mt -72.05 164.46 26.11 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.256 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.1 mt -132.73 164.18 27.35 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.1 m -70.05 138.81 87.47 Favored Pre-proline 0 C--N 1.306 -1.308 0 C-N-CA 122.891 0.476 . . . . 0.0 109.982 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.91 141.15 88.67 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 123.339 2.693 . . . . 0.0 116.09 -170.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.542 HG13 ' OG ' ' A' ' 99' ' ' SER . 35.7 mt -100.28 144.18 12.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 174.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 44.8 t -119.39 104.64 10.53 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.146 0.498 . . . . 0.0 109.672 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 N--CA 1.413 -2.32 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 176.16 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 CA--C 1.505 -0.786 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.4 m -72.38 124.03 24.29 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.51 -33.02 74.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.132 0.492 . . . . 0.0 110.444 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.47 87.69 6.64 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.461 0.648 . . . . 0.0 109.824 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.2 m -104.98 3.82 31.07 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.985 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 89' ' ' LEU . 4.8 tt -97.68 -0.01 46.3 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.323 1.535 . . . . 0.0 106.863 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -108.61 4.56 24.11 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.442 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -131.71 117.82 19.15 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -132.57 164.94 25.53 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.649 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -124.0 153.71 40.9 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.64 127.85 24.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.047 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.21 12.58 45.13 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.972 -0.633 . . . . 0.0 111.774 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -100.33 145.33 28.28 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.78 140.8 29.45 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.4 -163.42 1.67 Allowed 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.015 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.8 m -131.45 147.42 52.55 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.02 160.33 39.63 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.936 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.8 mm -93.27 110.71 23.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -67.62 122.28 17.71 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.2 m -60.19 -25.39 65.54 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 123.957 0.786 . . . . 0.0 112.482 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.32 -41.59 24.57 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.179 -172.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -108.0 -15.67 14.47 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.061 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.32 -4.07 78.78 Favored Glycine 0 N--CA 1.465 0.615 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.12 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.6 m -91.01 166.58 12.94 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.02 132.54 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.318 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -142.17 152.04 60.23 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.526 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -69.95 133.27 24.83 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.443 2.095 . . . . 0.0 111.607 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.64 146.91 29.51 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.825 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -112.77 135.77 53.14 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.2 mt -66.98 122.46 18.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 123.072 0.549 . . . . 0.0 110.595 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.79 -36.82 10.08 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.371 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.2 p -158.7 151.3 21.92 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.462 HG23 HD21 ' A' ' 138' ' ' LEU . 64.2 mt -125.37 132.27 71.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.436 ' OD1' ' HE3' ' A' ' 119' ' ' LYS . 9.6 t70 -108.48 104.1 13.37 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -72.78 -16.9 61.63 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HE3' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -73.51 -36.24 65.71 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.136 0.493 . . . . 0.0 110.12 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -98.48 -8.07 27.36 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.38 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 59.72 32.28 21.33 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.935 0.874 . . . . 0.0 109.938 -173.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.8 p -120.6 167.87 11.97 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.84 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.641 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.0 p -148.49 152.12 36.35 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.9 t -95.94 131.14 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.9 m -123.34 146.91 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 133' ' ' ARG . 75.8 t -105.65 120.68 56.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.723 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -68.43 114.13 6.59 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.639 0.587 . . . . 0.0 110.273 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.3 m -66.56 129.4 39.73 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.913 -174.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.09 -10.01 74.63 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.51 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -113.99 -51.25 2.79 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.977 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.11 6.18 45.77 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.93 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 96.2 m-20 -89.38 162.42 15.8 Favored 'General case' 0 CA--C 1.472 -2.057 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.248 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.1 ppt_? -135.6 136.05 40.74 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-O 121.27 0.557 . . . . 0.0 110.104 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -141.9 150.98 42.22 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.314 -174.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -102.64 118.99 38.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.683 0.754 . . . . 0.0 109.406 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -124.21 163.31 21.85 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.443 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -83.86 145.25 28.74 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.462 HD21 HG23 ' A' ' 116' ' ' ILE . 52.6 mt -58.39 -38.74 77.94 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.784 0.678 . . . . 0.0 111.003 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.8 m -80.49 -10.99 59.73 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.32 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.17 -9.63 27.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.601 0.715 . . . . 0.0 109.193 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.641 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.4 mt -68.56 166.25 17.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.01 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 18.8 mt -136.35 163.82 29.56 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.7 m -67.76 141.5 94.97 Favored Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.15 142.43 98.28 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 123.247 2.631 . . . . 0.0 114.59 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.526 HG13 ' OG ' ' A' ' 99' ' ' SER . 37.5 mt -93.01 136.66 24.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 36.6 t -158.52 98.49 1.54 Allowed 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 . . . . . 0 C--N 1.292 -1.933 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.289 -175.919 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 120.45 0.167 . . . . 0.0 111.378 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 p -130.66 157.84 41.67 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 122.008 -0.432 . . . . 0.0 109.946 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.13 -28.02 16.57 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.439 0.638 . . . . 0.0 109.788 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.7 22.13 2.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.132 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 p -108.84 30.79 6.19 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.876 0.846 . . . . 0.0 109.113 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.17 1.6 12.94 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.799 -1.091 . . . . 0.0 113.764 -172.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -110.39 -1.33 17.18 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.748 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -120.2 115.11 22.98 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.981 0.896 . . . . 0.0 110.608 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.449 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 86.1 m95 -132.65 163.97 27.75 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.975 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -128.95 157.57 41.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.735 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.65 128.04 26.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.9 6.79 56.92 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.925 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.29 144.27 28.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -85.84 152.82 22.7 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.537 0.684 . . . . 0.0 111.629 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.6 p -161.91 -170.95 2.7 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.919 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 74.7 m -127.41 144.42 51.06 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.09 160.05 40.1 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 mm -94.27 111.53 25.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -69.05 123.18 20.35 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.7 m -63.28 -18.84 64.01 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 123.969 0.793 . . . . 0.0 112.966 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -83.33 -41.55 18.1 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.346 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -106.37 -16.38 14.57 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.971 -1.092 . . . . 0.0 111.418 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.96 0.75 86.26 Favored Glycine 0 C--N 1.31 -0.874 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 71.0 m -90.89 164.59 13.98 Favored 'General case' 0 N--CA 1.421 -1.883 0 C-N-CA 124.885 1.274 . . . . 0.0 112.473 -176.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 mt -88.89 132.12 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.451 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.1 m-85 -139.46 152.5 69.12 Favored Pre-proline 0 C--N 1.284 -2.267 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.33 134.72 27.44 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.639 2.226 . . . . 0.0 111.18 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.41 153.59 40.64 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.208 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.0 m -119.65 135.39 54.83 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 57.0 mt -64.5 122.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 123.439 0.695 . . . . 0.0 110.652 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.71 -38.98 9.69 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.819 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.8 m -158.48 149.68 20.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.435 HG23 HD21 ' A' ' 138' ' ' LEU . 64.3 mt -123.56 132.43 71.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 122.971 0.508 . . . . 0.0 109.809 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.92 104.1 13.49 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -74.57 -14.66 60.82 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.954 0.407 . . . . 0.0 111.866 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -74.08 -40.93 62.42 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.238 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -96.84 -8.45 30.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.6 33.29 20.41 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.953 0.883 . . . . 0.0 110.026 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 61.1 p -120.72 165.33 15.25 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.983 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 141' ' ' LEU . 12.5 p -148.15 152.5 37.4 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 95.3 t -95.78 131.38 42.7 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 27.8 m -123.63 147.3 28.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 133' ' ' ARG . 62.7 t -105.23 122.81 58.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -69.42 114.22 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.479 0.656 . . . . 0.0 109.92 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.3 m -65.4 130.23 42.58 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.547 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.82 -24.86 15.6 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.792 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -99.39 -51.73 3.71 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 122.448 -0.442 . . . . 0.0 111.027 -176.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.36 19.78 17.47 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.437 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -103.51 162.03 13.38 Favored 'General case' 0 CA--C 1.479 -1.77 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.363 173.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.4 ppt_? -133.42 140.23 47.2 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.75 150.84 35.02 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.504 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 34.8 tt0 -103.18 122.54 44.93 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.534 0.683 . . . . 0.0 109.669 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -125.41 162.91 23.77 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 140' ' ' ASP . 19.2 m-80 -83.38 144.02 29.92 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.435 HD21 HG23 ' A' ' 116' ' ' ILE . 59.1 mt -58.2 -41.68 84.52 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.672 0.608 . . . . 0.0 110.515 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.8 m -80.08 -5.67 56.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.459 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.492 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 27.3 t70 -110.61 -2.18 16.5 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.56 0.695 . . . . 0.0 109.281 -176.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 123' ' ' CYS . 60.0 mt -68.6 163.92 22.58 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.686 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 35.3 mt -125.44 157.79 36.02 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.4 m -70.75 140.63 86.7 Favored Pre-proline 0 C--N 1.291 -1.948 0 O-C-N 123.479 0.487 . . . . 0.0 110.275 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.29 149.52 80.37 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.193 2.596 . . . . 0.0 113.126 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 147' ' ' GLU . 28.6 mt -90.15 139.28 17.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 32.9 t -140.8 24.95 2.18 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.897 0.856 . . . . 0.0 109.384 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.412 ' H ' HG22 ' A' ' 145' ' ' ILE . 43.6 mt-10 . . . . . 0 C--O 1.261 1.673 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.52 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.505 -0.765 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.8 t -113.05 -17.29 12.46 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.185 0.517 . . . . 0.0 111.822 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.19 -43.01 15.36 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.76 126.67 33.15 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 170.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -69.57 90.47 0.56 Allowed 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 122.09 0.948 . . . . 0.0 111.019 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tt -132.37 16.56 4.48 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.727 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -103.8 -8.58 19.68 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.302 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -104.34 109.2 20.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.003 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -128.41 163.6 24.51 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.981 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -126.51 155.44 42.34 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.26 132.61 30.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.97 18.19 44.6 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.215 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -113.2 149.82 33.17 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -86.01 149.58 25.07 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 123.647 0.779 . . . . 0.0 110.624 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -159.47 -168.72 2.38 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 68.7 m -130.38 145.3 51.78 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.99 160.3 40.11 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.635 0.255 . . . . 0.0 110.796 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.38 112.28 25.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.81 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.4 ' CD2' ' HB2' ' A' ' 104' ' ' GLU . 5.2 t90 -70.49 124.44 24.21 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 m -62.69 -23.45 67.14 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.53 0.681 . . . . 0.0 112.559 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 102' ' ' TRP . 5.0 mm-40 -81.23 -39.79 24.82 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.263 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -108.8 -15.8 14.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.923 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.89 -1.47 83.98 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 75.1 m -90.29 164.93 14.18 Favored 'General case' 0 N--CA 1.419 -2.0 0 C-N-CA 124.592 1.157 . . . . 0.0 112.928 -176.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.8 mt -87.75 132.92 31.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.259 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.7 m-85 -142.23 152.52 61.31 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.158 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 139.35 39.66 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 122.861 2.374 . . . . 0.0 111.868 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.9 157.49 43.23 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.463 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 m -119.55 135.56 54.73 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.9 mt -70.41 118.74 15.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 122.812 0.445 . . . . 0.0 110.538 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.38 -29.85 14.79 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.963 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.9 p -161.79 153.37 18.77 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.4 mt -126.94 133.98 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.485 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 11.1 t70 -108.41 100.98 10.2 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 174.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -72.01 -16.34 62.06 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -73.57 -40.4 63.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.283 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 37.9 mmt-85 -93.76 -7.8 42.51 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 60.85 30.28 19.55 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.343 1.057 . . . . 0.0 109.685 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -119.07 165.93 13.53 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.3 p -148.12 150.69 34.31 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 90.6 t -95.98 130.49 44.59 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.9 m -123.06 147.0 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 133' ' ' ARG . 62.2 t -104.85 120.1 54.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.083 178.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -66.93 115.13 6.34 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.352 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.1 m -72.6 129.3 37.95 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.454 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.48 -14.81 63.79 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -118.09 -44.61 2.69 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 122.456 -0.438 . . . . 0.0 110.96 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.26 8.23 56.61 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.987 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -90.55 163.03 14.74 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 117.777 0.788 . . . . 0.0 109.289 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.7 ppt_? -133.02 139.0 47.0 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -147.68 151.7 36.57 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.494 0.718 . . . . 0.0 109.075 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 38.8 tt0 -101.89 126.65 48.83 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.587 0.708 . . . . 0.0 109.835 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -129.27 163.38 25.79 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.131 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -85.84 144.06 27.92 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.5 mt -57.94 -40.12 79.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 123.736 0.648 . . . . 0.0 110.905 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.8 m -80.75 -5.21 56.81 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.266 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -106.99 -14.27 14.99 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 123' ' ' CYS . 53.3 mt -60.69 154.62 21.04 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-O 121.548 0.69 . . . . 0.0 110.527 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 36.7 mt -120.0 156.65 30.47 Favored 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.022 -176.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.2 m -68.8 140.65 91.8 Favored Pre-proline 0 C--N 1.28 -2.444 0 O-C-N 123.843 0.714 . . . . 0.0 109.289 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.74 145.91 98.16 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.361 2.041 . . . . 0.0 112.804 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.4 mt -98.99 148.99 5.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.3 m -85.01 20.51 1.85 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.02 0.928 . . . . 0.0 112.796 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 . . . . . 0 C--N 1.309 -1.172 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.855 -178.062 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.503 ' N ' HD21 ' A' ' 84' ' ' ASN . 0.8 OUTLIER . . . . . 0 CA--C 1.505 -0.77 0 CA-C-O 120.62 0.248 . . . . 0.0 111.533 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 m -105.67 87.35 2.58 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-O 121.401 0.62 . . . . 0.0 110.497 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.47 -55.75 0.05 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.726 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.37 166.78 22.66 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.9 t -107.22 29.79 6.8 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 89' ' ' LEU . 4.4 tt -79.95 -0.36 34.8 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-O 122.642 1.211 . . . . 0.0 109.553 -175.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 84' ' ' ASN . 19.9 pt20 -105.19 3.33 30.04 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.815 176.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.15 112.02 23.09 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.346 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -131.68 164.99 24.72 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.246 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -126.78 155.03 43.46 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.14 128.33 23.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 120.968 0.413 . . . . 0.0 109.946 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.64 5.32 54.05 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.917 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.41 140.78 29.19 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -89.28 144.14 26.31 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.22 -164.61 2.0 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 68.6 m -129.19 141.11 51.25 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.68 160.26 38.08 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.172 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.71 111.07 24.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.307 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -66.25 119.11 10.94 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.7 m -63.53 -17.35 62.69 Favored 'General case' 0 C--N 1.274 -2.678 0 C-N-CA 123.928 0.891 . . . . 0.0 113.099 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -83.14 -37.39 23.8 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 114.557 -1.202 . . . . 0.0 111.629 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -116.36 -15.55 10.95 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.245 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.28 -6.14 77.46 Favored Glycine 0 C--N 1.316 -0.538 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.059 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 78.0 m -90.38 164.98 14.11 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.5 mt -86.56 133.44 29.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.931 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -141.8 152.16 61.76 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.07 130.79 19.57 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.37 2.047 . . . . 0.0 111.667 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.59 151.41 39.0 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.199 -0.313 . . . . 0.0 110.537 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.6 m -116.87 135.76 53.48 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.163 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 52.2 mt -65.68 117.82 7.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 123.288 0.635 . . . . 0.0 110.913 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.99 -37.0 11.89 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.853 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -160.27 149.56 17.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.414 HG23 HD21 ' A' ' 138' ' ' LEU . 69.1 mt -122.2 133.89 67.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.43 102.49 11.37 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -70.95 -20.88 62.41 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.136 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -38.01 64.76 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.044 0.45 . . . . 0.0 110.977 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -92.1 -7.65 47.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.195 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 60.49 30.81 20.06 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 124.149 0.906 . . . . 0.0 110.102 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 52.1 p -121.75 166.79 13.78 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.231 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.645 ' SG ' HD11 ' A' ' 141' ' ' LEU . 10.7 p -148.51 152.13 36.34 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 92.5 t -95.57 131.37 42.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.7 m -123.14 147.19 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' A' ' 133' ' ' ARG . 67.1 t -106.93 121.57 59.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.54 112.94 5.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.568 0.699 . . . . 0.0 110.354 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.9 m -66.5 130.07 41.98 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.972 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.73 -5.5 83.53 Favored Glycine 0 N--CA 1.432 -1.627 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.201 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -117.28 -50.73 2.55 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.817 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.45 34.04 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 119.857 -1.163 . . . . 0.0 114.059 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -97.09 162.71 13.25 Favored 'General case' 0 CA--C 1.482 -1.661 0 C-N-CA 119.344 -0.943 . . . . 0.0 109.553 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.401 ' HB3' HG22 ' A' ' 126' ' ' VAL . 6.3 ppt_? -134.04 139.45 46.02 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.201 0.524 . . . . 0.0 109.866 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -147.13 150.44 34.98 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.378 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 41.4 tt0 -103.02 120.87 41.43 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -126.3 163.73 22.58 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.219 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 18.1 m-80 -85.06 142.79 29.31 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.414 HD21 HG23 ' A' ' 116' ' ' ILE . 51.5 mt -59.32 -36.49 75.76 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.877 0.846 . . . . 0.0 109.919 177.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.6 p -79.62 -10.3 59.77 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.665 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.405 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 32.2 t70 -110.07 -4.54 15.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.511 0.672 . . . . 0.0 109.763 -176.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.645 HD11 ' SG ' ' A' ' 123' ' ' CYS . 71.2 mt -67.23 162.71 22.01 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.716 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.5 mt -128.94 159.86 34.51 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.438 -177.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.4 m -69.43 140.43 90.03 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 123.495 0.497 . . . . 0.0 109.961 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.42 145.65 92.61 Favored 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 122.943 2.429 . . . . 0.0 114.599 -173.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 68.1 mt -86.5 157.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 113.523 -1.671 . . . . 0.0 106.505 174.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 28.5 t -76.72 85.39 3.35 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 122.112 0.958 . . . . 0.0 109.446 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 N--CA 1.409 -2.494 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 175.621 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1148 ' ' 2MR . . . . . 0.672 ' HA ' ' HE ' ' A' 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.6 t30 . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 49.5 m -136.24 83.31 2.0 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -177.99 -83.11 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.711 1.204 . . . . 0.0 107.92 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 90' ' ' GLN . . . 47.64 -82.39 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.365 1.866 . . . . 0.0 114.582 175.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 p -82.23 -12.95 57.77 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.59 0.71 . . . . 0.0 111.769 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 89' ' ' LEU . 1.7 tt -97.98 -1.08 43.53 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 122.433 1.111 . . . . 0.0 109.577 -178.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 20.9 pt20 -105.57 -3.53 22.24 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.755 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -125.41 119.83 29.36 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.904 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -132.12 164.37 26.44 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -130.95 155.9 46.01 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.57 128.28 25.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.78 7.62 52.97 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.755 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.41 147.34 25.35 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -91.54 150.94 20.97 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.2 p -155.63 -168.04 2.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 67.0 m -129.6 145.21 51.51 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.44 159.95 40.22 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 123.215 0.322 . . . . 0.0 110.281 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.9 mm -92.27 112.61 26.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.342 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -69.48 118.21 12.07 Favored 'General case' 0 CA--C 1.471 -2.077 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.2 m -58.88 -23.1 60.54 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 122.068 0.937 . . . . 0.0 112.194 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.06 -39.74 23.03 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.987 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -108.77 -16.54 14.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.704 0.764 . . . . 0.0 109.855 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.84 -6.53 69.87 Favored Glycine 0 C--O 1.225 -0.448 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.997 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 65.3 m -90.96 167.53 12.34 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.0 mt -88.0 132.13 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.506 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -140.1 152.47 67.47 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.209 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.09 130.4 18.86 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.416 2.077 . . . . 0.0 111.24 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.16 149.62 35.3 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.963 0.411 . . . . 0.0 110.312 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.6 m -117.54 136.17 53.44 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 56.7 mt -65.74 121.76 15.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 O-C-N 123.548 0.53 . . . . 0.0 111.156 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.14 -34.59 9.98 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.919 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.8 p -161.12 150.89 17.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 123' ' ' CYS . 67.7 mt -127.43 133.37 68.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 117.931 0.332 . . . . 0.0 110.111 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -108.82 103.68 12.79 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.65 -14.32 61.56 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.271 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -73.68 -41.3 62.85 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.877 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -98.22 -6.12 31.89 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.401 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 63.64 29.33 15.1 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.828 0.851 . . . . 0.0 109.308 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 47.1 p -117.29 165.41 13.49 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.916 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.625 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.6 p -148.55 152.39 36.74 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 120.676 0.274 . . . . 0.0 110.272 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.3 t -96.25 130.63 44.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.72 147.25 28.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 53.5 t -106.07 123.54 60.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.139 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -72.05 113.77 9.44 Favored 'General case' 0 C--O 1.257 1.5 0 CA-C-O 121.479 0.656 . . . . 0.0 110.475 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.5 m -69.2 130.21 42.01 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.742 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.76 -10.17 72.67 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.838 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -118.54 -53.05 2.34 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.719 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.21 17.43 15.87 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.728 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -99.71 165.61 11.51 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -132.99 142.46 48.85 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -145.51 151.28 37.92 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.98 121.65 42.57 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.424 0.631 . . . . 0.0 109.52 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -125.33 163.41 22.61 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 15.7 m-80 -85.62 143.48 28.41 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.1 mt -58.49 -38.3 77.35 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.682 0.754 . . . . 0.0 110.607 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.4 p -80.42 -8.67 59.62 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.992 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.542 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 12.6 t70 -105.33 -8.15 18.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.625 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.0 mt -65.86 157.8 29.56 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.625 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.3 mt -124.76 161.32 26.68 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -176.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.8 m -68.16 135.2 91.45 Favored Pre-proline 0 C--N 1.294 -1.846 0 O-C-N 123.542 0.526 . . . . 0.0 110.278 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -62.73 146.15 95.1 Favored 'Trans proline' 0 CA--C 1.508 -0.786 0 C-N-CA 123.729 2.953 . . . . 0.0 115.094 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.438 HG13 ' OG ' ' A' ' 99' ' ' SER . 45.7 mt -90.6 153.92 3.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 42.0 t 74.81 -1.77 3.0 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 125.198 1.399 . . . . 0.0 110.848 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 . . . . . 0 C--N 1.289 -2.057 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.495 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.579 ' N ' ' HG ' ' A' ' 88' ' ' SER . 16.5 m120 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.403 0.144 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.3 m -76.39 106.39 7.99 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 73.81 -49.61 0.68 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.008 2.123 . . . . 0.0 113.342 173.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.41 101.97 2.06 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.057 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.579 ' HG ' ' N ' ' A' ' 84' ' ' ASN . 15.0 m -152.44 19.33 0.64 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.5 tt -91.18 58.01 3.58 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -154.39 11.91 0.4 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.778 -1.556 . . . . 0.0 111.207 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -109.94 108.14 18.3 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.414 ' CD1' HD12 ' A' ' 141' ' ' LEU . 83.1 m95 -133.64 163.75 28.73 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.694 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -125.24 151.61 45.69 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.23 128.41 26.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.86 10.83 54.79 Favored Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.372 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -103.85 153.22 21.0 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -86.43 147.87 25.81 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 123.677 0.791 . . . . 0.0 110.51 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -156.64 -168.85 2.81 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 69.2 m -130.64 141.74 50.43 Favored 'General case' 0 C--N 1.264 -3.123 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.71 160.15 38.41 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 123.313 0.383 . . . . 0.0 110.651 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.4 mm -94.55 109.93 22.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.087 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -66.21 121.28 14.86 Favored 'General case' 0 CA--C 1.473 -1.996 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.9 m -61.33 -19.7 62.11 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 124.067 0.947 . . . . 0.0 112.341 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -84.36 -42.35 15.82 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.35 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -104.57 -16.09 15.13 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.648 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.25 -1.27 65.3 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 71.1 m -90.37 162.56 15.07 Favored 'General case' 0 N--CA 1.408 -2.569 0 C-N-CA 124.323 1.049 . . . . 0.0 112.177 -175.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.4 mt -86.6 133.77 29.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.099 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -140.31 152.26 66.42 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 131.5 19.49 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.425 2.083 . . . . 0.0 111.228 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.62 154.57 42.96 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.437 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.0 m -119.33 135.95 54.48 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.7 mt -68.77 124.12 23.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 122.922 0.489 . . . . 0.0 111.346 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.51 -32.32 11.88 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.876 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.4 p -163.89 152.84 13.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.429 HG23 HD21 ' A' ' 138' ' ' LEU . 68.7 mt -126.93 132.18 70.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 122.818 0.447 . . . . 0.0 109.826 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.418 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 10.1 t70 -109.4 102.54 11.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 173.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.51 -21.82 63.64 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.635 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -73.57 -36.25 65.55 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.603 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 35.2 mmt180 -93.35 -8.52 41.71 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 61.08 28.51 18.23 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.196 0.998 . . . . 0.0 110.186 -173.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 66.6 p -119.95 166.18 13.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.127 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.648 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.4 p -148.45 150.73 33.98 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.41 HG11 ' HD3' ' A' ' 133' ' ' ARG . 92.3 t -96.1 132.5 40.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 27.7 m -124.03 147.55 28.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.4 t -104.99 121.46 56.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.071 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -69.89 116.63 10.5 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-O 121.548 0.69 . . . . 0.0 110.84 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.2 m -66.2 129.86 41.24 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.176 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.78 -16.82 59.95 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.047 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -115.15 -51.81 2.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.432 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.26 17.06 28.12 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.644 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 90.6 m-20 -93.48 162.48 13.95 Favored 'General case' 0 CA--C 1.472 -2.053 0 C-N-CA 119.499 -0.88 . . . . 0.0 108.642 174.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.7 ppt_? -131.72 135.46 46.86 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -142.61 151.11 41.15 Favored 'General case' 0 N--CA 1.409 -2.486 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.323 -173.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -101.77 122.0 43.13 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.798 0.809 . . . . 0.0 109.904 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -126.82 163.54 23.36 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.434 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.463 ' HB2' ' CB ' ' A' ' 140' ' ' ASP . 17.9 m-80 -88.59 143.45 26.94 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.429 HD21 HG23 ' A' ' 116' ' ' ILE . 61.8 mt -57.07 -40.69 77.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.204 0.602 . . . . 0.0 111.253 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.6 t -80.87 -8.53 59.74 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.317 0.58 . . . . 0.0 110.736 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.463 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 21.4 t70 -102.16 -10.71 19.39 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.648 HD11 ' SG ' ' A' ' 123' ' ' CYS . 60.8 mt -66.59 157.81 31.43 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.23 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 28.5 mt -125.27 161.58 26.63 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -176.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.6 m -68.8 138.69 90.6 Favored Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 123.282 0.364 . . . . 0.0 110.557 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.84 147.07 95.09 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 123.543 2.829 . . . . 0.0 113.779 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.3 mt -94.54 145.9 7.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 40.9 t -147.98 98.7 2.98 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 . . . . . 0 C--N 1.295 -1.774 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.208 -178.683 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 p30 . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m -66.7 123.32 19.78 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 72.72 -8.2 1.29 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.895 1.278 . . . . 0.0 111.539 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.99 7.34 34.05 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.607 0.718 . . . . 0.0 110.023 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 8.7 t -105.96 19.5 20.43 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 89' ' ' LEU . 4.4 tt -92.07 25.41 2.87 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 79.5 mt-30 -102.43 -19.02 15.1 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.7 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 88' ' ' SER . 10.3 pt20 -88.18 110.14 20.46 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.954 0.883 . . . . 0.0 111.711 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -132.33 164.05 27.32 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.399 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -131.47 156.11 46.22 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.39 131.94 29.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.13 3.68 54.24 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.574 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.485 ' HB2' HD12 ' A' ' 113' ' ' ILE . 62.5 m-20 -99.56 139.48 35.16 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -83.66 145.51 28.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.8 p -153.45 -161.97 1.37 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 70.6 m -135.78 146.59 47.76 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.0 161.12 38.13 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.571 -176.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.8 mm -92.77 112.43 26.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -69.02 124.29 23.34 Favored 'General case' 0 CA--C 1.474 -1.964 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.1 m -59.52 -25.36 64.43 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.977 0.798 . . . . 0.0 112.366 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -81.53 -41.84 21.07 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.485 -0.78 . . . . 0.0 113.102 -174.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -105.82 -15.87 14.82 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.578 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.74 -0.74 76.18 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 78.3 m -89.94 164.62 14.49 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 124.013 0.925 . . . . 0.0 112.263 -176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.413 HG23 HD12 ' A' ' 142' ' ' LEU . 29.8 mt -88.39 131.2 36.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -140.08 152.39 67.34 Favored Pre-proline 0 C--N 1.291 -1.97 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.467 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.73 137.14 26.78 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.227 1.951 . . . . 0.0 111.399 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.96 148.66 29.35 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.893 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.3 m -112.42 136.05 52.38 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 96' ' ' ASP . 57.5 mt -66.39 118.64 9.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 C-N-CA 123.202 0.601 . . . . 0.0 110.945 -178.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.29 -41.92 8.79 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.934 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.0 m -157.58 149.71 22.44 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -123.48 132.26 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 123.314 0.384 . . . . 0.0 110.213 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.12 108.73 19.51 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -75.56 -17.42 60.06 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.166 -173.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -73.31 -41.73 63.19 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -94.21 -8.03 40.45 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.004 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 60.86 31.52 20.03 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.288 1.035 . . . . 0.0 110.035 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 49.3 p -119.38 167.38 11.97 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.729 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.7 p -148.33 151.83 36.04 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.637 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 98.0 t -96.07 132.59 39.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.8 m -123.87 148.41 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 68.0 t -106.24 120.56 57.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.475 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.47 116.03 8.56 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.675 0.61 . . . . 0.0 110.713 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.5 m -71.54 129.57 39.09 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.883 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.21 -14.9 64.4 Favored Glycine 0 N--CA 1.429 -1.793 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.908 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -117.71 -44.47 2.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 120.971 0.415 . . . . 0.0 110.718 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.8 10.8 52.04 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.011 -1.09 . . . . 0.0 114.437 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.29 162.58 14.56 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-N 117.93 0.865 . . . . 0.0 109.267 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 ppt_? -132.07 137.75 47.89 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -145.7 151.83 38.64 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 43.9 tt0 -101.72 124.73 47.86 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -176.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -129.16 163.77 24.81 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.629 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 17.8 m-80 -87.58 144.04 26.89 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 90' ' ' GLN . 62.9 mt -58.77 -39.33 80.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.676 0.75 . . . . 0.0 110.273 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.7 p -73.8 -17.12 61.12 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.481 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 16.0 t70 -101.89 -7.8 22.15 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -173.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 123' ' ' CYS . 62.4 mt -66.9 157.48 33.07 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.095 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 32.9 mt -126.25 160.81 29.28 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.4 m -69.83 139.39 88.32 Favored Pre-proline 0 C--N 1.293 -1.886 0 O-C-N 123.571 0.545 . . . . 0.0 110.4 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.62 153.17 63.57 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.921 3.081 . . . . 0.0 115.287 -172.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.42 HG13 ' OG ' ' A' ' 99' ' ' SER . 22.0 mt -100.3 153.93 4.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 43.4 t -117.26 82.45 1.82 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.48 0.657 . . . . 0.0 109.294 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 . . . . . 0 C--N 1.297 -1.689 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.411 -177.659 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.4 m95 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -128.51 154.76 45.79 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.19 127.07 24.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.84 8.99 47.19 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.527 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.406 ' HB3' HD12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -97.5 148.86 22.8 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -91.52 151.26 20.83 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -158.16 -169.58 2.84 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 121.479 0.657 . . . . 0.0 110.005 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.5 m -127.07 144.07 51.12 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 173.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.18 160.12 39.36 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.0 mm -93.82 109.59 22.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -68.62 123.71 21.62 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.9 m -63.19 -20.03 65.04 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.86 -39.48 19.84 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.517 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -108.03 -15.42 14.52 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.642 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.33 1.35 69.57 Favored Glycine 0 C--N 1.313 -0.717 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 77.4 m -90.55 164.19 14.32 Favored 'General case' 0 N--CA 1.405 -2.685 0 C-N-CA 124.303 1.041 . . . . 0.0 112.327 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -89.5 129.26 40.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.349 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -137.56 152.58 73.16 Favored Pre-proline 0 C--N 1.286 -2.187 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.795 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.97 133.33 23.11 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.624 2.216 . . . . 0.0 111.555 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.75 153.81 41.35 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.27 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 m -118.23 135.88 53.99 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 96' ' ' ASP . 51.3 mt -68.82 120.49 16.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 120.958 0.409 . . . . 0.0 110.587 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.71 -38.44 9.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.968 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -159.3 152.21 21.94 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 123' ' ' CYS . 63.4 mt -128.87 136.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 122.65 0.38 . . . . 0.0 110.343 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -109.27 99.52 8.78 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -71.27 -18.54 62.42 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.078 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -73.46 -40.58 64.05 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.21 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -90.83 -7.3 52.68 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 61.86 32.8 17.92 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.79 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.5 p -122.74 164.05 19.03 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.168 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.669 ' SG ' HD11 ' A' ' 141' ' ' LEU . 16.8 p -148.44 155.86 41.75 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.75 0.31 . . . . 0.0 110.396 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.77 130.19 46.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 31.6 m -123.3 147.24 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 133' ' ' ARG . 75.2 t -104.7 122.55 57.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.17 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -70.27 114.97 8.93 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.64 0.588 . . . . 0.0 110.192 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 45.7 m -67.76 131.83 46.3 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.069 -176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.1 -15.37 63.04 Favored Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.852 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -116.75 -47.88 2.69 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.732 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.34 14.38 38.7 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.938 -1.125 . . . . 0.0 114.086 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -94.63 162.63 13.71 Favored 'General case' 0 CA--C 1.479 -1.776 0 C-N-CA 119.606 -0.838 . . . . 0.0 108.986 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.2 ppt_? -133.78 136.38 44.5 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -141.98 151.76 42.81 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.62 -174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.76 120.52 40.5 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -125.75 163.49 22.74 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.254 -174.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -85.88 143.31 28.3 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.411 HD21 HG23 ' A' ' 116' ' ' ILE . 66.8 mt -58.57 -39.79 81.28 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.623 0.577 . . . . 0.0 110.683 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.6 t -80.91 -5.52 57.52 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.426 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -106.96 -8.53 16.58 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.514 0.673 . . . . 0.0 109.706 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.669 HD11 ' SG ' ' A' ' 123' ' ' CYS . 67.1 mt -66.59 162.61 20.57 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.856 176.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 41.3 mt -128.49 159.94 33.88 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 30.3 m . . . . . 0 C--N 1.296 -1.731 0 O-C-N 123.658 0.599 . . . . 0.0 111.595 -175.905 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.444 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 86.8 m95 . . . . . 0 N--CA 1.438 -1.055 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 8.9 ptpp? -128.95 153.45 47.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.16 127.43 24.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.75 8.71 56.95 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.761 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 2.5 t0 -99.96 146.8 26.28 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -83.67 154.95 23.4 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 121.294 0.569 . . . . 0.0 111.418 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -160.0 -174.47 4.58 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.4 m -125.03 140.97 52.43 Favored 'General case' 0 C--N 1.258 -3.386 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 174.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.76 159.97 38.99 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.152 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.98 111.58 25.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -68.76 121.96 17.59 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.6 m -63.49 -19.74 65.01 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 123.952 0.782 . . . . 0.0 112.821 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -84.57 -42.13 15.76 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.174 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -106.74 -15.47 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.674 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.14 -5.24 77.6 Favored Glycine 0 N--CA 1.462 0.431 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.425 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 68.0 m -90.65 166.99 12.86 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 123.75 0.82 . . . . 0.0 113.176 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.3 mt -86.88 133.2 30.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.984 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -140.67 152.46 66.07 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.477 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.24 127.8 14.71 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.237 1.958 . . . . 0.0 110.965 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.01 150.36 39.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 120.904 0.383 . . . . 0.0 110.192 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 m -114.99 135.84 53.79 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 53.0 mt -68.32 118.93 13.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.891 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.68 -36.69 12.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.911 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m -159.19 150.04 19.8 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.4 HG23 HD21 ' A' ' 138' ' ' LEU . 69.0 mt -126.94 132.78 69.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 122.971 0.508 . . . . 0.0 110.514 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -108.94 110.38 21.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -75.37 -21.34 58.4 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.992 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -73.51 -36.57 65.77 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.241 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -94.97 -8.86 35.73 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.359 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 57.63 35.65 25.9 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.924 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 47.1 p -121.93 163.01 20.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.905 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.599 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.2 p -148.34 153.45 38.64 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 120.816 0.341 . . . . 0.0 110.282 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.6 t -96.34 132.44 40.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.9 m -123.49 147.13 27.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.0 t -106.3 120.94 58.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -70.58 115.74 10.09 Favored 'General case' 0 C--O 1.259 1.577 0 CA-C-O 121.386 0.612 . . . . 0.0 109.978 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.0 m -69.04 129.58 40.31 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.313 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.81 -17.48 58.57 Favored Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.026 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.93 -52.72 2.73 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.207 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.11 22.17 8.96 Favored Glycine 0 N--CA 1.435 -1.383 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.734 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -105.62 161.91 13.97 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.7 ppt_? -135.08 136.08 41.74 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -143.18 151.32 40.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -101.96 119.74 39.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.634 0.73 . . . . 0.0 109.27 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -126.24 163.5 23.06 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.042 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.3 m-80 -85.36 143.93 28.34 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.4 HD21 HG23 ' A' ' 116' ' ' ILE . 60.5 mt -59.06 -37.01 76.04 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.794 0.807 . . . . 0.0 109.495 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.3 m -73.75 -19.76 60.69 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.117 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -102.57 -8.93 20.59 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.29 0.567 . . . . 0.0 110.332 -173.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.599 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.4 mt -63.45 160.72 15.71 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.939 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.9 mt -125.3 159.93 30.51 Favored 'General case' 0 C--N 1.254 -3.586 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.2 m . . . . . 0 C--N 1.29 -1.997 0 O-C-N 123.577 0.548 . . . . 0.0 110.264 -178.575 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.479 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 79.8 m95 . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -129.76 157.73 41.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.23 128.71 25.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.508 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.56 -1.77 36.76 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.204 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.481 ' HB2' HD12 ' A' ' 113' ' ' ILE . 24.6 m-20 -96.79 135.32 38.9 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 122.68 -0.306 . . . . 0.0 111.08 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 14.6 mtmt -77.47 147.76 35.73 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-O 121.335 0.588 . . . . 0.0 110.901 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.9 p -154.53 -166.5 2.35 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 114.579 -1.192 . . . . 0.0 107.96 -177.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 73.2 m -129.03 141.37 51.26 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.61 160.36 38.73 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.2 mm -93.92 112.58 27.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -68.33 120.72 14.91 Favored 'General case' 0 CA--C 1.473 -1.981 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.6 m -61.65 -20.46 63.44 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.947 0.779 . . . . 0.0 112.631 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -84.73 -39.8 18.06 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.565 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -109.02 -15.95 14.24 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.042 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.13 -3.95 78.45 Favored Glycine 0 N--CA 1.464 0.524 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.328 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 70.7 m -90.62 168.15 12.01 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.8 mt -90.31 133.64 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.666 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -142.36 152.01 59.54 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.43 135.19 26.06 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.505 2.137 . . . . 0.0 111.381 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.95 150.69 34.51 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.941 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 20.7 m -111.27 135.83 51.25 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 96' ' ' ASP . 44.5 mt -67.94 117.12 9.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 123.34 0.4 . . . . 0.0 110.49 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.08 -38.6 11.53 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.205 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 p -159.19 146.87 17.49 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.41 HG23 HD21 ' A' ' 138' ' ' LEU . 62.5 mt -124.36 135.32 64.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -109.35 106.23 15.95 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -75.73 -13.72 60.31 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -73.26 -41.88 63.14 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -96.39 -7.52 34.84 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.702 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 57.36 33.67 23.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.336 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 79.8 p -118.38 161.98 19.06 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.065 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.55 ' SG ' HD11 ' A' ' 141' ' ' LEU . 15.1 p -147.81 152.91 38.48 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.359 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 88.7 t -95.82 131.66 42.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.1 m -123.21 146.92 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 77.7 t -106.26 120.01 56.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -66.41 111.99 3.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.782 0.676 . . . . 0.0 110.386 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.4 m -65.62 129.95 41.56 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.727 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.32 -21.22 41.68 Favored Glycine 0 N--CA 1.425 -2.087 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.786 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -106.95 -50.46 3.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.101 -177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.72 3.56 37.02 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.149 -1.024 . . . . 0.0 114.223 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 95.1 m-20 -87.73 163.16 16.65 Favored 'General case' 0 CA--C 1.479 -1.772 0 CA-C-N 117.804 0.802 . . . . 0.0 109.916 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.8 ppt_? -134.25 136.53 43.67 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.079 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -144.92 151.24 38.36 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.971 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 39.9 tt0 -102.7 124.7 48.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -127.57 163.92 23.12 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -175.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 16.6 m-80 -87.37 142.88 27.55 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.41 HD21 HG23 ' A' ' 116' ' ' ILE . 51.0 mt -57.22 -39.76 76.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.431 0.634 . . . . 0.0 110.561 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 m -79.63 -4.63 52.51 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.883 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -108.96 -7.75 15.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.52 0.676 . . . . 0.0 109.306 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.55 HD11 ' SG ' ' A' ' 123' ' ' CYS . 67.7 mt -69.58 163.83 24.63 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.652 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 21.1 mt -130.65 162.85 28.48 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.31 -1.137 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.136 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 77.7 m95 . . . . . 0 CA--C 1.502 -0.887 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -130.92 154.96 47.56 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.17 127.43 22.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-O 121.032 0.444 . . . . 0.0 110.754 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.1 5.77 46.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.505 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -103.75 149.08 25.33 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 120.705 0.288 . . . . 0.0 110.23 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -88.5 150.91 22.86 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.808 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.41 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.4 p -155.82 -168.02 2.66 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.953 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.553 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.9 m -129.35 144.95 51.44 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.39 160.22 39.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.902 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.2 mm -93.89 110.04 22.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.73 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -66.31 121.79 16.05 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 t -61.18 -22.35 64.65 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 123.885 0.74 . . . . 0.0 110.589 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -80.58 -42.19 22.71 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.719 -173.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -106.37 -14.9 14.96 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.274 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.69 0.53 68.54 Favored Glycine 0 N--CA 1.462 0.429 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.97 164.15 14.09 Favored 'General case' 0 N--CA 1.403 -2.788 0 C-N-CA 124.852 1.261 . . . . 0.0 112.325 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.3 mt -88.02 133.51 30.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.61 0.764 . . . . 0.0 110.144 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -144.07 152.48 54.86 Favored Pre-proline 0 C--N 1.304 -1.397 0 C-N-CA 123.158 0.583 . . . . 0.0 109.868 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.07 133.68 23.68 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.695 2.263 . . . . 0.0 111.873 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.71 153.36 40.9 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.967 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.2 m -117.55 135.79 53.71 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 48.5 mt -66.25 118.1 8.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 123.104 0.562 . . . . 0.0 111.322 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.21 -38.43 10.57 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.97 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 m -158.26 151.85 23.45 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.414 HG23 HD21 ' A' ' 138' ' ' LEU . 63.5 mt -127.26 134.18 66.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -108.59 102.88 11.91 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -71.06 -18.45 62.56 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.27 -174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -72.82 -39.9 66.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -93.8 -7.51 43.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 61.81 27.49 16.79 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.793 0.837 . . . . 0.0 110.062 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.8 p -119.64 165.7 14.13 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.342 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.573 ' SG ' HD11 ' A' ' 141' ' ' LEU . 12.0 p -148.08 152.49 37.45 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.9 t -96.73 131.19 44.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.1 m -123.57 147.11 28.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 133' ' ' ARG . 55.3 t -106.75 122.89 61.31 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -70.95 114.49 9.06 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.545 0.688 . . . . 0.0 110.13 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.5 m -63.96 129.47 40.19 Favored 'General case' 0 N--CA 1.407 -2.607 0 CA-C-N 113.712 -1.586 . . . . 0.0 111.287 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.83 -13.97 57.64 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.316 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -109.66 -44.79 3.78 Favored 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 122.547 -0.384 . . . . 0.0 110.231 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.18 10.07 56.37 Favored Glycine 0 N--CA 1.436 -1.357 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.923 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -91.94 163.86 13.86 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 117.586 0.693 . . . . 0.0 109.487 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -135.27 139.11 44.15 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -145.82 151.21 37.56 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -101.39 121.85 42.67 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -128.65 163.21 25.56 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.957 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 19.9 m-80 -86.17 144.56 27.42 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.414 HD21 HG23 ' A' ' 116' ' ' ILE . 47.1 mt -57.93 -40.94 81.68 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.848 0.717 . . . . 0.0 110.652 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 m -81.38 -7.23 59.54 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.302 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 19.2 t70 -101.98 -5.03 25.13 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.573 HD11 ' SG ' ' A' ' 123' ' ' CYS . 68.8 mt -69.62 171.63 8.67 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.276 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 27.2 mt -138.34 162.89 33.22 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.0 m . . . . . 0 C--N 1.308 -1.237 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.519 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.9 m95 . . . . . 0 N--CA 1.435 -1.205 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -116.79 152.15 35.0 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.646 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.17 128.54 26.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.94 23.29 25.72 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.657 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -115.74 149.72 38.02 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 3.1 mtmt -84.23 148.78 26.53 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 123.026 0.53 . . . . 0.0 110.102 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 p -157.92 -167.89 2.36 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.7 m -131.18 142.08 50.15 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.47 160.16 38.25 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.907 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.0 mm -95.07 108.18 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -67.88 123.78 21.53 Favored 'General case' 0 CA--C 1.469 -2.147 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.289 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -62.04 -22.09 65.45 Favored 'General case' 0 C--N 1.282 -2.326 0 O-C-N 123.95 0.781 . . . . 0.0 112.674 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -83.58 -36.91 23.58 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -108.46 -16.46 14.22 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.155 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.2 0.45 70.96 Favored Glycine 0 C--N 1.304 -1.236 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.707 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 99.4 m -90.84 167.38 12.5 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 124.491 1.117 . . . . 0.0 111.887 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.39 133.1 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.48 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.47 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.3 m-85 -139.48 152.05 68.07 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.088 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.62 133.32 23.74 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.313 2.009 . . . . 0.0 111.189 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.02 156.64 44.05 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.818 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 23.0 m -119.99 135.52 54.89 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mt -70.31 123.88 25.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 122.747 0.419 . . . . 0.0 110.679 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.95 -36.07 10.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.164 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 64.1 m -161.38 149.97 15.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.43 HG23 HD21 ' A' ' 138' ' ' LEU . 71.1 mt -124.41 129.73 73.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -105.67 101.85 11.34 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -73.16 -12.67 60.97 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.234 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.56 -40.68 63.75 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.255 0.55 . . . . 0.0 109.605 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -99.32 -7.02 26.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.1 30.27 17.78 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.868 0.867 . . . . 0.0 110.306 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 52.7 p -119.99 165.53 14.56 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.245 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.597 ' SG ' HD11 ' A' ' 141' ' ' LEU . 15.6 p -148.09 152.74 37.87 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.1 t -96.15 131.01 44.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.6 m -122.98 146.83 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 133' ' ' ARG . 65.5 t -105.78 120.39 56.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.91 114.7 7.45 Favored 'General case' 0 C--O 1.257 1.462 0 O-C-N 123.923 0.764 . . . . 0.0 110.107 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 87.8 m -67.52 128.98 38.47 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.655 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.23 -22.82 30.27 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.696 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -100.82 -52.37 3.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 122.324 -0.515 . . . . 0.0 109.877 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.39 11.25 29.68 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.85 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -93.87 162.54 13.87 Favored 'General case' 0 CA--C 1.466 -2.265 0 C-N-CA 119.434 -0.907 . . . . 0.0 109.739 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.3 ppt_? -133.54 136.25 44.87 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -142.08 150.93 41.85 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -102.55 116.45 32.63 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.759 0.79 . . . . 0.0 109.271 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -121.03 163.78 17.78 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.617 -173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -85.88 139.87 30.88 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.43 HD21 HG23 ' A' ' 116' ' ' ILE . 71.0 mt -55.22 -40.82 71.29 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.375 0.67 . . . . 0.0 111.354 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.2 t -80.67 -6.2 58.05 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.797 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -104.76 -7.86 19.2 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.743 0.782 . . . . 0.0 109.052 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.597 HD11 ' SG ' ' A' ' 123' ' ' CYS . 66.1 mt -67.16 163.98 19.07 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.638 176.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 26.8 mt -132.39 163.66 28.21 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 p . . . . . 0 C--N 1.31 -1.113 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.379 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 75.0 m95 . . . . . 0 N--CA 1.431 -1.384 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.627 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 8.4 ptpp? -126.0 153.78 43.87 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.51 129.14 26.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.96 3.07 42.44 Favored Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.063 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.627 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 12.1 m-20 -98.01 136.32 38.44 Favored 'General case' 0 CA--C 1.486 -1.518 0 O-C-N 122.602 -0.352 . . . . 0.0 110.488 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 13.9 mtmt -81.19 143.7 32.15 Favored 'General case' 0 N--CA 1.401 -2.905 0 CA-C-O 121.291 0.567 . . . . 0.0 109.63 171.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.31 -167.51 2.73 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.9 m -128.6 145.11 51.23 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.33 160.26 39.58 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.682 0.614 . . . . 0.0 109.817 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mm -93.29 109.62 22.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.491 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -68.1 125.68 27.11 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.835 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.8 m -64.5 -20.82 66.44 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -83.95 -41.16 17.63 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -105.33 -15.96 14.89 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.392 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.25 0.86 79.1 Favored Glycine 0 C--N 1.311 -0.839 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.014 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.499 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 74.9 m -90.27 168.85 11.6 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 124.117 0.967 . . . . 0.0 111.75 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.1 mt -89.07 135.41 25.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.1 m-85 -142.99 152.12 57.76 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.46 136.13 27.94 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.663 2.242 . . . . 0.0 111.413 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.96 154.17 39.01 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 31.0 m -114.68 135.49 54.1 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.529 HD12 ' HB2' ' A' ' 96' ' ' ASP . 49.7 mt -67.39 115.51 5.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 122.949 0.499 . . . . 0.0 110.705 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.44 -35.41 13.0 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.193 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -157.96 148.38 20.56 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.425 HG23 HD21 ' A' ' 138' ' ' LEU . 65.5 mt -123.25 133.01 70.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -108.31 97.56 7.23 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -71.74 -14.73 62.09 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.977 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -73.24 -41.34 63.83 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.018 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -94.89 -6.88 41.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.216 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 62.56 29.52 17.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.4 1.08 . . . . 0.0 110.096 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 46.7 p -117.94 166.75 12.14 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.618 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.6 p -148.45 152.12 36.38 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.0 t -95.86 131.09 43.53 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.6 m -122.71 146.73 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 133' ' ' ARG . 72.4 t -105.28 119.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -68.14 111.1 4.3 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-O 121.574 0.702 . . . . 0.0 110.858 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 96.2 m -70.58 129.79 40.12 Favored 'General case' 0 N--CA 1.397 -3.101 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.576 -175.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.11 -13.81 63.04 Favored Glycine 0 N--CA 1.418 -2.502 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.296 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.7 -54.01 2.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.95 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 107.27 17.42 11.51 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.957 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -101.64 168.61 9.36 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.269 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.472 ' HB3' HG22 ' A' ' 126' ' ' VAL . 7.1 ppt_? -137.73 140.11 40.52 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -146.14 151.59 37.91 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 123.696 0.798 . . . . 0.0 109.43 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -101.67 123.35 45.52 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.497 0.665 . . . . 0.0 109.507 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -129.31 163.39 25.8 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.022 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 22.6 m-80 -85.8 146.03 26.95 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.425 HD21 HG23 ' A' ' 116' ' ' ILE . 52.5 mt -60.22 -35.15 74.79 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.751 0.786 . . . . 0.0 109.587 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.3 p -74.52 -17.87 60.69 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.667 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -105.47 -4.81 20.9 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.715 0.769 . . . . 0.0 110.471 -173.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.608 HD11 ' SG ' ' A' ' 123' ' ' CYS . 52.9 mt -68.11 160.73 28.38 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.886 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.6 mt -132.14 164.47 26.23 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 C--N 1.304 -1.377 0 C-N-CA 122.93 0.492 . . . . 0.0 110.151 178.164 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.444 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 78.8 m95 . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -130.07 152.72 49.22 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.52 131.46 29.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 123.481 0.488 . . . . 0.0 110.102 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.23 4.6 50.34 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.25 145.03 30.81 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -80.69 154.36 27.36 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-O 121.574 0.702 . . . . 0.0 111.138 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.3 p -159.67 -171.56 3.33 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.7 m -129.13 143.72 50.96 Favored 'General case' 0 C--N 1.261 -3.245 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.45 158.66 43.81 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.104 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -93.14 110.86 23.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.519 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.413 ' CD2' ' HB2' ' A' ' 104' ' ' GLU . 6.2 t90 -68.63 125.42 26.47 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m -60.9 -22.96 64.84 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.027 0.829 . . . . 0.0 112.829 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 102' ' ' TRP . 4.9 mm-40 -83.62 -42.0 17.2 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.739 -174.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -105.91 -16.23 14.7 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.058 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.67 1.02 75.98 Favored Glycine 0 C--N 1.312 -0.762 0 N-CA-C 111.419 -0.673 . . . . 0.0 111.419 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 78.7 m -89.92 165.86 13.84 Favored 'General case' 0 N--CA 1.414 -2.262 0 C-N-CA 124.028 0.931 . . . . 0.0 111.693 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -90.28 129.24 41.46 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.819 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 95.7 m-85 -134.63 152.22 77.31 Favored Pre-proline 0 C--N 1.285 -2.232 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.865 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.13 130.23 17.35 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.277 1.985 . . . . 0.0 110.837 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.12 150.73 39.86 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.942 0.401 . . . . 0.0 110.066 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.1 m -115.99 135.85 53.58 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 50.9 mt -64.7 123.79 18.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 123.602 0.564 . . . . 0.0 110.781 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.31 -38.2 8.16 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.147 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.1 p -159.43 148.58 18.2 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.458 HG23 HD21 ' A' ' 138' ' ' LEU . 69.7 mt -124.41 130.51 73.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.718 0.294 . . . . 0.0 110.526 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -109.37 103.36 12.27 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.03 -16.9 60.58 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.869 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -73.26 -39.08 65.71 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.061 0.457 . . . . 0.0 110.181 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -95.18 -7.63 38.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.606 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 62.56 26.81 15.91 Favored 'General case' 0 C--O 1.248 1.016 0 C-N-CA 124.8 1.24 . . . . 0.0 110.504 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 82.5 p -118.83 165.16 14.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.425 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.1 p -148.06 151.39 35.61 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 89.3 t -96.19 132.56 40.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 29.2 m -123.54 147.57 27.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 56.9 t -106.5 122.06 59.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.849 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -70.78 114.08 8.5 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 123.747 0.654 . . . . 0.0 110.71 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.7 m -65.54 130.33 42.93 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.908 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.16 -13.4 66.4 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.151 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.59 -48.93 2.67 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.901 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 101.28 7.11 50.1 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.426 -0.892 . . . . 0.0 114.193 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 89.2 m-20 -88.32 162.91 16.32 Favored 'General case' 0 CA--C 1.474 -1.946 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.214 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.6 ppt_? -132.38 136.45 46.82 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -144.06 151.1 39.19 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 40.6 tt0 -102.05 126.38 48.98 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -130.7 163.25 27.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.9 m-80 -84.33 144.92 28.54 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.458 HD21 HG23 ' A' ' 116' ' ' ILE . 55.0 mt -57.48 -42.74 83.26 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.557 0.694 . . . . 0.0 110.612 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 p -78.36 -7.83 57.75 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.217 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -101.83 -13.76 17.56 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.588 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.4 mt -61.2 160.39 10.46 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.231 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 27.8 mt -126.41 162.44 25.56 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.298 -1.65 0 O-C-N 123.596 0.56 . . . . 0.0 109.93 -179.749 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.5 m95 . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -125.83 153.41 44.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.42 128.26 26.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.34 10.98 40.22 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.921 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.63 150.06 27.34 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -91.76 150.06 21.29 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 120.956 0.408 . . . . 0.0 109.957 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -155.95 -168.38 2.75 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.603 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.7 m -128.36 141.16 51.51 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.62 160.42 36.7 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.7 mm -97.04 109.49 23.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -65.7 121.75 15.71 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -60.95 -19.55 61.04 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 124.104 0.878 . . . . 0.0 112.647 -175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.88 -43.12 14.4 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.016 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.53 -15.9 14.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.233 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.7 0.09 79.04 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-O 121.564 0.536 . . . . 0.0 112.058 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.491 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 79.4 m -89.63 162.49 15.59 Favored 'General case' 0 N--CA 1.407 -2.621 0 C-N-CA 123.772 0.829 . . . . 0.0 111.768 -177.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.4 mt -88.04 130.67 37.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.617 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -136.43 152.21 74.47 Favored Pre-proline 0 C--N 1.289 -2.054 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.789 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.02 130.21 17.44 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.279 1.986 . . . . 0.0 110.827 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.66 147.42 31.98 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 120.974 0.416 . . . . 0.0 110.324 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.4 m -113.68 135.89 53.43 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.4 mt -68.26 119.99 14.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 122.734 0.414 . . . . 0.0 110.601 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.89 -30.97 12.44 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.737 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.2 p -161.23 154.76 21.79 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.437 HG23 HD21 ' A' ' 138' ' ' LEU . 69.5 mt -128.33 132.8 67.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.19 102.9 12.0 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -72.13 -16.69 62.0 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.447 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -73.48 -40.26 64.26 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.467 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -97.12 -6.93 33.83 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.8 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 63.13 30.87 16.04 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-O 122.027 0.917 . . . . 0.0 109.949 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.1 p -120.67 166.72 13.3 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.922 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.648 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.6 p -148.7 152.19 36.22 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 87.4 t -95.84 130.61 44.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 22.5 m -123.29 147.31 27.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' A' ' 133' ' ' ARG . 66.9 t -106.0 121.26 58.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -71.2 114.69 9.52 Favored 'General case' 0 C--O 1.257 1.478 0 CA-C-O 121.611 0.72 . . . . 0.0 110.312 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.7 m -66.23 130.63 43.87 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.736 -1.575 . . . . 0.0 110.877 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.86 -21.26 42.58 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.201 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -108.14 -52.68 2.73 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.893 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.88 20.37 10.75 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.796 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -101.37 161.23 13.78 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.55 173.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.3 ppt_? -132.21 135.94 46.66 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -145.18 149.88 35.75 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 37.8 tt0 -102.92 124.29 48.16 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -127.79 163.4 24.43 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.331 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -83.11 142.09 31.5 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.437 HD21 HG23 ' A' ' 116' ' ' ILE . 44.6 mt -55.6 -41.61 73.67 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.921 0.763 . . . . 0.0 111.443 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 m -76.4 -15.66 59.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.895 0.378 . . . . 0.0 111.312 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -95.63 -9.55 31.81 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.802 0.81 . . . . 0.0 109.428 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.648 HD11 ' SG ' ' A' ' 123' ' ' CYS . 62.3 mt -65.35 163.58 15.3 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.284 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.1 mt -131.15 162.41 29.97 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.3 p . . . . . 0 C--N 1.308 -1.225 0 O-C-N 123.281 0.363 . . . . 0.0 110.141 -178.404 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 82.0 m95 . . . . . 0 N--CA 1.443 -0.818 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -125.78 155.61 40.77 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.66 128.22 25.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.989 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.75 -1.61 48.74 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.966 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.2 146.13 24.22 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -86.59 149.86 24.63 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.092 0.473 . . . . 0.0 111.039 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.9 p -156.7 -168.03 2.56 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.635 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.537 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.5 m -129.7 149.21 51.55 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.21 160.38 39.59 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 123.574 0.546 . . . . 0.0 109.684 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -94.07 110.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -68.44 124.28 23.1 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.8 m -64.34 -18.03 64.25 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 123.93 0.769 . . . . 0.0 112.662 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.86 -41.79 17.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -104.96 -15.16 15.2 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.626 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.67 2.0 68.23 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.555 ' HB2' ' CE2' ' A' ' 109' ' ' TYR . 98.7 m -90.71 165.03 13.91 Favored 'General case' 0 N--CA 1.406 -2.633 0 C-N-CA 124.494 1.117 . . . . 0.0 112.286 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 mt -90.83 131.33 38.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.556 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 107' ' ' CYS . 98.3 m-85 -141.41 152.31 63.46 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.74 134.98 31.67 Favored 'Trans proline' 0 C--O 1.24 0.624 0 C-N-CA 122.68 2.253 . . . . 0.0 112.143 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.23 157.24 43.53 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.945 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 m -121.46 135.46 55.04 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 49.3 mt -66.88 118.6 10.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 C-N-CA 123.5 0.72 . . . . 0.0 111.287 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.51 -38.04 11.09 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.627 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 p -157.92 152.21 24.54 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.522 HG23 HD21 ' A' ' 138' ' ' LEU . 64.6 mt -126.13 129.58 72.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -108.98 99.67 8.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.21 -20.72 65.74 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.171 -175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.447 ' HD3' ' H ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -72.04 -40.3 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 110.461 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -90.51 -7.87 51.84 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.072 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 65.17 26.83 12.38 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.853 1.261 . . . . 0.0 108.994 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 64.7 p -120.66 169.35 10.46 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.461 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.7 p -148.6 151.32 34.83 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 123.034 0.533 . . . . 0.0 109.618 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.7 t -96.19 132.33 40.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.9 m -123.64 148.37 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.44 121.06 58.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -67.44 115.09 6.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.787 0.68 . . . . 0.0 110.371 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.5 m -67.56 129.84 41.17 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.85 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.23 -16.29 56.2 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.142 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -109.89 -43.51 3.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.156 0.503 . . . . 0.0 110.536 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.06 59.58 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.006 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -87.95 162.96 16.59 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.179 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.6 ppt_? -133.68 136.21 44.57 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -144.66 151.4 38.91 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 44.4 tt0 -102.23 122.19 43.7 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 121.539 0.685 . . . . 0.0 109.75 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -126.22 163.52 22.98 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.89 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 20.3 m-80 -85.73 145.48 27.25 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 116' ' ' ILE . 39.2 mt -58.81 -39.65 81.81 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.641 0.588 . . . . 0.0 111.225 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.3 p -81.05 -10.14 59.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.16 0.505 . . . . 0.0 111.598 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 38.1 t70 -96.96 -13.82 22.11 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 123' ' ' CYS . 56.3 mt -63.99 160.25 18.26 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.549 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 24.0 mt -130.68 165.12 23.54 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 C--N 1.304 -1.397 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.318 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.4 m95 . . . . . 0 N--CA 1.437 -1.078 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -126.52 150.05 49.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.01 128.22 25.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.981 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.14 12.59 42.03 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.916 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.92 148.22 31.0 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -85.04 154.81 21.85 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.614 0.721 . . . . 0.0 111.649 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -161.25 -170.71 2.75 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.778 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.6 m -126.97 140.86 52.01 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.23 159.97 38.64 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.956 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.0 mm -93.1 113.62 28.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.229 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -69.17 119.77 13.97 Favored 'General case' 0 CA--C 1.467 -2.213 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.2 m -64.0 -17.68 63.55 Favored 'General case' 0 C--N 1.278 -2.503 0 O-C-N 123.983 0.802 . . . . 0.0 112.706 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.87 -42.61 16.19 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.274 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -105.71 -15.96 14.82 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.704 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.45 71.52 Favored Glycine 0 N--CA 1.461 0.326 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.132 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.5 m -90.75 166.5 13.09 Favored 'General case' 0 N--CA 1.406 -2.627 0 C-N-CA 124.052 0.941 . . . . 0.0 113.223 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.6 mt -89.39 134.51 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.61 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -141.46 152.26 63.16 Favored Pre-proline 0 C--N 1.304 -1.381 0 C-N-CA 123.032 0.533 . . . . 0.0 110.273 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 128.97 16.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.335 2.023 . . . . 0.0 111.023 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.1 150.34 37.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.12 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.5 m -113.87 136.25 53.09 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.22 121.06 15.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.231 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.18 -31.64 12.35 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.682 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.4 p -164.42 153.05 12.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.451 HG23 HD21 ' A' ' 138' ' ' LEU . 77.3 mt -127.12 129.55 71.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.74 0.416 . . . . 0.0 110.309 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.83 99.41 8.76 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -67.99 -19.75 64.97 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -73.25 -39.89 65.08 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.285 0.565 . . . . 0.0 109.893 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -89.97 -8.65 51.2 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.573 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 61.34 25.32 15.3 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.072 0.949 . . . . 0.0 110.492 -173.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 73.9 p -117.63 162.28 18.28 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.452 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.6 p -145.12 150.69 37.23 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 84.3 t -95.68 131.95 41.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 29.1 m -123.12 147.83 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 75.9 t -105.22 122.05 58.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -69.63 114.89 8.27 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.403 0.62 . . . . 0.0 110.077 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.9 m -66.36 129.96 41.6 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.717 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.53 -16.58 55.96 Favored Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.835 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -109.4 -46.65 3.51 Favored 'General case' 0 N--CA 1.434 -1.242 0 O-C-N 122.196 -0.591 . . . . 0.0 111.017 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.58 11.83 49.72 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.914 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -94.0 160.91 14.51 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.105 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.6 ppt_? -133.44 135.29 44.48 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -147.44 151.86 37.13 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -173.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 36.7 tt0 -102.02 126.8 49.04 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-O 121.981 0.896 . . . . 0.0 110.874 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -124.03 164.06 20.15 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.442 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.8 m-80 -86.93 144.38 26.98 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.451 HD21 HG23 ' A' ' 116' ' ' ILE . 44.5 mt -56.4 -44.1 79.94 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.725 0.64 . . . . 0.0 110.94 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.1 m -77.09 -9.82 58.98 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.262 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.03 -9.5 20.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.235 0.541 . . . . 0.0 109.813 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.585 HD11 ' SG ' ' A' ' 123' ' ' CYS . 63.9 mt -64.1 159.07 21.16 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.254 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 40.2 mt -126.76 162.29 26.16 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--N 1.302 -1.47 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.573 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.3 m95 . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -122.15 152.71 39.64 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.16 128.39 26.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.156 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.65 9.76 48.98 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.906 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.22 148.01 25.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -86.53 153.52 21.77 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.343 0.592 . . . . 0.0 110.841 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.8 p -162.77 -168.6 1.83 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.73 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 67.6 m -129.08 141.27 51.26 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.08 159.79 39.06 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -93.82 110.48 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -67.65 120.67 14.42 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.5 m -61.13 -21.51 63.8 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 123.814 0.696 . . . . 0.0 112.757 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -83.95 -37.35 22.4 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.381 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -111.17 -15.68 13.61 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.064 -177.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.59 -5.74 72.64 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.111 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.5 m -90.39 166.47 13.26 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 124.122 0.969 . . . . 0.0 113.593 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.2 mt -87.94 133.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.817 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -142.88 152.66 59.5 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.9 131.57 21.31 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.393 2.062 . . . . 0.0 111.522 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.38 154.51 41.71 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.9 m -118.75 135.92 54.24 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.1 mt -69.23 118.03 12.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.052 0.541 . . . . 0.0 110.687 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.87 -35.15 13.51 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.218 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.0 m -160.28 153.7 22.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.7 mt -127.2 134.2 66.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 123.479 0.487 . . . . 0.0 109.952 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -109.37 103.81 12.8 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -73.16 -18.53 61.26 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 120.971 0.415 . . . . 0.0 111.599 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.21 -37.39 66.45 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.017 0.437 . . . . 0.0 110.612 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -96.8 -7.71 32.98 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.801 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 61.81 26.49 16.08 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.027 0.918 . . . . 0.0 110.404 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.0 p -118.36 161.83 19.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.358 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' A' ' 141' ' ' LEU . 10.9 p -147.78 152.14 37.2 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.4 t -96.24 131.84 42.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.7 m -123.3 147.25 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.57 122.17 60.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -69.75 113.8 7.34 Favored 'General case' 0 CA--C 1.491 -1.293 0 O-C-N 123.68 0.612 . . . . 0.0 110.279 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.3 m -65.09 129.12 38.55 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.706 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.88 -20.21 40.76 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.694 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -105.3 -43.53 4.97 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.163 0.506 . . . . 0.0 110.416 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.28 59.94 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.095 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -91.93 163.99 13.81 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.4 ppt_? -133.52 135.94 44.72 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -143.4 150.39 39.02 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.37 120.9 41.28 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -126.63 163.74 22.8 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.115 -174.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 17.7 m-80 -85.6 142.96 28.73 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.01 -38.8 73.61 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.751 0.786 . . . . 0.0 110.272 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.5 p -78.88 -7.59 58.08 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.993 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 16.0 t70 -109.8 -4.66 15.91 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.801 0.81 . . . . 0.0 109.323 -175.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.553 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.8 mt -69.46 162.52 27.26 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.497 175.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 28.0 mt -130.66 162.33 29.64 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.304 -1.38 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.72 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 78.2 m95 . . . . . 0 CA--C 1.509 -0.602 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -130.92 155.45 46.75 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.303 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.62 127.05 23.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 O-C-N 123.561 0.538 . . . . 0.0 110.258 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.54 -0.82 32.5 Favored Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.339 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -100.51 148.03 25.24 Favored 'General case' 0 CA--C 1.479 -1.751 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.208 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 53.3 mtpt -87.97 155.26 19.93 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.314 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.0 p -157.58 -169.54 2.91 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.5 m -127.41 140.48 52.14 Favored 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 174.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.69 160.11 38.53 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -94.19 110.61 23.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.864 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -67.19 120.22 13.39 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 71.2 m -63.05 -17.86 62.71 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 124.107 0.88 . . . . 0.0 112.672 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.08 -40.73 17.95 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.149 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -110.27 -16.48 13.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.534 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.49 -4.64 83.75 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.318 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 66.0 m -90.61 165.39 13.76 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.6 mt -87.36 130.63 36.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.318 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -139.66 152.7 69.11 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.858 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.58 129.62 17.03 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.503 2.135 . . . . 0.0 111.575 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.87 39.77 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.081 -0.387 . . . . 0.0 110.122 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 22.3 m -116.7 136.04 53.29 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.33 121.71 15.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 123.11 0.564 . . . . 0.0 110.847 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.58 -35.28 9.19 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.675 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.1 p -157.83 152.26 24.77 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.403 HG23 HD21 ' A' ' 138' ' ' LEU . 66.2 mt -128.75 131.83 68.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -106.4 105.08 14.94 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -72.42 -20.15 61.47 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.83 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -74.87 -40.51 60.92 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.166 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -90.88 -7.97 50.72 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.684 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 60.3 29.17 18.79 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.357 1.063 . . . . 0.0 109.983 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.7 p -119.94 165.53 14.52 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.619 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 141' ' ' LEU . 10.7 p -147.85 152.15 37.14 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.6 t -95.94 130.82 44.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.1 m -123.17 146.75 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.9 t -106.29 120.41 57.29 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -69.07 112.76 5.89 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.492 0.663 . . . . 0.0 109.887 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.7 m -67.93 129.65 40.56 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.805 -174.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.9 -17.41 58.12 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.559 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -108.97 -47.4 3.45 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.719 0.295 . . . . 0.0 111.345 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.63 40.59 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.479 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -98.5 161.58 13.6 Favored 'General case' 0 CA--C 1.48 -1.713 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.453 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.5 ppt_? -134.16 136.29 43.69 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -142.93 151.35 40.86 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.673 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -101.73 121.39 41.97 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.831 0.824 . . . . 0.0 109.026 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -126.35 163.61 22.89 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.482 -1.236 . . . . 0.0 108.103 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -86.1 142.88 28.36 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.403 HD21 HG23 ' A' ' 116' ' ' ILE . 54.0 mt -56.16 -40.49 73.97 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.859 0.724 . . . . 0.0 110.586 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.6 t -80.44 -6.03 57.47 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.51 0.672 . . . . 0.0 110.345 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -106.28 -8.37 17.32 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 121.432 -0.793 . . . . 0.0 109.301 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.585 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.3 mt -66.8 159.18 28.62 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.111 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 33.9 mt -126.73 162.15 26.47 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.296 -1.744 0 O-C-N 123.464 0.478 . . . . 0.0 110.114 -179.319 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 75.9 m95 . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -119.62 153.38 35.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.83 128.29 25.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.641 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.68 7.08 54.09 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.256 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HB3' HD12 ' A' ' 113' ' ' ILE . 2.0 t0 -96.67 150.02 21.15 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -93.21 141.38 28.49 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-O 120.895 0.378 . . . . 0.0 110.044 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.0 p -152.11 -163.35 1.71 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 73.7 m -132.2 150.01 52.25 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.0 160.36 40.09 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.6 mm -92.83 113.44 27.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -70.77 125.59 27.26 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.7 m -62.52 -20.88 65.07 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 123.388 0.675 . . . . 0.0 112.708 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.96 -42.1 16.62 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.199 -174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -108.32 -14.65 14.64 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.034 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.85 -2.43 74.36 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 96.4 m -90.03 166.79 13.24 Favored 'General case' 0 N--CA 1.414 -2.227 0 C-N-CA 124.268 1.027 . . . . 0.0 112.723 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.8 mt -87.96 132.63 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.8 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 97.4 m-85 -140.98 152.02 64.05 Favored Pre-proline 0 C--N 1.291 -1.942 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.838 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.51 129.84 18.59 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.616 2.211 . . . . 0.0 112.25 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.49 149.85 38.12 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 m -114.64 136.11 53.41 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 96' ' ' ASP . 46.6 mt -69.01 119.81 15.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 O-C-N 123.476 0.485 . . . . 0.0 111.063 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.57 -37.1 11.01 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.883 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.3 p -159.65 153.24 22.64 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.452 HG23 HD21 ' A' ' 138' ' ' LEU . 72.4 mt -125.25 132.37 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -108.19 106.05 16.05 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -74.3 -20.48 60.11 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.802 -174.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -73.75 -38.99 64.56 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.117 0.484 . . . . 0.0 110.125 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -95.0 -7.25 40.33 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.617 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 61.63 28.45 17.62 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 124.141 0.976 . . . . 0.0 110.017 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 60.1 p -118.56 168.99 10.17 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.033 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.649 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.4 p -149.0 150.86 33.54 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.1 t -95.89 131.21 43.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.58 147.42 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.993 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 68.9 t -107.46 123.14 62.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -69.96 111.94 6.02 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.432 0.634 . . . . 0.0 110.339 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.9 m -62.77 129.82 42.19 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.966 -175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.66 -20.47 38.4 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.688 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -107.73 -41.44 5.01 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.039 0.447 . . . . 0.0 110.842 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.04 8.78 58.79 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.454 -0.879 . . . . 0.0 114.177 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -91.83 162.48 14.42 Favored 'General case' 0 CA--C 1.482 -1.664 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.031 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -134.44 138.41 44.74 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -144.82 150.86 37.88 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -102.59 122.17 43.84 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -126.41 164.02 22.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.418 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 16.4 m-80 -88.47 143.45 26.97 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.452 HD21 HG23 ' A' ' 116' ' ' ILE . 47.2 mt -55.84 -40.26 72.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 123.79 0.681 . . . . 0.0 111.612 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.0 t -76.39 -16.56 59.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.168 0.509 . . . . 0.0 110.118 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 9.0 t70 -101.16 -0.77 35.45 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.663 0.744 . . . . 0.0 109.684 -172.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.649 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.1 mt -72.05 164.46 26.11 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.256 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.1 mt -132.73 164.18 27.35 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.306 -1.308 0 C-N-CA 122.891 0.476 . . . . 0.0 109.982 -179.523 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 76.4 m95 . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -124.0 153.71 40.9 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.64 127.85 24.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.047 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.21 12.58 45.13 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.972 -0.633 . . . . 0.0 111.774 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -100.33 145.33 28.28 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.78 140.8 29.45 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.4 -163.42 1.67 Allowed 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.015 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.8 m -131.45 147.42 52.55 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.02 160.33 39.63 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.936 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.8 mm -93.27 110.71 23.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -67.62 122.28 17.71 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.2 m -60.19 -25.39 65.54 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 123.957 0.786 . . . . 0.0 112.482 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.32 -41.59 24.57 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.179 -172.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -108.0 -15.67 14.47 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.061 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.32 -4.07 78.78 Favored Glycine 0 N--CA 1.465 0.615 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.12 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.6 m -91.01 166.58 12.94 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.02 132.54 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.318 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -142.17 152.04 60.23 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.526 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -69.95 133.27 24.83 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.443 2.095 . . . . 0.0 111.607 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.64 146.91 29.51 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.825 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -112.77 135.77 53.14 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.2 mt -66.98 122.46 18.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 123.072 0.549 . . . . 0.0 110.595 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.79 -36.82 10.08 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.371 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.2 p -158.7 151.3 21.92 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.462 HG23 HD21 ' A' ' 138' ' ' LEU . 64.2 mt -125.37 132.27 71.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.436 ' OD1' ' HE3' ' A' ' 119' ' ' LYS . 9.6 t70 -108.48 104.1 13.37 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -72.78 -16.9 61.63 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HE3' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -73.51 -36.24 65.71 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.136 0.493 . . . . 0.0 110.12 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -98.48 -8.07 27.36 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.38 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 59.72 32.28 21.33 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.935 0.874 . . . . 0.0 109.938 -173.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.8 p -120.6 167.87 11.97 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.84 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.641 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.0 p -148.49 152.12 36.35 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.9 t -95.94 131.14 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.9 m -123.34 146.91 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 133' ' ' ARG . 75.8 t -105.65 120.68 56.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.723 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -68.43 114.13 6.59 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.639 0.587 . . . . 0.0 110.273 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.3 m -66.56 129.4 39.73 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.913 -174.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.09 -10.01 74.63 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.51 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -113.99 -51.25 2.79 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.977 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.11 6.18 45.77 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.93 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 96.2 m-20 -89.38 162.42 15.8 Favored 'General case' 0 CA--C 1.472 -2.057 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.248 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.1 ppt_? -135.6 136.05 40.74 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-O 121.27 0.557 . . . . 0.0 110.104 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -141.9 150.98 42.22 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.314 -174.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -102.64 118.99 38.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.683 0.754 . . . . 0.0 109.406 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -124.21 163.31 21.85 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.443 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -83.86 145.25 28.74 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.462 HD21 HG23 ' A' ' 116' ' ' ILE . 52.6 mt -58.39 -38.74 77.94 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.784 0.678 . . . . 0.0 111.003 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.8 m -80.49 -10.99 59.73 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.32 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.17 -9.63 27.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.601 0.715 . . . . 0.0 109.193 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.641 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.4 mt -68.56 166.25 17.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.01 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 18.8 mt -136.35 163.82 29.56 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.7 m . . . . . 0 C--N 1.312 -1.031 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.81 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.449 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 86.1 m95 . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -128.95 157.57 41.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.735 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.65 128.04 26.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.9 6.79 56.92 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.925 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.29 144.27 28.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -85.84 152.82 22.7 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.537 0.684 . . . . 0.0 111.629 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.6 p -161.91 -170.95 2.7 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.919 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 74.7 m -127.41 144.42 51.06 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.09 160.05 40.1 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 mm -94.27 111.53 25.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -69.05 123.18 20.35 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.7 m -63.28 -18.84 64.01 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 123.969 0.793 . . . . 0.0 112.966 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -83.33 -41.55 18.1 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.346 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -106.37 -16.38 14.57 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.971 -1.092 . . . . 0.0 111.418 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.96 0.75 86.26 Favored Glycine 0 C--N 1.31 -0.874 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 71.0 m -90.89 164.59 13.98 Favored 'General case' 0 N--CA 1.421 -1.883 0 C-N-CA 124.885 1.274 . . . . 0.0 112.473 -176.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 mt -88.89 132.12 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.451 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.1 m-85 -139.46 152.5 69.12 Favored Pre-proline 0 C--N 1.284 -2.267 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.33 134.72 27.44 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.639 2.226 . . . . 0.0 111.18 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.41 153.59 40.64 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.208 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.0 m -119.65 135.39 54.83 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 57.0 mt -64.5 122.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 123.439 0.695 . . . . 0.0 110.652 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.71 -38.98 9.69 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.819 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.8 m -158.48 149.68 20.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.435 HG23 HD21 ' A' ' 138' ' ' LEU . 64.3 mt -123.56 132.43 71.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 122.971 0.508 . . . . 0.0 109.809 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.92 104.1 13.49 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -74.57 -14.66 60.82 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.954 0.407 . . . . 0.0 111.866 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -74.08 -40.93 62.42 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.238 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -96.84 -8.45 30.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.6 33.29 20.41 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.953 0.883 . . . . 0.0 110.026 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 61.1 p -120.72 165.33 15.25 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.983 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 141' ' ' LEU . 12.5 p -148.15 152.5 37.4 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 95.3 t -95.78 131.38 42.7 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 27.8 m -123.63 147.3 28.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 133' ' ' ARG . 62.7 t -105.23 122.81 58.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -69.42 114.22 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.479 0.656 . . . . 0.0 109.92 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.3 m -65.4 130.23 42.58 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.547 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.82 -24.86 15.6 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.792 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -99.39 -51.73 3.71 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 122.448 -0.442 . . . . 0.0 111.027 -176.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.36 19.78 17.47 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.437 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -103.51 162.03 13.38 Favored 'General case' 0 CA--C 1.479 -1.77 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.363 173.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.4 ppt_? -133.42 140.23 47.2 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.75 150.84 35.02 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.504 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 34.8 tt0 -103.18 122.54 44.93 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.534 0.683 . . . . 0.0 109.669 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -125.41 162.91 23.77 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 140' ' ' ASP . 19.2 m-80 -83.38 144.02 29.92 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.435 HD21 HG23 ' A' ' 116' ' ' ILE . 59.1 mt -58.2 -41.68 84.52 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.672 0.608 . . . . 0.0 110.515 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.8 m -80.08 -5.67 56.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.459 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.492 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 27.3 t70 -110.61 -2.18 16.5 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.56 0.695 . . . . 0.0 109.281 -176.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 123' ' ' CYS . 60.0 mt -68.6 163.92 22.58 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.686 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 35.3 mt -125.44 157.79 36.02 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 C--N 1.291 -1.948 0 O-C-N 123.479 0.487 . . . . 0.0 110.275 -176.876 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.7 m95 . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -126.51 155.44 42.34 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.26 132.61 30.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.97 18.19 44.6 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.215 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -113.2 149.82 33.17 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -86.01 149.58 25.07 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 123.647 0.779 . . . . 0.0 110.624 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -159.47 -168.72 2.38 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 68.7 m -130.38 145.3 51.78 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.99 160.3 40.11 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.635 0.255 . . . . 0.0 110.796 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.38 112.28 25.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.81 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.4 ' CD2' ' HB2' ' A' ' 104' ' ' GLU . 5.2 t90 -70.49 124.44 24.21 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 m -62.69 -23.45 67.14 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.53 0.681 . . . . 0.0 112.559 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 102' ' ' TRP . 5.0 mm-40 -81.23 -39.79 24.82 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.263 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -108.8 -15.8 14.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.923 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.89 -1.47 83.98 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 75.1 m -90.29 164.93 14.18 Favored 'General case' 0 N--CA 1.419 -2.0 0 C-N-CA 124.592 1.157 . . . . 0.0 112.928 -176.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.8 mt -87.75 132.92 31.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.259 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.7 m-85 -142.23 152.52 61.31 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.158 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 139.35 39.66 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 122.861 2.374 . . . . 0.0 111.868 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.9 157.49 43.23 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.463 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 m -119.55 135.56 54.73 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.9 mt -70.41 118.74 15.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 122.812 0.445 . . . . 0.0 110.538 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.38 -29.85 14.79 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.963 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.9 p -161.79 153.37 18.77 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.4 mt -126.94 133.98 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.485 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 11.1 t70 -108.41 100.98 10.2 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 174.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -72.01 -16.34 62.06 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -73.57 -40.4 63.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.283 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 37.9 mmt-85 -93.76 -7.8 42.51 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 60.85 30.28 19.55 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.343 1.057 . . . . 0.0 109.685 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -119.07 165.93 13.53 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.3 p -148.12 150.69 34.31 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 90.6 t -95.98 130.49 44.59 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.9 m -123.06 147.0 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 133' ' ' ARG . 62.2 t -104.85 120.1 54.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.083 178.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -66.93 115.13 6.34 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.352 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.1 m -72.6 129.3 37.95 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.454 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.48 -14.81 63.79 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -118.09 -44.61 2.69 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 122.456 -0.438 . . . . 0.0 110.96 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.26 8.23 56.61 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.987 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.55 163.03 14.74 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 117.777 0.788 . . . . 0.0 109.289 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.7 ppt_? -133.02 139.0 47.0 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -147.68 151.7 36.57 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.494 0.718 . . . . 0.0 109.075 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 38.8 tt0 -101.89 126.65 48.83 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.587 0.708 . . . . 0.0 109.835 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -129.27 163.38 25.79 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.131 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -85.84 144.06 27.92 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.5 mt -57.94 -40.12 79.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 123.736 0.648 . . . . 0.0 110.905 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.8 m -80.75 -5.21 56.81 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.266 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -106.99 -14.27 14.99 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 123' ' ' CYS . 53.3 mt -60.69 154.62 21.04 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-O 121.548 0.69 . . . . 0.0 110.527 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 36.7 mt -120.0 156.65 30.47 Favored 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.022 -176.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.28 -2.444 0 O-C-N 123.843 0.714 . . . . 0.0 109.289 -179.563 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.1 m95 . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -126.78 155.03 43.46 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.14 128.33 23.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 120.968 0.413 . . . . 0.0 109.946 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.64 5.32 54.05 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.917 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.41 140.78 29.19 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -89.28 144.14 26.31 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.22 -164.61 2.0 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 68.6 m -129.19 141.11 51.25 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.68 160.26 38.08 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.172 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.71 111.07 24.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.307 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -66.25 119.11 10.94 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.7 m -63.53 -17.35 62.69 Favored 'General case' 0 C--N 1.274 -2.678 0 C-N-CA 123.928 0.891 . . . . 0.0 113.099 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -83.14 -37.39 23.8 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 114.557 -1.202 . . . . 0.0 111.629 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -116.36 -15.55 10.95 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.245 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.28 -6.14 77.46 Favored Glycine 0 C--N 1.316 -0.538 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.059 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 78.0 m -90.38 164.98 14.11 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.5 mt -86.56 133.44 29.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.931 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -141.8 152.16 61.76 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.07 130.79 19.57 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.37 2.047 . . . . 0.0 111.667 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.59 151.41 39.0 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.199 -0.313 . . . . 0.0 110.537 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.6 m -116.87 135.76 53.48 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.163 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 52.2 mt -65.68 117.82 7.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 123.288 0.635 . . . . 0.0 110.913 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.99 -37.0 11.89 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.853 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -160.27 149.56 17.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.414 HG23 HD21 ' A' ' 138' ' ' LEU . 69.1 mt -122.2 133.89 67.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.43 102.49 11.37 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -70.95 -20.88 62.41 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.136 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -38.01 64.76 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.044 0.45 . . . . 0.0 110.977 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -92.1 -7.65 47.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.195 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 60.49 30.81 20.06 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 124.149 0.906 . . . . 0.0 110.102 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 52.1 p -121.75 166.79 13.78 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.231 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.645 ' SG ' HD11 ' A' ' 141' ' ' LEU . 10.7 p -148.51 152.13 36.34 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 92.5 t -95.57 131.37 42.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.7 m -123.14 147.19 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' A' ' 133' ' ' ARG . 67.1 t -106.93 121.57 59.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.54 112.94 5.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.568 0.699 . . . . 0.0 110.354 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.9 m -66.5 130.07 41.98 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.972 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.73 -5.5 83.53 Favored Glycine 0 N--CA 1.432 -1.627 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.201 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -117.28 -50.73 2.55 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.817 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.45 34.04 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 119.857 -1.163 . . . . 0.0 114.059 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -97.09 162.71 13.25 Favored 'General case' 0 CA--C 1.482 -1.661 0 C-N-CA 119.344 -0.943 . . . . 0.0 109.553 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.401 ' HB3' HG22 ' A' ' 126' ' ' VAL . 6.3 ppt_? -134.04 139.45 46.02 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.201 0.524 . . . . 0.0 109.866 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -147.13 150.44 34.98 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.378 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 41.4 tt0 -103.02 120.87 41.43 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -126.3 163.73 22.58 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.219 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 18.1 m-80 -85.06 142.79 29.31 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.414 HD21 HG23 ' A' ' 116' ' ' ILE . 51.5 mt -59.32 -36.49 75.76 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.877 0.846 . . . . 0.0 109.919 177.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.6 p -79.62 -10.3 59.77 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.665 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.405 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 32.2 t70 -110.07 -4.54 15.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.511 0.672 . . . . 0.0 109.763 -176.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.645 HD11 ' SG ' ' A' ' 123' ' ' CYS . 71.2 mt -67.23 162.71 22.01 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.716 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.5 mt -128.94 159.86 34.51 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.438 -177.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.298 -1.673 0 O-C-N 123.495 0.497 . . . . 0.0 109.961 -179.013 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 78.5 m95 . . . . . 0 CA--C 1.505 -0.765 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -130.95 155.9 46.01 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.57 128.28 25.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.78 7.62 52.97 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.755 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.41 147.34 25.35 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -91.54 150.94 20.97 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.2 p -155.63 -168.04 2.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 67.0 m -129.6 145.21 51.51 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.44 159.95 40.22 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 123.215 0.322 . . . . 0.0 110.281 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.9 mm -92.27 112.61 26.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.342 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -69.48 118.21 12.07 Favored 'General case' 0 CA--C 1.471 -2.077 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.2 m -58.88 -23.1 60.54 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 122.068 0.937 . . . . 0.0 112.194 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.06 -39.74 23.03 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.987 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -108.77 -16.54 14.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.704 0.764 . . . . 0.0 109.855 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.84 -6.53 69.87 Favored Glycine 0 C--O 1.225 -0.448 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.997 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 65.3 m -90.96 167.53 12.34 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.0 mt -88.0 132.13 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.506 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -140.1 152.47 67.47 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.209 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.09 130.4 18.86 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.416 2.077 . . . . 0.0 111.24 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.16 149.62 35.3 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.963 0.411 . . . . 0.0 110.312 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.6 m -117.54 136.17 53.44 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 56.7 mt -65.74 121.76 15.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 O-C-N 123.548 0.53 . . . . 0.0 111.156 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.14 -34.59 9.98 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.919 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.8 p -161.12 150.89 17.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 123' ' ' CYS . 67.7 mt -127.43 133.37 68.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 117.931 0.332 . . . . 0.0 110.111 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -108.82 103.68 12.79 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.65 -14.32 61.56 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.271 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -73.68 -41.3 62.85 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.877 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -98.22 -6.12 31.89 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.401 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 63.64 29.33 15.1 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.828 0.851 . . . . 0.0 109.308 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 47.1 p -117.29 165.41 13.49 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.916 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.625 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.6 p -148.55 152.39 36.74 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 120.676 0.274 . . . . 0.0 110.272 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.3 t -96.25 130.63 44.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.72 147.25 28.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 53.5 t -106.07 123.54 60.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.139 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -72.05 113.77 9.44 Favored 'General case' 0 C--O 1.257 1.5 0 CA-C-O 121.479 0.656 . . . . 0.0 110.475 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.5 m -69.2 130.21 42.01 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.742 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.76 -10.17 72.67 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.838 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -118.54 -53.05 2.34 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.719 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.21 17.43 15.87 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.728 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -99.71 165.61 11.51 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -132.99 142.46 48.85 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -145.51 151.28 37.92 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.98 121.65 42.57 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.424 0.631 . . . . 0.0 109.52 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -125.33 163.41 22.61 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 15.7 m-80 -85.62 143.48 28.41 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.1 mt -58.49 -38.3 77.35 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.682 0.754 . . . . 0.0 110.607 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.4 p -80.42 -8.67 59.62 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.992 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.542 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 12.6 t70 -105.33 -8.15 18.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.625 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.0 mt -65.86 157.8 29.56 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.625 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.3 mt -124.76 161.32 26.68 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -176.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.294 -1.846 0 O-C-N 123.542 0.526 . . . . 0.0 110.278 -178.547 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.414 ' CD1' HD12 ' A' ' 141' ' ' LEU . 83.1 m95 . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 110.694 -0.113 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -125.24 151.61 45.69 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.23 128.41 26.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.86 10.83 54.79 Favored Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.372 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -103.85 153.22 21.0 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -86.43 147.87 25.81 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 123.677 0.791 . . . . 0.0 110.51 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -156.64 -168.85 2.81 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 69.2 m -130.64 141.74 50.43 Favored 'General case' 0 C--N 1.264 -3.123 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.71 160.15 38.41 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 123.313 0.383 . . . . 0.0 110.651 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.4 mm -94.55 109.93 22.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.087 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -66.21 121.28 14.86 Favored 'General case' 0 CA--C 1.473 -1.996 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.9 m -61.33 -19.7 62.11 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 124.067 0.947 . . . . 0.0 112.341 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -84.36 -42.35 15.82 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.35 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -104.57 -16.09 15.13 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.648 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.25 -1.27 65.3 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 71.1 m -90.37 162.56 15.07 Favored 'General case' 0 N--CA 1.408 -2.569 0 C-N-CA 124.323 1.049 . . . . 0.0 112.177 -175.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.4 mt -86.6 133.77 29.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.099 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -140.31 152.26 66.42 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 131.5 19.49 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.425 2.083 . . . . 0.0 111.228 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.62 154.57 42.96 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.437 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.0 m -119.33 135.95 54.48 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.7 mt -68.77 124.12 23.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 122.922 0.489 . . . . 0.0 111.346 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.51 -32.32 11.88 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.876 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.4 p -163.89 152.84 13.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.429 HG23 HD21 ' A' ' 138' ' ' LEU . 68.7 mt -126.93 132.18 70.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 122.818 0.447 . . . . 0.0 109.826 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.418 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 10.1 t70 -109.4 102.54 11.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 173.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.51 -21.82 63.64 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.635 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -73.57 -36.25 65.55 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.603 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 35.2 mmt180 -93.35 -8.52 41.71 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 61.08 28.51 18.23 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.196 0.998 . . . . 0.0 110.186 -173.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 66.6 p -119.95 166.18 13.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.127 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.648 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.4 p -148.45 150.73 33.98 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.41 HG11 ' HD3' ' A' ' 133' ' ' ARG . 92.3 t -96.1 132.5 40.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 27.7 m -124.03 147.55 28.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.4 t -104.99 121.46 56.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.071 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -69.89 116.63 10.5 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-O 121.548 0.69 . . . . 0.0 110.84 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.2 m -66.2 129.86 41.24 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.176 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.78 -16.82 59.95 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.047 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -115.15 -51.81 2.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.432 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.26 17.06 28.12 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.644 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 90.6 m-20 -93.48 162.48 13.95 Favored 'General case' 0 CA--C 1.472 -2.053 0 C-N-CA 119.499 -0.88 . . . . 0.0 108.642 174.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.7 ppt_? -131.72 135.46 46.86 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -142.61 151.11 41.15 Favored 'General case' 0 N--CA 1.409 -2.486 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.323 -173.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -101.77 122.0 43.13 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.798 0.809 . . . . 0.0 109.904 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -126.82 163.54 23.36 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.434 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.463 ' HB2' ' CB ' ' A' ' 140' ' ' ASP . 17.9 m-80 -88.59 143.45 26.94 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.429 HD21 HG23 ' A' ' 116' ' ' ILE . 61.8 mt -57.07 -40.69 77.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.204 0.602 . . . . 0.0 111.253 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.6 t -80.87 -8.53 59.74 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.317 0.58 . . . . 0.0 110.736 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.463 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 21.4 t70 -102.16 -10.71 19.39 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.648 HD11 ' SG ' ' A' ' 123' ' ' CYS . 60.8 mt -66.59 157.81 31.43 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.23 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 28.5 mt -125.27 161.58 26.63 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -176.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--N 1.297 -1.704 0 O-C-N 123.282 0.364 . . . . 0.0 110.557 -178.909 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 84.8 m95 . . . . . 0 C--O 1.244 0.805 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -131.47 156.11 46.22 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.39 131.94 29.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.13 3.68 54.24 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.574 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.485 ' HB2' HD12 ' A' ' 113' ' ' ILE . 62.5 m-20 -99.56 139.48 35.16 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -83.66 145.51 28.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.8 p -153.45 -161.97 1.37 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 70.6 m -135.78 146.59 47.76 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.0 161.12 38.13 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.571 -176.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.8 mm -92.77 112.43 26.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -69.02 124.29 23.34 Favored 'General case' 0 CA--C 1.474 -1.964 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.1 m -59.52 -25.36 64.43 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.977 0.798 . . . . 0.0 112.366 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -81.53 -41.84 21.07 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.485 -0.78 . . . . 0.0 113.102 -174.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -105.82 -15.87 14.82 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.578 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.74 -0.74 76.18 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 78.3 m -89.94 164.62 14.49 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 124.013 0.925 . . . . 0.0 112.263 -176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.413 HG23 HD12 ' A' ' 142' ' ' LEU . 29.8 mt -88.39 131.2 36.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -140.08 152.39 67.34 Favored Pre-proline 0 C--N 1.291 -1.97 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.467 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.73 137.14 26.78 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.227 1.951 . . . . 0.0 111.399 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.96 148.66 29.35 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.893 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.3 m -112.42 136.05 52.38 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 96' ' ' ASP . 57.5 mt -66.39 118.64 9.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 C-N-CA 123.202 0.601 . . . . 0.0 110.945 -178.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.29 -41.92 8.79 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.934 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.0 m -157.58 149.71 22.44 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -123.48 132.26 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 123.314 0.384 . . . . 0.0 110.213 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.12 108.73 19.51 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -75.56 -17.42 60.06 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.166 -173.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -73.31 -41.73 63.19 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -94.21 -8.03 40.45 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.004 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 60.86 31.52 20.03 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.288 1.035 . . . . 0.0 110.035 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 49.3 p -119.38 167.38 11.97 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.729 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.7 p -148.33 151.83 36.04 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.637 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 98.0 t -96.07 132.59 39.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.8 m -123.87 148.41 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 68.0 t -106.24 120.56 57.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.475 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.47 116.03 8.56 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.675 0.61 . . . . 0.0 110.713 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.5 m -71.54 129.57 39.09 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.883 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.21 -14.9 64.4 Favored Glycine 0 N--CA 1.429 -1.793 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.908 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -117.71 -44.47 2.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 120.971 0.415 . . . . 0.0 110.718 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.8 10.8 52.04 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.011 -1.09 . . . . 0.0 114.437 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -91.29 162.58 14.56 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-N 117.93 0.865 . . . . 0.0 109.267 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 ppt_? -132.07 137.75 47.89 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -145.7 151.83 38.64 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 43.9 tt0 -101.72 124.73 47.86 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -176.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -129.16 163.77 24.81 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.629 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 17.8 m-80 -87.58 144.04 26.89 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 62.9 mt -58.77 -39.33 80.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.676 0.75 . . . . 0.0 110.273 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.7 p -73.8 -17.12 61.12 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.481 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 16.0 t70 -101.89 -7.8 22.15 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -173.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 123' ' ' CYS . 62.4 mt -66.9 157.48 33.07 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.095 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 32.9 mt -126.25 160.81 29.28 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 C--N 1.293 -1.886 0 O-C-N 123.571 0.545 . . . . 0.0 110.4 -179.021 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 CA--C 1.514 -0.428 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.0 m -104.85 92.22 4.16 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.87 -38.2 85.87 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.67 -29.62 67.11 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.0 m -110.23 21.55 16.59 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.367 0.603 . . . . 0.0 110.359 -176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 mt -82.35 16.47 2.04 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -175.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -121.75 -16.25 7.72 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.642 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -116.62 130.13 56.56 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.073 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -139.05 163.91 31.17 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -128.51 154.76 45.79 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.19 127.07 24.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.84 8.99 47.19 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.527 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.406 ' HB3' HD12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -97.5 148.86 22.8 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -91.52 151.26 20.83 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -158.16 -169.58 2.84 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 121.479 0.657 . . . . 0.0 110.005 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.5 m -127.07 144.07 51.12 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 173.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.18 160.12 39.36 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.0 mm -93.82 109.59 22.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -68.62 123.71 21.62 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.9 m -63.19 -20.03 65.04 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.86 -39.48 19.84 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.517 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -108.03 -15.42 14.52 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.642 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.33 1.35 69.57 Favored Glycine 0 C--N 1.313 -0.717 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 77.4 m -90.55 164.19 14.32 Favored 'General case' 0 N--CA 1.405 -2.685 0 C-N-CA 124.303 1.041 . . . . 0.0 112.327 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -89.5 129.26 40.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.349 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -137.56 152.58 73.16 Favored Pre-proline 0 C--N 1.286 -2.187 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.795 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.97 133.33 23.11 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 122.624 2.216 . . . . 0.0 111.555 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.75 153.81 41.35 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.27 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 m -118.23 135.88 53.99 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 96' ' ' ASP . 51.3 mt -68.82 120.49 16.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 120.958 0.409 . . . . 0.0 110.587 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.71 -38.44 9.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.968 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -159.3 152.21 21.94 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 123' ' ' CYS . 63.4 mt -128.87 136.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 122.65 0.38 . . . . 0.0 110.343 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -109.27 99.52 8.78 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -71.27 -18.54 62.42 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.078 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -73.46 -40.58 64.05 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.21 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -90.83 -7.3 52.68 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 61.86 32.8 17.92 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.79 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.5 p -122.74 164.05 19.03 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.168 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.669 ' SG ' HD11 ' A' ' 141' ' ' LEU . 16.8 p -148.44 155.86 41.75 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 120.75 0.31 . . . . 0.0 110.396 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.77 130.19 46.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 31.6 m -123.3 147.24 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 133' ' ' ARG . 75.2 t -104.7 122.55 57.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.17 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -70.27 114.97 8.93 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 123.64 0.588 . . . . 0.0 110.192 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 45.7 m -67.76 131.83 46.3 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.069 -176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.1 -15.37 63.04 Favored Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.852 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -116.75 -47.88 2.69 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.732 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.34 14.38 38.7 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 119.938 -1.125 . . . . 0.0 114.086 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -94.63 162.63 13.71 Favored 'General case' 0 CA--C 1.479 -1.776 0 C-N-CA 119.606 -0.838 . . . . 0.0 108.986 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.2 ppt_? -133.78 136.38 44.5 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -141.98 151.76 42.81 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.62 -174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.76 120.52 40.5 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -125.75 163.49 22.74 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.254 -174.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -85.88 143.31 28.3 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.411 HD21 HG23 ' A' ' 116' ' ' ILE . 66.8 mt -58.57 -39.79 81.28 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 123.623 0.577 . . . . 0.0 110.683 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.6 t -80.91 -5.52 57.52 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.426 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -106.96 -8.53 16.58 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.514 0.673 . . . . 0.0 109.706 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.669 HD11 ' SG ' ' A' ' 123' ' ' CYS . 67.1 mt -66.59 162.61 20.57 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.856 176.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 41.3 mt -128.49 159.94 33.88 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 30.3 m -67.43 144.4 97.88 Favored Pre-proline 0 C--N 1.296 -1.731 0 O-C-N 123.658 0.599 . . . . 0.0 111.595 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.67 150.41 82.36 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 123.053 2.502 . . . . 0.0 112.27 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.4 mt -85.37 140.8 15.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 39.5 t -135.08 6.49 3.36 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.093 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.424 -1.77 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.818 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.502 -0.882 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.6 m -97.59 120.51 38.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 74.6 -35.92 0.31 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.825 1.65 . . . . 0.0 114.034 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.56 109.91 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.813 0.845 . . . . 0.0 112.374 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -91.94 0.66 57.47 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.19 0.995 . . . . 0.0 110.117 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 89' ' ' LEU . 5.1 tt -84.39 6.26 23.93 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 123.012 1.387 . . . . 0.0 108.364 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -99.32 -5.46 29.65 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.92 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -129.47 108.94 10.65 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.918 0.866 . . . . 0.0 111.102 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.444 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 86.8 m95 -119.73 164.48 15.88 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.054 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 8.9 ptpp? -128.95 153.45 47.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.16 127.43 24.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.75 8.71 56.95 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.761 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 93' ' ' LYS . 2.5 t0 -99.96 146.8 26.28 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -83.67 154.95 23.4 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 121.294 0.569 . . . . 0.0 111.418 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -160.0 -174.47 4.58 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.4 m -125.03 140.97 52.43 Favored 'General case' 0 C--N 1.258 -3.386 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 174.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.76 159.97 38.99 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.152 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.98 111.58 25.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -68.76 121.96 17.59 Favored 'General case' 0 CA--C 1.475 -1.919 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.6 m -63.49 -19.74 65.01 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 123.952 0.782 . . . . 0.0 112.821 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -84.57 -42.13 15.76 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.174 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -106.74 -15.47 14.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.674 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.14 -5.24 77.6 Favored Glycine 0 N--CA 1.462 0.431 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.425 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 68.0 m -90.65 166.99 12.86 Favored 'General case' 0 N--CA 1.412 -2.367 0 C-N-CA 123.75 0.82 . . . . 0.0 113.176 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.3 mt -86.88 133.2 30.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.984 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -140.67 152.46 66.07 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.477 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.24 127.8 14.71 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.237 1.958 . . . . 0.0 110.965 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.01 150.36 39.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 120.904 0.383 . . . . 0.0 110.192 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 m -114.99 135.84 53.79 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 53.0 mt -68.32 118.93 13.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.891 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.68 -36.69 12.21 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.911 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m -159.19 150.04 19.8 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.4 HG23 HD21 ' A' ' 138' ' ' LEU . 69.0 mt -126.94 132.78 69.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 122.971 0.508 . . . . 0.0 110.514 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -108.94 110.38 21.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -75.37 -21.34 58.4 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.992 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -73.51 -36.57 65.77 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.241 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -94.97 -8.86 35.73 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.359 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 57.63 35.65 25.9 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.924 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 47.1 p -121.93 163.01 20.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.905 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.599 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.2 p -148.34 153.45 38.64 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 120.816 0.341 . . . . 0.0 110.282 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 92.6 t -96.34 132.44 40.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.9 m -123.49 147.13 27.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.0 t -106.3 120.94 58.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -70.58 115.74 10.09 Favored 'General case' 0 C--O 1.259 1.577 0 CA-C-O 121.386 0.612 . . . . 0.0 109.978 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.0 m -69.04 129.58 40.31 Favored 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.313 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.81 -17.48 58.57 Favored Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.026 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.93 -52.72 2.73 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.207 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.11 22.17 8.96 Favored Glycine 0 N--CA 1.435 -1.383 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.734 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -105.62 161.91 13.97 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.7 ppt_? -135.08 136.08 41.74 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -143.18 151.32 40.52 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -101.96 119.74 39.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.634 0.73 . . . . 0.0 109.27 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -126.24 163.5 23.06 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.042 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.3 m-80 -85.36 143.93 28.34 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.4 HD21 HG23 ' A' ' 116' ' ' ILE . 60.5 mt -59.06 -37.01 76.04 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.794 0.807 . . . . 0.0 109.495 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.3 m -73.75 -19.76 60.69 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.117 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -102.57 -8.93 20.59 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.29 0.567 . . . . 0.0 110.332 -173.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.599 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.4 mt -63.45 160.72 15.71 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.939 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.9 mt -125.3 159.93 30.51 Favored 'General case' 0 C--N 1.254 -3.586 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.2 m -67.36 135.63 93.3 Favored Pre-proline 0 C--N 1.29 -1.997 0 O-C-N 123.577 0.548 . . . . 0.0 110.264 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.58 150.88 79.41 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 123.172 2.581 . . . . 0.0 113.372 -173.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.6 mt -81.25 172.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 18.8 p -73.33 17.01 0.15 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 124.16 0.984 . . . . 0.0 113.297 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 . . . . . 0 N--CA 1.427 -1.589 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -177.323 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.666 ' N ' ' HG ' ' A' ' 88' ' ' SER . 43.8 t30 . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 p -88.3 -13.34 41.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.353 0.597 . . . . 0.0 112.396 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -169.44 103.08 0.35 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.07 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 76.6 109.92 0.07 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.211 -1.813 . . . . 0.0 111.029 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.666 ' HG ' ' N ' ' A' ' 84' ' ' ASN . 50.5 m -108.64 13.75 24.96 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.567 0.699 . . . . 0.0 112.334 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 89' ' ' LEU . 5.8 tt -94.81 2.36 55.47 Favored 'General case' 0 C--O 1.202 -1.41 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -92.24 -3.62 55.23 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.801 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -135.26 136.31 41.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.153 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.479 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 79.8 m95 -141.93 165.08 28.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -175.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -129.76 157.73 41.38 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.23 128.71 25.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.508 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.56 -1.77 36.76 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.204 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.481 ' HB2' HD12 ' A' ' 113' ' ' ILE . 24.6 m-20 -96.79 135.32 38.9 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 122.68 -0.306 . . . . 0.0 111.08 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 14.6 mtmt -77.47 147.76 35.73 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-O 121.335 0.588 . . . . 0.0 110.901 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.9 p -154.53 -166.5 2.35 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 114.579 -1.192 . . . . 0.0 107.96 -177.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 73.2 m -129.03 141.37 51.26 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.61 160.36 38.73 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.2 mm -93.92 112.58 27.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -68.33 120.72 14.91 Favored 'General case' 0 CA--C 1.473 -1.981 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.6 m -61.65 -20.46 63.44 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.947 0.779 . . . . 0.0 112.631 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -84.73 -39.8 18.06 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.565 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -109.02 -15.95 14.24 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.042 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.13 -3.95 78.45 Favored Glycine 0 N--CA 1.464 0.524 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.328 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 70.7 m -90.62 168.15 12.01 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.8 mt -90.31 133.64 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.666 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -142.36 152.01 59.54 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.43 135.19 26.06 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.505 2.137 . . . . 0.0 111.381 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.95 150.69 34.51 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.941 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 20.7 m -111.27 135.83 51.25 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 96' ' ' ASP . 44.5 mt -67.94 117.12 9.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 123.34 0.4 . . . . 0.0 110.49 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.08 -38.6 11.53 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.205 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.2 p -159.19 146.87 17.49 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.41 HG23 HD21 ' A' ' 138' ' ' LEU . 62.5 mt -124.36 135.32 64.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -109.35 106.23 15.95 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -75.73 -13.72 60.31 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -73.26 -41.88 63.14 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -96.39 -7.52 34.84 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.702 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 57.36 33.67 23.62 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.336 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 79.8 p -118.38 161.98 19.06 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.065 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.55 ' SG ' HD11 ' A' ' 141' ' ' LEU . 15.1 p -147.81 152.91 38.48 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.359 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 88.7 t -95.82 131.66 42.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.1 m -123.21 146.92 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 77.7 t -106.26 120.01 56.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -66.41 111.99 3.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.782 0.676 . . . . 0.0 110.386 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.4 m -65.62 129.95 41.56 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.727 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.32 -21.22 41.68 Favored Glycine 0 N--CA 1.425 -2.087 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.786 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -106.95 -50.46 3.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.101 -177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.72 3.56 37.02 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.149 -1.024 . . . . 0.0 114.223 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 95.1 m-20 -87.73 163.16 16.65 Favored 'General case' 0 CA--C 1.479 -1.772 0 CA-C-N 117.804 0.802 . . . . 0.0 109.916 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.8 ppt_? -134.25 136.53 43.67 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.079 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -144.92 151.24 38.36 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.971 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 39.9 tt0 -102.7 124.7 48.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -127.57 163.92 23.12 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -175.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 16.6 m-80 -87.37 142.88 27.55 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.41 HD21 HG23 ' A' ' 116' ' ' ILE . 51.0 mt -57.22 -39.76 76.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.431 0.634 . . . . 0.0 110.561 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 m -79.63 -4.63 52.51 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.883 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -108.96 -7.75 15.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.52 0.676 . . . . 0.0 109.306 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.55 HD11 ' SG ' ' A' ' 123' ' ' CYS . 67.7 mt -69.58 163.83 24.63 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.652 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 21.1 mt -130.65 162.85 28.48 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.0 m -71.5 141.46 85.44 Favored Pre-proline 0 C--N 1.31 -1.137 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -60.66 142.65 98.4 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.339 2.026 . . . . 0.0 112.557 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.433 HG22 ' HG3' ' A' ' 147' ' ' GLU . 36.1 mt -84.67 144.33 9.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.714 -176.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 46.4 t -137.73 96.12 3.17 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.433 ' HG3' HG22 ' A' ' 145' ' ' ILE . 44.0 mt-10 . . . . . 0 C--N 1.287 -2.131 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.488 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.5 t -122.79 24.19 9.17 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.787 0.803 . . . . 0.0 110.188 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.48 -19.53 6.9 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.96 14.56 31.6 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.3 m 63.05 26.45 15.44 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.336 1.065 . . . . 0.0 109.954 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.613 ' O ' HD23 ' A' ' 89' ' ' LEU . 6.5 tt -84.89 0.81 49.8 Favored 'General case' 0 C--O 1.207 -1.147 0 C-N-CA 125.448 1.499 . . . . 0.0 110.498 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -99.46 6.67 45.89 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.37 -0.831 . . . . 0.0 110.365 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -140.75 127.53 20.42 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.397 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 77.7 m95 -138.18 164.72 28.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -130.92 154.96 47.56 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.17 127.43 22.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-O 121.032 0.444 . . . . 0.0 110.754 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.1 5.77 46.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.505 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -103.75 149.08 25.33 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 120.705 0.288 . . . . 0.0 110.23 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -88.5 150.91 22.86 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.808 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.41 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 25.4 p -155.82 -168.02 2.66 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.953 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.553 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.9 m -129.35 144.95 51.44 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.39 160.22 39.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.902 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.2 mm -93.89 110.04 22.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.73 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -66.31 121.79 16.05 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 t -61.18 -22.35 64.65 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 123.885 0.74 . . . . 0.0 110.589 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -80.58 -42.19 22.71 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.719 -173.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -106.37 -14.9 14.96 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.274 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.69 0.53 68.54 Favored Glycine 0 N--CA 1.462 0.429 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.97 164.15 14.09 Favored 'General case' 0 N--CA 1.403 -2.788 0 C-N-CA 124.852 1.261 . . . . 0.0 112.325 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.3 mt -88.02 133.51 30.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.61 0.764 . . . . 0.0 110.144 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -144.07 152.48 54.86 Favored Pre-proline 0 C--N 1.304 -1.397 0 C-N-CA 123.158 0.583 . . . . 0.0 109.868 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.07 133.68 23.68 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.695 2.263 . . . . 0.0 111.873 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.71 153.36 40.9 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.967 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.2 m -117.55 135.79 53.71 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 48.5 mt -66.25 118.1 8.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 123.104 0.562 . . . . 0.0 111.322 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.21 -38.43 10.57 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.97 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 m -158.26 151.85 23.45 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.414 HG23 HD21 ' A' ' 138' ' ' LEU . 63.5 mt -127.26 134.18 66.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -108.59 102.88 11.91 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -71.06 -18.45 62.56 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.27 -174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -72.82 -39.9 66.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -93.8 -7.51 43.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 61.81 27.49 16.79 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.793 0.837 . . . . 0.0 110.062 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.8 p -119.64 165.7 14.13 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.342 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.573 ' SG ' HD11 ' A' ' 141' ' ' LEU . 12.0 p -148.08 152.49 37.45 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.9 t -96.73 131.19 44.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.1 m -123.57 147.11 28.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 133' ' ' ARG . 55.3 t -106.75 122.89 61.31 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -70.95 114.49 9.06 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.545 0.688 . . . . 0.0 110.13 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.5 m -63.96 129.47 40.19 Favored 'General case' 0 N--CA 1.407 -2.607 0 CA-C-N 113.712 -1.586 . . . . 0.0 111.287 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.83 -13.97 57.64 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.316 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -109.66 -44.79 3.78 Favored 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 122.547 -0.384 . . . . 0.0 110.231 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.18 10.07 56.37 Favored Glycine 0 N--CA 1.436 -1.357 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.923 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -91.94 163.86 13.86 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-N 117.586 0.693 . . . . 0.0 109.487 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -135.27 139.11 44.15 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -145.82 151.21 37.56 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -101.39 121.85 42.67 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -128.65 163.21 25.56 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.957 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 19.9 m-80 -86.17 144.56 27.42 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.414 HD21 HG23 ' A' ' 116' ' ' ILE . 47.1 mt -57.93 -40.94 81.68 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.848 0.717 . . . . 0.0 110.652 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.1 m -81.38 -7.23 59.54 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.302 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 19.2 t70 -101.98 -5.03 25.13 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.573 HD11 ' SG ' ' A' ' 123' ' ' CYS . 68.8 mt -69.62 171.63 8.67 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.276 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 27.2 mt -138.34 162.89 33.22 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.0 m -67.62 137.75 93.24 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.53 142.33 94.6 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.042 2.495 . . . . 0.0 115.327 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.505 HG13 ' OG ' ' A' ' 99' ' ' SER . 39.8 mt -92.17 159.0 2.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 114.3 -1.318 . . . . 0.0 107.831 176.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.4 t 73.44 11.89 4.79 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.801 1.64 . . . . 0.0 109.779 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 . . . . . 0 C--N 1.301 -1.533 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.622 177.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.425 ' HA ' HE22 ' A' ' 90' ' ' GLN . 45.2 m -139.09 98.58 3.55 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.723 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.09 -9.39 17.84 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.91 157.35 37.63 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.487 -0.778 . . . . 0.0 108.933 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -94.22 23.92 4.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.85 0.833 . . . . 0.0 109.407 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.83 33.65 3.51 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.466 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 47.5 mt-30 -113.66 -48.47 2.93 Favored 'General case' 0 C--O 1.209 -1.027 0 C-N-CA 120.451 -0.499 . . . . 0.0 112.24 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -100.66 136.1 41.06 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.746 0.784 . . . . 0.0 112.692 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -135.0 164.72 26.98 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.732 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -116.79 152.15 35.0 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.646 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.17 128.54 26.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.94 23.29 25.72 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.657 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -115.74 149.72 38.02 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 3.1 mtmt -84.23 148.78 26.53 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 123.026 0.53 . . . . 0.0 110.102 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.5 p -157.92 -167.89 2.36 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.7 m -131.18 142.08 50.15 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.47 160.16 38.25 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.907 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.0 mm -95.07 108.18 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -67.88 123.78 21.53 Favored 'General case' 0 CA--C 1.469 -2.147 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.289 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.7 m -62.04 -22.09 65.45 Favored 'General case' 0 C--N 1.282 -2.326 0 O-C-N 123.95 0.781 . . . . 0.0 112.674 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -83.58 -36.91 23.58 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -108.46 -16.46 14.22 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.155 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.2 0.45 70.96 Favored Glycine 0 C--N 1.304 -1.236 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.707 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 99.4 m -90.84 167.38 12.5 Favored 'General case' 0 N--CA 1.413 -2.295 0 C-N-CA 124.491 1.117 . . . . 0.0 111.887 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.39 133.1 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.48 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.47 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.3 m-85 -139.48 152.05 68.07 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.088 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.62 133.32 23.74 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.313 2.009 . . . . 0.0 111.189 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.02 156.64 44.05 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.818 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 23.0 m -119.99 135.52 54.89 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mt -70.31 123.88 25.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 122.747 0.419 . . . . 0.0 110.679 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.95 -36.07 10.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.164 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 64.1 m -161.38 149.97 15.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.43 HG23 HD21 ' A' ' 138' ' ' LEU . 71.1 mt -124.41 129.73 73.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -105.67 101.85 11.34 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -73.16 -12.67 60.97 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.234 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -73.56 -40.68 63.75 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.255 0.55 . . . . 0.0 109.605 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -99.32 -7.02 26.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.1 30.27 17.78 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.868 0.867 . . . . 0.0 110.306 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 52.7 p -119.99 165.53 14.56 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.245 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.597 ' SG ' HD11 ' A' ' 141' ' ' LEU . 15.6 p -148.09 152.74 37.87 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.1 t -96.15 131.01 44.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.6 m -122.98 146.83 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 133' ' ' ARG . 65.5 t -105.78 120.39 56.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.91 114.7 7.45 Favored 'General case' 0 C--O 1.257 1.462 0 O-C-N 123.923 0.764 . . . . 0.0 110.107 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 87.8 m -67.52 128.98 38.47 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.655 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.23 -22.82 30.27 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.696 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -100.82 -52.37 3.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 122.324 -0.515 . . . . 0.0 109.877 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.39 11.25 29.68 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.85 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -93.87 162.54 13.87 Favored 'General case' 0 CA--C 1.466 -2.265 0 C-N-CA 119.434 -0.907 . . . . 0.0 109.739 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.3 ppt_? -133.54 136.25 44.87 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -142.08 150.93 41.85 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -102.55 116.45 32.63 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.759 0.79 . . . . 0.0 109.271 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -121.03 163.78 17.78 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.617 -173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -85.88 139.87 30.88 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.527 ' HB3' ' O ' ' A' ' 90' ' ' GLN . 71.0 mt -55.22 -40.82 71.29 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.375 0.67 . . . . 0.0 111.354 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.2 t -80.67 -6.2 58.05 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.797 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -104.76 -7.86 19.2 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.743 0.782 . . . . 0.0 109.052 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.597 HD11 ' SG ' ' A' ' 123' ' ' CYS . 66.1 mt -67.16 163.98 19.07 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.638 176.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 26.8 mt -132.39 163.66 28.21 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 p -67.94 140.55 93.83 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.37 142.78 98.94 Favored 'Trans proline' 0 CA--C 1.504 -0.992 0 C-N-CA 123.215 2.61 . . . . 0.0 115.006 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.519 HG13 ' OG ' ' A' ' 99' ' ' SER . 39.4 mt -91.6 138.11 20.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 173.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 34.9 t -136.5 22.89 3.17 Favored 'General case' 0 C--N 1.275 -2.649 0 CA-C-O 121.746 0.784 . . . . 0.0 108.964 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 C--N 1.3 -1.576 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.086 -177.506 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.6 t30 . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 m -89.39 87.52 7.13 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.55 -12.15 21.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.235 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.91 161.18 40.62 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 m -84.06 84.4 7.61 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.14 -0.16 14.76 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.259 1.028 . . . . 0.0 109.554 -176.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -108.65 -22.11 12.4 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.012 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -141.85 134.7 28.71 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 75.0 m95 -129.09 165.46 21.18 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -175.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.627 ' HG2' ' OD2' ' A' ' 96' ' ' ASP . 8.4 ptpp? -126.0 153.78 43.87 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.51 129.14 26.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.96 3.07 42.44 Favored Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.063 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.627 ' OD2' ' HG2' ' A' ' 93' ' ' LYS . 12.1 m-20 -98.01 136.32 38.44 Favored 'General case' 0 CA--C 1.486 -1.518 0 O-C-N 122.602 -0.352 . . . . 0.0 110.488 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 13.9 mtmt -81.19 143.7 32.15 Favored 'General case' 0 N--CA 1.401 -2.905 0 CA-C-O 121.291 0.567 . . . . 0.0 109.63 171.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.31 -167.51 2.73 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.9 m -128.6 145.11 51.23 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.33 160.26 39.58 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.682 0.614 . . . . 0.0 109.817 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mm -93.29 109.62 22.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.491 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -68.1 125.68 27.11 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.835 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.8 m -64.5 -20.82 66.44 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -83.95 -41.16 17.63 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -105.33 -15.96 14.89 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.392 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.25 0.86 79.1 Favored Glycine 0 C--N 1.311 -0.839 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.014 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.499 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 74.9 m -90.27 168.85 11.6 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 124.117 0.967 . . . . 0.0 111.75 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.1 mt -89.07 135.41 25.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.1 m-85 -142.99 152.12 57.76 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.46 136.13 27.94 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.663 2.242 . . . . 0.0 111.413 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.96 154.17 39.01 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 31.0 m -114.68 135.49 54.1 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.529 HD12 ' HB2' ' A' ' 96' ' ' ASP . 49.7 mt -67.39 115.51 5.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 122.949 0.499 . . . . 0.0 110.705 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.44 -35.41 13.0 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.193 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.7 m -157.96 148.38 20.56 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.425 HG23 HD21 ' A' ' 138' ' ' LEU . 65.5 mt -123.25 133.01 70.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -108.31 97.56 7.23 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -71.74 -14.73 62.09 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.977 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -73.24 -41.34 63.83 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.018 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -94.89 -6.88 41.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.216 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 62.56 29.52 17.0 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.4 1.08 . . . . 0.0 110.096 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 46.7 p -117.94 166.75 12.14 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.618 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.6 p -148.45 152.12 36.38 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.0 t -95.86 131.09 43.53 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 24.6 m -122.71 146.73 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 133' ' ' ARG . 72.4 t -105.28 119.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -68.14 111.1 4.3 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-O 121.574 0.702 . . . . 0.0 110.858 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 96.2 m -70.58 129.79 40.12 Favored 'General case' 0 N--CA 1.397 -3.101 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.576 -175.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.11 -13.81 63.04 Favored Glycine 0 N--CA 1.418 -2.502 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.296 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.7 -54.01 2.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.95 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 107.27 17.42 11.51 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.957 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -101.64 168.61 9.36 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.269 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.472 ' HB3' HG22 ' A' ' 126' ' ' VAL . 7.1 ppt_? -137.73 140.11 40.52 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -146.14 151.59 37.91 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 123.696 0.798 . . . . 0.0 109.43 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -101.67 123.35 45.52 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.497 0.665 . . . . 0.0 109.507 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -129.31 163.39 25.8 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.022 -175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 22.6 m-80 -85.8 146.03 26.95 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.425 HD21 HG23 ' A' ' 116' ' ' ILE . 52.5 mt -60.22 -35.15 74.79 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.751 0.786 . . . . 0.0 109.587 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.3 p -74.52 -17.87 60.69 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.667 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -105.47 -4.81 20.9 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.715 0.769 . . . . 0.0 110.471 -173.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.608 HD11 ' SG ' ' A' ' 123' ' ' CYS . 52.9 mt -68.11 160.73 28.38 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.886 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.6 mt -132.14 164.47 26.23 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 39.9 m -67.4 137.61 93.73 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 122.93 0.492 . . . . 0.0 110.151 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.92 147.25 84.7 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.29 2.66 . . . . 0.0 115.118 -171.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.7 mt -100.29 142.02 16.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 38.9 t -136.35 115.01 11.98 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 C--N 1.29 -1.995 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.906 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.1 t -77.18 149.54 35.56 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-O 121.252 0.548 . . . . 0.0 110.768 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.69 -20.78 49.33 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.99 92.1 8.85 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 121.975 0.893 . . . . 0.0 109.36 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 m -104.38 31.38 4.68 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.94 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.494 ' O ' HD23 ' A' ' 89' ' ' LEU . 4.1 tt -88.78 1.84 54.54 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 123.355 1.55 . . . . 0.0 107.477 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.91 3.07 33.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.619 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -128.9 119.05 23.71 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.137 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.444 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 78.8 m95 -135.92 164.66 27.45 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 -177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -130.07 152.72 49.22 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.52 131.46 29.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 123.481 0.488 . . . . 0.0 110.102 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.23 4.6 50.34 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.25 145.03 30.81 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -80.69 154.36 27.36 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-O 121.574 0.702 . . . . 0.0 111.138 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.3 p -159.67 -171.56 3.33 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.7 m -129.13 143.72 50.96 Favored 'General case' 0 C--N 1.261 -3.245 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.45 158.66 43.81 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.104 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -93.14 110.86 23.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.519 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.413 ' CD2' ' HB2' ' A' ' 104' ' ' GLU . 6.2 t90 -68.63 125.42 26.47 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m -60.9 -22.96 64.84 Favored 'General case' 0 C--N 1.287 -2.141 0 O-C-N 124.027 0.829 . . . . 0.0 112.829 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 102' ' ' TRP . 4.9 mm-40 -83.62 -42.0 17.2 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.739 -174.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -105.91 -16.23 14.7 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.058 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.67 1.02 75.98 Favored Glycine 0 C--N 1.312 -0.762 0 N-CA-C 111.419 -0.673 . . . . 0.0 111.419 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 78.7 m -89.92 165.86 13.84 Favored 'General case' 0 N--CA 1.414 -2.262 0 C-N-CA 124.028 0.931 . . . . 0.0 111.693 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.5 mt -90.28 129.24 41.46 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.819 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 95.7 m-85 -134.63 152.22 77.31 Favored Pre-proline 0 C--N 1.285 -2.232 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.865 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.412 ' HG3' ' HB3' ' A' ' 147' ' ' GLU . 56.3 Cg_endo -71.13 130.23 17.35 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.277 1.985 . . . . 0.0 110.837 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.12 150.73 39.86 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.942 0.401 . . . . 0.0 110.066 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.1 m -115.99 135.85 53.58 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 50.9 mt -64.7 123.79 18.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 123.602 0.564 . . . . 0.0 110.781 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.31 -38.2 8.16 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.147 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.1 p -159.43 148.58 18.2 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.458 HG23 HD21 ' A' ' 138' ' ' LEU . 69.7 mt -124.41 130.51 73.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.718 0.294 . . . . 0.0 110.526 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -109.37 103.36 12.27 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.03 -16.9 60.58 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.869 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -73.26 -39.08 65.71 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.061 0.457 . . . . 0.0 110.181 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -95.18 -7.63 38.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.606 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 62.56 26.81 15.91 Favored 'General case' 0 C--O 1.248 1.016 0 C-N-CA 124.8 1.24 . . . . 0.0 110.504 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 82.5 p -118.83 165.16 14.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.425 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.1 p -148.06 151.39 35.61 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 89.3 t -96.19 132.56 40.16 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 29.2 m -123.54 147.57 27.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 56.9 t -106.5 122.06 59.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.849 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -70.78 114.08 8.5 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 123.747 0.654 . . . . 0.0 110.71 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.7 m -65.54 130.33 42.93 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.908 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.16 -13.4 66.4 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.151 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -116.59 -48.93 2.67 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.901 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 101.28 7.11 50.1 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.426 -0.892 . . . . 0.0 114.193 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 89.2 m-20 -88.32 162.91 16.32 Favored 'General case' 0 CA--C 1.474 -1.946 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.214 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.6 ppt_? -132.38 136.45 46.82 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -144.06 151.1 39.19 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 40.6 tt0 -102.05 126.38 48.98 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -130.7 163.25 27.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.9 m-80 -84.33 144.92 28.54 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.458 HD21 HG23 ' A' ' 116' ' ' ILE . 55.0 mt -57.48 -42.74 83.26 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.557 0.694 . . . . 0.0 110.612 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 p -78.36 -7.83 57.75 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.217 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -101.83 -13.76 17.56 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.588 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.4 mt -61.2 160.39 10.46 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.231 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 27.8 mt -126.41 162.44 25.56 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.1 m -67.36 137.05 93.59 Favored Pre-proline 0 C--N 1.298 -1.65 0 O-C-N 123.596 0.56 . . . . 0.0 109.93 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -59.65 147.24 92.79 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.364 2.709 . . . . 0.0 114.818 -172.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.457 HG13 ' OG ' ' A' ' 99' ' ' SER . 35.3 mt -93.73 141.06 15.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 174.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.38 43.7 0.83 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 124.886 1.274 . . . . 0.0 110.624 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.412 ' HB3' ' HG3' ' A' ' 110' ' ' PRO . 34.7 tt0 . . . . . 0 N--CA 1.426 -1.628 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 CA--C 1.503 -0.855 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.8 m -72.98 122.23 21.37 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.42 -18.72 65.53 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.578 0.351 . . . . 0.0 111.134 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 68.94 96.22 0.06 Allowed 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 125.228 1.411 . . . . 0.0 113.28 172.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.3 m -113.11 86.43 2.38 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.53 ' O ' HD23 ' A' ' 89' ' ' LEU . 2.6 tt -109.34 -2.79 17.59 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.484 1.135 . . . . 0.0 110.07 -175.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -118.92 0.55 11.37 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.206 175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -130.05 109.56 10.94 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -126.71 164.35 21.49 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -125.83 153.41 44.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.42 128.26 26.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.34 10.98 40.22 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.921 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.63 150.06 27.34 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -91.76 150.06 21.29 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 120.956 0.408 . . . . 0.0 109.957 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -155.95 -168.38 2.75 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.603 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 66.7 m -128.36 141.16 51.51 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.62 160.42 36.7 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.7 mm -97.04 109.49 23.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -65.7 121.75 15.71 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.7 m -60.95 -19.55 61.04 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 124.104 0.878 . . . . 0.0 112.647 -175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.88 -43.12 14.4 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.016 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.53 -15.9 14.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.233 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.7 0.09 79.04 Favored Glycine 0 C--N 1.317 -0.476 0 CA-C-O 121.564 0.536 . . . . 0.0 112.058 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.491 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 79.4 m -89.63 162.49 15.59 Favored 'General case' 0 N--CA 1.407 -2.621 0 C-N-CA 123.772 0.829 . . . . 0.0 111.768 -177.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.4 mt -88.04 130.67 37.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.617 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -136.43 152.21 74.47 Favored Pre-proline 0 C--N 1.289 -2.054 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.789 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.02 130.21 17.44 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.279 1.986 . . . . 0.0 110.827 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.66 147.42 31.98 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 120.974 0.416 . . . . 0.0 110.324 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.4 m -113.68 135.89 53.43 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.4 mt -68.26 119.99 14.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 122.734 0.414 . . . . 0.0 110.601 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.89 -30.97 12.44 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.737 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.2 p -161.23 154.76 21.79 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.437 HG23 HD21 ' A' ' 138' ' ' LEU . 69.5 mt -128.33 132.8 67.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.19 102.9 12.0 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -72.13 -16.69 62.0 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.447 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -73.48 -40.26 64.26 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.467 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -97.12 -6.93 33.83 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.8 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 63.13 30.87 16.04 Favored 'General case' 0 C--O 1.252 1.236 0 CA-C-O 122.027 0.917 . . . . 0.0 109.949 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.1 p -120.67 166.72 13.3 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.922 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.648 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.6 p -148.7 152.19 36.22 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 87.4 t -95.84 130.61 44.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 22.5 m -123.29 147.31 27.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' A' ' 133' ' ' ARG . 66.9 t -106.0 121.26 58.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -71.2 114.69 9.52 Favored 'General case' 0 C--O 1.257 1.478 0 CA-C-O 121.611 0.72 . . . . 0.0 110.312 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.7 m -66.23 130.63 43.87 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.736 -1.575 . . . . 0.0 110.877 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.86 -21.26 42.58 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.201 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -108.14 -52.68 2.73 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.893 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.88 20.37 10.75 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.796 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -101.37 161.23 13.78 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.55 173.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.3 ppt_? -132.21 135.94 46.66 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -145.18 149.88 35.75 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 37.8 tt0 -102.92 124.29 48.16 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -127.79 163.4 24.43 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.331 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -83.11 142.09 31.5 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.437 HD21 HG23 ' A' ' 116' ' ' ILE . 44.6 mt -55.6 -41.61 73.67 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.921 0.763 . . . . 0.0 111.443 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 m -76.4 -15.66 59.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.895 0.378 . . . . 0.0 111.312 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -95.63 -9.55 31.81 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.802 0.81 . . . . 0.0 109.428 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.648 HD11 ' SG ' ' A' ' 123' ' ' CYS . 62.3 mt -65.35 163.58 15.3 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.284 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 29.1 mt -131.15 162.41 29.97 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.3 p -69.17 138.46 89.62 Favored Pre-proline 0 C--N 1.308 -1.225 0 O-C-N 123.281 0.363 . . . . 0.0 110.141 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.84 142.42 96.28 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.688 2.259 . . . . 0.0 114.468 -173.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.509 HG13 ' OG ' ' A' ' 99' ' ' SER . 58.1 mt -80.91 152.34 4.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 114.249 -1.341 . . . . 0.0 107.888 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 47.0 t -124.1 106.57 10.45 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--N 1.298 -1.663 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.071 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 119.591 -0.242 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.6 p 56.01 -167.52 0.1 Allowed 'General case' 0 C--N 1.354 0.794 0 C-N-CA 124.508 1.123 . . . . 0.0 110.553 -173.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.44 -8.79 46.81 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.486 0.66 . . . . 0.0 109.637 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.77 80.48 8.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.976 0.893 . . . . 0.0 111.253 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -164.11 19.5 0.06 Allowed 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 126.26 1.824 . . . . 0.0 106.737 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.37 63.32 4.86 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 122.701 1.239 . . . . 0.0 108.955 -168.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -141.88 -0.43 1.33 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.167 -1.833 . . . . 0.0 110.564 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -126.82 113.63 16.86 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.405 0.622 . . . . 0.0 111.138 -174.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 82.0 m95 -130.57 163.98 25.9 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -125.78 155.61 40.77 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.66 128.22 25.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.989 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.75 -1.61 48.74 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.966 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.2 146.13 24.22 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -86.59 149.86 24.63 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.092 0.473 . . . . 0.0 111.039 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 24.9 p -156.7 -168.03 2.56 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.635 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.537 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.5 m -129.7 149.21 51.55 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.21 160.38 39.59 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 123.574 0.546 . . . . 0.0 109.684 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.4 mm -94.07 110.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -68.44 124.28 23.1 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.8 m -64.34 -18.03 64.25 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 123.93 0.769 . . . . 0.0 112.662 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -83.86 -41.79 17.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -104.96 -15.16 15.2 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.626 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.67 2.0 68.23 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.555 ' HB2' ' CE2' ' A' ' 109' ' ' TYR . 98.7 m -90.71 165.03 13.91 Favored 'General case' 0 N--CA 1.406 -2.633 0 C-N-CA 124.494 1.117 . . . . 0.0 112.286 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.7 mt -90.83 131.33 38.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.556 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 107' ' ' CYS . 98.3 m-85 -141.41 152.31 63.46 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.74 134.98 31.67 Favored 'Trans proline' 0 C--O 1.24 0.624 0 C-N-CA 122.68 2.253 . . . . 0.0 112.143 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.23 157.24 43.53 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.945 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 m -121.46 135.46 55.04 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 49.3 mt -66.88 118.6 10.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 C-N-CA 123.5 0.72 . . . . 0.0 111.287 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.51 -38.04 11.09 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.627 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 p -157.92 152.21 24.54 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.522 HG23 HD21 ' A' ' 138' ' ' LEU . 64.6 mt -126.13 129.58 72.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -108.98 99.67 8.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.21 -20.72 65.74 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.171 -175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.447 ' HD3' ' H ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -72.04 -40.3 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 110.461 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -90.51 -7.87 51.84 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.072 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 65.17 26.83 12.38 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.853 1.261 . . . . 0.0 108.994 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 64.7 p -120.66 169.35 10.46 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.461 -177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.7 p -148.6 151.32 34.83 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 123.034 0.533 . . . . 0.0 109.618 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 91.7 t -96.19 132.33 40.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 30.9 m -123.64 148.37 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.44 121.06 58.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -67.44 115.09 6.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.787 0.68 . . . . 0.0 110.371 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.5 m -67.56 129.84 41.17 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.85 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.23 -16.29 56.2 Favored Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.142 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -109.89 -43.51 3.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.156 0.503 . . . . 0.0 110.536 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.34 7.06 59.58 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.006 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -87.95 162.96 16.59 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.179 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.6 ppt_? -133.68 136.21 44.57 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -144.66 151.4 38.91 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 44.4 tt0 -102.23 122.19 43.7 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 121.539 0.685 . . . . 0.0 109.75 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -126.22 163.52 22.98 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.89 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 20.3 m-80 -85.73 145.48 27.25 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 116' ' ' ILE . 39.2 mt -58.81 -39.65 81.81 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.641 0.588 . . . . 0.0 111.225 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.3 p -81.05 -10.14 59.73 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.16 0.505 . . . . 0.0 111.598 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 38.1 t70 -96.96 -13.82 22.11 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 123' ' ' CYS . 56.3 mt -63.99 160.25 18.26 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.549 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 24.0 mt -130.68 165.12 23.54 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.0 m -66.84 136.82 94.6 Favored Pre-proline 0 C--N 1.304 -1.397 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.89 145.21 97.1 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.409 2.74 . . . . 0.0 115.556 -172.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.503 HG13 ' OG ' ' A' ' 99' ' ' SER . 28.9 mt -103.2 140.16 22.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 114.313 -1.312 . . . . 0.0 107.592 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 43.2 t -162.85 98.68 0.97 Allowed 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 C--N 1.284 -2.26 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.799 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.5 m -75.39 112.76 12.03 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.49 -7.37 53.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.858 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 67.74 81.67 0.19 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 125.443 1.497 . . . . 0.0 111.146 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.3 m -109.32 15.94 22.74 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.629 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 89' ' ' LEU . 1.8 tt -99.42 -1.02 39.69 Favored 'General case' 0 C--O 1.209 -1.074 0 CA-C-O 123.132 1.444 . . . . 0.0 107.67 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -110.4 -2.32 16.68 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.685 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -115.33 109.45 17.94 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -129.33 164.41 23.63 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -126.52 150.05 49.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.01 128.22 25.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.981 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.14 12.59 42.03 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.916 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.92 148.22 31.0 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -85.04 154.81 21.85 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-O 121.614 0.721 . . . . 0.0 111.649 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -161.25 -170.71 2.75 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.778 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 75.6 m -126.97 140.86 52.01 Favored 'General case' 0 C--N 1.273 -2.718 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.23 159.97 38.64 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.956 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.0 mm -93.1 113.62 28.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.229 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -69.17 119.77 13.97 Favored 'General case' 0 CA--C 1.467 -2.213 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.2 m -64.0 -17.68 63.55 Favored 'General case' 0 C--N 1.278 -2.503 0 O-C-N 123.983 0.802 . . . . 0.0 112.706 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.87 -42.61 16.19 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.274 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -105.71 -15.96 14.82 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.704 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.15 -3.45 71.52 Favored Glycine 0 N--CA 1.461 0.326 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.132 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.5 m -90.75 166.5 13.09 Favored 'General case' 0 N--CA 1.406 -2.627 0 C-N-CA 124.052 0.941 . . . . 0.0 113.223 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.6 mt -89.39 134.51 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.61 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -141.46 152.26 63.16 Favored Pre-proline 0 C--N 1.304 -1.381 0 C-N-CA 123.032 0.533 . . . . 0.0 110.273 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 128.97 16.03 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.335 2.023 . . . . 0.0 111.023 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.1 150.34 37.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.12 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.5 m -113.87 136.25 53.09 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.22 121.06 15.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.231 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.18 -31.64 12.35 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.682 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.4 p -164.42 153.05 12.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.451 HG23 HD21 ' A' ' 138' ' ' LEU . 77.3 mt -127.12 129.55 71.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.74 0.416 . . . . 0.0 110.309 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.83 99.41 8.76 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -67.99 -19.75 64.97 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -73.25 -39.89 65.08 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.285 0.565 . . . . 0.0 109.893 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -89.97 -8.65 51.2 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.573 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 61.34 25.32 15.3 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.072 0.949 . . . . 0.0 110.492 -173.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 73.9 p -117.63 162.28 18.28 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.452 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.6 p -145.12 150.69 37.23 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 84.3 t -95.68 131.95 41.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 29.1 m -123.12 147.83 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 75.9 t -105.22 122.05 58.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -69.63 114.89 8.27 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.403 0.62 . . . . 0.0 110.077 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.9 m -66.36 129.96 41.6 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.717 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.53 -16.58 55.96 Favored Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.835 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -109.4 -46.65 3.51 Favored 'General case' 0 N--CA 1.434 -1.242 0 O-C-N 122.196 -0.591 . . . . 0.0 111.017 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.58 11.83 49.72 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.914 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -94.0 160.91 14.51 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.105 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.6 ppt_? -133.44 135.29 44.48 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -147.44 151.86 37.13 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -173.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 36.7 tt0 -102.02 126.8 49.04 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-O 121.981 0.896 . . . . 0.0 110.874 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -124.03 164.06 20.15 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.442 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 17.8 m-80 -86.93 144.38 26.98 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.451 HD21 HG23 ' A' ' 116' ' ' ILE . 44.5 mt -56.4 -44.1 79.94 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.725 0.64 . . . . 0.0 110.94 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 21.1 m -77.09 -9.82 58.98 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.262 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -102.03 -9.5 20.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.235 0.541 . . . . 0.0 109.813 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.585 HD11 ' SG ' ' A' ' 123' ' ' CYS . 63.9 mt -64.1 159.07 21.16 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.254 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 40.2 mt -126.76 162.29 26.16 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.5 m -71.75 137.5 82.83 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.441 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 22.7 Cg_endo -60.14 139.69 88.63 Favored 'Trans proline' 0 CA--C 1.502 -1.093 0 C-N-CA 122.542 2.161 . . . . 0.0 113.424 -172.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 147' ' ' GLU . 19.5 mt -77.48 142.98 13.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 45.2 t -119.78 16.59 12.7 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 122.052 0.929 . . . . 0.0 109.098 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.536 ' H ' HG22 ' A' ' 145' ' ' ILE . 5.9 mm-40 . . . . . 0 C--N 1.292 -1.91 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.839 -175.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -167.42 149.72 5.92 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.5 -15.08 38.61 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.03 107.95 8.07 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.783 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.8 m -82.38 9.8 8.35 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.347 0.594 . . . . 0.0 111.369 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.594 ' O ' HD23 ' A' ' 89' ' ' LEU . 4.8 tt -79.03 10.17 3.7 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 123.093 1.425 . . . . 0.0 109.529 -178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -107.05 1.25 24.16 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.352 -0.842 . . . . 0.0 109.46 174.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -121.56 122.14 39.02 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -136.44 163.93 29.34 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -122.15 152.71 39.64 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.16 128.39 26.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.156 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.65 9.76 48.98 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.906 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -101.22 148.01 25.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -86.53 153.52 21.77 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.343 0.592 . . . . 0.0 110.841 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.8 p -162.77 -168.6 1.83 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.73 -176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 67.6 m -129.08 141.27 51.26 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.08 159.79 39.06 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.7 mm -93.82 110.48 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -67.65 120.67 14.42 Favored 'General case' 0 CA--C 1.478 -1.81 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.5 m -61.13 -21.51 63.8 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 123.814 0.696 . . . . 0.0 112.757 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -83.95 -37.35 22.4 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.381 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -111.17 -15.68 13.61 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 118.78 -1.168 . . . . 0.0 110.064 -177.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.59 -5.74 72.64 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.111 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.5 m -90.39 166.47 13.26 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 124.122 0.969 . . . . 0.0 113.593 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.2 mt -87.94 133.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.817 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -142.88 152.66 59.5 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.9 131.57 21.31 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.393 2.062 . . . . 0.0 111.522 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.38 154.51 41.71 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.9 m -118.75 135.92 54.24 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.1 mt -69.23 118.03 12.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.052 0.541 . . . . 0.0 110.687 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.87 -35.15 13.51 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.218 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.0 m -160.28 153.7 22.18 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 74.7 mt -127.2 134.2 66.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 O-C-N 123.479 0.487 . . . . 0.0 109.952 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -109.37 103.81 12.8 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -73.16 -18.53 61.26 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 120.971 0.415 . . . . 0.0 111.599 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -73.21 -37.39 66.45 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.017 0.437 . . . . 0.0 110.612 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -96.8 -7.71 32.98 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.801 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 61.81 26.49 16.08 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.027 0.918 . . . . 0.0 110.404 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.0 p -118.36 161.83 19.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.358 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' A' ' 141' ' ' LEU . 10.9 p -147.78 152.14 37.2 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.4 t -96.24 131.84 42.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.7 m -123.3 147.25 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.57 122.17 60.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -69.75 113.8 7.34 Favored 'General case' 0 CA--C 1.491 -1.293 0 O-C-N 123.68 0.612 . . . . 0.0 110.279 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.3 m -65.09 129.12 38.55 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.706 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.88 -20.21 40.76 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.694 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -105.3 -43.53 4.97 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.163 0.506 . . . . 0.0 110.416 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.28 59.94 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.095 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -91.93 163.99 13.81 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.4 ppt_? -133.52 135.94 44.72 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -143.4 150.39 39.02 Favored 'General case' 0 N--CA 1.414 -2.254 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.37 120.9 41.28 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -126.63 163.74 22.8 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.115 -174.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 17.7 m-80 -85.6 142.96 28.73 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.01 -38.8 73.61 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.751 0.786 . . . . 0.0 110.272 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.5 p -78.88 -7.59 58.08 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.993 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 16.0 t70 -109.8 -4.66 15.91 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.801 0.81 . . . . 0.0 109.323 -175.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.553 HD11 ' SG ' ' A' ' 123' ' ' CYS . 65.8 mt -69.46 162.52 27.26 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.497 175.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 28.0 mt -130.66 162.33 29.64 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m -70.99 141.41 86.7 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.438 ' HA ' ' OG ' ' A' ' 99' ' ' SER . 10.0 Cg_endo -58.3 140.01 92.74 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 121.968 1.779 . . . . 0.0 112.629 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 59.1 mt -69.2 150.82 10.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.134 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 71.2 m -75.81 78.53 2.74 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-O 121.582 0.706 . . . . 0.0 109.845 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 . . . . . 0 N--CA 1.429 -1.489 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.909 178.803 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 . . . . . 0 CA--C 1.507 -0.689 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -128.69 -3.45 5.32 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.481 0.658 . . . . 0.0 111.464 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.17 -27.38 12.93 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.262 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 90' ' ' GLN . . . -132.11 19.24 4.5 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.828 0.823 . . . . 0.0 111.179 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.9 p -90.89 12.61 18.95 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.01 -1.09 35.2 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.104 0.954 . . . . 0.0 110.214 -178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 30.1 pt20 -106.42 3.4 27.29 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.56 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -132.54 120.57 22.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.26 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -139.03 164.29 30.15 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -130.92 155.45 46.75 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.303 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.62 127.05 23.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 O-C-N 123.561 0.538 . . . . 0.0 110.258 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.54 -0.82 32.5 Favored Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.339 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -100.51 148.03 25.24 Favored 'General case' 0 CA--C 1.479 -1.751 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.208 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 53.3 mtpt -87.97 155.26 19.93 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.314 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.0 p -157.58 -169.54 2.91 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.5 m -127.41 140.48 52.14 Favored 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 174.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.69 160.11 38.53 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -94.19 110.61 23.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.864 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -67.19 120.22 13.39 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 71.2 m -63.05 -17.86 62.71 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 124.107 0.88 . . . . 0.0 112.672 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.08 -40.73 17.95 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.149 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -110.27 -16.48 13.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.534 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.49 -4.64 83.75 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.318 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 66.0 m -90.61 165.39 13.76 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.6 mt -87.36 130.63 36.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.318 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -139.66 152.7 69.11 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.858 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.58 129.62 17.03 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.503 2.135 . . . . 0.0 111.575 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.87 39.77 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.081 -0.387 . . . . 0.0 110.122 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . 22.3 m -116.7 136.04 53.29 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.33 121.71 15.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 123.11 0.564 . . . . 0.0 110.847 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -101.58 -35.28 9.19 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.675 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 75.1 p -157.83 152.26 24.77 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.403 HG23 HD21 ' A' ' 138' ' ' LEU . 66.2 mt -128.75 131.83 68.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -106.4 105.08 14.94 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -72.42 -20.15 61.47 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.83 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -74.87 -40.51 60.92 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.166 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -90.88 -7.97 50.72 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.684 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 60.3 29.17 18.79 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.357 1.063 . . . . 0.0 109.983 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.7 p -119.94 165.53 14.52 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.619 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 141' ' ' LEU . 10.7 p -147.85 152.15 37.14 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.6 t -95.94 130.82 44.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.1 m -123.17 146.75 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.9 t -106.29 120.41 57.29 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -69.07 112.76 5.89 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.492 0.663 . . . . 0.0 109.887 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.7 m -67.93 129.65 40.56 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.805 -174.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 92.9 -17.41 58.12 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.559 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -108.97 -47.4 3.45 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 120.719 0.295 . . . . 0.0 111.345 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.63 40.59 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.479 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -98.5 161.58 13.6 Favored 'General case' 0 CA--C 1.48 -1.713 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.453 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 5.5 ppt_? -134.16 136.29 43.69 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -142.93 151.35 40.86 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.673 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -101.73 121.39 41.97 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.831 0.824 . . . . 0.0 109.026 -176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -126.35 163.61 22.89 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.482 -1.236 . . . . 0.0 108.103 -174.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -86.1 142.88 28.36 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.403 HD21 HG23 ' A' ' 116' ' ' ILE . 54.0 mt -56.16 -40.49 73.97 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 123.859 0.724 . . . . 0.0 110.586 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.6 t -80.44 -6.03 57.47 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.51 0.672 . . . . 0.0 110.345 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -106.28 -8.37 17.32 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 121.432 -0.793 . . . . 0.0 109.301 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.585 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.3 mt -66.8 159.18 28.62 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.111 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 33.9 mt -126.73 162.15 26.47 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.4 m -68.37 135.3 90.99 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 123.464 0.478 . . . . 0.0 110.114 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.92 147.12 95.84 Favored 'Trans proline' 0 CA--C 1.505 -0.927 0 C-N-CA 123.236 2.624 . . . . 0.0 113.78 -172.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.3 mt -87.04 136.18 23.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 20.1 t -95.92 91.55 6.07 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-O 121.401 0.619 . . . . 0.0 109.654 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 C--N 1.294 -1.828 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.284 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 . . . . . 0 CA--C 1.508 -0.655 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.8 m -95.37 134.08 38.57 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.78 81.86 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.278 0.561 . . . . 0.0 111.265 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.92 106.0 14.98 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.637 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.6 p -80.4 2.72 23.84 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.835 0.826 . . . . 0.0 111.566 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.55 ' O ' HD23 ' A' ' 89' ' ' LEU . 5.1 tt -95.66 6.15 49.65 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.935 1.35 . . . . 0.0 107.589 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -102.02 -0.28 33.9 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.187 176.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -129.3 126.58 39.32 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.129 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -137.36 164.82 27.68 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -119.62 153.38 35.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.83 128.29 25.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.641 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.68 7.08 54.09 Favored Glycine 0 N--CA 1.434 -1.487 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.256 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HB3' HD12 ' A' ' 113' ' ' ILE . 2.0 t0 -96.67 150.02 21.15 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -93.21 141.38 28.49 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-O 120.895 0.378 . . . . 0.0 110.044 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 27.0 p -152.11 -163.35 1.71 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.542 ' OG ' HG13 ' A' ' 145' ' ' ILE . 73.7 m -132.2 150.01 52.25 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.0 160.36 40.09 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.6 mm -92.83 113.44 27.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -70.77 125.59 27.26 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.7 m -62.52 -20.88 65.07 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 123.388 0.675 . . . . 0.0 112.708 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.96 -42.1 16.62 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.199 -174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -108.32 -14.65 14.64 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.502 -0.879 . . . . 0.0 112.034 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.85 -2.43 74.36 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 96.4 m -90.03 166.79 13.24 Favored 'General case' 0 N--CA 1.414 -2.227 0 C-N-CA 124.268 1.027 . . . . 0.0 112.723 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.8 mt -87.96 132.63 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.8 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 97.4 m-85 -140.98 152.02 64.05 Favored Pre-proline 0 C--N 1.291 -1.942 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.838 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.51 129.84 18.59 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.616 2.211 . . . . 0.0 112.25 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.49 149.85 38.12 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 m -114.64 136.11 53.41 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 96' ' ' ASP . 46.6 mt -69.01 119.81 15.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 O-C-N 123.476 0.485 . . . . 0.0 111.063 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.57 -37.1 11.01 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.883 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.3 p -159.65 153.24 22.64 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.452 HG23 HD21 ' A' ' 138' ' ' LEU . 72.4 mt -125.25 132.37 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -108.19 106.05 16.05 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -74.3 -20.48 60.11 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.802 -174.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -73.75 -38.99 64.56 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.117 0.484 . . . . 0.0 110.125 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -95.0 -7.25 40.33 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.617 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 61.63 28.45 17.62 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 124.141 0.976 . . . . 0.0 110.017 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 60.1 p -118.56 168.99 10.17 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.033 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.649 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.4 p -149.0 150.86 33.54 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 89.1 t -95.89 131.21 43.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.58 147.42 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.993 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 68.9 t -107.46 123.14 62.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -69.96 111.94 6.02 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.432 0.634 . . . . 0.0 110.339 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 91.9 m -62.77 129.82 42.19 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.966 -175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.66 -20.47 38.4 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.688 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -107.73 -41.44 5.01 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.039 0.447 . . . . 0.0 110.842 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.04 8.78 58.79 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.454 -0.879 . . . . 0.0 114.177 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -91.83 162.48 14.42 Favored 'General case' 0 CA--C 1.482 -1.664 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.031 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -134.44 138.41 44.74 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -144.82 150.86 37.88 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -102.59 122.17 43.84 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -126.41 164.02 22.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.418 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 16.4 m-80 -88.47 143.45 26.97 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.452 HD21 HG23 ' A' ' 116' ' ' ILE . 47.2 mt -55.84 -40.26 72.59 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 123.79 0.681 . . . . 0.0 111.612 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.0 t -76.39 -16.56 59.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.168 0.509 . . . . 0.0 110.118 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 9.0 t70 -101.16 -0.77 35.45 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.663 0.744 . . . . 0.0 109.684 -172.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.649 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.1 mt -72.05 164.46 26.11 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.256 174.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.1 mt -132.73 164.18 27.35 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.1 m -70.05 138.81 87.47 Favored Pre-proline 0 C--N 1.306 -1.308 0 C-N-CA 122.891 0.476 . . . . 0.0 109.982 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.91 141.15 88.67 Favored 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 123.339 2.693 . . . . 0.0 116.09 -170.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.542 HG13 ' OG ' ' A' ' 99' ' ' SER . 35.7 mt -100.28 144.18 12.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 174.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 44.8 t -119.39 104.64 10.53 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.146 0.498 . . . . 0.0 109.672 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 N--CA 1.413 -2.32 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 176.16 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 34.7 t30 . . . . . 0 CA--C 1.505 -0.786 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.4 m -72.38 124.03 24.29 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.51 -33.02 74.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.132 0.492 . . . . 0.0 110.444 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.47 87.69 6.64 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.461 0.648 . . . . 0.0 109.824 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.2 m -104.98 3.82 31.07 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.985 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.553 ' O ' HD23 ' A' ' 89' ' ' LEU . 4.8 tt -97.68 -0.01 46.3 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 123.323 1.535 . . . . 0.0 106.863 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -108.61 4.56 24.11 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.442 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -131.71 117.82 19.15 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -132.57 164.94 25.53 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.649 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -124.0 153.71 40.9 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.64 127.85 24.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.047 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.21 12.58 45.13 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.972 -0.633 . . . . 0.0 111.774 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -100.33 145.33 28.28 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.78 140.8 29.45 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.4 -163.42 1.67 Allowed 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.015 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 72.8 m -131.45 147.42 52.55 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.02 160.33 39.63 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.936 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.8 mm -93.27 110.71 23.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -67.62 122.28 17.71 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.2 m -60.19 -25.39 65.54 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 123.957 0.786 . . . . 0.0 112.482 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.32 -41.59 24.57 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.179 -172.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -108.0 -15.67 14.47 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.061 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.32 -4.07 78.78 Favored Glycine 0 N--CA 1.465 0.615 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.12 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.6 m -91.01 166.58 12.94 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.02 132.54 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.318 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -142.17 152.04 60.23 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.526 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -69.95 133.27 24.83 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.443 2.095 . . . . 0.0 111.607 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.64 146.91 29.51 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.825 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -112.77 135.77 53.14 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.2 mt -66.98 122.46 18.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 123.072 0.549 . . . . 0.0 110.595 -177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.79 -36.82 10.08 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.371 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.2 p -158.7 151.3 21.92 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.462 HG23 HD21 ' A' ' 138' ' ' LEU . 64.2 mt -125.37 132.27 71.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.436 ' OD1' ' HE3' ' A' ' 119' ' ' LYS . 9.6 t70 -108.48 104.1 13.37 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -72.78 -16.9 61.63 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HE3' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -73.51 -36.24 65.71 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.136 0.493 . . . . 0.0 110.12 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -98.48 -8.07 27.36 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.38 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 59.72 32.28 21.33 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.935 0.874 . . . . 0.0 109.938 -173.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.8 p -120.6 167.87 11.97 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.84 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.641 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.0 p -148.49 152.12 36.35 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.9 t -95.94 131.14 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.9 m -123.34 146.91 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.907 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 133' ' ' ARG . 75.8 t -105.65 120.68 56.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.723 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -68.43 114.13 6.59 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.639 0.587 . . . . 0.0 110.273 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.3 m -66.56 129.4 39.73 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.913 -174.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.09 -10.01 74.63 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.51 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -113.99 -51.25 2.79 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.977 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.11 6.18 45.77 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.93 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 96.2 m-20 -89.38 162.42 15.8 Favored 'General case' 0 CA--C 1.472 -2.057 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.248 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.1 ppt_? -135.6 136.05 40.74 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-O 121.27 0.557 . . . . 0.0 110.104 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -141.9 150.98 42.22 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.314 -174.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -102.64 118.99 38.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.683 0.754 . . . . 0.0 109.406 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -124.21 163.31 21.85 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.443 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -83.86 145.25 28.74 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.462 HD21 HG23 ' A' ' 116' ' ' ILE . 52.6 mt -58.39 -38.74 77.94 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.784 0.678 . . . . 0.0 111.003 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.8 m -80.49 -10.99 59.73 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.32 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -97.17 -9.63 27.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.601 0.715 . . . . 0.0 109.193 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.641 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.4 mt -68.56 166.25 17.45 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.01 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 18.8 mt -136.35 163.82 29.56 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.7 m -67.76 141.5 94.97 Favored Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.15 142.43 98.28 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 123.247 2.631 . . . . 0.0 114.59 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.526 HG13 ' OG ' ' A' ' 99' ' ' SER . 37.5 mt -93.01 136.66 24.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 36.6 t -158.52 98.49 1.54 Allowed 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 . . . . . 0 C--N 1.292 -1.933 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.289 -175.919 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 120.45 0.167 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 p -130.66 157.84 41.67 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 122.008 -0.432 . . . . 0.0 109.946 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.13 -28.02 16.57 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.439 0.638 . . . . 0.0 109.788 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.7 22.13 2.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.132 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 p -108.84 30.79 6.19 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 121.876 0.846 . . . . 0.0 109.113 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.17 1.6 12.94 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.799 -1.091 . . . . 0.0 113.764 -172.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -110.39 -1.33 17.18 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.748 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -120.2 115.11 22.98 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.981 0.896 . . . . 0.0 110.608 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.449 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 86.1 m95 -132.65 163.97 27.75 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.975 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -128.95 157.57 41.26 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.735 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.65 128.04 26.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.9 6.79 56.92 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.925 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.29 144.27 28.6 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -85.84 152.82 22.7 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.537 0.684 . . . . 0.0 111.629 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.6 p -161.91 -170.95 2.7 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.919 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 74.7 m -127.41 144.42 51.06 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.09 160.05 40.1 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.1 mm -94.27 111.53 25.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -69.05 123.18 20.35 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.7 m -63.28 -18.84 64.01 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 123.969 0.793 . . . . 0.0 112.966 -177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -83.33 -41.55 18.1 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.346 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -106.37 -16.38 14.57 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.971 -1.092 . . . . 0.0 111.418 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.96 0.75 86.26 Favored Glycine 0 C--N 1.31 -0.874 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 71.0 m -90.89 164.59 13.98 Favored 'General case' 0 N--CA 1.421 -1.883 0 C-N-CA 124.885 1.274 . . . . 0.0 112.473 -176.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 mt -88.89 132.12 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.451 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.1 m-85 -139.46 152.5 69.12 Favored Pre-proline 0 C--N 1.284 -2.267 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.33 134.72 27.44 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.639 2.226 . . . . 0.0 111.18 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.41 153.59 40.64 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.208 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.0 m -119.65 135.39 54.83 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 92' ' ' TRP . 57.0 mt -64.5 122.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 123.439 0.695 . . . . 0.0 110.652 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.71 -38.98 9.69 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.819 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.8 m -158.48 149.68 20.77 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.435 HG23 HD21 ' A' ' 138' ' ' LEU . 64.3 mt -123.56 132.43 71.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 C-N-CA 122.971 0.508 . . . . 0.0 109.809 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.92 104.1 13.49 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -74.57 -14.66 60.82 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.954 0.407 . . . . 0.0 111.866 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -74.08 -40.93 62.42 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.238 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -96.84 -8.45 30.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.6 33.29 20.41 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-O 121.953 0.883 . . . . 0.0 110.026 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 61.1 p -120.72 165.33 15.25 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.983 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 141' ' ' LEU . 12.5 p -148.15 152.5 37.4 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 95.3 t -95.78 131.38 42.7 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 27.8 m -123.63 147.3 28.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 133' ' ' ARG . 62.7 t -105.23 122.81 58.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -69.42 114.22 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.479 0.656 . . . . 0.0 109.92 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.3 m -65.4 130.23 42.58 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.547 -174.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.82 -24.86 15.6 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.792 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -99.39 -51.73 3.71 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 122.448 -0.442 . . . . 0.0 111.027 -176.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.36 19.78 17.47 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.437 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -103.51 162.03 13.38 Favored 'General case' 0 CA--C 1.479 -1.77 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.363 173.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.4 ppt_? -133.42 140.23 47.2 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.75 150.84 35.02 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.504 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 34.8 tt0 -103.18 122.54 44.93 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.534 0.683 . . . . 0.0 109.669 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -125.41 162.91 23.77 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 140' ' ' ASP . 19.2 m-80 -83.38 144.02 29.92 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.435 HD21 HG23 ' A' ' 116' ' ' ILE . 59.1 mt -58.2 -41.68 84.52 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.672 0.608 . . . . 0.0 110.515 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.8 m -80.08 -5.67 56.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.459 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.492 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 27.3 t70 -110.61 -2.18 16.5 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.56 0.695 . . . . 0.0 109.281 -176.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 123' ' ' CYS . 60.0 mt -68.6 163.92 22.58 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.686 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 35.3 mt -125.44 157.79 36.02 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 13.4 m -70.75 140.63 86.7 Favored Pre-proline 0 C--N 1.291 -1.948 0 O-C-N 123.479 0.487 . . . . 0.0 110.275 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.29 149.52 80.37 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.193 2.596 . . . . 0.0 113.126 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 147' ' ' GLU . 28.6 mt -90.15 139.28 17.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 32.9 t -140.8 24.95 2.18 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.897 0.856 . . . . 0.0 109.384 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.412 ' H ' HG22 ' A' ' 145' ' ' ILE . 43.6 mt-10 . . . . . 0 C--O 1.261 1.673 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 CA--C 1.505 -0.765 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.8 t -113.05 -17.29 12.46 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.185 0.517 . . . . 0.0 111.822 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.19 -43.01 15.36 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.76 126.67 33.15 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 170.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -69.57 90.47 0.56 Allowed 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 122.09 0.948 . . . . 0.0 111.019 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tt -132.37 16.56 4.48 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.727 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -103.8 -8.58 19.68 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.302 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -104.34 109.2 20.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.003 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -128.41 163.6 24.51 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.981 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -126.51 155.44 42.34 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.26 132.61 30.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.97 18.19 44.6 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.215 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -113.2 149.82 33.17 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -86.01 149.58 25.07 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 123.647 0.779 . . . . 0.0 110.624 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.2 p -159.47 -168.72 2.38 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 68.7 m -130.38 145.3 51.78 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.99 160.3 40.11 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.635 0.255 . . . . 0.0 110.796 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.38 112.28 25.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.81 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.4 ' CD2' ' HB2' ' A' ' 104' ' ' GLU . 5.2 t90 -70.49 124.44 24.21 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.0 m -62.69 -23.45 67.14 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.53 0.681 . . . . 0.0 112.559 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 102' ' ' TRP . 5.0 mm-40 -81.23 -39.79 24.82 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.263 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -108.8 -15.8 14.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.923 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.89 -1.47 83.98 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 75.1 m -90.29 164.93 14.18 Favored 'General case' 0 N--CA 1.419 -2.0 0 C-N-CA 124.592 1.157 . . . . 0.0 112.928 -176.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.8 mt -87.75 132.92 31.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.259 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.7 m-85 -142.23 152.52 61.31 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.158 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 139.35 39.66 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 122.861 2.374 . . . . 0.0 111.868 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.9 157.49 43.23 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.463 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 m -119.55 135.56 54.73 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.9 mt -70.41 118.74 15.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 122.812 0.445 . . . . 0.0 110.538 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.38 -29.85 14.79 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.963 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.9 p -161.79 153.37 18.77 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.4 mt -126.94 133.98 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.485 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 11.1 t70 -108.41 100.98 10.2 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 174.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -72.01 -16.34 62.06 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -73.57 -40.4 63.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.283 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 37.9 mmt-85 -93.76 -7.8 42.51 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 60.85 30.28 19.55 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.343 1.057 . . . . 0.0 109.685 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -119.07 165.93 13.53 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 141' ' ' LEU . 9.3 p -148.12 150.69 34.31 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 90.6 t -95.98 130.49 44.59 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 25.9 m -123.06 147.0 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 133' ' ' ARG . 62.2 t -104.85 120.1 54.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.083 178.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -66.93 115.13 6.34 Favored 'General case' 0 CA--C 1.487 -1.458 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.352 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.1 m -72.6 129.3 37.95 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.454 -174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.48 -14.81 63.79 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -118.09 -44.61 2.69 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 122.456 -0.438 . . . . 0.0 110.96 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.26 8.23 56.61 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.987 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.55 163.03 14.74 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 117.777 0.788 . . . . 0.0 109.289 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 7.7 ppt_? -133.02 139.0 47.0 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -147.68 151.7 36.57 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.494 0.718 . . . . 0.0 109.075 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 38.8 tt0 -101.89 126.65 48.83 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.587 0.708 . . . . 0.0 109.835 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -129.27 163.38 25.79 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.131 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -85.84 144.06 27.92 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.5 mt -57.94 -40.12 79.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 123.736 0.648 . . . . 0.0 110.905 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.8 m -80.75 -5.21 56.81 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.266 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -106.99 -14.27 14.99 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 123' ' ' CYS . 53.3 mt -60.69 154.62 21.04 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-O 121.548 0.69 . . . . 0.0 110.527 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 36.7 mt -120.0 156.65 30.47 Favored 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.022 -176.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.2 m -68.8 140.65 91.8 Favored Pre-proline 0 C--N 1.28 -2.444 0 O-C-N 123.843 0.714 . . . . 0.0 109.289 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.74 145.91 98.16 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.361 2.041 . . . . 0.0 112.804 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.4 mt -98.99 148.99 5.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.3 m -85.01 20.51 1.85 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.02 0.928 . . . . 0.0 112.796 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 . . . . . 0 C--N 1.309 -1.172 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.855 -178.062 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.406 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 4.1 m-20 . . . . . 0 CA--C 1.505 -0.77 0 CA-C-O 120.62 0.248 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.6 m -105.67 87.35 2.58 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-O 121.401 0.62 . . . . 0.0 110.497 -175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.47 -55.75 0.05 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.726 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.37 166.78 22.66 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.9 t -107.22 29.79 6.8 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 89' ' ' LEU . 4.4 tt -79.95 -0.36 34.8 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-O 122.642 1.211 . . . . 0.0 109.553 -175.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 84' ' ' ASN . 19.9 pt20 -105.19 3.33 30.04 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.815 176.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -113.15 112.02 23.09 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.346 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -131.68 164.99 24.72 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.246 -175.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -126.78 155.03 43.46 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.14 128.33 23.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 120.968 0.413 . . . . 0.0 109.946 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.64 5.32 54.05 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.917 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.41 140.78 29.19 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -89.28 144.14 26.31 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.22 -164.61 2.0 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 68.6 m -129.19 141.11 51.25 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.68 160.26 38.08 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.172 -177.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.71 111.07 24.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.307 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -66.25 119.11 10.94 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.7 m -63.53 -17.35 62.69 Favored 'General case' 0 C--N 1.274 -2.678 0 C-N-CA 123.928 0.891 . . . . 0.0 113.099 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -83.14 -37.39 23.8 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 114.557 -1.202 . . . . 0.0 111.629 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -116.36 -15.55 10.95 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.245 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.28 -6.14 77.46 Favored Glycine 0 C--N 1.316 -0.538 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.059 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 78.0 m -90.38 164.98 14.11 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.5 mt -86.56 133.44 29.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.931 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -141.8 152.16 61.76 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.07 130.79 19.57 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.37 2.047 . . . . 0.0 111.667 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.59 151.41 39.0 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 122.199 -0.313 . . . . 0.0 110.537 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.6 m -116.87 135.76 53.48 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.163 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 52.2 mt -65.68 117.82 7.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 123.288 0.635 . . . . 0.0 110.913 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.99 -37.0 11.89 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.853 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -160.27 149.56 17.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.414 HG23 HD21 ' A' ' 138' ' ' LEU . 69.1 mt -122.2 133.89 67.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.43 102.49 11.37 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -70.95 -20.88 62.41 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.136 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -38.01 64.76 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.044 0.45 . . . . 0.0 110.977 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -92.1 -7.65 47.98 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.195 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 60.49 30.81 20.06 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 124.149 0.906 . . . . 0.0 110.102 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 52.1 p -121.75 166.79 13.78 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.231 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.645 ' SG ' HD11 ' A' ' 141' ' ' LEU . 10.7 p -148.51 152.13 36.34 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 92.5 t -95.57 131.37 42.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 32.7 m -123.14 147.19 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' A' ' 133' ' ' ARG . 67.1 t -106.93 121.57 59.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.54 112.94 5.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.568 0.699 . . . . 0.0 110.354 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.9 m -66.5 130.07 41.98 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.972 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.73 -5.5 83.53 Favored Glycine 0 N--CA 1.432 -1.627 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.201 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -117.28 -50.73 2.55 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.817 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.45 34.04 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 119.857 -1.163 . . . . 0.0 114.059 178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -97.09 162.71 13.25 Favored 'General case' 0 CA--C 1.482 -1.661 0 C-N-CA 119.344 -0.943 . . . . 0.0 109.553 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.401 ' HB3' HG22 ' A' ' 126' ' ' VAL . 6.3 ppt_? -134.04 139.45 46.02 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 121.201 0.524 . . . . 0.0 109.866 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -147.13 150.44 34.98 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.378 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 41.4 tt0 -103.02 120.87 41.43 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -126.3 163.73 22.58 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.219 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 18.1 m-80 -85.06 142.79 29.31 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.414 HD21 HG23 ' A' ' 116' ' ' ILE . 51.5 mt -59.32 -36.49 75.76 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.877 0.846 . . . . 0.0 109.919 177.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.6 p -79.62 -10.3 59.77 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.665 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.405 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 32.2 t70 -110.07 -4.54 15.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.511 0.672 . . . . 0.0 109.763 -176.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.645 HD11 ' SG ' ' A' ' 123' ' ' CYS . 71.2 mt -67.23 162.71 22.01 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.716 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.5 mt -128.94 159.86 34.51 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.438 -177.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.4 m -69.43 140.43 90.03 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 123.495 0.497 . . . . 0.0 109.961 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.42 145.65 92.61 Favored 'Trans proline' 0 CA--C 1.508 -0.819 0 C-N-CA 122.943 2.429 . . . . 0.0 114.599 -173.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 68.1 mt -86.5 157.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 113.523 -1.671 . . . . 0.0 106.505 174.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 28.5 t -76.72 85.39 3.35 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 122.112 0.958 . . . . 0.0 109.446 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 . . . . . 0 N--CA 1.409 -2.494 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 175.621 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . 0.672 ' HE ' ' HA ' ' A' 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.6 t30 . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 49.5 m -136.24 83.31 2.0 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -177.99 -83.11 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.711 1.204 . . . . 0.0 107.92 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 90' ' ' GLN . . . 47.64 -82.39 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.365 1.866 . . . . 0.0 114.582 175.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 p -82.23 -12.95 57.77 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.59 0.71 . . . . 0.0 111.769 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 89' ' ' LEU . 1.7 tt -97.98 -1.08 43.53 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 122.433 1.111 . . . . 0.0 109.577 -178.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 20.9 pt20 -105.57 -3.53 22.24 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.755 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -125.41 119.83 29.36 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.904 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -132.12 164.37 26.44 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -130.95 155.9 46.01 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.57 128.28 25.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.78 7.62 52.97 Favored Glycine 0 N--CA 1.434 -1.485 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.755 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.41 147.34 25.35 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -91.54 150.94 20.97 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.2 p -155.63 -168.04 2.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 67.0 m -129.6 145.21 51.51 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 173.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.44 159.95 40.22 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 123.215 0.322 . . . . 0.0 110.281 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.9 mm -92.27 112.61 26.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.342 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -69.48 118.21 12.07 Favored 'General case' 0 CA--C 1.471 -2.077 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.2 m -58.88 -23.1 60.54 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 122.068 0.937 . . . . 0.0 112.194 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.06 -39.74 23.03 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.987 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -108.77 -16.54 14.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.704 0.764 . . . . 0.0 109.855 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.84 -6.53 69.87 Favored Glycine 0 C--O 1.225 -0.448 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.997 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 65.3 m -90.96 167.53 12.34 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.0 mt -88.0 132.13 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.506 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -140.1 152.47 67.47 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.209 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.09 130.4 18.86 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.416 2.077 . . . . 0.0 111.24 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.16 149.62 35.3 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.963 0.411 . . . . 0.0 110.312 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.6 m -117.54 136.17 53.44 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 56.7 mt -65.74 121.76 15.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 O-C-N 123.548 0.53 . . . . 0.0 111.156 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -100.14 -34.59 9.98 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.919 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 74.8 p -161.12 150.89 17.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.403 HG12 ' HB3' ' A' ' 123' ' ' CYS . 67.7 mt -127.43 133.37 68.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 117.931 0.332 . . . . 0.0 110.111 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -108.82 103.68 12.79 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -72.65 -14.32 61.56 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.271 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -73.68 -41.3 62.85 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.877 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -98.22 -6.12 31.89 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.401 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 63.64 29.33 15.1 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.828 0.851 . . . . 0.0 109.308 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 47.1 p -117.29 165.41 13.49 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.916 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.625 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.6 p -148.55 152.39 36.74 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 120.676 0.274 . . . . 0.0 110.272 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.3 t -96.25 130.63 44.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.72 147.25 28.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 53.5 t -106.07 123.54 60.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.139 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -72.05 113.77 9.44 Favored 'General case' 0 C--O 1.257 1.5 0 CA-C-O 121.479 0.656 . . . . 0.0 110.475 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 55.5 m -69.2 130.21 42.01 Favored 'General case' 0 N--CA 1.408 -2.554 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.742 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.76 -10.17 72.67 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.838 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -118.54 -53.05 2.34 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.719 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.21 17.43 15.87 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.728 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -99.71 165.61 11.51 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -132.99 142.46 48.85 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -145.51 151.28 37.92 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.98 121.65 42.57 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.424 0.631 . . . . 0.0 109.52 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -125.33 163.41 22.61 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 15.7 m-80 -85.62 143.48 28.41 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.1 mt -58.49 -38.3 77.35 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.682 0.754 . . . . 0.0 110.607 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.4 p -80.42 -8.67 59.62 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.992 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.542 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 12.6 t70 -105.33 -8.15 18.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.625 HD11 ' SG ' ' A' ' 123' ' ' CYS . 61.0 mt -65.86 157.8 29.56 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.625 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 30.3 mt -124.76 161.32 26.68 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -176.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.8 m -68.16 135.2 91.45 Favored Pre-proline 0 C--N 1.294 -1.846 0 O-C-N 123.542 0.526 . . . . 0.0 110.278 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -62.73 146.15 95.1 Favored 'Trans proline' 0 CA--C 1.508 -0.786 0 C-N-CA 123.729 2.953 . . . . 0.0 115.094 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.438 HG13 ' OG ' ' A' ' 99' ' ' SER . 45.7 mt -90.6 153.92 3.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 42.0 t 74.81 -1.77 3.0 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 125.198 1.399 . . . . 0.0 110.848 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 . . . . . 0 C--N 1.289 -2.057 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.495 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.579 ' N ' ' HG ' ' A' ' 88' ' ' SER . 16.5 m120 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.403 0.144 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.3 m -76.39 106.39 7.99 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 73.81 -49.61 0.68 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.008 2.123 . . . . 0.0 113.342 173.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.41 101.97 2.06 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.057 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.579 ' HG ' ' N ' ' A' ' 84' ' ' ASN . 15.0 m -152.44 19.33 0.64 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.5 tt -91.18 58.01 3.58 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -154.39 11.91 0.4 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.778 -1.556 . . . . 0.0 111.207 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -109.94 108.14 18.3 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.414 ' CD1' HD12 ' A' ' 141' ' ' LEU . 83.1 m95 -133.64 163.75 28.73 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.694 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -125.24 151.61 45.69 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.23 128.41 26.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.86 10.83 54.79 Favored Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.372 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -103.85 153.22 21.0 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -86.43 147.87 25.81 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 123.677 0.791 . . . . 0.0 110.51 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -156.64 -168.85 2.81 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.551 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 69.2 m -130.64 141.74 50.43 Favored 'General case' 0 C--N 1.264 -3.123 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.71 160.15 38.41 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 123.313 0.383 . . . . 0.0 110.651 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.4 mm -94.55 109.93 22.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.087 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -66.21 121.28 14.86 Favored 'General case' 0 CA--C 1.473 -1.996 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.9 m -61.33 -19.7 62.11 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 124.067 0.947 . . . . 0.0 112.341 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -84.36 -42.35 15.82 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.35 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -104.57 -16.09 15.13 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.648 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.25 -1.27 65.3 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 71.1 m -90.37 162.56 15.07 Favored 'General case' 0 N--CA 1.408 -2.569 0 C-N-CA 124.323 1.049 . . . . 0.0 112.177 -175.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.4 mt -86.6 133.77 29.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.099 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -140.31 152.26 66.42 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 131.5 19.49 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.425 2.083 . . . . 0.0 111.228 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.62 154.57 42.96 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.437 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.0 m -119.33 135.95 54.48 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.7 mt -68.77 124.12 23.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 122.922 0.489 . . . . 0.0 111.346 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -97.51 -32.32 11.88 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.876 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 45.4 p -163.89 152.84 13.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.429 HG23 HD21 ' A' ' 138' ' ' LEU . 68.7 mt -126.93 132.18 70.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 122.818 0.447 . . . . 0.0 109.826 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.418 ' OD1' ' HG2' ' A' ' 120' ' ' ARG . 10.1 t70 -109.4 102.54 11.42 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 173.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.51 -21.82 63.64 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.635 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -73.57 -36.25 65.55 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.603 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HG2' ' OD1' ' A' ' 117' ' ' ASP . 35.2 mmt180 -93.35 -8.52 41.71 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 61.08 28.51 18.23 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.196 0.998 . . . . 0.0 110.186 -173.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 66.6 p -119.95 166.18 13.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.127 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.648 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.4 p -148.45 150.73 33.98 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.41 HG11 ' HD3' ' A' ' 133' ' ' ARG . 92.3 t -96.1 132.5 40.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 27.7 m -124.03 147.55 28.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 132' ' ' ASN . 59.4 t -104.99 121.46 56.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.071 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -69.89 116.63 10.5 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-O 121.548 0.69 . . . . 0.0 110.84 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.2 m -66.2 129.86 41.24 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.176 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.78 -16.82 59.95 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.047 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -115.15 -51.81 2.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.432 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.26 17.06 28.12 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 119.893 -1.146 . . . . 0.0 113.644 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 90.6 m-20 -93.48 162.48 13.95 Favored 'General case' 0 CA--C 1.472 -2.053 0 C-N-CA 119.499 -0.88 . . . . 0.0 108.642 174.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 6.7 ppt_? -131.72 135.46 46.86 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -142.61 151.11 41.15 Favored 'General case' 0 N--CA 1.409 -2.486 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.323 -173.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -101.77 122.0 43.13 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.798 0.809 . . . . 0.0 109.904 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -126.82 163.54 23.36 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.434 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.463 ' HB2' ' CB ' ' A' ' 140' ' ' ASP . 17.9 m-80 -88.59 143.45 26.94 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.429 HD21 HG23 ' A' ' 116' ' ' ILE . 61.8 mt -57.07 -40.69 77.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.204 0.602 . . . . 0.0 111.253 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.6 t -80.87 -8.53 59.74 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.317 0.58 . . . . 0.0 110.736 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.463 ' CB ' ' HB2' ' A' ' 137' ' ' ASN . 21.4 t70 -102.16 -10.71 19.39 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.648 HD11 ' SG ' ' A' ' 123' ' ' CYS . 60.8 mt -66.59 157.81 31.43 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.23 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 28.5 mt -125.27 161.58 26.63 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -176.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.6 m -68.8 138.69 90.6 Favored Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 123.282 0.364 . . . . 0.0 110.557 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.84 147.07 95.09 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 123.543 2.829 . . . . 0.0 113.779 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.3 mt -94.54 145.9 7.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 40.9 t -147.98 98.7 2.98 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 . . . . . 0 C--N 1.295 -1.774 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.208 -178.683 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 p30 . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.2 m -66.7 123.32 19.78 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 72.72 -8.2 1.29 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.895 1.278 . . . . 0.0 111.539 -177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.99 7.34 34.05 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.607 0.718 . . . . 0.0 110.023 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 8.7 t -105.96 19.5 20.43 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.465 ' O ' HD23 ' A' ' 89' ' ' LEU . 4.4 tt -92.07 25.41 2.87 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 138' ' ' LEU . 79.5 mt-30 -102.43 -19.02 15.1 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.7 178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 88' ' ' SER . 10.3 pt20 -88.18 110.14 20.46 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.954 0.883 . . . . 0.0 111.711 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -132.33 164.05 27.32 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.399 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -131.47 156.11 46.22 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.39 131.94 29.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.13 3.68 54.24 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.574 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.485 ' HB2' HD12 ' A' ' 113' ' ' ILE . 62.5 m-20 -99.56 139.48 35.16 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -83.66 145.51 28.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.8 p -153.45 -161.97 1.37 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 70.6 m -135.78 146.59 47.76 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.0 161.12 38.13 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.571 -176.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.8 mm -92.77 112.43 26.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -69.02 124.29 23.34 Favored 'General case' 0 CA--C 1.474 -1.964 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.1 m -59.52 -25.36 64.43 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.977 0.798 . . . . 0.0 112.366 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -81.53 -41.84 21.07 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.485 -0.78 . . . . 0.0 113.102 -174.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -105.82 -15.87 14.82 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.578 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.74 -0.74 76.18 Favored Glycine 0 C--N 1.312 -0.777 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 109' ' ' TYR . 78.3 m -89.94 164.62 14.49 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 124.013 0.925 . . . . 0.0 112.263 -176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.413 HG23 HD12 ' A' ' 142' ' ' LEU . 29.8 mt -88.39 131.2 36.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 107' ' ' CYS . 96.0 m-85 -140.08 152.39 67.34 Favored Pre-proline 0 C--N 1.291 -1.97 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.467 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.73 137.14 26.78 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.227 1.951 . . . . 0.0 111.399 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.96 148.66 29.35 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.893 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.3 m -112.42 136.05 52.38 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 96' ' ' ASP . 57.5 mt -66.39 118.64 9.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 C-N-CA 123.202 0.601 . . . . 0.0 110.945 -178.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.29 -41.92 8.79 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.934 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.0 m -157.58 149.71 22.44 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 65.8 mt -123.48 132.26 71.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 123.314 0.384 . . . . 0.0 110.213 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.12 108.73 19.51 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -75.56 -17.42 60.06 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.166 -173.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -73.31 -41.73 63.19 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -94.21 -8.03 40.45 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.004 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 60.86 31.52 20.03 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.288 1.035 . . . . 0.0 110.035 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 49.3 p -119.38 167.38 11.97 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.729 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.7 p -148.33 151.83 36.04 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.637 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 98.0 t -96.07 132.59 39.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 133' ' ' ARG . 28.8 m -123.87 148.41 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 68.0 t -106.24 120.56 57.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.475 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -68.47 116.03 8.56 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.675 0.61 . . . . 0.0 110.713 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.5 m -71.54 129.57 39.09 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.883 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.21 -14.9 64.4 Favored Glycine 0 N--CA 1.429 -1.793 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.908 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -117.71 -44.47 2.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 120.971 0.415 . . . . 0.0 110.718 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 97.8 10.8 52.04 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.011 -1.09 . . . . 0.0 114.437 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -91.29 162.58 14.56 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-N 117.93 0.865 . . . . 0.0 109.267 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 2.5 ppt_? -132.07 137.75 47.89 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -145.7 151.83 38.64 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 43.9 tt0 -101.72 124.73 47.86 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -176.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -129.16 163.77 24.81 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.629 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 17.8 m-80 -87.58 144.04 26.89 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 90' ' ' GLN . 62.9 mt -58.77 -39.33 80.69 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.676 0.75 . . . . 0.0 110.273 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.7 p -73.8 -17.12 61.12 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.481 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 16.0 t70 -101.89 -7.8 22.15 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -173.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 123' ' ' CYS . 62.4 mt -66.9 157.48 33.07 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.095 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 32.9 mt -126.25 160.81 29.28 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.4 m -69.83 139.39 88.32 Favored Pre-proline 0 C--N 1.293 -1.886 0 O-C-N 123.571 0.545 . . . . 0.0 110.4 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.62 153.17 63.57 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.921 3.081 . . . . 0.0 115.287 -172.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.42 HG13 ' OG ' ' A' ' 99' ' ' SER . 22.0 mt -100.3 153.93 4.52 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 43.4 t -117.26 82.45 1.82 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.48 0.657 . . . . 0.0 109.294 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 . . . . . 0 C--N 1.297 -1.689 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.411 -177.659 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1148 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_